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Anorexia nervosa (AN) is a psychiatric disorder that has severe impacts on physical and 
mental health. More effective prevention interventions may reduce the burden of AN, 
however this rests on targeting factors with known causal effects on AN development. This 
thesis aims to further knowledge of the nature of association between anxiety disorders and 
AN, to inform the utility of addressing anxiety disorder pathology for AN prevention. 
Four studies were completed. Study 1 comprised a systematic review of investigations 
probing the longitudinal association between anxiety and subsequent AN onset; findings 
indicated that anxiety disorder pathology generally, rather than that specific to a given 
diagnosis, may be relevant to AN. In Study 2 the association of anxiety disorder presence 
with later AN behaviour was assessed in a large adolescent population cohort; a positive 
association was supported. Study 3 assessed the association of anxiety disorder presence, and 
the worry central to anxiety disorders, with AN. Two methods were used: longitudinal data 
analysis; and Mendelian randomization (MR), a framework for causal inference. Evidence 
provided strong support for a prospective association between anxiety disorders and AN, yet 
suggested only worry (i.e. not anxiety disorders more broadly) causally influenced AN risk. 
Study 4 assessed the causal influence of worry, depressed affect and neuroticism (of which 
worry and depressed affect are manifestations) on anxiety disorders and AN using MR. 
Statistical evidence supported neuroticism causally influencing both anxiety disorders and 
AN, with worry the specific component relevant to AN. 
Outcomes support a causal role of worry in AN development, and suggest that the anxiety 
disorder and AN association is to some extent explained by the two sharing causal risk 
factors. The mechanism by which worry translates into AN risk requires elucidation, however 
findings indicate addressing processes underlying worry may improve the efficacy of AN 
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1 Chapter 1: Introduction, Literature Review, Aims and Rationale 
In this chapter I define and introduce the key concepts of my thesis, and state the aims of my 
doctoral research. The chapter begins by describing the phenomenology of anorexia nervosa 
(AN), and provides a brief outline of disorder epidemiology. Existing prevention and 
treatment interventions, and their outcomes, are discussed. This highlights the requirement 
for a better understanding of AN, and in particular the need to identify factors causally 
influencing AN pathology that may be targeted within prevention and treatment efforts. Next, 
the theoretical model in which the doctoral research is grounded is presented, comprising the 
reproduction of part of a published theory paper. The full version of the theory paper can be 
found in Appendix A.  
My thesis research addresses a particular hypothesis posed by the theoretical model, which is 
that anxiety pathology causally influences the development of AN. A detailed literature 
review outlining existing evidence relevant to this hypothesis is provided, followed by a 
discussion of current gaps in the literature. The thesis aims are outlined, and I conclude this 
chapter by detailing the research approaches and methods adopted to address the thesis aims, 
and by considering the implications of knowledge resulting from my studies. Some parts of 
 
 Lloyd EC, Frampton I, Verplanken B, Haase AM. How extreme dieting becomes compulsive: a novel 
hypothesis for the role of anxiety in the development and maintenance of anorexia nervosa. Medical hypotheses. 
2017 Oct 1;108:144-50.  
Author contributions: I conceived of the theoretical model and drafted the manuscript. IF, BV and AMH refined 




this chapter comprise reproduced exerts from a recent publication of mine. The full 
publication may be found in Appendix B.  
1.1 Anorexia Nervosa 
1.1.1 Phenomenology 
Anorexia nervosa (AN) is a serious eating disorder characterised by severe restriction of food 
intake and distorted cognition surrounding eating and weight gain. According to the latest 
version of the Diagnostic and Statistical Manual (DSM-5; (1)), for a diagnosis of AN to be 
made individuals must persistently restrict their energy intake relative to individual 
requirements, in a manner that results in the maintenance of a significantly low body weight. 
A significantly low body weight is one that is less than minimally expected given age, sex, 
developmental trajectory and physical health. In addition to abnormal eating behaviour and 
low weight, individuals must display an intense fear of gaining weight/becoming fat or 
persistently engage in behaviour that prevents weight gain. The final criterion required for 
AN diagnosis is the presence of either: a disturbance in the perception of weight or shape 
(distorted self-image); heightened influence of weight or shape on self-evaluation (tendency 
to judge oneself purely based on perceived weight or shape); or persistent failure to recognise 
the seriousness of maintaining the current low body weight (1).  
 
 Lloyd EC, Øverås M, Rø Ø, Verplanken B, Haase AM. Predicting the restrictive eating, exercise, and weight 
monitoring compulsions of anorexia nervosa. Eating and Weight Disorders-Studies on Anorexia, Bulimia and 
Obesity. 2019 Mar 21:1-7.  
Author contributions: I conceived of the study idea, completed all statistical analyses, and drafted the 
manuscript. MØ collected the data used to complete the study. MØ, ØR, BV and AMH refined manuscript 
drafts. All authors approved the final version of the manuscript for publication. 
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Two subtypes of AN have been identified: restricting and binge-purge, which may be 
distinguished by whether regular binge eating and purging behaviour occurs. Binge eating 
involves consuming a large amount of food in a discrete period of time with the experience of 
feeling out of control, or being unable to stop eating (1). Purging includes any behaviour 
designed to compensate for food intake, for example laxative/diuretic misuse and over-
exercise. The subtypes show a high degree of cross-over; pure restricting AN for the entire 
duration of illness is uncommon (2). 
The behaviour of AN is incredibly stereotyped. Individuals with AN tend to consume a diet 
low in both energy density and fat, and this is usually supported by rules and rituals 
surrounding eating that dictate how and when, as well as what, may be eaten (3-5). Many 
individuals with AN engage in excessive levels of exercise (6, 7), which frequently takes on a 
rigid and rule-driven nature (8), and promotes the maintenance of a low weight. Another 
typical feature of AN is repeated engagement in behaviours designed to check weight and 
shape – or body checking (9, 10) – for example looking in a mirror, or weighing oneself. 
These body-related behaviours also tend to be undertaken in a ritualised manner (11).  
The abnormal behaviours surrounding eating and weight are thought to be supported by 
disordered thinking, or cognition. Individuals with AN typically endorse strong desires for 
thinness and weight loss, fears surrounding eating and weight gain, and dissatisfaction, 
concern and preoccupation with weight, shape and eating (12). This collection of cognitive 
symptoms is referred to as AN psychopathology, and is indeed associated with the eating, 
exercise and body checking behaviours characteristic of AN in clinical samples (13-18).  
Distorted self-perception has been considered a primary cognitive feature of AN, with the 
widespread assumption that over-estimation of body weight in AN drives engagement in 
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illness behaviour. However, recent evidence suggests that rather than individuals with AN 
perceiving their bodies inaccurately, they instead hold internal representations or models of 
their body that are inaccurate (19, 20). Thus, fatness may not be seen but rather felt, and 
individuals with AN do report feeling themselves to be too fat (21). Such attitudes and beliefs 
surrounding fatness are associated with the restrictive eating of AN (21), and are perhaps a 
consequence of the discrepancy between actual and ideal (or desired) body size. Individuals 
with AN aspire to a bodyweight that is considerably underweight (20). There is some 
evidence to suggest greater visual attention towards bodily areas of least satisfaction in AN 
relative to HC (22), which may emphasise the contrast between actual and ideal body weight.  
The core behavioural and cognitive features of AN described overlap with those of a number 
of psychiatric illnesses. Disordered eating behaviour and cognition is observed across the 
collection of eating disorders. Over-valuation of weight and shape, restrictive eating, binge 
eating, compensatory behaviours (i.e. purging and excessive exercise), and body checking are 
central to bulimia nervosa pathology (23), while individuals with avoidant and restrictive 
food intake disorder present with food avoidance (24). Anxiety disorders and AN share the 
symptoms of excessive concern and fear, while obsessive-compulsive disorder and AN both 
manifest as engagement in repetitive, ritualised or rule-based behaviours (1, 25). Body 
dysmorphic disorder is defined by preoccupation with appearance, though specifically 
preoccupation with perceived deficits in appearance (generally the face, hair and skin (26-
28)), in contrast to the preoccupation with weight, shape and eating in AN. Individuals with 
body dysmorphic disorder also engage in ritualised and perseverative acts, including 
grooming behaviours. Notably checking behaviours are particularly common expressions of 
OCD (e.g. checking doors are locked; (29)) and body dysmorphic disorder (e.g. frequent 
looking in the mirror at the identified imperfection; (28)), as well as AN (body-checking). 
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The existence of symptom dimensions that cut across AN and these other psychiatric 
conditions is likely to explain the high comorbidity between these illnesses (30), and raises 
the question of whether the illnesses are truly distinct entities. Despite these criticisms, which 
have been raised in relation to psychiatric diagnoses more generally, the current evidence is 
not sufficient to support a move away from the application of unique diagnoses based on 
presence of a collection of disorder-specific symptoms (31, 32). Equally, while eating 
disorder pathology no doubt exists along continuum (e.g.(33-35)), the current classification 
systems make a categorical distinction between the presence and absence of AN. Severity 
classes for AN, using weight and duration specifiers, have been introduced into diagnostic 
manuals, however current data do not support these predicting psychopathology or treatment 
outcome (36, 37). The clinical utility of current severity markers, which supplement 
categorical diagnoses, thus appears somewhat limited.  
1.1.2 Epidemiology 
Whilst the precise female-to-male ratio differs across studies, it is clear that AN 
disproportionately affects women (38). It is estimated that approximately 1-4% of women in 
Western countries will meet diagnostic criteria for AN across the lifetime (39). The most 
common period of AN onset is during adolescence, and more specifically between the ages of 
15 and 19 (40). The occurrence of threshold AN is rare in individuals under the age of 13 
(41), and new cases in mid-life/elderly populations are also unusual (42). Early studies 
suggested AN predominantly affected those of higher socio-economic status, however more 
recent evidence does not support the disorder discriminating based on background (43). 
Fewer epidemiological studies of eating disorders have been completed in non-Western 
countries, and the potential lack of cross-cultural sensitivity in diagnostic instruments 
presents a challenge to the validity of those studies that have been completed. However, 
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robust data suggest that AN prevalence in East Asian countries is not dissimilar from that of 
Western countries (44).  
1.1.3 Complications of AN 
AN has the highest all-cause mortality rate of all psychiatric disorders, estimated to be 5.9% 
(45, 46), which translates into a risk of death that is at least six-fold times that which would 
be expected for age. The high mortality rate results from medical complications of 
malnutrition that affect almost every bodily system (47), as well as elevated rates of suicide 
in AN populations (48). The effects of AN on menstrual function (49-51) and bone health 
(52, 53) are lasting, and individuals recovered from the disorder have an increased risk of 
pregnancy complications (54) and bone fracture (55).  
Not only do individuals with AN have lower mental wellbeing and quality of life (56, 57), 
but so do their carers (58). The costs of healthcare and social support required by individuals 
with AN and their carers is costly, and has financial implications on these individuals as well 
as public service providers. The costs of lost employment opportunities resulting from AN 
enhance the financial burden to patients and carers, as well as the economy (59). 
1.1.4 Existing treatment and prevention for anorexia nervosa 
The eating disorders field lacks consistent definitions of recovery, and studies have used 
various criteria when assessing recovery from AN, which include a combination of 
maintaining a healthy weight (body mass index; BMI > 19/20) and the absence of abnormal 
behaviour (e.g. restrictive and rigid eating patterns) or cognition (e.g. concern about over-
eating or fatness) surrounding eating and weight (60). Regardless of the criteria applied, 
when individuals have been followed up for their recovery status, on average less than half of 
AN individuals have achieved recovery (61). Notably this is the case even when studies have 
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used BMI-based definitions of recovery (62), with recovery from AN arguably constituting 
more than simply maintaining an acceptable weight (63). The likelihood of recovery does 
increase over time for those who do not die from AN, however the time to achieve recovery 
is extremely protracted (61), and AN tends to take a chronic course. For example, a recent 
study found that less than a third of individuals with AN were recovered at the ten-year 
follow-up point (64), although 62.8 % had recovered at the 22 year follow-up. An additional 
concern is that even when recovery is achieved, relapse rates are high (i.e. 30.8%), with risk 
particularly elevated in the first two years following discharge from a treatment setting (65). 
Established and recommended interventions for AN predominantly seek to address the 
dietary restriction central to the illness, and the cognitions (i.e. AN psychopathology) and 
relational difficulties thought to drive restrictive eating behaviour. For adults recommended 
psychological treatments take the form of individual talking therapies. For children and 
adolescents, family-based therapy is implemented as the first-line treatment where possible, 
and when this is inappropriate given individual circumstances, or unsuccessful, individual 
talking therapies are advised (66). Current evidence does not indicate the utility of 
pharmacotherapy in the treatment of AN (67).When treatments have been evaluated, those 
currently recommended result in less than half of both adults and children/adolescents 
sustaining full recovery at follow-up, which is typically between 6 and 24 months post-
treatment, and there is limited evidence to support the application of one treatment over 
another (68, 69). The recovery rate of existing treatments constitutes very little gain in 
treatment efficacy across the past decade or so (61, 69), and the need for improved treatments 
remains. Furthermore, the available evidence has been evaluated as subject to a high risk of 
bias, suggesting outcomes may actually be less favourable than they appear (69, 70). 
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There is some evidence to support better outcomes of adolescent AN (greater chance of 
recovery) in the longer term (71, 72). Rather than being a result of greater treatment efficacy 
however, this is more likely to reflect the prognostic advantages of reduced duration of 
illness, given outcomes of adolescent and adult treatment interventions are similar in terms of 
recovery rate (68, 69). Indeed biological, psychological and social consequences of AN are 
suggested to promote the maintenance of pathology (73). The sense of control that is 
generated, as well as the care from others that is provoked by having the illness, are examples 
of the way in which AN is experienced as valuable by individuals with the disorder. This, in 
turn, likely contributes to the reluctance or ambivalence towards recovery that is frequently 
reported (74). 
The difficulty in treating AN makes effective prevention particularly important. Existing 
eating disorder prevention interventions typically target eating-disorder specific features and 
risk factors – namely dietary restriction and drives for thinness/body dissatisfaction. There is 
some evidence to support the efficacy of existing universal eating disorder prevention efforts 
(i.e. those directed at an entire population, regardless of risk or symptom status) and those 
administered to individuals identified as being at elevated risk of eating disorder 
development. However, the quality of existing evidence is low, and whether these 
improvements translate into reduced onset of eating disorders is unclear. Furthermore, there 
is little evidence to support symptom improvement in individuals already experiencing 




1.1.5 Current understanding of anorexia nervosa aetiology 
A limited understanding of the factors contributing to the development and maintenance of 
AN introduces major challenges to the successful prevention and treatment of the disorder, 
since it remains unclear which factors should be targeted within interventions. There have 
been marked recent developments in the study of AN, with studies probing the role of various 
neurobiological, psychological and social/environmental risk and maintaining factors (77, 
78). However, as yet, evidence for the influence of any single factor on AN development 
remains weak (70). Consequentially, outcomes of treatment and prevention efforts continue 
to be inadequate, sustaining the high loss of life to AN, the substantial physical and mental 
health burden of the illness, and costs to patients, carers, public health and social care 
providers and the economy. 
1.2 Theoretical model of illness 
1.2.1 Anorexia nervosa as a compulsive disorder 
There are a number of models of AN aetiology, which give rise to particular hypotheses 
concerning risk and maintaining factors, and that have guided previous research. The model 
guiding my doctoral research is based on the understanding of AN as a compulsive disorder. 
Compulsivity is a transdiagnostic trait that describes a tendency for repeated engagement in a 
given behaviour despite this behaviour being maladaptive, and resulting in unwanted 
outcomes (79). The restrictive eating behaviour of AN has been suggested to be compulsive, 
as has the exercise and weight monitoring that individuals with the disorder often engage in 
(e.g. (80)). Indeed, this behaviour persists in the face of negative consequences, both 
immediate, for example interfering with academic/occupational/social interests, and longer-
term; the behaviours promoting further, and potentially dangerous, weight loss. Furthermore, 
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compulsions are well characterised to possess a strong urge-like quality (81), and individuals 
with AN report feeling a “need” to engage in restrictive eating and exercise that is incredibly 
difficult to overcome (82). While individuals with AN often express desires to recover, they 
are seemingly unable to stop engaging in behaviour that contributes to the maintenance of an 
extremely low weight (17, 82, 83).  
Compulsivity is central to obsessive-compulsive disorder (OCD) as well as to 
substance/alcohol and behavioural addictions (84, 85). The National Institute of Mental 
Health (NIMH) Research Domain Criteria (RDoC) encourage a transdiagnostic approach to 
the study of psychiatric disorders, or research focusing on features common to multiple 
psychiatric diagnoses. Aligning with RDoC recommendations, the current theoretical model 
of AN was developed from a review of relevant literature across various compulsive 
disorders.  
1.2.2 A transdiagnostic model of compulsivity 
One model of compulsive behaviour proposes that it relies on the same neural circuitry as 
that underlying behavioural habits (86). Compulsivity is suggested to result from an 
imbalance between habit and goal-directed systems, which are reliant on different brain 
regions – the former on the dorsal striatum, and the latter on the ventral medial prefrontal 
cortex (87-89). The habit system guides behaviour based on past outcomes of actions, due to 
the formation of stimulus-response (S-R) links that result from, and strengthen with, 
behavioural repetition (89). S-R links are a pairing of a response with contexts (physical 
stimuli or emotions) that are either present when the response is made, or that appear between 
the response and its outcome, and form when the response is followed by a favourable 
(reinforcing) outcome (90-92). The establishment of S-R links means stimuli come to initiate 
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the responses they are paired with automatically, even when these responses are inappropriate 
given the current goals (92). In contrast, the goal-directed system considers predicted 
outcomes of various actions, and the present value of these outcomes, to elicit behaviour 
tailored to the current situation and conducive to achieving desired outcomes (93). It is 
suggested that compulsive behaviour arises from a failure of the goal-directed system to 
override the influence of the habit system when the latter produces maladaptive responses 
(86, 94). This theoretically could result from the formation of very strong habits, or from a 
dysfunctional goal-directed system. Both abnormalities are implicated in compulsive 
disorders, with strong disorder habits suggested to result from excessive repetition of 
disorder-relevant behaviour, due to the reinforcing effects of this behaviour.  
1.2.3 A novel account of AN 
One account of AN proposes that the reinforcement of starvation, resulting in excessive 
engagement in this behaviour, as well as goal-directed system dysfunction, leads to 
compulsive starvation (80). It is suggested that when individuals experience starvation as 
highly favourable, in terms of feeling in control and receiving compliments on their 
appearance (i.e. positive reinforcement), they will repeat the behaviour. To develop the 
model guiding my current research (i.e. that detailed in the publication found in Appendix A), 
my co-authors and I adapted and extended the existing account (80). In doing so, we were 
able to explain individual differences in the reinforcement of starvation, and the emergence 
of goal-directed system dysfunction, that in turn contribute to AN onset and maintenance. 
Knowledge of the underpinnings of reinforcement and goal-directed system abnormalities in 
other disorders was considered when developing the model, such that AN continued to be 
understood within a transdiagnostic framework.  
12 
 
1.2.4 The proposed role of anxiety in AN pathology 
In our novel theoretical model, anxiety is proposed to cause both reinforcement and goal-
directed system abnormalities in individuals who develop AN. We suggest that high levels of 
anxiety serve to make the anxiety-reducing (anxiolytic) effects of dietary restriction more 
reinforcing, thus increasing the likelihood of the behaviour being repeated and a habit 
forming. Anxiety relief is a proposed outcome of starvation, suggested to be mediated via 
reduced activity of serotonergic and noradrenergic neurotransmitter systems (95-98) 
implicated in anxiety (99, 100), due to reduced intake of their dietary precursors (101). In 
addition to the physiological effects of starvation, distraction from alternative concerns, for 
which there may not be any immediate solutions, by focusing on food intake and weight may 
serve as a useful anxiety reduction strategy (102). Attention to aversive thoughts regarding 
negative evaluations about the self by others are lower in current as compared to recovered 
AN (103). In addition, emotion regulation difficulties that contribute to anxiety (104) are 
negatively associated with BMI in AN populations (105). Individuals with AN report the 
disorder providing a means to avoid negative emotions (74), further supporting AN behaviour 
functioning as a highly valuable coping strategy to those with elevated anxiety. 
Where starvation is experienced as particularly reinforcing, in terms of the anxiety relief 
provided, our account proposes that a strong drive to continue with starvation is induced, 
which in turn leads to a fear of weight gain or fatness, and preoccupation with food and 
weight. These psychological symptoms, which collectively represent the psychopathology of 
AN (106), promote further engagement in dietary restriction, encouraging the formation and 
strengthening of restrictive eating habits (17, 107). In this way, our theory acknowledges the 
importance of AN-typical anxieties (i.e. those surrounding weight gain) in disorder aetiology. 
However, we suggest anxieties surrounding weight gain develop and worsen due to the 
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existence of anxieties not focused on weight gain, as a result of dietary restriction alleviating 
anxieties not focused on weight gain, and thus being experienced as beneficial.  
Anxiety is also suggested to negatively affect goal-directed system function in AN, 
increasing dependence on the habit system for learning, and encouraging habit formation. 
Stress, a non-specific outcome of anxiety, corresponds with atrophy (degeneration) of the 
medial prefrontal cortex that is responsible for goal-directed behaviour, increased volume of 
the dorsal striatum implicated in habit learning and performance, and a dominance of habit-
based learning over that goal-directed (108-110). Further supporting anxiety negatively 
affecting the goal-directed system, prefrontal cortex abnormalities are observed in individuals 
with anxiety disorders (111), along with a reliance on the habit system for learning (112).  
To summarise, our model suggests that anxiety encourages the development of compulsive 
starvation through two pathways: 1. by heightening the reinforcement of starvation, causing 
excessive repetition of the behaviour (via the development of AN psychopathology), to result 
in the formation of strong habits; and 2. by causing goal-directed system dysfunction, to 
accelerate the formation, strengthening and dominance of restrictive eating habits. It is 
suggested that starvation becoming compulsive has adverse implications on anxiety, the goal-
directed system, and psychological symptoms of AN, to encourage the formation of a vicious 
cycle that ensures the persistence of extreme dietary restriction. The resurgence in anxiety is 
suggested to increase the desire to starve as a means of managing anxiety, particularly as over 
time the focus of anxiety increasingly surrounds eating and weight gain. Further engagement 
in starvation results, strengthening restrictive eating habits and serving to make changes to 




Figure 1-1 Theoretical model guiding the doctoral research  
1.3 A central hypothesis 
One central hypothesis of our theoretical model is that anxiety unrelated to eating and weight 
gain, or that which cannot be explained by the presence of AN pathology, plays a causal role 
in the development of AN. The DSM-5 anxiety disorders, termed anxiety pathology, are 
characterised by disproportionate levels of anxiety given cultural and contextual factors. This 
primary feature is the basis of diagnosis across the disorders (1), and marked by various 
emotional (e.g. upset/distress), cognitive (e.g. concentration/sleep difficulties), physiological 
(e.g. breathing difficulties) and behavioural (e.g. avoidance of certain stimuli/situations) 
expressions that are common across the anxiety disorders (113). The anxiety of anxiety 
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disorders (anxiety pathology) is focused on stimuli or situations that do not surround eating 
and weight gain (Table 1-1), and thus under our model anxiety pathology causally influences 
AN development – a proposal that is common to a number of accounts of illness (e.g. (97, 
102, 114-116)). 
Table 1-1 Focus of Anxiety in DSM-5 Anxiety Disorders  
Anxiety disorder Focus of anxiety 
Separation anxiety 
disorder 
Separation from those to whom the individual is attached 
Specific phobia Particular objects (e.g. spiders) or situations (e.g. flying, 
driving) 
Social anxiety disorder Social interactions and possibility of scrutinization by others 
Panic Disorder Experiencing panic attacks, in the context of having recurrent 
panic attacks 




Various (e.g. work, school, health) 
Selective mutisma Speaking in specific situations 
Note: Adapted from information presented in Diagnostic and Statistical Manual of Mental 
Disorders Fifth Edition by American Psychiatric Association, 2013. Arlington, VA: 
American Psychiatric Association. Copyright 2013 by American Psychiatric Association. 
a Selective mutism is a rare childhood disorder, and the diagnosis is not included in 
epidemiologic studies. It frequently co-occurs with other anxiety disorders and overlaps 




1.4 Associations between anxiety disorder and anorexia nervosa pathology 
There is much evidence to support an association between anxiety pathology and AN. The 
prevalence of anxiety disorders is substantially elevated amongst individuals with AN, as 
compared to the general population (32). When directly compared, it is found individuals 
with AN are more likely to have a current (117, 118) or past (119) diagnosis of an anxiety 
disorder as compared to healthy controls (HC), or individuals without AN. When considering 
anxiety disorder symptoms, as opposed to diagnosis, both anxiety disorder-specific (e.g. 
social anxiety disorder symptoms), and nonspecific symptoms (common across the collection 
of anxiety disorders) are elevated amongst AN (120, 121). Individuals endorsing extreme 
levels of dietary restriction in the absence of a clinical AN diagnosis also have more severe 
anxiety disorder symptoms (122). Potentially lending support to the idea that anxiety 
pathology causally influences AN, anxiety pathology is positively associated with AN 
severity. Comorbid anxiety disorders predict lower BMI (123), and greater self-reported 
eating disorder psychopathology (124, 125) in individuals with AN. More severe anxiety 
pathology predicts greater endorsement of eating rituals (5), compulsive exercise (126, 127)) 
and AN psychopathology (128) in AN too. 
Worry is one of the core symptoms of anxiety disorders, comprising a form of repetitive 
thinking that involves appraising the uncertain but potentially negative outcome of a given 
scenario (129, 130). General worry is elevated across the collection of anxiety disorders (131, 
132), though the dominating concerns are specific to the given anxiety disorder diagnosis (1). 
In social anxiety disorder worries are largely centred on social situations (133), whilst 
individuals with separation anxiety disorder predominantly worry about being apart from 
those to whom they are attached (134). As well as being a core component of anxiety 
disorders, worry is well-supported to comprise a vulnerability and maintaining factor for 
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anxiety disorders, giving rise to various other symptoms of illness -  including distress, 
avoidance, and hyperarousal (e.g. increased vigilance/heart rate) (130, 135-139). Given the 
centrality of worry to anxiety disorders, reported associations between worry and AN are 
consistent with the proposed role of anxiety pathology in AN. General worry is well-
established to be greater in individuals with AN as compared to HC (120, 140-142), and 
worry is positively associated with the severity of AN psychopathology, in both clinical and 
non-clinical samples (120, 141, 142).  
As well as the symptoms central to anxiety disorders, certain dispositional characteristics 
typical of individuals with anxiety disorders have been implicated in AN. Trait anxiety, the 
stable and longstanding tendency to experience a sense of threat, and harm avoidance, a 
personality trait characterised by excessive worry and fear, reflect increased vulnerability to 
anxiety disorders, and are elevated in individuals with anxiety disorders (143-148). Both trait 
anxiety and harm avoidance are reported to be greater in individuals with AN as compared to 
individuals without the disorder (149-152). Trait anxiety is also associated with the severity 
of AN pathology. Greater trait anxiety predicts reduced caloric intake (153), more severe AN 
psychopathology (120, 150) and greater engagement in excessive exercise (154), in AN 
populations. Positive associations between trait anxiety and AN psychopathology (155), as 
well as compulsive exercise (156), in non-clinical groups have also been reported.  
1.4.1 Unclear direction of association 
Whilst it is apparent there are associations between anxiety disorder and AN pathology, the 
evidence outlined so far is cross-sectional. As such, the relationships demonstrated could be 
reflective of AN pathology increasing anxiety, rather than the reverse. The association 
between malnutrition and anxiety in AN is currently unclear (157), however nutrition affects 
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various hormonal (e.g. cortisol) and neurotransmitter (e.g. serotonin) systems implicated in 
anxiety, changes to which have been observed in AN (158-161). Furthermore, there is some 
evidence to support negative mood increasing following more severe dietary restriction in 
AN (162), and in individuals without AN dietary restriction results in negative psychological 
and emotional changes (163, 164).  
1.4.2 Establishing the temporal nature of association 
For a risk factor to cause a disease the risk factor must precede the disease outcome (165), 
and thus establishing whether anxiety pathology is predictive of later AN onset can help with 
interpretation of cross-sectional associations, and inform the direction of potential effect. 
Longitudinal studies can be of retrospective or prospective design. In retrospective studies, 
presence of the outcome is established at the outset, and the earlier exposure of participants to 
risk or protective factors of interest is assessed. In a prospective cohort study, a group of 
individuals who differ in their exposure to risk/protective factors are followed over a period 
of time, with the development of the outcome subsequently recorded. Both types of study aim 
to establish whether a given risk factor, or exposure, (e.g. anxiety) predicts later development 
of an outcome (e.g. AN), but differ in whether presence of the outcome is known when the 
study commences.  
Existing longitudinal studies support anxiety pathology preceding the onset of AN. 
Individuals with AN report comorbid anxiety disorders to appear prior to the onset of AN 
(32, 119), and other retrospective studies have found evidence consistent with elevated 
childhood anxiety in individuals who develop AN relative to those who do not (166-168). A 
large prospective study using population registry data reported anxiety disorder presence to 
predict an increased likelihood of subsequent AN diagnosis (169), and childhood worry is 
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prospectively associated with adolescent AN (170). Retrospective studies have found that in 
individuals with AN, more severe anxiety disorder pathology prior to AN onset is associated 
with greater AN severity, both in terms of lower BMI (171) and increased engagement in 
behaviours implemented to avoid weight gain (e.g. laxative and appetite suppressant use 
(172)). Trait anxiety, social anxiety and worry have each been found to be prospectively 
associated with higher levels of AN psychopathology in non-clinical samples (155, 173, 174).  
1.5 Robust evidence is lacking 
The findings outlined above suggest that anxiety disorder pathology is not only associated 
with AN, but actually precedes AN cognition and behaviour. While the evidence described is 
consistent with the proposal that anxiety pathology causally influences AN development, the 
robustness of this causal inference is unclear, for various reasons considered in the following 
section. 
1.5.1 Absence of systematic aggregation and appraisal of relevant evidence  
Firstly, whether longitudinal associations between anxiety pathology and subsequent AN are 
supported across all studies that have probed this relationship is uncertain. It is a known 
phenomenon that negative findings (or studies not identifying an association) are less likely 
to be published (175). It is also possible that studies observing positive associations have 
been repeatedly cited in the literature, and importantly that they have been cited more than 
studies not observing the same association. Such citation bias would lead to an inflated 
perception of the relevance of anxiety to AN. Whether this is the case cannot be evaluated 
given there has not yet been an attempt to aggregate relevant longitudinal study findings 
(176). Furthermore, the quality of existing longitudinal investigations is unclear, and has not 
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been considered in a rigorous manner. It may be that the existing published studies suffer 
from methodological limitations that preclude confidence in the validity of their findings.  
1.5.2 Bias in observational research 
Establishing that a longitudinal association is robust is necessary to demonstrate causality, 
but it is not sufficient for causal inferences to be made. Studies of longitudinal design are 
subject to particular biases that can distort estimates of effect. As a consequence, a collection 
of longitudinal studies may support the same conclusion, but if all estimates are biased the 
conclusion could be invalid. Key sources of bias in studies of traditional observational 
epidemiology (i.e. cross-sectional and longitudinal data analyses) are confounding and 
reverse causation. Confounding describes the situation whereby one factor causally 
influences both the proposed causal risk factor, or exposure (e.g. anxiety), and the outcome 
(e.g. AN), leading to an association between the two that is not causal in nature. There are 
many factors that may confound the association between the pathology of two psychiatric 
disorders, given the clustering of poor health outcomes, and their multiple and complex 
associations with various other disadvantageous events and experiences (177). Differences in 
the distribution of risk factors and diseases in demographic groups, for example individuals 
grouped by gender or socio-economic status, can also give rise to spurious associations 
between a proposed risk factor and disease outcome (178). Methods to control the influence 
of confounders in observational studies have been developed, for example including 
confounding variables in statistical models (adjustment), or matching participants based on 
confounding factors. However, these methods rely on the identification and perfect 
measurement of all confounders, which is unlikely ever to be the case. As such, all estimates 
of longitudinal observational analyses will be biased by confounding to a greater or lesser 
extent (179).  
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Whilst the risk of reverse causation in longitudinal research might be reduced as compared to 
cross-sectional analyses, it remains possible that a detected association reflects the influence 
of the outcome on the risk factor. This situation could occur in prospective studies if there 
was no/insufficient accounting for the presence of the outcome at baseline (when the risk 
factor is assessed), or prior to baseline. In retrospective studies, bias by reverse causation 
would occur if the reporting of the exposure is affected by the outcome itself. In the example 
of anxiety and AN, those with AN may report greater earlier anxiety than was actually 
experienced in attempts to explain AN development, while HC may provide more accurate 
descriptions. The differential reporting bias across AN and HC groups could invalidate study 
conclusions. 
1.5.3 Limited triangulation 
All research approaches are prone to bias, however the key sources of bias differ across 
different approaches. One consequence of this is that where there is alignment of findings 
from studies using different approaches to address the same question, there may be greater 
confidence that identified associations reflect causal processes (180, 181). This is particularly 
so when the biases would be expected to operate in different directions, in terms of biasing 
statistical estimates of effect towards or away from the null.  
Considering the association of anxiety pathology with outcomes related to, but not exactly, 
AN diagnosis provides the opportunity for a subtle form of triangulation that can inform the 
validity of conclusions from studies probing the anxiety pathology and AN diagnosis 
association. Different outcomes will be subject to different forms of measurement error that 
may bias results, and the potential source and effects of confounding are likely to vary with 
exact outcome. Consistency across studies addressing the association of an exposure with 
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various related outcomes can therefore promote confidence in causal conclusions arising 
from the body of evidence. Even greater confidence in conclusions may be achieved when 
findings from studies using wholly different designs converge. However, as yet, only 
observational studies have probed the association between anxiety pathology specifically 
(rather than considering this within a cluster of other factors) and AN onset. This has 
prevented the triangulation of evidence across studies using very different approaches, 
limiting certainty in the conclusion arising from observational findings that anxiety pathology 
causally influences AN development.  
1.6 Thesis aims 
 My doctoral work aims to further understanding of the nature of association between anxiety 
disorders and anorexia nervosa by addressing the current gaps in the literature. In particular, I 
seek to inform whether there is robust evidence for a causal influence of anxiety pathology on 
AN development. I use a variety of studies and epidemiologic methods to address the 
research question, allowing for comparison of findings across different investigations, 
promoting valid conclusions and a comprehensive understanding (180, 181).  
1.7 How thesis aims will be achieved 
1.7.1 Aggregation of all relevant longitudinal evidence 
To determine whether all studies investigating the longitudinal association between anxiety 
pathology and subsequent AN onset identify the same predictive effect, the first study of this 
thesis comprises a systematic review of studies probing the anxiety-AN association of 
interest. A systematic review of the literature collects and summarises all research addressing 
a particular question in a transparent and reproducible manner, to provide conclusions based 
on all available evidence that are as fair and balanced as possible (182). The standardised 
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appraisal of the quality of each study included in the review allows the risk of bias, or risk of 
findings being invalid, to be assessed in a consistent and objective manner. As a result, 
findings deemed less trustworthy may be given less weight in the overall summary of 
evidence, promoting the accuracy of review conclusions. The risk of bias across the 
collection of evidence may also be assessed, to determine the level of confidence in review 
findings. Completion of the systematic review thus addresses current uncertainty surrounding 
the reliability and validity of reported, and repeatedly cited, associations between anxiety 
pathology and subsequent AN development, with these associations necessary but not 
sufficient to demonstrate causal influence. 
As well as enabling the identification of methodological limitations of existing research, a 
systematic review can highlight particular gaps in current knowledge that when resolved 
could enhance understandings in important ways. The completion of the review can therefore 
direct future research in a manner that promotes its quality and utility, as well as provide an 
overview of the existing evidence.  
1.7.2 Triangulation across studies of different design  
In the second study of the thesis I consider the prospective association between anxiety 
pathology and a restrictive eating behaviour that is typical of AN. Studying the risk factors 
for core features of AN, rather than for AN diagnosis, allows for triangulation across studies 
using different outcomes. It also informs particular hypotheses concerning the mechanisms 
by which elevated anxiety increases AN risk, for example whether or not restrictive eating 
serves as a coping mechanism for some individuals.  
To address the fact that to date observational research only has been used to assess 
associations between anxiety pathology and AN, and to enable triangulation of findings 
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across studies of wholly different design, I implement a relatively novel approach to study the 
proposed causal association: Mendelian randomization (183). MR is a form of instrumental 
variable analysis in which genetic variants associated with an exposure of interest are used as 
instruments to probe the association between this exposure and an outcome. MR is able to 
overcome bias due to confounding and reverse causation, enabling causal inferences to be 
made from analysis outcomes. Like any approach, MR does make a number of assumptions 
that when violated will potentially result in estimates of association between exposure and 
outcome being biased and subsequent conclusions being invalid (184). However the sources 
of bias in MR investigations differ from those of an observational study (181). Thus, 
completion of MR analyses offers an opportunity to strengthen inferences concerning the 
association between anxiety and AN pathology that have been made from observational 
research. In Study 3 findings from an MR analysis are directly compared with those of a 
complementary longitudinal observational study. Both investigations consider the association 
of anxiety disorders, and the worry central to these disorders, with AN development.  
1.7.3 Exploration of shared risk factors of anxiety disorders and AN 
The findings of Study 3 added to existing knowledge (summarised in the literature review of 
the current chapter) surrounding the nature of association between anxiety disorders and AN. 
In particular, findings indicated that the tendency to worry is a causal risk factor for AN, 
whilst the anxiety disorders that also result from elevated worry do not causally influence AN 
development. This outcome suggests that the association between anxiety disorders and AN 
is to some extent explained by a common process (namely worry) underlying both 
psychopathologies. To further explore this hypothesis, in Study 4 I considered the causal 
influence of worry on anxiety disorders, as well as AN, within a MR framework. I also 
considered the specificity of worry as a shared risk factor for anxiety disorders and AN. 
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Worry and depressed affect are manifestations of the personality trait neuroticism, which is 
defined as the tendency to experience negative emotion (185, 186). In Study 4 I probed the 
causal influence of neuroticism and depressed affect, in addition to worry, on both anxiety 
disorders and AN. Outcomes of observational research implicate neuroticism in multiple 
psychiatric disorders (187), including anxiety disorders (188) and AN (189). However, 
determining whether certain expressions of neuroticism are particularly relevant to anxiety 
and AN pathologies enables a more precise understanding of their shared mechanisms of 
illness. Examining associations within a MR framework allows for stronger inferences 
concerning the causal role of neuroticism, relative to existing observational findings.  
1.8 Study data and measurement of key variables 
All studies of this thesis comprise secondary data analyses. The key variables of my analyses 
(i.e. AN and anxiety disorder pathology) were measured in various ways across the different 
studies. In the systematic review AN was largely assessed by way of validated diagnostic 
interviews, as was the case in the MR studies. In my prospective investigations, which 
examined relationships within data collected by a large population cohort study, the Avon 
Longitudinal Study of Parents and Children (ALSPAC), AN cognition and behaviour was 
captured by way of self and parent-report. AN diagnoses were assigned if a cluster of 
symptoms (constituting the core features of/diagnostic criteria for, AN) was present, as per a 
previous approach in this cohort (e.g. (170, 190)). 
Assessment of anxiety phenotypes also varied across studies. In the systematic review 
anxiety pathology was typically measured using questionnaires. Anxiety disorder assessment 
in ALSPAC involved the use of clinical interviews administered to either parents or children 
– though diagnoses were derived via the application of computer algorithms to interview 
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responses, rather than from clinician judgements. In the MR investigation, anxiety disorder 
diagnoses were based on outcomes of diagnostic interviews, though worry, neuroticism and 
depressed affect were measured using self-report questionnaires.  
Although the reliance on secondary data has limitations in terms of the measures available 
(i.e. psychiatric phenotypes were not always assessed using the gold-standard diagnostic 
interview), I note that the completion of my doctoral work would not have been possible 
without using existing data. Furthermore, potential measurement issues do not undermine the 
ability of my findings to inform future research that may use the ideal measures of 
concepts/constructs of interest.  
The use of secondary data also meant that ethical approval was not required in the course of 
completing my doctoral work. Access to ALSPAC data and the publication of findings based 
on this data did require approval from the study executive team, which was sought and 
granted where appropriate. See Appendix C for the relevant request forms. 
1.9 Implications of findings 
Where there is robust support for a causal influence of anxiety pathology on AN, this may 
inform the development of novel prevention interventions that may be more effective than 
existing programmes. The administration of such interventions using a randomized-
controlled trial (RCT) design would enable further tests of causal hypotheses, as well as 
robust assessment of intervention efficacy. RCTs constitute the gold-star standard study 
design for demonstrating causality: because the proposed causal factor (anxiety pathology) is 
modified in an RCT, straightforward assessment of cause and effect is possible (165); while 
random assignment can (in a high-quality trial) ensure minimal bias by confounding (191). 
The design, implementation and evaluation of interventions, and particularly in a RCT 
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setting, is expensive in both money and time. It is therefore important to be confident that 
manipulating anxiety pathology is likely to have favourable effects on AN incidence before 
completing such investigations (181). Confidence may be promoted via the aggregation of 
findings from longitudinal studies, and triangulation of findings from observational research 
with findings from studies of alternative design. 
Probing the causal influence of anxiety disorders on AN informs how the two may be related, 
and contributes to knowledge of AN aetiology; so too does exploring shared risk factors for 
anxiety disorders and AN. Elucidation of shared risk factors thus enables further refinement 
of models of illness that are relevant for AN prevention interventions, as well as for 
psychopathology prevention more broadly.  
 
1.10 Summary 
AN is a serious illness that results in significant mortality. The disorder comprises a 
substantial health burden to individuals with the illness and their carers, which has negative 
financial implications for public health and social care providers, as well as the wider 
economy. Improved knowledge of factors contributing to the development and maintenance 
of AN may highlight novel targets of prevention and treatment interventions, to improve their 
efficacy. It has been proposed that anxiety pathology causally influences AN onset. Cross-
sectional associations between anxiety pathology and AN are well-supported, and there is 
some longitudinal evidence consistent with anxiety preceding AN onset. However, whether 
findings across all longitudinal studies support anxiety pathology predicting increased risk of 
AN is unclear, as is whether the conclusions of studies better able to make causal inferences 
converge with those of longitudinal design. My doctoral work aims to address the limitations 
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of the current evidence, to allow for robust evaluation of the nature of association between 
anxiety pathology and AN development. In addition, the causal influence of potential shared 
risk factors on anxiety disorder and AN pathology is explored, to further inform mechanisms 
underlying the relationship between the two. Outcomes may inform aetiological 
understandings, to direct future research and intervention development. In the following 
chapter I describe the precise research questions of the thesis, and provide further detail of 




2 Chapter 2: Overview of doctoral research 
In this chapter I define the precise research questions of my doctoral work, and provide a 
detailed outline of the four studies that have enabled me to address these questions. I describe 
the interdisciplinary nature of the body of work in this thesis, and conclude the chapter by 
outlining my contribution to each study of the thesis and providing a timeline of the doctoral 
work. 
2.1 Research questions 
My doctoral work aims to inform the nature of association between anxiety pathology and 
AN. In order to address this broad question, I have broken it down into four more precise 
research questions:  
1. What is the state of current evidence for the existence of a longitudinal association 
between anxiety disorder pathology and subsequent AN, across all relevant studies? 
a) Does the body of evidence support anxiety disorder pathology predicting 
subsequent AN? 
b) Does the quality of existing evidence allow for confidence in conclusions 
concerning longitudinal associations? 
c) What could future longitudinal studies do to enhance their quality and further 
knowledge?  
2. Does anxiety disorder presence prospectively predict engagement in restrictive eating 
behaviour that is typical of AN? 
3. Do findings from Mendelian Randomization (MR) analyses converge with those of 
prospective longitudinal investigations to support a causal influence of anxiety 
pathology on AN? 
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4. Does worry causally influence anxiety disorder and AN development, to contribute to 
the association reported in observational research? 
a) Do findings from MR analyses support a causal influence of worry on anxiety 
disorders as well as AN? 
b) Is the evidence for worry operating as a shared causal risk factor for both 
anxiety disorder and AN pathology specific to worry, or generalise to other 
vulnerability factors? 
2.2 Studies of the thesis 
Each of the four defined research questions are addressed within a separate study. In this 
section an outline of each of the studies is provided. I articulate how each study maps on to a 
particular research question, and how the studies build upon each other to produce a coherent 
understanding. 
2.2.1 Study 1 
Study 1 addresses the first research question. It comprises a systematic review of research 
probing the longitudinal association between anxiety and subsequent AN development or 
maintenance. Findings of existing research are synthesised, and the quality of studies 
evaluated. There was no evidence to support specific anxiety disorders predicting the onset of 
AN. There was some indication that the presence of any one of the collection of anxiety 
disorders is associated with greater risk of AN, however clarification is required. The main 
conclusion of the review relevant to this thesis is that further research is needed to establish 
whether anxiety pathology predicts AN development, given the low quality of the body of 
evidence aggregated. In particular, retrospective studies may be biased by inaccurate recall, 
and prospective cohort studies are limited by the small number of anxiety disorder and AN 
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cases. The need to understand the mechanisms by which anxiety disorders and AN are 
associated is highlighted. Specifically, whether anxiety disorders directly cause AN, or 
whether they signal the propensity to develop anxieties typical of AN should be clarified. The 
hypothesis that restrictive eating behaviour functions to reduce anxiety is a recommended 
area of future research. Study 1 is presented in Chapter 3. 
2.2.2 Study 2 
In Study 2, the second key question of the thesis, concerning whether anxiety disorder 
presence predicts eating behaviour typical of AN is addressed. This study builds upon the 
findings of Study 1, addressing identified gaps in the literature by exploring the predictive 
effect of any anxiety disorder, rather than particular diagnoses. I consider the association of 
anxiety pathology with a restrictive eating behaviour typical of AN: fasting for weight loss or 
to avoid weight gain. Since this eating behaviour is more prevalent than AN, the statistical 
analysis is not subject to bias resulting from rarity of the outcome, unlike previous research 
that has used AN diagnosis as the outcome. The use of an outcome related to, but different 
from, AN diagnosis also allows assessment of whether findings are consistent across studies 
differing in their precise methodology, which can inform the robustness of conclusions 
surrounding the anxiety pathology and AN relationship. Outcomes of Study 2 supported the 
existence of a prospective association between anxiety disorder presence and AN behaviour 
during adolescence. The link between anxiety pathology and restrictive eating behaviour is 
consistent with the particular hypothesis that limiting food intake may function to reduce or 
manage anxiety unrelated to eating and weight gain. However, this relationship may also be 
explained by anxiety disorders signalling the potential to develop anxieties typical of AN. 
Study 2 is presented in Chapter 4. 
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2.2.3 Study 3 
Study 3 addresses research question 3, and comprises the triangulation of findings from two 
investigations that probe the association of worry and anxiety disorder presence with AN 
onset. The first investigation consists of a longitudinal observational analysis, and the second 
a MR analysis. While the findings across the two studies were not consistent, there was 
strong evidence to support a causal influence of worry on AN development in the MR 
analysis. In contrast, although a longitudinal association between anxiety disorders and 
subsequent AN development was supported, there was no strong evidence to support this 
association being causal. As worry is causally implicated in the development of anxiety 
disorders themselves, outcomes of Study 3 suggest that worry could confound the anxiety 
disorder-AN association in studies of observational design. Study 3 is detailed in Chapter 6. 
2.2.4 Study 4 
In Study 4, the conclusion of study 3 is examined further. Specifically, the association of 
worry with both anxiety disorders and AN is assessed within a MR framework, testing the 
hypothesis that worry causally influences risk for both anxiety disorders and AN. Worry and 
depressed affect are manifestations of neuroticism, and indeed subcomponents of a broader 
neuroticism measure. MR analyses testing the causal influence of neuroticism and depressed 
affect on both anxiety disorders and AN are undertaken, in addition to those probing the 
causal influence of worry. The independent influences of worry and depressed affect on both 
anxiety disorders and AN are probed within multivariable MR analyses. Outcomes of Study 4 
are able to determine the specificity of worry as a shared causal risk factor, and the 
independence of its effects on anxiety disorders and AN relative to other components of 
neuroticism. Findings thus inform the structure of transdiagnostic influences, whilst also 
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contributing to aetiologic understandings more generally. The findings suggest that while the 
broad factor of neuroticism causally influences both anxiety disorders and AN, worry is the 
specific component of neuroticism that increases AN risk. In contrast, neither subcomponent 
of neuroticism (i.e. worry or depressed affect) is supported to predict anxiety disorders 
independently of the other. Study 4 is described in Chapter 7. 
2.3 Schematic of the thesis 
Figure 2-1 provides an overview of the thesis. The schematic demonstrates how research 
questions were developed from the theoretical model and literature review, and how studies 
of the thesis address the research questions. The way in which initial investigations have 
informed subsequent research, and the contribution of each study outcome to the broader 




Figure 2-1 Schematic of the thesis  
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2.4 Study presentation 
The studies in this thesis appear in the IMRAD (Introduction, Methods, Results, and 
Discussion) manuscript format. They are presented as per manuscripts that have either been 
published (Study 1), are under review (Studies 2 and 3), or are prepared for journal 
submission (Study 4). Where minor changes that prevent duplication or promote 
understanding have been made, these are fully disclosed. The studies implement a range of 
designs, and statistical approaches, to address particular research questions. Additional 
methodological information for Study 2 is presented prior to the manuscript, within the same 
chapter (Chapter 4). A detailed MR methods section is provided in Chapter 5, separately 
from the two studies implementing MR that are presented in Chapters 6 and 7.   
2.5 Interdisciplinary nature of doctoral work 
My doctoral work has involved the adoption of an interdisciplinary approach. Understanding 
the aetiology of AN represents a complex problem that cannot be achieved within the 
constraints of a single discipline (192, 193), given the likely role of many interacting factors 
and processes. The theory guiding my doctoral research integrates biological and 
psychological understandings to explain eating behaviour within the context of a serious 
psychiatric illness. Factors, processes and concepts across various disciplines including 
biology, neuroscience, psychology, psychiatry and dietetics were integrated to develop the 
model, and to interpret outcomes of my doctoral work that addresses model hypotheses. The 
studies of my thesis involve a range of methodologies, and methodologies that are informed 
by different disciplines. Completing analyses and interpreting results has required me to draw 
from the domains of psychiatry, psychology, biology, epidemiology, economics, mathematics 
and genetics. Using knowledge held within multiple different domains at each stage of my 
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research (design, completion, interpretation) has enabled me to comprehensively address my 
specific research questions. This, in turn, has promoted the development of a fuller account of 
the anxiety pathology and AN association that may direct future research and practice.  
2.6 Completion of the doctoral research  
2.6.1 My role in the doctoral research  
I was fully engaged with each aspect of the research process, for each study of this thesis. A 
summary of my activities in respect of the four studies is provided in Table 2-1. Further detail 
is provided in the chapters in which studies are presented. 
Table 2-1 Table to Show My Role in Each of the Studies of the Thesis 
 
2.6.2 Timeline of doctoral activities 
I completed the studies and other activities relevant to this thesis between October 2016 and 
August 2019. Figure 2-2 displays a timeline of my doctoral work. 











Study 1 9 9 9 9 9 
Study 2 9 9 9 9 9 
Study 3 9 9 9 9 9 
Study 4 9 9 9 9 9 
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3 Chapter 3: Systematic review of studies probing the longitudinal 
association between anxiety and anorexia nervosa 
3.1 Overview 
This chapter outlines Study 1, which is a systematic review of longitudinal research assessing 
the association between anxiety unrelated to eating and weight gain and subsequent AN. The 
study is presented as a reproduction of the accepted version of the manuscript published by 
the journal Psychiatry Research, with one exception. The journal requested that anorexia 
nervosa not be abbreviated to AN in the article, however I use the abbreviation in this chapter 
for consistency with the rest of my doctoral work. The systematic review was completed in 
accordance with a published protocol paper, which is available in Appendix D. Notably 
there were some slight diversions from the protocol, which are explicitly, as well as fully, 
detailed and justified.  
 
 Lloyd EC, Haase AM, Foster CE, Verplanken B. A systematic review of studies probing longitudinal 
associations between anxiety and anorexia nervosa. Psychiatry research. 2019 May 8.  
Author contributions: I conceived of the study, completed systematic searches, study screening, data extraction 
and quality assessment, and drafted the manuscript. AMH assisted with study screening, data extraction, quality 
assessment and manuscript refinement. CEF and BV assisted with study screening and manuscript refinement. 
All authors approved the final version of the manuscript for publication. 
 Lloyd EC, Haase AM, Verplanken B. Anxiety and the development and maintenance of anorexia nervosa: 
protocol for a systematic review. Systematic reviews. 2018 Dec;7(1):14.  
Author contributions: I developed the protocol idea, and drafted the manuscript. AMH and BV refined the study 




AN is an eating disorder characterised by persistent dietary restriction and an intense fear of 
weight gain despite maintenance of a low body weight (1). The disorder has the highest 
mortality rate of any psychiatric disorder (45) and lasting and aversive implications on 
physical health (47). Recovery rates of established treatments remain below 50% (68). While 
there is some evidence to support the efficacy of particular prevention interventions in 
asymptomatic populations, individuals already displaying symptoms of an eating disorder do 
not seem to benefit from existing programmes (75, 76). The scope for improved prevention 
and treatment is clear, however achievement of this remains complicated by uncertainty 
surrounding AN aetiology (78).  
Existing interventions typically address eating disorder specific cognition (e.g. drives for 
thinness, heightened valuation of weight and shape) and/or eating behaviour (e.g. dietary 
restriction) that precede and characterise AN (194). Augmenting existing interventions with 
modules that target other factors identified as playing a causal role in AN development and/or 
maintenance could be highly beneficial. Clinical observations support high levels of anxiety 
generally in individuals with AN. Subsequently, a number of theoretical accounts of AN 
propose anxiety unrelated to eating and weight gain, from this point referred to as anxiety, to 
be causal in AN development. Specifically, it has been proposed that the restrictive eating, 
and focus on food intake and weight, that characterises AN may reduce anxiety in individuals 
who develop AN, encouraging continuation of dietary restriction, and to increasingly extreme 
degrees (e.g. (97, 102, 116, 195, 196)). The majority of anxiety disorders typically emerge in 
childhood and early adolescence (197, 198), while AN onset is most common during mid-late 
adolescence (40), consistent with the proposed causal role of anxiety in AN pathology. 
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One implication of the hypothesis that anxiety causally influences AN pathology is that 
targeting anxiety in prevention and treatment efforts could be a promising avenue for 
improving the outcome of current interventions. Evidence for prevention interventions 
reducing negative affect (depressive and anxious symptomatology) is weak (75). Whether 
existing treatment interventions improve anxiety is unclear since this is not typically reported 
(157). However, anxiety remains elevated upon recovery in AN (32, 199), suggesting anxiety 
may not be sufficiently addressed within AN treatment.  
There are few, if any, reported trials of adjunctive therapies designed specifically to reduce 
anxiety within the context of AN interventions. Without such data, observational studies 
allow for initial tests of the hypothesis that anxiety plays a causal role in the development and 
maintenance of AN. Associations between anxiety and AN are reliably reported in cross-
sectional studies. Trait anxiety is greater in AN as compared to HC (e.g. (149, 150)). Anxiety 
disorder pathology and the prevalence of anxiety disorder diagnoses are also elevated 
amongst AN as compared to HC (117, 120, 128). Existing findings support a role for anxiety 
in AN maintenance as well. When studies have compared individuals who have recovered 
from AN to those who have not, anxiety and anxiety disorder pathology is elevated in the 
latter group (32, 200, 201).  
Correlation is not causation however, and alternative explanations for the pattern of findings 
summarised exist. Cross-sectional research is particularly vulnerable to bias by reverse 
causation, and it is possible the observed associations reflect that physical, psychological and 
social consequences of AN behaviour result in heightened anxiety. Longitudinal studies 
assess whether an exposure of interest (in this case anxiety) predicts the later occurrence of a 
given outcome (i.e. AN), to establish the temporal nature of association, thus allowing for 
stronger inferences concerning causality as compared to cross-sectional research. The current 
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systematic review gathers longitudinal studies that have assessed whether stable anxiety 
phenotypes (i.e. trait anxiety and anxiety disorder pathology) predict subsequent AN onset or 
AN recovery. It is hoped that this process will help to outline the possible role of anxiety in 
AN, which may inform future research and clinical practice. The review is completed in 
accordance with a published protocol (see (202), or Appendix D).  
3.3 Methods 
3.3.1.1 Search strategy 
Medline and PsychInfo were searched using the Ovid Interface and the search strategy 
detailed in Appendix D for studies published prior to 16th August 2018. The search strategy 
was developed by Caitlin Lloyd (ECL) following multiple preliminary searches. To capture 
all relevant studies, the strategy was amended (with search criteria broadened) from that 
detailed in the published protocol.  
3.3.1.2 Eligibility criteria 
The eligibility criteria for studies of the current review are detailed in Table 3-1. 
Table 3-1 Screening Criteria 
Domain Criteria 
Research question Studies must have intended to evaluate the longitudinal 
association between anxiety and later AN onset or recovery 
Design Retrospective and prospective cohort and case-control studies 
Participants Human  
Individuals in AN sample must meet or have previously met full 
diagnostic criteria for AN 
Exposure Symptoms or diagnosis of any anxiety disorder (excluding OCD 
or PTSD) 
Trait anxiety/Anxious tendencies 
Exposure measurement Anxiety exposure must have been assessed with validated 
measure 




Timing The AN outcome is measured at least one year following the 
anxiety exposure 
Language English 
Publication type Article published in peer-reviewed journal 
OCD: Obsessive-compulsive disorder; PTSD: Posttraumatic stress disorder 
In the case of prospective studies, these were considered to meet participant eligibility criteria 
if AN diagnoses were assigned based on the presence of core clinical features of AN, with 
AN definitions mapping onto formal diagnostic criteria (i.e. DSM or ICD specifications). 
This was to promote the inclusion of relevant cohort studies, which often adopt such 
population assessment strategies when studying eating disorders in the general population 
(e.g (203, 204)).  
Obsessive-compulsive disorder (OCD) and Posttraumatic stress disorder (PTSD) symptoms 
or diagnosis were not eligible exposures given OCD and PTSD are no longer classified as 
anxiety disorders (1). Studies solely assessing associations between OCD/PTSD 
psychopathology and AN outcomes were therefore not included in the current review. 
Additional inclusion/exclusion criteria varied according to whether studies were probing the 
role of anxiety in the development of, or recovery from, AN. Studies assessing the role of 
anxiety in AN onset must have included a healthy control group (i.e. alternative eating 
disorder or psychiatric control group was not sufficient), however this was not required for 
studies probing the role of anxiety in AN recovery. Studies assessing the role of anxiety in 
recovery from AN must have provided a definition of recovery to be eligible. 
The application of timing criteria in risk factor studies assessing the role of anxiety in AN 
development was lenient. Included retrospective studies probed anxiety in the entire 
childhood period prior to AN symptom onset, potentially capturing anxiety in the year 
preceding AN onset. These studies were included since the purpose of our timing eligibility 
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criteria was to mitigate bias due to reverse causality, and the studies each took steps to 
minimise this same bias while capturing anxiety that preceded AN (i.e. the exposure of 
interest). 
3.3.1.3 Data collection 
ECL and an independent reviewer separately screened the titles and abstracts of studies 
retrieved from database searches. Full texts of eligible studies were retrieved via institutional 
membership permissions, and independently screened by ECL and Charlie Foster for 
inclusion in the review. An additional reviewer (Bas Verplanken) resolved discrepancies at 
both stages. References of eligible studies were screened to identify additional studies for 
inclusion in the review; no further studies were identified. 
3.3.1.4 Data extraction and synthesis 
Tailored data extraction forms were used to extract relevant information as per the study 
protocol (202), by two independent reviewers (ECL and Anne Marie Haase; AMH). All 
reported estimates of association were extracted, with the most adjusted estimate deemed the 
best one. Where data/study information of interest was missing, authors were contacted in 
attempts to retrieve it. 
Studies were grouped according to whether they assessed the role of anxiety in AN onset or 
recovery, and according to the type of anxiety assessed (i.e. trait anxiety/anxious tendencies 
or anxiety disorder pathology). A qualitative synthesis of study findings was then completed. 
Ideally a meta-analysis would have been undertaken, however various issues prevented 
pooling effect estimates across studies. First, some study reports did not provide the estimate 
of association between the anxiety exposure and subsequent AN, meaning a quantitative  
synthesis would not be based on all relevant data. Second, whilst in all cohort studies anxiety 
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was treated as the independent variable and AN as the dependent variable in the statistical 
analysis, this was not the case for cohort studies. As such, available effect estimates are not 
even theoretically comparable across all studies. Finally, anxiety exposures differed markedly 
between studies and were measured on different scales, which makes meaningful 
interpretation of a pooled effect challenging.  
3.3.1.5 Risk of bias and quality assessment 
Risk of bias was assessed using the Newcastle Ottawa Scale (NOS; (205)) by two 
independent reviewers (ECL and AMH). Use of this quality assessment instrument reflects a 
diversion from the protocol (202), and is justified given the suitability of the NOS for both 
case-control and cohort studies. The scale assesses study quality across three domains. 
Studies may be awarded a single star for ‘Selection’ and ‘Exposure/Outcome’ items, and a 
maximum of two stars for ‘Comparability’. The cohort study rating scale was modified 
slightly, with the follow-up interval item removed given review inclusion criteria specified an 
interval of one year between anxiety exposure and AN outcome assessment. As such, case-
control studies could receive a maximum rating of nine stars, while cohort studies could 
achieve scores of up to eight stars.  
To aid evaluation of the strength of the body of evidence included in the review, we provide a 




3.4.1 Study selection 
Following deduplication, 1921 studies were identified from literature searches, 215 of which 
were included in the full-text screen. Eight studies were subsequently deemed eligible for 
inclusion in the review. The screening process is detailed further in Figure 3-1.  
Figure 3-1 PRISMA flow diagram to show study selection process 
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Seven studies assessed the longitudinal association between anxiety and AN onset, and only 
one study probed the association of anxiety with later recovery from AN. A number of 
studies considered anxiety within a cluster of more general psychological or psychiatric 
symptoms, for example probing associations between negative affect/psychiatric comorbidity 
and AN outcomes. These studies were excluded, since inclusion criteria specified that only 
investigations of the association between anxiety-specific exposures and AN were eligible. 
This inclusion criterion was applied to promote straightforward interpretation of the 
collection of evidence, however it is noted that this contributed to the small number of studies 
included in the present review. For the same reason of seeking to aid interpretation, of the 
studies probing associations between anxiety and AN maintenance, only those that focused 
on recovery from AN were included. This decision also reduced the number of eligible 
studies given other outcomes (e.g. relapse, remission) have been studied to inform the 
relevance of particular exposures to AN maintenance.  
3.4.2 Study characteristics 
Details of the studies included in the present review are available in Table 3-2.
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Table 3-2 Characteristics of Studies Included in the Review 
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AN: anorexia nervosa; BDI: Beck Depression Inventory Short Version; BMI: body mass index; ED: eating disorder; EDE: Eating Disorder Examination; EDE-
Q: Eating Disorder Examination Questionnaire version; EDI: Eating Disorder Inventory; HAM-A: Hamilton Rating Scale for Anxiety; K-SADS: Schedule for 
Affective Disorders and Schizophrenia for School-Age Children; MDD: major depressive disorder; OCD: obsessive-compulsive disorder; ORFI: Oxford Risk 
Factor Questionnaire; RFQ: Risk Factor Questionnaire; SCID: Structured Clinical Interview for DSM-IV; SES: socio-economic status; SPIN: Social Phobia 
Inventory. Best estimate is the fully adjusted estimate of association. 
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Of the seven studies probing the role of anxiety phenotypes in AN development, four 
considered childhood anxiety, and three considered anxiety disorder diagnoses. The single 
study probing the role of anxiety in AN recovery assessed the association between non-
specific anxiety disorder symptoms, as opposed to particular anxiety disorder pathology, and 
AN.  
Of the eight included studies, five detailed the best (fully adjusted) effect estimates for 
associations of interest, and these five studies all assessed the predictive effect of anxiety on 
AN development. Notably, one further study provided estimates for the unadjusted analysis 
assessing the association between anxiety and AN onset (206). Another study (169) provided 
estimates pertaining to the predictive effect of anxiety disorders present in the period prior to 
AN onset, including those anxiety disorders emerging in the year before AN onset. The study 
indicated that associations did not qualitatively differ when anxiety disorders diagnosed in the 
year prior to AN development were excluded from the analysis, but sensitivity analysis 
estimates were not available.  
3.4.3 Qualitative synthesis 
3.4.3.1 Anxiety and AN development 
Childhood anxiety 
All studies assessing the role of childhood anxiety in AN development were of retrospective 
case-control design. Studies used diagnostic items from structured clinical interviews, either 
the Structured Clinical Interview for DSM-IV disorders (SCID) (207) or the Eating Disorder 
Examination (12), to establish AN status. HC were excluded if they had experienced lifetime 
clinically significant eating disorder pathology. To address the research question of whether 
individuals with AN were more likely to be anxious during childhood than HC, all 
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participants completed assessments developed to identify risk factors for AN onset. In two 
studies (167, 208) a semi-structured interview, the Oxford Risk Factor Interview (209), was 
administered. The other two studies (166, 206) assessed childhood experiences by way of a 
self-report questionnaire compiled by the authors. The childhood risk factor measures are 
reported to have acceptable psychometric properties (166, 210), however assessment of 
childhood anxiety generally consists of a single question. In all studies AN participants were 
asked explicitly to focus on the childhood period prior to emergence of their first AN 
symptom when responding to questions. 
One study found that individuals with AN were more likely to experience separation anxiety 
than their healthy sisters, who comprised the control group (167). Two studies (166, 206) 
may have included an overlapping sample; it was not possible to verify whether this was the 
case. Of these two studies, one reported greater childhood anxiety in AN relative to HC – 
both in and outside of school (166). The other study (206) found evidence consistent with 
elevated childhood anxiety in AN, however anxiety was not independently associated with 
AN: the relationship disappeared when covariates (including interpersonal factors and 
visuoperceptual ability) were added to the prediction model. The fourth study (208) observed 
an increased proportion of individuals with AN reporting childhood anxiety as compared to 
HC, while a reduced proportion of AN reported anxiety compared to a bulimia nervosa (BN) 
comparison group. There was no difference in the proportion of AN and individuals of a 
psychiatric control group (individuals with anxiety and depressive disorders) reporting 
childhood anxiety, and statistical analyses did not provide strong evidence for an association 
between childhood anxiety and group membership.  
Across the collection of retrospective findings there is evidence to support individuals with 
AN being more likely to recall anxiety in childhood as compared to HC. However, whether 
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childhood anxiety is able to explain unique variation in AN development is unclear from the 
existing body of research.  
Anxiety disorders 
All three studies assessing the predictive effect of anxiety disorders on AN onset were 
prospective in design. One study assessed whether social anxiety disorder at age 15, 
measured using a validated self-report instrument, the 17-item Social Phobia Inventory (211), 
predicted lifetime AN two years later, and found no evidence to support an association (212). 
Lifetime AN was assessed using a self-report questionnaire, and recorded if individuals 
reported an episode in which they had engaged in dieting behaviour, and experienced weight-
concerns as well as amenorrhea during this episode. Notably a BMI criterion was not applied. 
A further cohort study (213) assessed associations of panic disorder, overanxious disorder, 
separation anxiety disorder, simple phobia, and social phobia (measured at age 16), with 
lifetime AN at age 30. Lifetime anxiety disorders were assessed with epidemiologic (214) 
and clinical versions of the Kiddie-Schedule for Affective Disorders and Schizophrenia. The 
AN outcome was determined using a combination of structured interviews: the Longitudinal 
Interval Follow-Up Evaluation (215), and the SCID for DSM-IV disorders (207) non-patient 
version. Analyses were adjusted for all other anxiety disorders, as well as depression and 
OCD. None of the anxiety disorders explained unique variance in subsequent AN onset. In 
both prospective cohort studies described the AN outcome was extremely rare.  
A further study (169) completed in a childhood cohort adopted a population register linkage 
approach to identify all individuals who received specialist psychiatric treatment across a 23 
year period. Generalised anxiety disorder (GAD) and social phobia diagnoses were associated 
with increased likelihood of later AN in analyses adjusted for a range of potential 
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confounders including age, sex, and family psychiatric history. When hospital contact for 
other psychiatric disorders (not including anxiety/stress disorders or OCD) was added to 
statistical models, evidence for social phobia (though not GAD) predicting increased risk of 
AN remained. The presence of any anxiety disorder (or OCD/PTSD diagnosis) also predicted 
increased risk of subsequent AN diagnosis in adjusted analyses. There was no strong 
evidence to support a unique predictive effect of any single anxiety disorder when analyses 
were adjusted for hospital contact due to other anxiety disorders/PTSD/OCD.  
The prospective studies do not provide evidence to support a specific anxiety disorder 
diagnosis predicting AN development independently of other anxiety disorders and 
OCD/PTSD. However, findings of one large study (169) suggest that the presence of any 
anxiety disorder (i.e. collapsing across diagnostic categories) predicts AN onset.  
3.4.3.2 Anxiety and AN maintenance 
The single study probing the association between anxiety and recovery from AN (216) found 
no evidence to support anxiety symptoms at the end of index hospitalization predicting 
recovery 13 years later. Participants fulfilled DSM-IV criteria for AN at the start of the study, 
and anxiety was assessed with the Hamilton Anxiety Scale (217). Recovery was assessed by 
way of self-report questionnaire, and defined by: maintenance of BMI between 18.5 and 25 
kg/m2; absence of excessive exercise; and normal eating behaviour (i.e. regular and 
appropriate food intake, absence of fear of food/obsessive behaviour concerning eating or 
weight-monitoring, ability to eat with others). This study did observe relapse (a reduction of 
1.5 BMI points in the context of a high drive for thinness) at the two-year follow-up to be 
more likely in individuals with high levels of anxiety at the end of hospitalisation.  
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Evidence from a single study is not consistent with anxiety symptoms predicting recovery 
from AN. However, whether this finding is robust is unclear, as is whether different types of 
anxiety show different associations with AN recovery.  
3.4.4 Quality assessment 
Outcomes of the study quality assessment are detailed fully in Appendix D (Table 1). The 
quality of individual studies ranged from fair to high, and each of the studies adopted 
methods designed to minimise bias. Cohort studies generally obtained higher scores, and 
these studies typically included representative populations, used robust methods to assess 
exposures and outcomes, and adjusted for various covariates in the analysis. Case-control 
studies used convenience sampling methods to recruit participants, and did not blind 
assessors to case status when evaluating whether the anxiety exposure was present. Although 
cases and controls were matched to some extent, this was fairly limited, which also 
contributed to the lower quality rating of case-control studies, as compared to those of cohort 
design. 
The quality across the body of research was evaluated in the context of the scope of the 
review. That is, the collection of evidence was not downgraded for being observational in 
nature, given the particular aim of aggregating longitudinal studies. Nonetheless, across 
included studies assessing the association between anxiety and AN onset, the quality was 
considered low. Retrospective studies are limited by their reliance on accurate recall, and 
resulting conclusions are invalidated when this assumption is violated. Furthermore, anxiety 
was generally assessed with a single question in retrospective studies, reducing the sensitivity 
and specificity of assessment. The prospective cohort studies were limited by the rarity of 
anxiety disorder exposures and the AN outcome, which can inflate effect estimates as well as 
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reduce sensitivity to a true association (218, 219). While the record linkage study is not 
subject to this limitation, anxiety disorder and AN diagnoses were identified only when 
specialist psychiatric treatment was sought. This approach will have resulted in under 
identification of diagnoses (e.g. when psychiatric disorders were treated within general 
practice settings), with such measurement error introducing bias into estimates of association. 
The follow-up periods of prospective studies did not always encompass the entire period of 
peak AN onset (i.e. age 14-19 (40)), which will also have complicated the detection of true 
associations. Consistency across findings indicates a higher quality of the body of evidence 
(220), and was lacking – even when considering findings of prospective and case-control 
studies separately. That there was a single study assessing the role of anxiety in AN recovery 
suggests evidence concerning this outcome is weak. 
3.5 Discussion 
The purpose of this systematic review was to identify longitudinal studies probing the 
association of anxiety with either AN development or recovery. A small number of eligible 
studies were identified. Findings of retrospective case-control studies generally supported 
individuals with AN being more likely to report childhood anxiety than HC. Evidence from 
two prospective cohort studies and the single prospective population registry study did not 
support specific anxiety disorders explaining unique variation in AN risk. Findings of the 
population registry study did however support the presence of any anxiety disorder (i.e. 
pathology common across the anxiety disorders) predicting subsequent AN development. The 
high risk of bias, and inconsistency, across the collection of findings resulted in a weak body 
of evidence concerning the role of anxiety in AN onset. The single eligible study assessing 
the association between anxiety and later AN recovery did not produce evidence that 
supported an association. However, strong conclusions cannot be made on the basis of 
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findings from one study. Thus, while there is not robust evidence for an association between 
anxiety and AN onset or maintenance, this does not necessarily reflect the absence of a 
meaningful relationship. 
The case-control and cohort studies probing the role of anxiety in AN onset considered 
different anxiety exposures, however findings across the study design categories may actually 
point towards the same conclusion. The presence of any anxiety disorder predicting increased 
risk for AN, while specific anxiety disorder diagnoses had no unique explanatory power (169, 
213), suggests anxiety (regardless of its particular focus) is associated with subsequent AN. 
This interpretation is consistent with the association between general childhood anxiety and 
AN in retrospective studies (166, 167, 206). It is also consistent with the high comorbidity 
between various anxiety disorders and AN – with the anxiety disorders reported to almost 
always precede AN onset (32, 119). 
Confidence in anxiety predicting increased risk of later AN is complicated by the 
vulnerability of studies included in the review to various sources of bias. In the retrospective 
case-control studies, the order of anxiety and AN onset may have been confused, such that 
findings of anxiety being associated with increased risk of AN actually reflect the reverse 
direction of association. Alternatively, individuals with AN may have mistakenly reported 
greater anxiety in childhood, or prior to AN onset, in attempts to explain illness development. 
Inaccuracies in memory recall are well known, and pose serious threats to the validity of 
retrospective study findings (221). Case-control studies also accounted for relatively few 
plausible confounders in the study design, which may have inflated effect estimates. Indeed, 
the statistical evidence for associations did weaken upon greater adjustment in these studies 
(206). However, it is possible for anxiety to universally precede AN, and even to be causally 
relevant to the onset of the disorder, while other AN-specific risk factors explain a greater 
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proportion of unique variation in onset. The prospective studies were also subject to 
limitations. The inclusion of PTSD/OCD within the any anxiety disorder category in the 
population registry study may have led to inaccurate conclusions over the predictive effect of 
DSM-5 anxiety disorders. On the other-hand, sample size and measurement issues likely 
reduced sensitivity to true associations between specific anxiety disorders and AN.  
To clarify the potential role of anxiety in AN onset, further high-quality research that 
minimises the risk of biased conclusions is required. Future observational studies should 
control for potential confounders in the study design as far as possible. Novel methods that 
minimise bias due to confounding can assess the robustness of findings from longitudinal 
research. Mendelian randomization (MR) (183) is a method that uses genetic variants to 
instrument an exposure, minimising bias due to confounding and reverse causation (for an 
overview see (184)). MR analyses have produced evidence consistent with a causal influence 
of genetic liability to worry, though not anxiety disorders, on AN development (222). Further 
investigation using different anxiety exposures, participant populations, and specific MR 
methods is encouraged. To assess whether a longitudinal association is likely to be spurious, 
future studies might include supplementary control analyses whereby the relationship (that 
cannot plausibly be causal) of a third factor with exposure or outcome is assessed (see (223)).  
Future prospective studies should include a sufficient number of participants (and particularly 
cases) for adequate power to detect associations between anxiety exposures and AN. Use of 
population registry datasets, and selection of cohorts based on AN risk or anxiety status, is 
particularly recommended. Future studies should also aim to minimise measurement error in 
anxiety and AN assessment as far as possible. Meta-analysis of longitudinal findings is not 
indicated on the basis of existing data. Obtaining a pooled estimate of association and an 
indication of variability in effect estimates across studies would inform the strength of 
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evidence concerning the potential role of anxiety in AN. To facilitate future meta-analyses, 
studies probing the association between anxiety and subsequent AN outcomes should assess 
associations from the direction of exposure to outcome, and report fully adjusted effect 
estimates.  
Future research might also directly assess differential associations of different anxiety 
exposures (i.e. specific anxiety disorder diagnoses versus transdiagnostic components 
common to anxiety disorders) with AN pathology. While anxiety disorder diagnoses and 
dimensional anxiety constructs are overlapping phenotypes, variation in their 
independent/unique associations with AN could inform mechanisms of association. For 
example, should a general tendency to experience anxiety explain associations between 
anxiety disorders and AN, this might suggest that anxiety disorders are only related to AN 
insofar as they signal a propensity to develop concerns typical of AN. In contrast, should 
anxiety disorder presence better predict AN onset as compared to anxious tendencies, this 
might support AN cognition and behaviour having favourable effects on anxiety disorder 
pathology (e.g.(97, 102, 114, 196)). Exploration of factors moderating the effects of anxiety 
on AN risk might also help to elucidate pathways of association. Probing the interaction 
between restrictive eating and anxiety disorder presence in the prediction of AN onset could 
indicate whether AN behaviour likely functions to mitigate fears particular to anxiety 
disorders.  
Outcomes of the present review also highlight the need for further studies investigating the 
role of anxiety in AN recovery. This is particularly so given longitudinal studies considering 
alternative AN maintenance outcomes have produced conflicting findings. For example, 
greater trait anxiety predicted reduced likelihood of AN remission (224), yet in a separate 
study general anxiety symptoms were not associated with likelihood of AN diagnosis at 
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follow-up (225). Notably the definitions of AN maintenance outcomes in these other studies 
overlap with each other and with the definition of recovery in the included study. Therefore, 
differences in exact outcome cannot necessarily explain finding disparity. The follow-up 
period of the included AN recovery study was thirteen years; future studies might consider 
shorter follow-up periods to avoid masking important proximal predictive effects of anxiety. 
While out of scope for the current review (see (202)), we note that studying AN behaviour in 
relation to both trait and state forms of anxiety could be highly informative for understanding 
how anxiety may maintain AN pathology (e.g. (226, 227)). 
The limited confidence that can be placed in findings of the present review prevents 
outcomes informing aetiological models of AN, and intervention practice. However, by 
identifying the need for further research concerning the role of anxiety in AN pathology, and 
posing directions for future research, we may indirectly promote a better understanding. This 
in turn may inform the utility of addressing anxiety, or processes underlying anxiety, in both 
AN prevention and treatment, for improved intervention outcomes. Ideally future studies will 
include those of experimental or trial design that are best able to demonstrate causal 
relationships.  
This review adhered to a published protocol (202), with transparent reporting and 
justification of any diversions ensuring integrity of the research. The inclusion of studies 
investigating the influence of a variety of anxiety phenotypes allowed for comparison 
between these phenotypes in terms of their associations with AN. This approach promotes the 
development of novel and testable hypotheses that may be addressed within future research.  
The review has important limitations. The focus on recovery as the specific maintenance 
outcome was implemented to promote homogeneity of included studies. The distinction 
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between different outcomes of AN (i.e. recovery, relapse, remission, disorder absence) in 
current research is to some extent false however, given the absence of consistent 
operationalisations of these terms (60). As such, informative evidence may have been missed. 
Despite the absence of meta-analytic estimates, we intended to evaluate the strength of the 
body of evidence generated by the review using a modified version of the Grading of 
Assessment, Development and Evaluation (GRADE) system (220). This could have further 
informed the quality of evidence collected in the course of the review. However, marked 
differences in the design of studies assessing the role of anxiety in AN onset, and inclusion of 
only one study considering AN recovery, prevented GRADE evaluation being a meaningful 
exercise.  
To conclude, the evidence aggregated within the review has provided an important basis for 
future research, however it is not sufficient for robust evaluation of whether anxiety 
exposures are longitudinally associated with AN development or maintenance. The review 
unequivocally establishes the need for further research in this area, ideally within studies of 
trial as well as observational design, to in turn inform AN prevention and treatment. Future 
investigations should seek to adopt methods that minimise potential biases, and that may 
inform pathways of association.  
3.6 Contribution to thesis 
The systematic review summarises the state of the existing evidence concerning the 
longitudinal association between anxiety pathology and AN. The review identifies that there 
is currently no strong evidence to support anxiety exposures (anxious tendencies or anxiety 
disorders) predicting the subsequent development of AN, and thus acting as risk factors for 
AN onset. Rather than indicating the absence of a meaningful relationship between anxiety 
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pathology and subsequent AN though, findings highlight the need for further research in this 
area.  
The review identifies common limitations of existing studies that serve to limit confidence in 
the resulting findings. Developing an awareness of particular methodological issues enabled 
me to consider these issues in my own quantitative work. As a consequence, in the remaining 
studies of this thesis, I implemented methods that enabled me to avoid or reduce the 
identified problems, and subsequent bias. In each of studies 2-4, I adopt methods designed to 
minimise bias due to confounding and reverse causation, and also avoid the modelling of rare 
outcomes that can inflate estimates of effect and reduce precision of these estimates.  
Review outcomes suggest that anxiety, regardless of its focus, may be relevant to AN onset. 
One resulting hypothesis is that the presence of any anxiety disorder will be predictive of AN 
development. This specific question has only been explored within one study to date, and the 
particular study included OCD and PTSD diagnoses (no longer considered anxiety disorders 
(1)) as anxiety disorders. To clarify, studies 2 and 3 assess the predictive effect of having one 
of a collection of DSM-5 anxiety disorders (collapsing across diagnoses) on future AN 
diagnosis and behaviour. Study 3 also considers the association of a core and common 
anxiety disorder component, worry, with AN, to further inform the role of anxiety pathology 
that exists across the anxiety disorders in AN.   
The systematic review also prompts consideration of the difficulty in determining whether 
anxiety pathology causes AN. In particular, the possibility that the anxiety pathology and AN 
association could be explained by an underlying propensity to be anxious (that only translates 
into AN risk when anxiety becomes directed onto weight gain and eating) is raised. This has 
informed the interpretation of findings of other studies of this thesis, as well as the particular 
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research questions addressed in these studies. In Study 4, the potential for common processes 
to contribute to anxiety disorder and AN pathology is directly explored. In Study 2, whether 
restrictive eating functions to reduce anxiety pathology is considered, which can also inform 
the mechanism by which anxiety pathology and AN are related.  
To conclude, the systematic review promotes a balanced evaluation of whether there is 
evidence to support a longitudinal association between anxiety pathology and subsequent 
AN. Findings highlight the need for further study and identify directions for future research 
that may improve its quality and elucidate mechanisms underlying observed associations. 
Such directions are pursued within subsequent studies of this thesis.  
66 
 
4 Chapter 4: Anxiety disorders predict fasting to control weight - a 
longitudinal large cohort study of adolescents 
4.1 Overview 
In this chapter I present an investigation into the prospective association between anxiety 
disorder diagnosis and subsequent fasting for weight loss or to avoid weight gain in 
adolescent females of the population cohort, the Avon Longitudinal Study of Parents and 
Children (ALSPAC). The study is described as it appears in the manuscript that is currently 
undergoing second review, except for some very minor changes that prevent duplication or 
provide additional information that may be helpful for the readers’ comprehension. Before 
presenting the study, I provide a rationale and detailed description in respect of the methods 
used. Following the study manuscript, I outline the contribution of the study to the thesis.   
4.2 Detailed methodology  
4.2.1 Design 
The study assesses the prospective association between the presence of an anxiety disorder 
(any of a collection of diagnoses), and subsequent engagement in fasting (not eating for at 
least an entire day) for weight loss or to avoid weight gain. The study is repeated measures in 
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design, using data concerning anxiety disorder diagnosis and fasting that was assessed at 
three time-points across the adolescent period. There were two longitudinal waves of data: at 
wave one children were 13-14 at anxiety disorder assessment and 15-16 when fasting was 
assessed; at wave two adolescents were 15-16 at anxiety disorder assessment and 17-18 when 
fasting was assessed. The primary analysis considers the association between anxiety disorder 
presence and fasting across both longitudinal waves of data. 
4.2.2 Clustering within repeated measures data 
Considering the association between anxiety disorder presence and fasting across two 
longitudinal waves, rather than assessing the association separately at each wave, means that 
the observations (participant data) included in the analysis are not independent. Participants’ 
repeated measures data tends to be correlated, meaning the within-participant variance is 
typically smaller than between-participant variance. In other words, measurements taken 
from the same participant at different points in time will be more similar than measurements 
taken from different participants at any given timepoint. This has important implications, 
which need to be considered in the analysis. For predictors that do not vary over time (time-
invariant factors), such as ethnicity, data points will be simply be duplicated when two waves 
of data are considered simultaneously. Treating all data points as independent when assessing 
the association between time-invariant factors and a repeated measures outcome would result 
in an underestimation of the standard error of the coefficient of association. This is because 
participants contributing to both waves will be counted twice in the sample size used for 
standard error calculations (228), while values of the predictor do not vary, and values of the 
outcome are clustered within participants (i.e. more similar than a set of independent 
observations). In contrast, the standard errors relating to estimated associations between a 
predictor and outcome that are both assessed at multiple time-points, tend to be over-
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estimated when data points from the same participant are treated as independent (229). This 
can be explained by the fact that a change in the predictor for a given participant may not be 
associated with a change in outcome to the same extent that a difference in the value of a 
predictor between participants is related to a difference in the outcome between these same 
participants. As a consequence, there is greater uncertainty surrounding the estimate of 
association between an exposure and an outcome, inflating the standard error.  
4.2.3 Generalized Estimating Equation models 
To account for the correlation between participants repeated measures responses (i.e. fasting 
at multiple time-points) when assessing the association between anxiety disorders and fasting, 
I used a Generalized Estimating Equation (GEE) approach (230). The GEE is an extension of 
the generalized linear model that allows for correlated data (228). A GEE analysis involves 
the regression of the response variable (fasting) onto covariates (anxiety disorders and other 
variables included in the regression model) and the correlation structure (model of correlation 
between repeated measures responses) separately. In the current analysis an unstructured 
working correlation was specified. This meant that the correlation between participants’ 
repeated (fasting) responses was estimated using the collected data, rather than assuming a 
particular structure within the repeated response data. There were only two timepoints at 
which the fasting outcome was assessed in the current study, and the sample size was 
relatively large. Selection of an unstructured working correlation thus enabled accurate 
specification of the correlation between fasting responses at the two longitudinal waves 
without resulting in a loss of precision due to estimation of many parameters (231). Robust 
standard errors, which do not assume equality of the between-participant and within-
participant variances in respect of the (fasting) response variable, were calculated. 
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4.2.3.1 Time-varying associations 
To investigate associations between anxiety and fasting within particular waves, the data 
were stratified by wave of analysis and associations modelled using binary logistic 
regression. The comparison of the anxiety and fasting association between different waves is 
not a formal test of whether the association varies with time, however it may provide an 
indication. I did not include the anxiety by time interaction term in the GEE model, which 
would allow a formal test of the effect of time on the association. This was because a 
substantially larger sample size would be required for robust assessment of an interaction 
effect (232, 233). 
4.2.4 Missing data 
Missing data results when not all participants of a study have provided measurements in 
respect of all variables. Participants may drop out from data collection at an earlier time-
point, and then participate at later time-points, or they may drop-out and never re-join. The 
latter is termed attrition, and increases with the length of follow-up. If participants missing 
data systematically differ from those who do not, analyses can result in biased inferences. 
Whether biased inferences will result from missing data is dependent on the mechanism 
underlying the missingness. The three possible mechanisms are: 
1. Missing completely at random (MCAR) 
2. Missing at random (MAR) 
3. Missing not at random (MNAR) (234) 
When data are MCAR, the available data is a completely random sample, and whether data is 
missing is not dependent on observed or unobserved measurements. In this situation the 
analysis of complete cases (i.e. including only individuals not missing any data in the 
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analysis) will always produce estimates that are in large samples, or asymptotically, unbiased. 
When data are MAR, missingness is related to the values of observed data, but unrelated to 
values of unobserved data. Thus, any differences between observed and missing values can 
be explained by observed data. When data are MNAR, missingness depends on unobserved 
data. This means that there are systematic differences between missing and observed values 
that cannot be explained by observed data (234). Whether complete case analyses with data 
that are MAR or MNAR will produce biased estimates is dependent on the precise analysis 
undertaken, and the variables predicting missingness (235). GEE models make the 
assumption that missingness is independent of the outcome having conditioned on the 
covariates (236), or that missingness cannot be predicted by values of the outcome once 
values of the confounders have been accounted for. This can be seen as a special case of 
MCAR, as opposed to MAR where missingness may depend on observed values of the 
outcome.  
Participants were included in the GEE analysis if they provided a complete set of data in 
respect of one of the longitudinal waves, as well as fasting at baseline information, amounting 
to 33.3% of all consenting females initially recruited to ALSPAC. Anxiety and fasting data 
was not imputed, given the proportion of missing data meant that an inadequate imputation 
model would introduce bias into the analysis. In addition, limited gains in terms of bias and 
efficiency result from imputation when data is missing from variables of interest (i.e. the 
exposure or outcome) given the cases missing data hold little information about associations 
between exposure and outcome (237). To satisfy GEE assumptions concerning missing data 
mechanisms, thus minimising bias resulting from the adoption of a (within-wave) complete 
case approach, predictors of missingness were included as covariates in the analysis model 
(236). Predictors of missingness in the ALSPAC dataset have been previously reported as 
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socio-economic status, mother age at delivery and mother parity (248). I confirmed these 
variables as predictors of missing anxiety disorder and fasting data by creating a missingness 
indicator that was regressed onto the potential predictors of missingness. This analysis 
demonstrated the independent association between each of the demographic predictors and 
the chance of being a complete case (i.e. having all anxiety and fasting data) (Table 4-1).  
Table 4-1 Predictors of Being a Complete Case in the GEE Analysis 
Outcome: complete case 
N=4742 
OR [95% CI] P 
Predictor   
Mother age at delivery 1.09 [1.07, 1.11] <0.001 
Socio-economic status 1.45 [1.18, 1.77] <0.001 
Mother parity 0.69 [0.6, 0.8] <0.001 
 
The GEE included binge eating and purging at the timepoint prior to fasting assessment (in 
respect of each of the longitudinal waves), to protect against confounding. Restricting 
analyses to individuals with complete data for the collection of covariates (i.e. predictors of 
missingness and potential confounders), rather than requiring complete anxiety and fasting 
data only, would have resulted in the exclusion of a further 27.72% of participants at wave 1, 
and an additional 24.10% of participants at wave 2. The loss of these participants would have 
removed relevant information concerning the association between anxiety and fasting, 
reducing precision in respect of effect estimates of interest (237). As such, missing data for 
demographic covariates and binge eating/purging was replaced using multiple imputation. 
4.2.5 Multiple imputation 
Multiple imputation involves the generation of several datasets containing plausible values of 
missing data. Analyses are completed with each dataset, and the results combined across the 
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multiple analyses in a manner that accounts for the uncertainty arising from the presence of 
missing data (238).  
The first stage of multiple imputation involves the creation of multiple copies of the dataset, 
with the missing values replaced in each one. Missing values are predicted based on 
participant data for other variables, and associations present between variables of the dataset. 
There are a number of multiple imputation methods, and the most appropriate one depends on 
the number and type of variables requiring imputation, as well as the pattern of missingness. 
Since participants included in analyses of the current study were missing data in respect of all 
potential confounders and predictors of missingness, multiple variables required imputation. 
A multivariate imputation method was therefore necessary. When missingness has a stepped 
pattern, with missingness on one variable implying missingness on others in the dataset, 
missingness is said to be monotone. In this case, variables are imputed in order from that 
missing the least information, to that missing the most. Only once a variable has had its 
missing values imputed, may it be used in the imputation of other variables.  
4.2.5.1 Multiple imputation with chained equations 
In this case there was not a monotone pattern of missingness, and so an iterative procedure 
was required, where the replaced missing values used to impute other variables are updated in 
the course of the imputation procedure. The majority of imputation variables were binary, 
and thus did not satisfy the multivariate normal distribution assumption of joint modelling 
imputation approaches (239). As such, the multiple imputation by chained equations (MICE) 
method was adopted. The chained equation approach imputes missing values for each 
variable separately, with each variable modelled as a function of others in the dataset (239). 
Distinct equations are used to predict missing values for each imputation variable, allowing 
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variables to be modelled according to different distributions (i.e. logistic regression is used to 
model binary variables, while linear regression models continuous variables). The use of 
distinct imputation models for each variable also means that certain predictor variables may 
be omitted from particular imputation equations. This was necessary in my imputation model 
due to instances of perfect prediction, whereby the value of one categorical predictor always 
occurred with a particular category of the variable being imputed. Perfect prediction results in 
coefficients of plus or minus infinity, and failure to fit the logistic regression model.  
4.2.5.2 The imputation model 
Imputed data is based on observed relationships between variables included in the imputation 
model. As a consequence, if analysis variables are not included in the imputation model, 
meaningful structures in the observed data would be weakened, resulting in biased estimates 
of association in the main analysis (238). As such, while data in respect of anxiety disorder 
and fasting variables was not imputed, these variables were included in imputation equations. 
Where particular variables were excluded from imputation equations to avoid perfect 
prediction, the collinearity between these variables and others that were included in 
imputation equations should have prevented the dampening of relevant associations within 
imputed datasets.  
To improve the accuracy of imputed values, auxiliary variables not included in the main 
analysis, but associated with the analysis variables requiring imputation, should be included 
in prediction equations of the imputation model (240). As such, weight status variables 
(indicating whether participants were overweight or not), in respect of measurements taken at 
the three time-points of interest (i.e. age 13-14; 15-16; 17-18) were included in the imputation 
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model. Indicators of binge eating, purging and anxiety disorder status, at age 18, were also 
used to impute missing covariate data.  
Multiple imputation assumes that data are MAR. In order to satisfy this assumption the 
imputation model should include predictors of missingness (241). Demographic predictors of 
missingness (which themselves required imputation) were included in all imputation 
equations. The precise imputation model used in the current analysis was developed 
following preliminary testing and subsequent refinement. The Stata code for the imputation 
model, which includes specification of the regression equations, can be found in Appendix E. 
4.2.5.3 The imputation procedure  
To generate an imputed dataset MICE starts with a simple imputation for every missing value 
(here, the mean of observed values for a given variable). Next the missing values for one 
variable are set back to missing, and observed values for this same variable are regressed onto 
those variables specified in the imputation model (both observed and imputed values). 
Missing values are then replaced with predictions based on parameters derived from the fitted 
regression model. This estimation and replacement process is completed for each variable 
missing data. One run through each of the variables missing data to impute missing values 
equates to one cycle, or iteration. At the end of one iteration all missing values will have been 
replaced (242).The total number of iterations is specified, and in this case I used Stata’s 
default value of 10. The initial values used in each iteration (other than the first) are the 
values predicted in the previous iteration. At the end of all iterations, ideally the imputed 
values will have converged to become stable. The set of imputed values estimated during the 
final iteration are retained, resulting in one imputed dataset. The entire imputation process is 
then repeated to result in multiple imputed datasets. I specified 70 imputations, given the 
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recommendation that the number of imputed datasets should be at least as large as the 
proportion of missing data for efficient (less variable) estimation of associations of interest 
(243). Imputed covariate data was required for 25.8% of participants. Unbiased results may 
be obtained when up to 90% of data is missing, providing data are MAR and the imputation 
model is specified correctly (244). 
4.2.5.4 Analysis with multiply imputed data 
In the second part of a multiple imputation analysis, the imputed data is analysed. Estimates 
of interest are derived in each of the imputed datasets, generating multiple estimates that are 
then averaged. Standard errors in respect of parameter estimates are calculated based on 
variance arising from the presence of missing data and variability in estimates across imputed 
datasets, in addition to the standard sampling variance (234). In this way multiple imputation 
accounts for the uncertainty arising from the presence of missing data. 
4.2.5.5 Imputation model checking 
Descriptive statistics between imputed and observed data were compared, to confirm that 
these were not largely dissimilar. I also assessed the convergence of imputed values for each 
variable, in each imputed dataset, using trace plots, which plot mean and standard deviation 
estimates in respect of imputed data against the iteration number. Long term trends in 
predicted values indicate a lack of convergence, and was not an issue for any of the imputed 




4.3 The study 
Having provided a detailed description of the methods relevant to this study, I now present 
the study itself, as it appears in the manuscript that is currently under review (other than for 
the existence of minor changes that are detailed). 
4.4 Introduction 
Anorexia nervosa (AN) is a severe eating disorder that has a range of adverse consequences 
for long-term physical health (47), and the highest mortality rate of any psychiatric disorder 
(45). The defining feature of AN is persistent starvation (1, 245), which is accompanied by 
significant fear of weight gain despite the maintenance of a very low weight. Lifetime 
prevalence of AN is estimated to be 3.64% amongst women (246), with AN incidence highest 
during adolescence (40). Generally time to recovery is protracted (200, 247), and a significant 
proportion of individuals experience severe and enduring AN (248), meeting full diagnostic 
criteria for many years (61).  
Various aetiological models propose that anxiety is a causal risk factor for the development 
of AN (97, 116, 196, 249, 250). It is suggested that dietary restriction alleviates anxiety, 
meaning the behaviour has particularly favourable outcomes for individuals with high levels 
of anxiety. Such favourable outcomes encourage continued, and progressively more extreme, 
engagement in dietary restriction. Over time this leads to a dependence on dietary restriction, 
 
 Lloyd, E. C., Haase, A. M., Zerwas, S., & Micali, N. Anxiety disorders predict fasting to control weight: a 
longitudinal large cohort study of adolescents. 
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in particular for the management of anxiety that is increasingly focused on eating and weight 
gain, reflecting the presence of AN pathology. 
Studies have addressed model hypotheses by probing associations between anxiety disorders 
and AN. Cross-sectional associations are well characterised, with AN populations displaying 
increased rates of anxiety disorders as compared to populations of individuals without AN 
(32, 117). Cross-sectional data cannot address questions of temporality however, and while 
retrospective studies report anxiety disorders to frequently precede AN onset (117), findings 
may be affected by recall bias (194). One study using population registry data reported 
enhanced risk of subsequent AN in individuals diagnosed with anxiety disorders (251). 
However, in this study anxiety disorder and AN diagnoses were detected only if individuals 
received specialist care (i.e. beyond that of a general practitioner), which may have biased 
conclusions. In a nationally representative cohort, obsessive-compulsive disorder (OCD) 
predicted subsequent AN but there was no predictive effect of anxiety disorders (a category 
that does not include OCD or posttraumatic stress disorder (PTSD) in the latest diagnostic 
manuals) on later AN (213). Notably the low prevalence of AN resulted in imprecise 
estimates in this study.  
One approach to identifying factors predictive of relatively rare illnesses within community 
samples is to consider disorder symptoms, rather than diagnoses, as the outcome variables. 
The greater prevalence of symptoms, as compared with diagnoses, within a population means 
that under this approach studies are better able to accurately identify factors associated with 
the pathology of interest. Restrictive eating is a diagnostic criterion and core feature of AN 
(1), but also precedes the onset of the disorder such that it is characterised as a prodromal 
symptom (194, 252, 253). It may, then, be particularly advantageous to study predictors of 
restrictive eating behaviours typical of AN, in terms of identifying factors prospectively 
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associated with disorder development. Furthermore, probing associations between anxiety 
and eating behaviour allows for a more direct assessment of the mechanistic hypothesis that 
anxiety increases risk of AN by encouraging continued and progressively more extreme 
engagement in dietary restriction.  
A previous study reported no longitudinal predictive influence of anxiety symptoms on 
disordered eating (254), however the specific association with dietary restriction was not 
assessed. Fasting for weight loss or to avoid weight gain is an extreme form of food 
avoidance that exists across the eating disorders, but is most prevalent in AN (255, 256), and 
associated with greater AN severity (257). A recent investigation observed a prospective 
association between certain latent anxiety factors, derived from a collection of anxiety 
disorder symptoms, with fasting. In this study anxiety disorder pathology was assessed at age 
ten, and disordered eating behaviour at age 14 (170). Whether the reported associations are 
maintained over time, and particularly during the mid-late adolescent period in which AN 
incidence is highest (40), remains unclear. Further, whether anxiety has a predictive influence 
on fasting behaviour over a shorter time period is unknown. Yet, understanding whether 
associations vary with developmental and predictive periods could elucidate mechanisms by 
which anxiety is related to fasting, to further understanding of AN aetiology.  
The aim of the current study was to extend previous research by investigating the predictive 
influence of anxiety disorder pathology on fasting two years later, in mid-late adolescence, in 
a large population cohort, the Avon Longitudinal Study of Parents and Children (ALSPAC). 





4.5.1 Data source 
ALSPAC is a prospective population cohort study of families in the Bristol area of the United 
Kingdom (258, 259). Mothers were eligible for the study if their expected dates of delivery 
were between 1st April 1991 to 31st December 1992, and 14,151 pregnant women were 
initially recruited. When the eldest child participants were aged seven an attempt to increase 
the sample was made. In the total sample, there were 15,247 pregnancies, 15,458 foetuses, 
and 14,701 children alive at one year old. The ALSPAC study website contains details of all 
data collected from study participants. This is facilitated by use of the fully searchable 
variable catalogue and data dictionary (http://www.bristol.ac.uk/alspac/researchers/access/). 
Ethics approval for the study was obtained from the ALSPAC Ethics and Law Committee 
and the Local Research Ethics Committees.  
4.5.2 Participants 
We assessed whether the presence of an anxiety disorder at wave 13-14 and wave 15-16 
predicted fasting at the subsequent wave (wave 15-16 and wave 17-18, respectively). 
Participants of the current study were individuals who had provided anxiety disorder and 
fasting data for at least one of the prospective analyses of interest. Participants also had to 
have provided data to indicate whether they engaged in fasting at baseline (wave 13-14) to be 
included. The timing of data collection, in terms of the developmental stage of participants, 
has been standardised across participants in ALSPAC as far as possible. At wave 13-14: 
median age of anxiety disorder assessment was 13 years, 10 months; fasting was assessed at 
14 years.  At wave 15-16: median age of anxiety disorder assessment was 15 years, 5 months; 
fasting was assessed at 16 years. At wave 17-18, adolescents were aged 18 when fasting was 
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assessed. Participants remain eligible for follow-up in ALSPAC unless they withdraw 
consent or are untraceable (258, 259). As a result, there are participants who have responded 
to assessment invitations at later, and not earlier, time-points, and who are included in the 
second, but not first, longitudinal analysis of the study. 
Preliminary investigations found that both the exposure (anxiety disorder presence) and 
outcome (fasting) were extremely rare for males; in one analysis there were no males in the 
anxiety disorder and fasting category. Rare events and associated data sparseness affect the 
validity and precision of regression coefficient values (218, 219). The utility of a statistical 
test is also limited when there are no individuals in a category of interest. Given the data are 
not such to allow robust assessment of associations between anxiety disorders and fasting in 
males, even with methods designed to handle rare outcomes, we restricted our main analysis 
to females (n = 2,406).  
Figure 4-1 comprises a diagram of the data collection process, and details the number of 
participants at each stage. 
 





Fasting for weight loss was assessed by response to the question “During the past year, how 
often did you fast (not eat for at least a day) to lose weight or avoid gaining weight?”. This 
question was based on one of the validated Youth Risk Behavior Surveillance System (260, 
261), and was posed to adolescents in mailed questionnaires. Participants could select from 
the following response options: less than once a month; monthly; weekly. The fasting 
outcome variable was a binary indicator of whether individuals had engaged in fasting 
behaviour on at least a monthly basis during the previous year. Monthly fasting has 
previously been used as a criterion to derive AN diagnoses (204), supporting use of the 
outcome when attempting to identify predictors of AN behaviour. Furthermore, monthly 
fasting reported at age 16 predicts subsequent AN diagnosis (at age 18) in females of the 
ALSPAC sample (see Appendix E, Table 2 for relevant analyses).  
4.5.3.2 Anxiety disorders 
Anxiety disorder presence was assessed by the Development and Wellbeing Assessment 
(DAWBA; (262)). The DAWBA comprises a package designed to generate psychiatric 
diagnoses based on DSM-IV (263) and ICD-10 (264) criteria. In the current study computer 
algorithms determined the likelihood of individuals experiencing an anxiety disorder using 
response data collected from semi-structured interviews. There are six possible categories, 
ranging from level 0 (<0.1% chance of having an anxiety disorder), to level 5 (>70% chance 
of having an anxiety disorder). Individuals in the top two bands were at least 50% likely to 
have a given anxiety disorder and were assigned a diagnosis. This approach has been shown 
to produce anxiety disorder diagnoses that broadly align with clinician ratings (265). At wave 
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13-14 adolescent symptoms were parent-reported and the presence of generalised anxiety 
disorder, social phobia, specific phobia and separation anxiety disorder was assessed. At 
wave 15-16 adolescent symptoms were self-reported, and the presence of generalised anxiety 
disorder, social phobia, specific phobia, panic disorder, and agoraphobia assessed.  
Because of the rarity of anxiety disorders in the sample, we collapsed across diagnoses to 
create binary variables that indicated whether any of the assessed anxiety disorders were 
present, at each wave. These ‘any anxiety disorder’ exposure variables were used in analyses 
of the current study. When classifying individuals according to anxiety disorder diagnosis, 
obsessive-compulsive disorder and posttraumatic stress disorder were not considered since 
they are not included as anxiety disorders in current psychiatric diagnostic manuals. 
4.5.3.3 Co-variates 
Potential confounders of the anxiety disorder and fasting association were identified based on 
theory asserting the importance of particular variables in AN development, and previous 
findings regarding predictors of anxiety and restrictive eating. Specifically, these variables 
were: fasting at baseline (wave 13-14); binge eating at the earlier wave; purging at the earlier 
wave; and weight status (i.e. underweight, normal weight, overweight/obese) at the earlier 
wave. Prior research supports the proposal that unhealthy restrictive eating practices remain 
fairly stable throughout adolescence and young adulthood (266). Binge eating and purging 
are associated with both restrictive eating and anxiety symptoms (267-269). Cross-sectional 
evidence supports greater restrictive eating amongst overweight/obese adolescents (270, 
271), while longitudinal studies have reported associations between childhood body mass 
index (BMI) and AN risk in both directions (272). 
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Baseline fasting was assessed using the same question as that used to derive the outcome 
variable and indicated whether in the past year the individual had engaged in any fasting (i.e. 
less than monthly, or more frequently). Binge eating and purging were assessed in the same 
questionnaires that enquired about fasting behaviour at each of the waves, using questions 
adapted from those of the Youth Risk Behavior Surveillance System Questionnaire (260). 
Binge eating was recorded if the adolescent reported episodes of eating large amounts of food 
while feeling out of control in the past year, purging was recorded if adolescents reported 
making themselves sick or using laxatives to lose weight/avoid gaining weight in the past 
year. The questions about binge eating and purging have been validated in an adolescent 
sample (273). Weight status was determined using age, gender and body mass index 
information (BMI) collected from adolescents, along with UK reference data (274) and cut-
offs defined by the World Health Organisation (275) and the International Obesity Taskforce 
(276). BMI was calculated using objective weight and height measurements taken during 
clinic assessments at each wave. At wave 13-14 self-reported weight and height information 
was used when objective information was missing.  
Univariable regression analyses assessed whether the potential confounders actually met 
criteria for confounding. Variables were considered confounders if they were associated with 
exposure (anxiety) and outcome (fasting two years later) to a threshold of p < .10 at either of 
the longitudinal waves. Baseline fasting, binge eating and purging met criteria for 
confounding (details in Appendix E, Table 3) and were subsequently included as covariates 
in the main analysis. 
Predictors of missing data were also included as covariates in the main analyses so as to 
satisfy missing data assumptions of statistical models (236). Predictors of missingness in 
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ALSPAC are the demographic variables social economic status (SES), mother age at 
delivery, and mother parity (258). SES was derived from the lowest social class of both 
parents (manual or non-manual background). Mother parity was a binary indicator of whether 
the study child was the mothers’ first pregnancy to be carried to birth. Information in respect 
of these demographic variables was determined from questionnaire data. 
 
4.5.4 Statistical analysis (abbreviated) 
All statistical analyses were conducted in Stata 15.1 (277).  Generalized Estimating Equation 
(GEE) models (230) with an unstructured working correlation estimated the longitudinal 
association between anxiety disorder presence and odds of fasting at the subsequent wave, 
across both longitudinal waves (i.e. associations between anxiety disorder presence at wave 
13-14 and fasting at wave 15-16, and between anxiety disorder presence at wave 15-16 and 
fasting at wave 17-18). The anxiety disorder exposure, and disordered eating covariates 
(binge eating and purging), were treated as time-varying predictors, while all other covariates 
(SES, mother parity and mother age at delivery) were time invariant. Models were adjusted 
for wave of assessment, and robust standard errors were calculated.  
To determine whether associations differed across the course of adolescence, we stratified the 
longitudinal data by wave of analysis and performed binary logistic regression analyses. 
Models included the same predictors as the GEE analyses, and estimated coefficients using 
the maximum likelihood estimator.  
We also investigated whether anxiety disorders predicted engagement in future fasting in the 
subpopulation of individuals who reported no fasting at baseline. The same method as that of 
the full sample analysis was used. These analyses should be regarded as exploratory given the 
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reduced sample size, and in particular the reduced number of cases. Stata code for the main 
analyses is provided in Appendix E. 
Cross-sectional analyses of associations between anxiety and fasting across three waves of 
data (i.e. wave 13-14, wave 15-16 and wave 17-18) were also completed. GEE and logistic 
regression models estimated associations across and within the waves respectively, as for the 
longitudinal analyses. Results of cross-sectional analyses are available in Appendix E (Table 
4). 
4.5.4.1 Attrition (expanded) 
The availability of data varied with wave of analysis; at wave 13-14 the sample size was 
2204, and this reduced to 1382 at wave 15-16. Missing covariate data was imputed using the 
multiple imputation by chained equation (MICE) approach, implemented with the mi impute 
chained command in Stata (278). MICE assumes data points are missing at random, and is 
suitable for data that is not multivariate normal (242, 279). We created 70 imputed datasets. 
All variables of the analysis were included in the imputation models. Weight status variables 
from each of the waves, and anxiety disorder, binge eating and purging indicators at wave 17-
18, were also included in imputation models given associations of these variables with 
analysis covariates. Appendix E (Table 5) details associations between variables in the 
imputation model. 
4.5.4.2 Sensitivity analyses (expanded) 
Various sensitivity analyses were performed to determine the robustness of findings from the 
main imputed data analyses. First, complete case analyses were undertaken, excluding 
participants who did not have all outcome and covariate data for at least one of the 
longitudinal analyses of the GEE. Next, participants who did not meet criteria for certain of 
86 
 
the assessed anxiety disorders, but were missing data in respect of other diagnoses (recorded 
as having no anxiety disorder in the main analysis) were excluded. Finally, analyses were 
completed with the exclusion of participants reporting monthly fasting with concurrent binge 
eating or purging, and excluding participants who reported fasting and were missing data 
concerning binge eating or purging. This analysis informed whether the association between 
anxiety disorders and fasting is specific, as compared to indicating a relationship between 
anxiety disorders and disordered eating more generally. The exclusion of observations due to 
missing anxiety data, or binge eating/purging responses, was on a per wave basis: participants 
could be excluded at one wave and not another.  
Outcomes and resulting inferences in respect of all sensitivity analyses did not qualitatively 
differ from those of the main analysis. Coefficients were estimated with less confidence in 
sensitivity analyses however, as a result of the reduced sample size, and in particular the 
reduction in number of individuals endorsing the fasting outcome at each wave. The 
decreased number of fasting cases not only impacts the efficiency of subsample analyses (i.e. 
inflates the standard error), but can also introduce bias away from the null into estimates of 
association (218, 219). For these reasons outcomes of the main imputed data analyses are 
reported in this chapter, however full results of the sensitivity analyses are available in 
Appendix E (Tables 6-8). 
4.6  Results 
4.6.1.1 Sample characteristics 
Demographic information, and prevalence information for fasting, anxiety disorder and binge 
eating/purging variables is provided in Table 4-2. For a breakdown of anxiety disorder 
prevalence by anxiety disorder, see Appendix E (Table 9).  
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Table 4-2 Frequencies for Demographic Variables and Anxiety Disorder Presence 
Demographic Variables Frequencies 
N (%) 
Parent lowest combined social class at 
enrolment a 
 
Manual  300 (12.47) 
Non-manual 1,696 (70.79) 
Missing 410 (17.04)  
Ethnicity   
White 2,108 (87.61) 
Other ethnic group 37 (1.54) 
Missing 261 (10.85) 
Mother Parityb   
Primipari 1,068 (44.39) 
Multipari 1,180 (49.04) 




Underweight 212 (8.81) 
Normal weight 1,516 (63.01) 
Overweight/Obese 382 (15.88) 
Missing 296(12.30) 
Wave 15-16    
Underweight 150 (6.11) 
Normal weight 1,086 (45.14) 
Overweight/Obese 225 (9.35) 
Missing 945 (39.28) 
Wave 17-18    
Underweight 147 (6.11) 
Normal weight 1,242 (51.62) 
Overweight/Obese 308 (16.96) 
Missing 609 (25.31) 
Fasting Prevalence  
Wave 13-14 
Any fasting in past year 
 
Yes 217 (9.02) 
No  2,189 (90.98) 
Wave 15-16 
Monthly fasting in past year 
 
Yes 202 (8.40) 
No  2,090 (86.87) 
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Missing 114 (4.74) 
Wave 17-18 
Monthly fasting in past year 
 
Yes 124 (5.15) 
No  1,554 (64.59) 
Missing 728 (30.26) 
Anxiety Disorder Prevalence 
Wave 13-14 
Any anxiety disorder  
  
Yes 29 (1.21)  
No  2,272 (94.43) 
Missing 105 (4.36) 
Wave 15-16 
Any anxiety disorder  
  
Yes 47 (1.95) 
No  1,838 (76.39) 
Missing 521 (21.65) 
Covariate Prevalence 
Wave 13-14 
Binge eating in past year 
 
Yes 163 (6.77) 
No  1,976 (82.13) 
Missing 267 (11.10) 
Purging in past year 
 
Yes 53 (2.20) 
No  2,341 (97.30) 
Missing 12 (0.50) 
Wave 15-16 
Binge eating in past year 
 
Yes 352 (14.63) 
No  1,941 (80.67) 
Missing 113 (4.70) 
Purging in past year 
 
Yes 232 (9.64) 
No  2,068 (85.95) 
Missing 106 (4.41) 
a Parent occupation is a proxy indicator for socio-economic status, with manual and non-
manual occupations coded according to 1991 Office of Population, Censuses and Surveys 
classification. 
b Parity describes whether the study child was the first carried to birth by the mother. 
Primipari indicates child was the first pregnancy carried to birth by the mother; multipari 
indicates the mother had previous viable pregnancies. 




4.6.1.2 Longitudinal analysis 
GEE model estimates of effect and precision supported a longitudinal association between 
anxiety disorders and fasting, whereby anxiety disorder presence predicted an increased 
likelihood of engagement in fasting at the following wave (adjOR = 2.07 [95% CI 1.03, 
4.17], p = 0.04). The statistical evidence for the association between anxiety disorder 
presence at wave 13-14 and fasting at wave 15-16 estimated by the logistic regression model 
was not strong (adjOR=0.23 [95% CIs: 0.03, 1.83], p = 0.165). However, logistic regression 
model estimates indicated that individuals with an anxiety disorder at wave 15-16 were at 
greater risk of fasting at wave 17-18, and this was supported by the statistical evidence 
(adjOR=6.38 [95% CIs: 2.81, 14.49], p < 0.001).  
Findings of the exploratory GEE analysis supported anxiety disorder presence predicting 
increased likelihood of fasting at the following wave, for those individuals who reported no 
fasting at baseline (wave 13-14): adjOR = 2.61 [95% CIs:1.23, 5.54], p = 0.012. Outcomes of 
exploratory logistic regression models stratified by wave did not provide strong evidence for 
a predictive effect of anxiety disorders at wave 13-14 (adjOR = 0.58 [95% CI: 0.07, 4.47], p 
= 0.599). However, there was strong evidence to support anxiety disorder presence at wave 
15-16 predicting engagement in fasting at wave 17-18 in individuals who did not report 
baseline fasting (adjOR = 6.41 [95% CI: 2.56, 16.05], p < 0.001).  Table 4-3 provides full 
information in respect of effect estimates from the longitudinal analysis, including 
coefficients of all model covariates (baseline fasting, binge eating, purging, SES, mother 
parity, mother age at delivery of child, and wave of analysis). 
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Table 4-3 Longitudinal Associations of Anxiety Disorders and Covariates with Fasting  
 
Outcome: Fasting 
for weight loss/to 
avoid weight gain 
at subsequent wave 
Main analysis Exploratory analysis that excludes individuals reporting any fasting at baseline 
 GEE model Logistic regression models stratified by wave GEE model 
Logistic regression models stratified 
by wave 
  Wave 13-14 Wave 15-16  Wave 13-14  
Wave 15-16 
 
Total N 2406 2204 1382  2189  
2005 1276 



































































0.006 NA NA NA NA NA NA 































































































































0.005 NA NA NA NA 





The current study aimed to determine whether there was a longitudinal association between 
anxiety disorders and fasting for weight loss/to avoid weight gain in an adolescent sample. 
Findings partially supported our hypotheses. For females, across two longitudinal analyses, 
meeting diagnostic criteria for an anxiety disorder predicted an increased likelihood of fasting 
two years later, at the following wave. Exploratory analyses confirmed this association was 
present in a subset of individuals who did not engage in fasting at baseline. However, the 
prospective association observed was time-sensitive: post-hoc analyses (stratified by wave) 
confirmed that anxiety disorder presence predicted future fasting at wave 15-16, but not at 
wave 13-14. Outcomes of cross-sectional analyses (Appendix E, Table 4) were similar to 
those of longitudinal analyses: anxiety disorder presence predicted an increased risk of 
concurrent fasting across three waves of data (waves 13-14, 15-16, 17-18), but the 
relationship was stronger at the latter two waves. 
A recent study in the same population cohort identified associations of physical anxiety 
disorder symptoms assessed at age 10 with fasting behaviour at the 13-14 wave (170). We 
build upon this finding to identify more proximal predictive effects of anxiety disorders on 
fasting, and effects beyond early adolescence, i.e. the mid-late adolescent period. The 
collection of findings suggests that the predictive influence of anxiety on fasting varies over 
time: anxious pathology in childhood and mid-adolescence predicts increased risk of later 
fasting, while anxious pathology in early adolescence does not.  
However, it is possible issues with the measurement of anxiety disorders at wave 13-14 
prevented the detection of meaningful associations at this wave. Symptoms of anxiety 
disorders were parent-reported at wave 13-14; non-physical symptoms that could not be 
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articulated by adolescents, or that did not have observable outcomes, may have gone 
unreported. In support of this, parental report of covert internalizing symptoms, for example 
worry, is particularly discordant with child-reported symptoms (280). Parental assessment of 
child psychological symptoms tends not to correspond highly with child report generally 
however (281), with discrepancies increasing from childhood to adolescence (282). Rather 
than simply being erroneous, it is possible parent-reported symptoms reflect a different aspect 
of anxiety disorders as compared to self-report, and one that is differentially associated with 
fasting. Indeed, previous studies support the value of multiple informants when assessing 
psychiatric pathology (283), and have even indicated that parents may be the better source of 
information when making psychiatric assessments in some cases (265, 284). Future studies 
might consider using diagnostic information based on parent and child/adolescent reports 
when seeking to understand how anxiety disorder pathology may be associated with 
disordered eating outcomes.  
Sensitivity analyses demonstrated that anxiety disorder presence predicted fasting in the 
absence of binge eating and purging. Dietary restriction intended to influence weight/shape, 
and not binge eating and purging, is the defining feature of AN, and required for diagnosis - 
while the opposite is true for other eating disorders (1). It could be that there is a stronger 
association between anxiety disorders and the eating pathology characteristic of AN, as 
compared to associations between anxiety and eating behaviour that is more typical of other 
eating disorders. This could explain why a previous cohort study (254), reported no 
predictive effect of anxiety disorders on disordered eating more generally (i.e. binge eating 
and purging in addition to restrictive eating).  
Consistent with restrictive eating being characterised as a prodromal syndrome of AN (194), 
fasting predicted subsequent AN in the study sample. That anxiety disorders predict 
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engagement in fasting behaviour that is both indicative of increased AN risk and 
characteristic of AN (255, 256) aligns with outcomes of longitudinal studies in clinical 
populations. These studies consistently report anxiety disorders to precede, or to predict 
increased risk for, AN diagnosis (32, 119, 169). The associations that have been observed 
across various studies potentially lend support to the idea that individuals with non-weight 
gain-associated anxiety come to rely on dietary restriction as a means of managing this 
anxiety. Once the initial benefits of dietary restriction, in terms of anxiety regulation, are 
experienced, individuals may be driven to repeat the behaviour to the point of dependence 
(80, 97, 249, 250). In this case, anxiety disorder pathology may be said to causally influence 
the development of eating patterns symptomatic and predictive of AN. However, it is also 
possible that anxiety disorders signal the presence of an underlying predisposition to develop 
anxieties around weight gain and eating, and it is these that encourage engagement in severe 
forms of dietary restriction (285, 286). In this case, non-weight gain-associated anxiety does 
not causally affect the development of restrictive eating behaviour, it simply highlights 
increased risk of engagement in such behaviour.  
Parsing the two explanations apart to understand the relevance of anxiety disorders to 
disordered restrictive eating and AN is challenging. It has been found previously that 
adolescents with AN are more likely to later develop anxiety disorders compared to 
adolescents without AN (204). The bidirectional associations that appear to exist between 
anxiety disorders and AN could reflect shared risk mechanisms. This perspective is supported 
by relatives of individuals with AN being more likely to have an anxiety disorder diagnosis 
compared to relatives of individuals without AN (287). Genetic correlations between 
generalised anxiety disorder and AN have been reported (118), further suggesting anxiety 
disorders and AN share genetic risk factors. Alternatively, bidirectional associations between 
95 
 
anxiety disorders and AN indicate the operation of a vicious cycle. Anxiety unrelated to 
weight gain may be dealt with initially by restrictive eating, encouraging the restrictive eating 
to continue. Adaptions within various neurobiological systems in response to limited food 
intake could then result in a resurgence of anxiety, elevating this beyond initial levels, to 
promote further engagement in dietary restriction (114, 249). Understanding how anxiety 
disorders are associated with extreme forms of dietary restriction has implications for the 
development of effective eating disorder prevention and treatment interventions, and should 
therefore be a priority of future research. 
This study has a number of strengths. The large sample size and population-based nature 
increase the validity and reliability of findings. The prospective design minimised risks of 
recall bias and reverse causation, and use of validated interviews in anxiety disorder 
assessment reduces potential measurement error. The GEE approach and calculation of robust 
standard errors enabled the correlation between participants’ repeated fasting responses to be 
taken into account during the statistical analysis, promoting unbiased inferences. 
It is also recognized that our study has limitations. First, the anxiety disorders assessed, and 
the informants of anxiety symptoms (i.e. parents or adolescents), differed by wave. This 
introduces challenges to directly comparing associations across the different waves. Second, 
DAWBA diagnoses based on computer-generated bandings have been found previously to 
result in underestimation of disorder prevalence relative to clinician-assigned DAWBA 
diagnoses. However, although reduced sensitivity to anxiety disorder pathology theoretically 
could introduce bias, effect estimates for associations of various factors with DAWBA 
psychiatric diagnoses do not differ according to whether diagnoses are computer-generated or 
clinician-assigned (265). Third, the measure of fasting was questionnaire-based, which may 
have affected measurement validity. This limitation also applies to the assessment of binge 
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eating and purging. All disordered eating questions have been validated in previous studies 
however (260, 261). Finally, findings may not generalise to other populations given ALSPAC 
participants are not representative of the UK population in terms of ethnicity. Since SES is a 
predictor of attrition in ALSPAC, findings may not extend to individuals from less 
advantaged backgrounds.  
While findings can inform of the risk factors for fasting, with restrictive eating a prodromal 
syndrome and core symptom of AN, the knowledge generated from this study cannot be 
directly applied to AN. Fasting is more prevalent amongst adolescents and young adults than 
AN (288, 289), and many individuals who engage in the behaviour will never meet criteria 
for AN. In addition, our study conclusions cannot be extrapolated to males given male 
participants were not included in the final analysis. The rarity of fasting in male adolescents 
likely reflects differences in the presentation of disordered eating in males as compared to 
females. Excessive or compulsive exercise is more frequently endorsed, relative to restrictive 
eating, by male adolescents, which is not the case for females (290). Compulsive exercise has 
been reported to be more severe in males with AN as compared to females with the disorder 
(291), suggesting exercise may be a core feature of AN pathology in males. It might be 
valuable for future research in community samples to consider excessive exercise outcomes 
when attempting to understand determinants of behaviour typical of AN in male populations.  
Despite the discussed limitations, our study demonstrates that in females there is a predictive 
effect of anxiety disorders present in adolescence on subsequent fasting behaviour that is 
itself a risk factor for AN. Findings highlight anxiety disorder pathology as a potential target 
for eating disorder prevention efforts, although further research is required to determine the 
mechanisms underlying the observed association. Advances in the understanding of genetic 
risk factors and neurocognitive antecedents/outcomes of anxiety disorders and AN may 
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elucidate the nature of the relationship between anxiety and restrictive eating, with studies of 
experimental design testing hypotheses surrounding causation. 
 
4.8 Contribution to thesis 
Study 2 informs the temporal nature of association between anxiety disorder and AN 
pathology. Findings indicate that anxiety disorder presence predicts subsequent fasting 
behaviour that is both typical of, and a risk factor for, AN, at least during mid-adolescence. 
The anxiety disorder exposure included four/five disorders (depending on wave of analysis), 
and thus the detected association supports that anxiety, regardless of its focus, is relevant to 
AN. This finding may be compared with outcomes of prospective studies identified in the 
systematic review, which did not observe unique associations between specific diagnoses and 
AN development, to promote a more nuanced understanding of the anxiety pathology and AN 
relationship. In particular, the collection of evidence supports the relevance of common 
components of anxiety disorders (i.e. those that exist across the anxiety disorders) to AN.   
The association of such anxiety pathology with restrictive eating is consistent with the 
possibility that anxiety and AN are associated due to dietary restriction serving a general 
functional role of anxiety reduction. Thus, findings of Study 2 may also inform the 
mechanism by which anxiety disorders and AN are related. The consideration of an AN 
behaviour and risk factor as the outcome (i.e. fasting), rather than AN diagnosis, facilitates 
comparison between studies using different AN-related outcomes. This provides one way of 
determining the validity of detected associations and resulting conclusions concerning the 
anxiety pathology and AN relationship, given the choice of outcome has implications on the 
precise sources of bias affecting a study. For example, the outcome selected will impact the 
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particular confounders of the exposure-outcome association, as well as the nature of potential 
measurement error. 
The association detected in Study 2 is necessary, though not sufficient, to demonstrate a 
causal influence of anxiety pathology on AN behaviour. In Chapter 6 I present Study 3, 
which comprises the triangulation of findings across a longitudinal observational analysis and 
a Mendelian Randomization (MR) analysis, to promote greater confidence in causal 
inferences concerning the association of anxiety pathology with AN diagnosis. 
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5 Chapter 5: Mendelian randomization methods for Chapters 7 and 8  
The aim of this chapter is to provide an overview of the Mendelian randomization (MR) 
method used across studies 3 and 4, which are presented in Chapters 6 and 7, respectively. I 
begin by providing a glossary of key terms that may aid in the interpretation of this methods 
chapter. I then outline the motivation and theory behind MR, and consider the key 
assumptions of the method. Next, I explain how MR analyses are completed, describing the 
specific statistical methods and MR approaches that I used in studies 3 and 4, which were 




5.1 Glossary of key terms in this chapter 
Allele Genetic variants detected at a given position in the 
DNA sequence. 
Chromosome A molecule of DNA. 
Deoxyribonucleic acid (DNA) Hereditary or genetic material.  
Exposure Potential causal risk factor. In a MR analysis the 
exposure is instrumented by a genetic variant (i.e. the 
genetic variant replaces the exposure in the analysis of 
association between exposure and outcome), to 
determine whether the exposure causally influences 
the outcome. 
Gene Stretch of DNA that codes for the production of 
functional molecules. 
Genome-wide association study 
(GWAS) 
Study assessing association of a given trait with 
genetic variants across the genome.  
Instrumental variable Variable associated with risk factor of interest. The 
instrumental variable acts only via the risk factor to 
affect the outcome, and is not associated with 
variables that confound the association between 
exposure and outcome. In a MR analysis the 
instrument is a genetic variant. 
Linkage disequilibrium Association between alleles at different locations in 
the DNA sequence. 
Outcome Outcome variable of interest. In a MR analysis the 
association between the instrument and outcome is 
assessed to determine whether the exposure causally 
influences the outcome. 
Phenotype An observable characteristic, or trait. 
Pleiotropy The effect of a genetic variant on multiple traits. 
Population stratification The existence of different disease rates and allele 
frequencies within subpopulations, to result in 
associations between genetic variants and disease at 
the population level.  
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Single nucleotide polymorphism Positions on a chromosome where the genetic code 






5.2 Rationale for Mendelian randomization 
The intention of observational research in an epidemiological context is to identify causal 
associations that improve understanding of disease aetiology. However, traditional 
observational studies are vulnerable to particular biases that make it difficult to infer 
causality. The major source of bias in observational research is unmeasured confounding, or 
the influence of a given factor (a confounder) on both the exposure (risk factor; e.g. anxiety 
disorders) and outcome (e.g AN), which has not been accounted for in the statistical analysis 
(183). Here, it is not valid to naively compare individuals who vary with regard to the 
exposure, due to their differing in other ways that are relevant to disease aetiology. 
Confounding is a frequent occurrence in epidemiology since exposures of interest are 
typically associated with a wide range of behavioural (e.g. smoking, alcohol consumption), 
physiological (e.g. inflammatory markers, adiposity) and socio-demographic (e.g. social 
class, years of education) factors that are known to influence disease outcomes (292). 
Observational studies typically include potential confounders as covariates in the analysis, to 
remove the variance in outcome resulting from their effects. However, residual confounding 
is largely inevitable given it is likely that some confounders will not be identified, and others 
will not be perfectly measured (179).  
Another key source of bias in observational research is reverse causation, which can arise in 
longitudinal as well as cross-sectional research. This is actually a form of confounding, with 
earlier presence of a given outcome affecting existence of this same outcome later in time, as 
well as the development of the risk factor (184). In retrospective research recall bias may 
underlie reverse causation, with the disease outcome affecting the accurate reporting of an 
exposure (293).  
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MR (183) minimises bias due to confounding that complicates the interpretation of findings 
from observational research (294). MR comprises an instrumental variable analysis. Under 
this approach, genetic variants that are fixed at conception serve as instruments for exposures 
of interest, to determine whether an exposure causally influences a given outcome, and the 
magnitude of this influence. Put another way, instead of directly assessing the association 
between an exposure and an outcome, as in a traditional observational study, MR tests the 
association between a genetic variant strongly related to the exposure and an outcome (Figure 
5-1). 
Figure 5-1 Diagram of Mendelian randomization analysis 
 
The risk of bias due to confounding and reverse causation is minimised under a MR approach 
since generally inherited genetic variants associated with, and serving as instruments for, the 
exposure trait of interest (e.g. anxiety disorders) will not systematically be inherited with 
variants associated with other traits. In particular, the inheritance of a genetic variant 
instrumenting a given exposure is independent of the inheritance of genetic variants 
associated with traits that confound associations between the directly measured exposure and 
the outcome in an observational study (183, 292). This is a consequence of processes 
occurring during meiotic cell division, or the production of gametes (sex cells) containing the 
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genetic material transmitted from parents to offspring at conception, which are described in 
Mendel’s second law – the law of independent assortment (295). Further reducing the risk of 
bias due to reverse causation, inherited genetic variants cannot be altered by disease 
outcomes, and so associations between the two must reflect a direction of association from 
variant to outcome.  
5.3 Assumptions of MR 
MR makes three key assumptions concerning each of the genetic instruments in the analysis, 
which are discussed in turn below.  
Assumption 1: There is an association between genetic instrument and exposure. 
If this assumption is violated, the absence of association between instrument and outcome 
may falsely be interpreted as reflecting the absence of causal influence of the exposure on the 
outcome.  
Assumption 2: The genetic variant is not associated with the outcome through any pathway 
other than via the exposure. 
This assumption is known as the exclusion restriction assumption. The assumption is violated 
if the genetic variant directly influences the outcome. It would also be violated if the genetic 
variant is independently associated with a trait other than the exposure, and this other trait 
causally influences the outcome (e.g. Figure 5-2). For example, a genetic variant associated 
with anxiety may also be associated with working memory, via a distinct pathway. Should 
working memory affect AN risk, the MR estimate of the effect of anxiety disorders on AN 





Figure 5-2 Diagram of exclusion restriction assumption violation 
Pleiotropy refers to the process of a genetic variant causally influencing multiple traits, and is 
likely to be common given the established heritability of many measurable traits (296). 
Vertical pleiotropy describes the association of a variant with multiple outcomes, but with 
one outcome mediating genetic effects on the other outcomes. The presence of vertical 
pleiotropy is the subject of investigation in a MR analysis. In contrast, horizontal pleiotropy 
describes the independent association of a genetic variant with multiple outcomes, and 
comprises the largest potential source of bias in MR studies (297-299). Figure 5-3 
demonstrates possible pleiotropic effects of genetic variants. 
106 
 
Figure 5-3 Possible pleiotropic effects of genetic variants 
While the risk of a genetic instrument exhibiting horizontal pleiotropic effects is reduced 
when it has known and specific biological functions, the way in which genetic variation 
translates into risk for psychological traits and psychiatric disorders is largely unclear (300). 
Thus, protection from horizontal pleiotropy by using variants with known mechanisms is 
largely not possible when assessing effects of psychiatric or psychological exposures under a 
MR framework.  
Linkage disequilibrium is a known violation of the law of independent assortment, and 
describes the correlation between, or joint inheritance of, two genetic variants. Violations of 
the exclusion restriction assumption can occur when variants in LD with an instrument are 
associated with the outcome via a pathway that does not involve the exposure. However, LD 
is most likely between variants located in close proximity on the genome, and it is unlikely 
variants in similar locations independently influence a disease outcome (301).  
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Population stratification, which describes systematic genetic variation between 
subpopulations (e.g. particular ethnic groups), also poses a risk to the exclusion restriction 
assumption. Where population stratification occurs it is possible associations between a 
genetic variant and an outcome are confounded by demographic factors that are not of 
interest (302). Risks of population stratification may be minimised by including only 
individuals of particular ancestries (e.g. European heritage) in the MR study (294, 299). 
Assumption 3: Absence of association between genetic variant and factors that confound the 
association between exposure and outcome. 
Violation of this assumption would result in biased MR estimates, since gene-outcome 
associations would be influenced by mechanisms other than a causal influence of exposure on 
outcome. Associations of genetic instruments with variables that act as confounders in 
observational studies could be induced by pleiotropy, LD or population stratification (294). 
This assumption cannot be fully tested given the extent of possible confounding factors. 
However, empirical evidence suggests minimal associations between genetic variants 
instrumenting a particular exposure of interest, and the various socio-economic and 
behavioural factors that tend to confound associations in observational research (292).  
 
5.4 Completing analyses  
There are a number of different methods that may be used to complete MR analyses, and to 
derive estimates of causal effect (303). In the following section I describe the methods used 
in my analyses.  
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5.4.1 Instrument identification 
The first step in a MR study is to identify genetic variants associated with the exposure that 
will serve as instruments in the analysis. Notably genetic instruments do not need to causally 
influence the exposure for the MR analysis to produce valid estimates (183). The most 
common type of genetic variation that exists amongst individuals in a population are single 
nucleotide polymorphisms (SNPs). SNPs constitute a difference in just one of the nucleotide 
bases that make up DNA (adenine, thymine, guanine, cytosine) at a particular genetic region 
(locus), and are typically the genetic instruments employed in MR studies. The least common 
variant must occur in at least 1% of the population for a sequence alternative to be classified 
as a SNP, rather than a mutation, and usually there are two possible alleles (or variants) of a 
SNP (304).  
Genome-wide association studies (GWASs) assess the association between SNPs across the 
entire human genome and an observed trait, or phenotype, of interest. In these studies, the 
phenotype is regressed onto each SNP. Publicly available summary GWAS data for my 
exposures of interest was used to identify instruments in each MR analysis. Summary GWAS 
data typically details the SNPs included in the GWAS (identifier, chromosomal location, 
possible alleles and allele frequency information - or proportion of individuals with a given 
variant of each SNP in the study sample), and outcomes of the regression of phenotype on 
each SNP (coefficient estimates, standard error estimates, and statistical significance values).  
Where there is only a weak association between the instrument and outcome, confounding 
factors are likely to explain a greater proportion of the variance in exposure and outcome, as 
compared to the genetic variant, which biases the estimate of causal effect (305). To 
minimise the risk of this so-called weak instrument bias, I used only those variants associated 
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with the exposure at the genome-wide significance level (5 x 10-8) as instruments in my MR 
analyses. To further evaluate the strength of association between instrument and exposure I 
considered the F statistic (306), which represents the ratio of variance in exposure explained 
versus unexplained by the instrument. The F-statistic may be approximated from GWAS 
summary data, by dividing the estimate for the instrument-exposure association by its 
standard error (307). In analyses with multiple variants the mean F value can be calculated. 
Instruments with a mean F statistic of below 10 are more likely to be weak (308). Across all 
of my primary MR analyses the mean F statistic of genetic instruments was over 30, 
suggesting low risk of weak instrument bias. The use of genetic instruments robustly 
associated with the exposure can also reduce the risk of horizontal pleiotropy (promoting 
satisfaction of MR assumption 3), since these variants are less likely to be non-specific, or 
associated with multiple traits (297, 309). 
Variants associated with the exposure at the genome-wide significance level (5 x10-8) were 
clumped so that only those independently associated with the exposure were used as 
instruments in my analyses: variants with the smallest p value in particular LD blocks (blocks 
of correlated variants, informed by reference data from the 1000 Genomes Project (310)) 
were identified for use as instruments. To qualify as independent, variants had to be 
correlated at an r2 < 0.001, where r2 is the squared correlation coefficient for two indicator 
variables, reflecting the co-occurrence of particular alleles at two SNP locations (311). SNPs 
also had to be at least a distance apart of 10,000kb, or 10,000 nucleotide bases, to meet 
independence criteria.  
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5.4.2 Obtaining estimates of association between instruments and outcome 
The next step in a MR analysis is to determine the association between the instruments and 
the outcome of interest (i.e. derive coefficients for the regression of the outcome onto each 
identified instrument, and corresponding standard errors). Estimates of the gene-exposure and 
gene-outcome associations are required to estimate causal effects in a MR analysis. 
Historically these associations have been assessed in the same sample. However, when this is 
not the case, MR analyses will yield valid estimates and inferences providing samples in 
which the associations are assessed are drawn from the same underlying population (299). 
The use of different samples for assessment of instrument-exposure and instrument-outcome 
associations comprises a two-sample MR approach (312), and was adopted in my studies. 
Two-sample MR assumes the two samples are not overlapping (299, 313). To identify 
associations between instruments and the outcome, instrumental SNPs were ‘looked up’ in 
publicly available summary GWAS data in respect of the outcome. Exposure and outcome 
GWAS used in my MR analyses were completed in mixed-sex samples of European ancestry 
to promote satisfaction of the homogeneous (same) population assumption of two-sample 
MR. There was minimal overlap between exposure and outcome GWAS samples in each of 
my MR analyses. 
Two-sample MR has some particular advantages. Firstly, the method allows for use of large 
consortia GWAS to identify genetic instruments and to assess associations between 
instrument and outcome (314). This increases statistical power to identify instruments, 
allowing for inclusion of a greater number of instruments in the analysis, and increases 
precision of estimated instrument-outcome associations, both of which serve to enhance 
power in a MR analysis (312). Second, because instrument-exposure and instrument-outcome 
associations are estimated in different samples, variance explained by confounders in the 
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separate regressions will not be correlated. As a consequence of this, when instruments are 
weak, the bias introduced into the MR estimate is towards the null (312), and the analysis is 
therefore conservative.  
 
5.4.3 Harmonisation of exposure and outcome GWAS 
To perform two-sample MR, data concerning the association of instruments with exposure 
and outcome, and therefore data from exposure and outcome GWAS, must be combined. 
Appropriate harmonization is necessary to ensure the MR estimate is not distorted (315), and 




Figure 5-4 The implemented harmonization process 
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5.4.4 Estimation of causal effects 
5.4.4.1 The Wald ratio method 
The ratio of coefficients, or Wald ratio, method (316) is the simplest of MR analyses able to 
derive estimates of the causal effect. A single genetic instrument is included in the analysis, 
with the causal effect of exposure on outcome (BY| X) calculated by dividing the coefficient 
for regression of the outcome on genetic variant z (BY| z) by the coefficient for regression of 
the exposure on genetic variant z (BX|z). This may be more intuitive when we consider the 
MR assumption that the effect of the instrument on the outcome is entirely mediated by the 
exposure (Figure 5-5). 
Figure 5-5 Diagram to show mediation pathway of interest in MR 
The mediation equation for the indirect effect of genetic variant z on the outcome is: 
(1) BY| z = BX|z * BY|X  
Rearranging the equation to determine the coefficient in respect of the effect of exposure on 
outcome gives us the Wald ratio formula: 
(2) BY| X = BY|z / BX|Z  
Notably there are no covariates included in the MR analysis, since the genetic instrument is 
assumed to be independent of potential confounders, as described in section 5.3. 
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The primary determinant of variability surrounding a MR ratio estimate is the variance in 
exposure explained by the genetic variant, or the R2 value in the regression of exposure on 
genetic variant, with R2 and MR effect estimate precision positively associated (317, 318). 
Sample size also determines the precision of ratio estimates, although in the two-sample 
setting it is the outcome GWAS size that predominantly dictates power – the size of the 
sample in which gene-exposure estimates are derived typically has little influence (312). 
5.4.4.2 Inverse-variance weighted method 
Where multiple SNPs are eligible genetic instruments for a given exposure, ratio estimates of 
causality may be combined to produce a weighted average, using an inverse variance 
weighted (IVW) formula adopted from the meta-analysis literature (319, 320). The 
contribution of each ratio estimate to the combined estimate of causal effect is inversely 
proportionate to its variance. The IVW estimate may also be derived from a weighted linear 
regression of the instrument-outcome association coefficients on the instrument-exposure 
association coefficients, with weights inversely proportional to the precision of instrument-
outcome association estimates. The IVW estimate corresponds to the slope of the line of best 
fit that passes through the origin.  
Similar to ratio estimates, the main determinant of IVW estimate precision is the variance in 
exposure explained by the genetic instruments (i.e. R2) (321). Providing instruments 
contribute uniquely to the R2 value, a greater number of instruments will enhance statistical 
power in a MR analysis, and thus multiple variant analyses are more powerful as compared to 
the single variant analysis (321, 322). However, the greater number of instruments in an 
analysis increases the risk that one of these will exert horizontal pleiotropic effects (309).  
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5.5 Assessing the robustness of MR findings 
Should any of the core MR assumptions concerning the instruments be violated, estimates of 
causal effect are liable to be biased, and consequential inferences may be invalid (323, 324). 
When multiple independent genetic variants are included as instruments in a MR analysis, 
additional statistical tests may be undertaken to determine the robustness of detected effects, 
and conclusions concerning causality.  
5.5.1 Tests of heterogeneity 
It is theoretically possible for all genetic instruments of a MR analysis to violate at least one 
of the instrumental variable assumptions. However, it is unlikely that bias resulting from 
horizontal pleiotropy or other mechanisms would impact the estimate of each independent 
genetic variant in the same way, in the absence of an underlying causal effect (325). Probing 
the consistency of ratio estimates across different SNPs of the MR analysis provides a means 
of validating causal conclusions arising from the overall estimate, and of identifying variants 
that may be distorting the IVW estimate.  
Statistical heterogeneity refers to the estimation of different effects, and exists when the 
variation of ratio estimates combined in an IVW analysis is greater than would be expected 
by chance (326). Statistical heterogeneity is indexed with Cochran’s Q statistic (327), which 
tests the null hypothesis that estimates are assessing the same effect. The Q test of statistical 
heterogeneity is sample size-dependent, with power to detect heterogeneity across ratio 
estimates of different SNPs increasing with the number of SNPs included in an analysis. The 
I2 statistic indicates the amount of variation in effect estimates that is due to heterogeneity 
rather than chance (328). I2 indexes the impact rather than extent of heterogeneity, and is not 
sample size-dependent. An I2 value of 0% indicates no influence of heterogeneity on the 
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variability of ratio estimates, while larger values indicate a greater influence of heterogeneity 
on SNP ratio estimate variability. Confidence intervals for I2 may be calculated to index the 
uncertainty around I2 estimates, using formulae from the meta-analysis literature (328).  
Where there was evidence to support the presence or influence of heterogeneity across 
individual SNP ratio estimates that were combined in a MR analysis, I completed leave-one-
out analyses. This involves repeating the MR IVW analysis, leaving out one SNP at a time, to 
highlight SNPs with a large effect on the estimate of heterogeneity, and which may be 
violating instrumental variable assumptions. MR analyses may then be repeated with the 
exclusion of offending variants. I also plotted the ratio estimates of individual SNPs in each 
multiple variant MR analysis, regardless of whether heterogeneity was statistically indicated, 
enabling further visual inspection of variability across the estimates.  
5.5.2 Sensitivity analyses 
There are several robust MR methods that rely on weaker underlying assumptions concerning 
the genetic instruments of an analysis. These methods serve as sensitivity analyses, to 
confirm whether inferences arising from the IVW estimate are likely to be valid (329). I 
completed three analyses that provide unbiased estimates of causal effect in the event that a 
subset of genetic variants violate the key instrumental variable assumptions. These were MR 
Egger, weighted median, and weighted mode, analyses - considered in turn below. 
5.5.2.1 MR Egger  
MR Egger (297) does not assume the validity of any of the genetic instruments in an analysis, 
and will produce consistent (asymptotically unbiased) estimates of causal effect in the event 
that all variants exert horizontal pleiotropic effects. MR Egger assumes that any direct effects 
of the genetic instrument on the outcome (or effects not mediated by the exposure) are 
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independent of the strength of the instrument (i.e. the magnitude of association between 
variant and exposure). As a consequence, estimates arising from stronger genetic instruments 
are assumed to be less biased. This is known as the Instrument Strength Independent of 
Direct Effect (InSIDE) assumption, and is weaker than the exclusion restriction assumption. 
There is currently no clear evidence to support associations between the magnitude of genetic 
effects on traits that are not causally related (330), indicating the plausibility of the InSIDE 
assumption (184).  
The MR Egger estimate is derived by regressing estimates of the instrument-outcome 
association on those of the instrument-exposure association, as per one approach to derive 
IVW estimates. However, in an IVW analysis the intercept term that comprises the average 
value of horizontal pleiotropic effects is constrained to zero, while the intercept is estimated 
in a MR Egger model. If the estimated intercept does not differ from zero in a MR Egger 
analysis, this suggests an absence of directional or unbalanced pleiotropy (i.e. no pleiotropic 
effects, or pleiotropic effects of different variants cancel each other out). In this event the 
IVW estimate will not be biased. In contrast, when the intercept does differ from zero, 
directional pleiotropy may be concluded, meaning the IVW estimate is invalid. The causal 
effect estimated by the MR Egger test (the regression slope) is corrected for detected 
unbalanced horizontal pleiotropic effects.  
An example of bias due to horizontal pleiotropy in the IVW estimate, and the correction 
under MR Egger is shown in Figure 5-6 below. Each data point corresponds to a SNP 
estimate; the slope of the best fitting line through the data points and origin is the IVW 
estimate. The presence of unbalanced horizontal pleiotropy means that the intercept is non-




Figure 5-6 Example plot of gene-outcome estimates against gene-exposure estimates in the 
presence of unbalanced horizontal pleiotropy 
Because MR Egger estimates the intercept parameter, precision depends on variability of the 
instrument-exposure associations across genetic variants of the analysis, in addition to the 
factors contributing to the standard error term of the IVW estimate (i.e. R2) (324). Reduced 
variability across instrument-exposure associations results in lower precision of both intercept 
(unbalanced horizontal pleiotropy) and slope (causal effect) estimates (331). Thus, although 
more robust to pleiotropic effects, the MR Egger test has reduced power to reject the null 
hypothesis as compared to the IVW method (297). When the variability of SNP-exposure 
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estimates is lower than what might be expected from the standard errors of these estimates, 
the estimate of causal effect shrinks on average to zero (324). As a consequence, bias towards 
the null is greater in MR Egger analyses, relative to IVW analyses, when genetic instruments 
are weak (307). When the SNP-exposure estimates do not vary at all, MR Egger parameters 
cannot be formally identified (331).  
An adaption of the Q statistic, known as Rucker’s Q (or Q’) estimates heterogeneity across 
SNP ratio estimates under a MR Egger framework, or while allowing for unbalanced 
horizontal pleiotropy (323, 332). Comparing heterogeneity estimates in respect of IVW and 
MR Egger models (i.e. Q versus Q’) informs whether MR Egger regression provides a better 
fit to the data as compared to the IVW analysis, and thus whether directional pleiotropy is 
likely to bias IVW estimates (323). A large value of Q – Q’ would indicate a better fit of the 
MR Egger model. 
5.5.2.2 Weighted median 
The weighted median estimate (333) is the median value of a weighted distribution of ratio 
estimates. The overall estimate will be unbiased provided that valid instruments contribute to 
at least 50% of the overall weight. Weights applied to ratio estimates to calculate the 
weighted median are the inverse of their variance (as in the IVW analysis), subsequently 
standardised by dividing the weight for each genetic variant over the total of the weights. 
Unlike MR Egger, the weighted median approach requires a proportion of variants to be valid 
instruments for consistent estimation. However, when the InSIDE assumption of MR Egger is 
violated, the weighted median estimate is less biased as compared to that of MR Egger. 
Power in weighted median analyses is generally greater as compared to IVW analyses, and 
considerably enhanced over MR Egger (333).  
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5.5.2.3  Weighted mode 
The weighted mode estimate is the most frequent (modal) value of a (inverse variance) 
weighted distribution of estimates. Provided the most frequent effect in the distribution is a 
valid estimate, the method provides a consistent estimate of the causal effect (334). The 
weighted mode method provides a less biased estimate of the causal effect, as compared to 
IVW and weighted median estimates, when unbalanced horizontal pleiotropic effects are 
present. When the InSIDE assumption is violated, the weighted mode estimate is also less 
biased than that of the Egger estimate. The exception is when there is a large proportion (i.e. 
80%) of invalid instruments, as this serves to reduce the extent of InSIDE assumption 
violation (334). Weighted mode analyses have reduced power relative to IVW and weighted 
median methods, but greater power as compared to MR Egger analyses (334).  
5.5.2.4 Single instrument analyses 
When there was a single SNP independently associated with the given exposure at the 
genome-wide significance level, sensitivity analyses could not be completed. In this case I 
ran additional analyses, using a significance threshold of 5 x 10-6 for instrument 
identification. The use of weaker instruments increases the potential for bias towards the null, 
however estimates of mean F statistics remained above 20, exceeding the proposed threshold 
of 10 (308). The reduced significance threshold for instrument identification enabled 
completion of IVW and sensitivity analyses, as well as assessments of heterogeneity across 
SNP estimates. Outcomes of these analyses could then inform the validity of conclusions 




5.5.3 Confirming the direction of causal effect 
Should a genetic variant be robustly associated with both exposure and outcome, this could 
reflect a causal influence of outcome on exposure. However, if the instrument is associated 
with the outcome via the exposure (as is tested under a MR framework), then the instrument 
should explain greater variance in the exposure as compared to the outcome (335). This may 
be assessed with the Steiger test (336), which in a MR setting involves comparing R2 from the 
regression of exposure onto genetic variant, with the R2 from the regression of outcome onto 
genetic variant. Where there was evidence to support a causal effect of exposure on outcome 
in the primary MR analysis, Steiger tests were completed for each instrument of the MR 
analysis.  
R2 values are not generally included in GWAS summary statistics, but may be estimated from 
summary statistic information. P value and sample size information is used to estimate SNP 
R2 values in respect of traits measured on a continuous scale (quantitative traits). For binary 
traits such as AN, where individuals are categorised as cases (meeting AN criteria) or HC, 
SNP R2 is estimated using allele frequency and sample size information, along with the odds 
ratio estimate for association between SNP and the trait, and estimated trait prevalence in the 
population (335). Completion of Steiger tests enabled the identification of variants more 
strongly associated with the outcome as compared to the exposure, allowing removal of these 
variants (termed Steiger filtering) and repetition of MR analyses with only the filtered 
variants. Should the majority of variants remain in the analysis after Steiger filtering, and 
should effects observed in subsequent sensitivity analyses be consistent with those of original 
analyses, confidence in original causal conclusions would be enhanced.  
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5.6 Diagram of MR methods 
For a summary of the methods I used to complete MR analyses, see Figure 5-7.  
Figure 5-7 Overview of MR methods used in my studies 
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5.7 Interpretation of MR effect estimates 
While outcomes of MR analyses inform the nature of a given relationship, care should be 
taken when interpreting estimates of causal effect, for reasons considered below. 
5.7.1 Issues with binary outcomes 
Mendelian randomization analyses in Chapters 6 and 7 were completed with respect to a 
binary outcome: AN diagnosis, reflecting whether individuals met criteria for lifetime AN 
diagnosis or not. The gene-outcome association was estimated with logistic regression, to 
provide the log-odds of liability for AN in relation to possessing particular gene variants, 
which may be exponentiated into an odds ratio. Odds ratios are non-collapsible; that is, the 
population average effect does not equate to the effect within strata of the same population, 
and will likely vary with values of the exposure (337). The fact the odds ratio is not 
consistent across different populations does not invalidate tests of causality within a MR 
framework when outcomes are binary (338, 339). However MR estimates in this situation 
should be interpreted as reflecting marginal, or population-averaged, effects (340). Instead of 
focusing on the precise value of estimates, consideration of the magnitude and direction of an 
estimated association, alongside the strength of supporting statistical evidence, is encouraged 
when considering a binary outcome (341). 
5.7.2 Issues with binary exposures 
In Chapter 6, I assessed the causal influence of anxiety disorder case status, which is a binary 
exposure, on AN risk. The MR estimates for this analysis will reflect the causal effect in the 
group for whom the association between case status and genotype holds, or those for whom 
anxiety disorder case status is accurately predicted by genotype. This effect is unlikely to be 
the same as the causal effect that exists in the entire population from which the sample is 
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drawn. An additional issue is that when the binary variable is a dichotomisation of an 
underlying continuous trait, the exclusion restriction assumption is violated. This is because 
there are likely to be associations between exposure and outcome within the two categories of 
the exposure. Thus, the influence of the exposure is via its continuous, as well as binary, 
form. Psychiatric pathology exists along a continuum (342), meaning that MR analyses in 
respect of a binary case-control exposure (e.g. indicating anxiety disorder presence or 
absence) provide a valid test of the null hypothesis, but estimates of causal effect have no 
clear interpretation (343). 
5.7.3 Translation into likely effects of an RCT 
While the purpose of MR is to establish the causal influence of modifiable risk factors on 
disease outcomes, effect estimates from MR studies are unlikely to equate to effect estimates 
resulting from an RCT designed to modify the same exposure (344). MR estimates indicate 
consequences of lifetime exposure to a given risk factor, while RCTs assess the effect of a 
short-term intervention that modifies the risk factor. MR also captures the effect of variation 
in exposure within the typical range. Chronic exposure to more usual levels of the risk factor 
may have different effects to acute changes in more extreme levels of the risk factor, which 
RCTs typically aim to achieve. It is also possible that buffering, or adaption, to the exposure 
conveyed by the genotype occurs (a phenomenon known as canalization), which would result 
in MR underestimating the influence of exposure on outcome (301). Finally, the difference in 
the level of a risk factor instrumented by a SNP is typically small, given modest associations 
between single variants and the exposure trait. In contrast, interventions designed to modify a 
given risk factor aim to produce more substantial changes in the exposure. A linear 
extrapolation of MR estimates to predict the exact effects of an RCT may not be valid (344). 
These caveats do not undermine the potential for MR to inform the nature or magnitude of an 
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association, but they do encourage caution over the direct application of findings to an RCT 
setting (344). 
5.8 Using MR to strengthen causal inference 
In Study 3 (Chapter 6) I consider whether conclusions arising from MR analyses are 
consistent with outcomes of a prospective longitudinal study. Whilst MR is less vulnerable to 
the confounding that affects observational studies, it does rely on particular assumptions that 
if violated could bias effect estimates and result in invalid inferences. However, the potential 
sources of bias in a two-sample MR study differ from those affecting studies of conventional 
observational design. As such, it would not be expected for findings across studies to 
converge on the same conclusion unless this conclusion was valid (181). This is particularly 
so given certain sources of bias in two-sample MR (e.g. that resulting from use of weak 
instruments) result in bias towards the null, or bias in the opposite direction to that caused by 
confounding in observational research.  The key assumptions of the prospective observational 
and MR studies of Chapter 6 are outlined in Table 5-1 below. 
Table 5-1 Comparison of Key Assumptions of the Prospective Observational Study and the 
MR Study of the Triangulation Investigation Presented in Chapter 6 
Prospective Observational Study MR study 
Absence of unmeasured or residual 
confounding 
Absence of bias due to horizontal pleiotropy 
Absence of reverse causation Absence of population stratification 
Missing data does not depend on 
unobserved data 
Robust association between genetic 
instrument and exposure 
 
Consistency of findings across studies can promote confidence in resulting conclusions, yet 
inconsistency is also informative. Discrepancies across study findings may highlight the 
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presence of bias that serves to invalidate outcomes of a prospective longitudinal study, or 
promote further investigation designed to clarify the nature of association under study. Where 
inconsistencies suggest confounding of observational analyses, this may give rise to novel 
hypotheses concerning shared risk factors that can be explored in future research. 
5.9 Multivariable MR 
The single exposure MR analysis may be extended to include multiple exposures, to evaluate 
the unique causal influence of each of a set of risk factors. This is known as multivariable 
MR (345), and was implemented in Chapter 7. In this case the estimate of causal effect for 
exposure X1 is adjusted for the direct influence of exposure X2, and vice versa, as in a 
multiple regression model. Similar assumptions to those of the single exposure MR analysis 
apply in respect of the genetic instruments, and must be met for multivariable MR estimates 
of association to be valid. These assumptions are: 
1. The genetic instrument is associated with one or more of the exposures. 
2. The genetic instrument does not affect the outcome other than via the exposures. 
3. The genetic instrument is not associated with confounders of any of the exposure-
outcome associations. 
GWAS summary statistics for each exposure are used to identify independent variants 
associated with each of the exposures at the genome-wide significance level (5 x 10-8), as in 
the univariable case. A list of independent genetic variants associated with any of a set of 
given exposures of interest may then be generated, with these variants serving as instruments 









Figure 5-8 Generation of instrument list in multivariable MR 
GWAS data for the exposures and outcome are then harmonized, capturing estimates of 
association between each of the genetic instruments with all of the exposures and the 
outcome, as shown in Figure 5-9.  
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Figure 5-9 Harmonization of exposure and outcome GWAS datasets in multivariable MR 
In the primary multivariable MR analysis (multivariable IVW analysis), SNP-outcome 
associations are regressed onto corresponding SNP-exposure associations, for all risk factors 
simultaneously (345). When fitting the regression model, inverse variance weights in respect 
of SNP-outcome associations are applied (346). The estimates of effect resulting from a 
multivariable MR analysis correspond to independent and direct causal effects of each of the 
exposures: they do not capture effects mediated by other exposures included in the model 
(345).  
Variants associated with one given exposure will not generally be robustly associated with 
other exposures in the multivariable analysis, unless the two exposures are themselves 
causally related. As a consequence, the risk of horizontal pleiotropic effects that are not 
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accounted for by inclusion of multiple exposures increases in a multivariable IVW analysis, 
relative to a univariable analysis. MR Egger has been extended to the multivariable setting, 
allowing for the estimation of, and correction for, bias due to pleiotropy in the multivariable 
IVW analysis (347). The assumption that instrument strength is independent of any direct 
effect (i.e. the InSIDE assumption) is more likely to be satisfied in the multivariable setting, 
as compared to univariable MR Egger regression. This is because there will be fewer 
components in the residual direct effect (from SNP to outcome) as the influence of other 
exposures (through which horizontal pleiotropic effects of the SNP may act) is accounted for 
in the multivariable model. In MR Egger regression the variants are oriented so that the 
estimates of SNP effect on the exposure are with respect to the risk-increasing allele, 
ensuring that the SNP-exposure association is always positive (297). This means that the 
estimated bias term is consistent across SNPs in the analysis. In multivariable MR the risk-
increasing allele may vary across the exposures, and it is recommended that variants be 
oriented with respect to the exposure of primary interest. An example of SNP orientation with 
respect to exposure 1 is shown in Figure 5-10.  
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Figure 5-10 Example of orientation of SNP estimates in multivariable MR Egger analysis 
The estimates of multivariable MR Egger are less precise than those of multivariable IVW 
analyses. Estimates are more precise compared to those of univariable MR Egger analyses 
when the inclusion of additional exposures (or sets of SNP-exposure associations) increases 
the variance explained in SNP-outcome associations (347). However, precision in 
multivariable MR Egger (and IVW) analyses also depends on the correlation between SNP-
exposure estimates for the different exposures (i.e. correlation between BX1 and BX2). 
Standard errors of causal effect estimates increase as the correlation between BX1 and BX2 
increases (347). As in the univariable setting, multivariable MR Egger serves as a sensitivity 
analysis to assess the robustness of conclusions arising from IVW estimates of association. 
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Thus, when estimates of multivariable IVW and MR Egger models are consistent, and 
pleiotropy is not indicated, there may be greater confidence in the validity of inferences 




6 Chapter 6: Triangulation across an observational study and a 
Mendelian randomization study to understand the nature of association 
between anxiety phenotypes and anorexia nervosa 
In this chapter I describe an investigation that adopted a triangulation approach to the study 
of anxiety disorders and AN. Specifically, the investigation compared findings across a 
prospective longitudinal study and a Mendelian randomization (MR) study, to assess the 
association of two anxiety pathology phenotypes with AN. In each study, the association of 
anxiety disorders, and the worry central to these disorders, with AN is probed. The 
investigation is presented as it appears in the manuscript currently undergoing review, aside 
from slight changes to the methods sections for both observational and MR analyses. This is 
to provide further detail that may be useful to the reader, and to prevent duplication of the 
previous MR methods chapter. A previous version of the manuscript, which included the MR 
analyses of the current chapter, though not the observational analyses, was published as a 
preprint on bioRxiv. Sections of the preprint appear in current chapter, and the full version is 
 
 Lloyd EC, Sallis HM, Verplanken B, Haase AM, Munafò MR. Assessing the causal influence of anxiety 
phenotypes on anorexia nervosa: a triangulation approach. 
 Lloyd EC, Sallis HM, Verplanken B, Haase AM, Munafò MR. Bidirectional effects of anxiety and anorexia 
nervosa: A Mendelian randomization study. BioRxiv. 2018 Jan 1:451500. 
Author contributions (to both papers): I conceived of, and designed, the studies, accessed data, completed all 
statistical analyses, and drafted manuscripts. MRM contributed to study idea development and design, and 
assisted with the refinement of manuscripts. HMS, BV and AMH refined manuscript drafts. All authors 
approved the final version of manuscripts submitted for publication. 
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available in Appendix F. I conclude this chapter by considering the contribution of the 
triangulation study to the thesis.  
6.1 Introduction 
Anorexia nervosa (AN) is a serious eating disorder characterised by persistent restriction of 
caloric intake and fear of weight gain in the context of a low body weight (1). The lifetime 
prevalence rate of AN is estimated to be as great as 4% in women (246). The disorder has a 
range of lasting physical health complications, and the highest mortality rate of any 
psychiatric illness (45), yet no single treatment or set of treatments is consistently successful 
(68).  
Despite considerable recent research into AN, with respect to a range of possible causal 
mechanisms (e.g. genetic, neural, psychological and personality factors), the aetiology 
remains largely unknown. A number of models of illness propose a causal role of anxiety that 
does not surround eating and weight gain (i.e., anxiety not explained by a diagnosis of AN) in 
the development of AN. In particular, it is suggested that for those who develop AN, dietary 
restriction reduces anxiety, making restrictive eating a valuable coping mechanism, to 
encourage its continuation (97, 98, 102, 196). Empirical research findings provide some 
support for such models. Anxiety disorder prevalence is elevated in AN populations, as 
compared to the general population (32, 117), and retrospective studies report anxiety 
disorder pathology to precede the onset of AN (32, 119). The small collection of prospective 
research provides mixed support for associations between specific anxiety disorder diagnoses 
and AN development (169, 212, 213). However, there is some indication that anxiety 
disorder pathology generally (i.e. not particular to certain diagnoses) predicts increased risk 
of subsequent AN (169, 170). 
134 
 
Prospective studies are more robust to bias resulting from reverse causation compared with 
cross-sectional and retrospective studies, but all observational research is vulnerable to bias 
due to confounding by unmeasured, or inadequately measured, factors (183). The potential 
for shared causal risk factors to explain associations between anxiety disorders and AN 
means that conclusions concerning the causal effects of anxiety disorders on AN cannot be 
based on findings of prospective studies alone.  
Triangulating, or integrating, findings across prospective studies with those of alternative 
design that are subject to different potential biases can strengthen causal inferences (181). As 
such, we aimed to compare findings across studies using different methods to probe 
associations between anxiety and AN (180). The precise exposures of interest were worry, a 
transdiagnostic and cognitive component of anxiety disorders, and anxiety disorders 
themselves, which comprise a broader collection of cognitive and physical symptoms (131, 
348). 
The first study is a prospective cohort study that uses longitudinal data from the Avon 
Longitudinal Study of Parents and Children (ALSPAC) to determine whether worry and 
anxiety disorder presence at age 10 predict lifetime AN by age 24. The second study used a 
two-sample Mendelian randomisation (MR) approach (183, 312) to address whether worry, 
and genetic liability for anxiety disorders (case-control and quantitative phenotypes), causally 
influence AN risk.  
MR uses genetic variants associated with an exposure of interest (here, worry, and anxiety 
disorders) as instruments for examining the association between an exposure and an outcome 
(Figure 6-1; (183)). MR (described comprehensively in (184)) provides a test of causal 
association that is subject to minimal bias by the confounding and reverse causation that 
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complicates interpretation of observational research. Converging evidence across the 
Observational and MR studies would thus provide a stronger basis for causal inference.  
 
Figure 6-1 Diagram of Mendelian randomization analysis 
6.2 Observational Study 
6.2.1 Methods 
6.2.1.1 Data sources (expanded) 
The Avon Longitudinal Study of Parents and Children (ALSPAC;(258, 259) is a prospective 
population cohort study. Initially, 14,541 mothers living in Avon, UK, whose expected 
delivery dates were between 1st April 1991 to 31st December 1992 were recruited. Further 
eligible mothers have since been recruited, and the total sample comprises 15,247 
pregnancies, 14, 973 live births, and 14,899 children alive at one year. The ALSPAC study 
website provides details of all available data, through a fully searchable data dictionary and 
variable search tool (for more information, see: 
http://www.bristol.ac.uk/alspac/researchers/our-data/). Ethics approval for the study was 




The present study includes data from all consenting participants alive at one year (n = 
14,882). Demographic information for participants of the current study is shown in Table 6-1. 
 
Table 6-1 Characteristics of Participants in the Observational Study 
Demographic Variable Frequencies 
N (%) 
Sex  
Male 7,601 (51.08)  
Female 7,280 (48.92) 
Social economic status  
Manual 2,808 (18.87) 
Non-manual 9,398 (63.15) 
Missing 2,676 (17.98)  
Ethnicity   
Non-white 609 (4.09) 
White 11,468 (77.06) 
Missing 2,805 (18.85)  
Mother Parity   
Primipari 5,770 (38.77) 
Multipari 7,154 (48.07) 
Missing 1,958 (13.16) 
 
Lifetime AN at age 24 was evaluated by determining, at four data collection waves (when 
participants were aged 14, 16, 18 and 24), whether participants met DSM-5 diagnostic criteria 
for AN, based on previously defined thresholds (see (204)) outlined in Table 6-2. If 
participants did not meet diagnostic criteria at timepoints where responses were recorded, but 






Table 6-2 Criteria Used to Derive Anorexia Nervosa Diagnoses at Each Wave in ALSPAC 
Sample 
Age Weight criteria 
Child report Parent report 
14 Underweight Self-reported weight/shape concern OR 
engaged in fasting for weight loss or to avoid 
weight gain at least monthly OR engaged in 
excessive exercise 
Presence of fear of weight 
gain AND fat avoidance in 
the 3 months prior to 
assessment 
16 Underweight Engaged in fasting for weight loss or to avoid 
weight gain at least monthly OR engaged in 
excessive exercise 
Presence of fear of weight 
gain AND fat avoidance in 
the 3 months prior to 
assessment 
18 Underweight Self-reported weight/shape concern OR 
engaged in fasting for weight loss or to avoid 
weight gain at least monthly OR engaged in 
excessive exercise 
N/A 
24 Underweight Self-reported weight/shape concern OR 
engaged in fasting for weight loss or to avoid 
weight gain at least monthly OR engaged in 
excessive exercise 
N/A 
Note: Underweight at ages 14 – 18 was determined using gender specific norms from UK 
reference data, and corresponded to WHO grade 1 thinness (275). At age 24 underweight was 
defined as BMI < 18.5.  
 
To establish the presence of AN symptoms that formed the basis of diagnosis, at each wave 
participants answered questions surrounding eating and exercise behaviours adapted from 
those of the Youth Risk Behavior Surveillance System (260). Fasting was assessed with the 
question “How often in the past year have you fasted (not eaten for at least a day) to lose 
weight or avoid gaining weight?”. Excessive exercise was recorded when participants 
reported exercising for weight loss or to avoid weight gain in the past year, and one of the 
following: exercising despite illness/injury; exercise interfering with other activities; 
experiencing guilt when missing an exercise session. Body dissatisfaction was probed at 
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wave 14, 18 and 24, using questions of the weight/shape concern scale of the McKnight Risk 
Factor Questionnaire (349). The number of items administered varied with wave, and body 
dissatisfaction was recorded as present if the mean response met a previously used threshold 
(350), amounting to high levels of weight concern. Self-report data at age 24 were collected 
and managed using REDCap electronic data capture tools hosted at the University of Bristol 
(351). Parent-reported child AN symptoms were collected using the Development and 
Wellbeing Assessment (DAWBA; (262)). The DAWBA generates psychiatric diagnoses for 
children and adolescents based on DSM-IV (263) and ICD-10 (264) criteria. It comprises a 
structured interview designed to identify the presence and impact of relevant symptoms. The 
AN symptoms fear of weight gain and fat avoidance were marked as present when reported 
as severe or extreme. Objective height and weight measurements collected during clinic 
assessments at each of the waves was used to determine whether participants were 
underweight. 
Anxiety exposures were assessed when children were aged 10 using the parent-report 
DAWBA (262). Worry was measured using responses to a question of the generalised 
anxiety disorder section of the DAWBA (262). Mothers were asked whether their child 
worried, and responded using the possible options ‘yes’ or ‘no’, providing a binary variable 
that was used in the current investigation. The presence of the following anxiety disorders 
was also assessed: generalised anxiety disorder; separation anxiety disorder; social phobia; 
and specific phobia. Computer algorithms assigned children to DAWBA bands that indicated 
the likelihood of children meeting DSM-IV criteria for each anxiety disorder. Children in the 
top two bands were at least 50% likely to have the anxiety disorder in question and assigned a 
diagnosis. This approach produces diagnoses that broadly align with clinician ratings (265). 
Notably DAWBA computer-generated diagnoses based on parent-reported symptoms have 
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been found to better correspond with clinician-made diagnoses than DAWBA computer-
generated diagnoses based on child reports (265). From the assessment of the four anxiety 
disorders, a binary anxiety disorder variable was derived, indicating whether participants met 
criteria for any anxiety disorder at age 10. 
Plausible confounders of the association between anxiety exposures and AN were identified 
from existing literature. These were sex, socio-economic status (a binary variable based on 
occupations of both parents), mother parity (a binary indicator of whether mothers had 
previous viable pregnancies), mother lifetime AN, and child body mass index (BMI) z-score 
at baseline (age 10). Variables were determined from questionnaire data, apart from the BMI 
variable, which was derived from clinic-assessed height and weight, child gender, and UK 
reference data (274). Mother lifetime AN was assessed at three timepoints; where data was 
missing at one or more timepoint, and negative responses were recorded at others, mother 
lifetime AN was considered missing. Figure 6-2 shows the data collection process in respect 
of all variables. 
Figure 6-2 ALSPAC data collection process for the Observational Study variables 
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6.2.1.2 Statistical analysis (expanded) 
Statistical analyses were completed using Stata15 (277). To assess prospective associations 
between anxiety phenotypes and subsequent AN, binary logistic regression was used 
(unadjusted, and adjusted for all potential confounders). Models were subsequently adjusted 
for the other anxiety exposure (i.e. anxiety disorder presence or worry), to assess the unique 
variance in lifetime AN explained by worry and anxiety disorders. Stata code for the 
regression analyses is provided in Appendix F. 
All missing data was imputed using a multiple imputation by chained equation (MICE) 
approach, which assumes data are missing at random. Missing data in ALSPAC is predicted 
by mother age at delivery, as well socio-economic status and mother parity (248). These 
variables were included in imputation models, along with all other analysis variables. 
Variables used to derive AN diagnoses at each wave were also included in the imputation 
model, to improve prediction. In total, 100 datasets were imputed. Analyses were completed 
using complete case, maximum available and multiple imputation data. We focus on 
outcomes of imputed data analyses given the improved efficiency of this approach, but report 
results of all analyses. Descriptive information concerning observed and imputed data for all 
variables, and diagnostic trace plots for imputed analysis variables, is available in Appendix 
F (Table 1, Figures 1 and 2). Stata code for the imputation model is also provided in 
Appendix F. For further details of missing data mechanisms and MICE procedures see 
Chapter 4 (sections 4.2.4-4.2.5).  
6.2.2 Results 
In unadjusted analyses, worry at age 10 was associated with increased risk of AN by age 24, 
however the statistical evidence provided modest support for the association (OR = 1.60, 
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95% CI: 0.93 to 2.77, p = 0.090). Furthermore, the association was attenuated towards the 
null when adjusting for potential confounders, with wide confidence intervals around the 
estimate resulting in weak evidence for an association (OR = 1.41, 95% CI: 0.78 to 2.56, p = 
0.256). When anxiety disorders were added to the model the magnitude of association was 
further reduced (OR = 1.34, 95% CI: 0.74 to 2.44, p = 0.332). 
In unadjusted analyses there was statistical evidence for an association between anxiety 
disorders and AN, with individuals meeting anxiety disorder criteria at age 10 more likely to 
develop AN by age 24 (OR = 2.85, 95% CI: 1.22 to 6.63, p = 0.016). In analyses adjusted for 
potential confounders the results remained consistent (OR = 3.12, 95% CI: 1.14 to 8.55, p = 
0.027). Adding worry to the model also did not alter the results substantially (OR = 2.87, 
95% CI: 1.05 to 7.82, p = 0.039). 
Though less precise, point estimates of associations in complete case and maximum available 
data analyses were consistent with those of imputed data analyses, and the pattern of results 




Table 6-3 Estimates of Multiple Logistic Regression Analyses of Lifetime AN at Age 24 on 
Anxiety Phenotypes 
Imputed data analyses  
N Variable N cases with AN and 
variable/without variable 
OR [95% CI] P value 
Unadjusted 14,882 Worry NAa 1.6 [0.93, 2.77] 0.090 
14,882 Anxiety 
disorder 
NAa 2.85 [1.22, 6.63] 0.016 
Adjusted 14,882 Worry NAa 1.41 [0.78, 2.56] 0.256 
14,882 Anxiety 
disorder 
NAa 3.12 [1.14, 8.55] 0.027 
Maximally 
adjusted 
14,882 Worry NAa 1.34 [0.74, 2.44] 0.332 
14,882 Anxiety 
disorder 
NAa 2.87 [1.05, 7.82] 0.039 
Complete case analyses  
N Variable N cases with AN and 
variable/without variable 
OR [95% CI] P value 
Unadjusted 1,977 Worry 38/14 1.76 [0.94, 3.26] 0.075 
1,977 Anxiety 
disorder 
3/49 3.62 [1.07, 12.23] 0.038 
Adjusted 1,977 Worry 38/14 1.55 [0.82, 2.94] 0.177 
1,977 Anxiety 
disorder 
3/49 2.97 [0.75, 11.79] 0.121 
Maximally 
adjusted 
1,977 Worry 38/14 1.49 [0.78, 2.83] 0.226 
1,977 Anxiety 
disorder 
3/49 2.64 [0.66, 10.57] 0.169 
Maximum available data analyses  
N Variable N cases with AN and 
variable/without variable 
OR [95% CI] P value 
Unadjusted 2,396 Worry 49/17 1.87 [1.07, 3.27] 0.027 
2,338 Anxiety 
disorder 
3/63 2.80 [0.84, 9.31] 0.093 
Adjusted 2,039 Worry 38/14 1.55 [0.82, 2.93] 0.179 
1,999 Anxiety 
disorder 
3/49 3.00 [0.76, 11.89] 0.118 
Maximally 
adjusted 
1,977 Worry 38/14 1.49 [0.78, 2.83] 0.226 
1,977 Anxiety 
disorder 
3/49 2.64 [0.66, 10.57] 0.169 
aN varies across imputations. Proportion of AN cases with worry is .68, proportion of AN 
cases with anxiety disorder is 0.06, across imputations.  
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Adjusted model covariates: sex, socio-economic status, mother parity, mother AN, child body 
mass index z-score at baseline (age 10). Maximally adjusted models include all covariates 
and the other anxiety phenotype. 
 
6.2.3 Discussion 
Outcomes of the Observational Study do not support a robust association between worry at 
age 10 and later AN development. In contrast, there was evidence supporting the presence of 
an anxiety disorder at age 10 predicting increased risk of subsequent AN. This latter finding 
aligns with outcomes of cross-sectional and retrospective research (117). The prospective 
association between any anxiety disorder and subsequent AN development has been reported 
previously (169). The evidence for prospective associations between specific anxiety disorder 
diagnoses and AN development is not strong (352). However, prior analyses have tested 
whether particular anxiety disorder diagnoses explain variation in AN onset over and above 
the explanatory effects of other anxiety disorders (169, 213), when large unique predictive 
effects may be absent. Alternatively, methodological limitations could have reduced 
sensitivity to detect associations in past investigations. For example, some studies (e.g. (169, 
212)) did not extend follow-up periods to encompass the entire period in which AN onset is 
most common (i.e. age 15-19 (40)). 
The absence of clear evidence for an association between worry and AN conflicts with 
findings of cross-sectional studies reporting greater worry in AN as compared to healthy 
controls (e.g. (120)). The finding is also surprising given worry is a core component of 
anxiety disorders (131). Worry was measured coarsely in this study however, and may also 
have been less accurately reported by parents as compared to other anxiety disorder 
symptoms, given its unobservable nature (280). Measurement error in the assessment of 
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worry may have rendered the current investigation more sensitive to associations between 
anxiety disorders and AN, as compared to between worry and AN.  
Findings were broadly consistent across analyses with complete case, maximally available, 
and imputed, data, supporting the reliability and validity of analysis outcomes. Statistical 
adjustment for plausible confounders minimised the risk of biased estimates. However, it is a 
limitation that disordered cognition and behaviour surrounding eating and weight gain at 
baseline could not be included as a covariate, due to this information not being captured in 
ALSPAC. 
6.3 MR Study 
6.3.1 Methods 
6.3.1.1 Data sources (expanded) 
Details of the GWAS data used in the MR Study are provided in Table 6-4. The worry 
phenotype was quantitative, and measured by items comprising the worry dimension of the 
Eysenck Personality Questionnaire - Revised short-form neuroticism subscale (353) (further 
details in Appendix F). The worry dimension was derived from a factor analysis of the 
neuroticism questionnaire items (354), and is further supported by the fact genetic variants 
across the genome are similarly associated with each of the worry items, and less strongly 
related to items loading on other factors (355). The anxiety disorder case-control phenotype 
reflects the presence of five core anxiety disorders (generalised anxiety disorder, panic 
disorder, social phobia, agoraphobia, specific phobia). The quantitative anxiety disorder 
phenotype indicates liability for a common dimension of anxiety disorders, and was 
developed from modelling covariation across the same five core anxiety disorders (356). The 
AN phenotype was binary, indicating a diagnosis of lifetime AN, or eating disorder not 
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otherwise specified AN subtype (357). Participants gave informed consent for study 
participation and data sharing, as described in articles detailing original GWAS for each 
phenotype. 
 
Table 6-4 Characteristics of GWAS used to complete Mendelian Randomization Analyses of 
MR Study 
Phenotype Study Resource Sample size Population Data Source  
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6.3.1.2 Genetic instrument selection 
Genetic instruments for each exposure were identified from relevant GWAS summary 
statistics (Table 6-4). A significance threshold of 5 x 10-8 was used to select independent 
single nucleotide polymorphisms (SNPs) robustly associated with each exposure. Where a 
single SNP was identified as an eligible instrument, we ran an additional sensitivity analysis 
using a significance threshold of 5 x 10-6 for instrument identification. Palindromic SNPs and 
SNPs missing from outcome GWAS were replaced by proxy variants that were associated 
with original instruments at an R2 value of > 0.85. See Appendix F (Table 2) for more 
information regarding proxy variants.  
There were 60 SNPs associated with the worry exposure, 57 of which (or proxies) were 
available in the AN GWAS. Instruments for anxiety disorder phenotypes originally included 
one independent SNP. When the SNP-exposure threshold was reduced, seven SNPs were 
independently associated with the anxiety disorder case-control phenotype, and nine with the 
quantitative phenotype. All anxiety disorder SNPs were available in the AN GWAS. 
6.3.1.3 Statistical analysis (abbreviated) 
GWAS summary statistics were downloaded from consortium/study websites (Table 1). MR 
analyses were implemented in R (359) using the TwoSampleMR package of MR-Base (360) 
and local data. Notably, covariates are not included in MR analysis models, given the 
assumption of MR that genetic instruments for a given exposure are not associated with 
confounders of the exposure-outcome relationship (183). 
For single SNP instruments, the Wald ratio (ratio of coefficients) method estimated the causal 
effect. Where multiple SNPs were identified as eligible instruments, ratio estimates across 
different SNPs were combined in an inverse variance weighted (IVW) analysis.  
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When multiple genetic variants instrumented an exposure, various sensitivity analyses were 
completed to determine the robustness of the IVW estimate. MR Egger estimated horizontal 
pleiotropic effects present in the IVW analysis (297), and provided a pleiotropy-corrected 
estimate of the causal effect. Weighted median and weighted mode analyses, which provide 
consistent causal estimates when a proportion of genetic instruments are invalid, were also 
performed (297, 334). Consistency across the independent SNP estimates provides strong 
support for the validity of conclusions concerning causal associations (325). Cochrane’s Q 
and I2 statistics indexed heterogeneity across ratio estimates combined in the IVW analysis. 
When substantial heterogeneity was detected, leave-one-out analyses were completed: the 
IVW analysis was completed leaving out one SNP each time, enabling detection of variants 
having an undue influence on results. Rucker’s Q indexed heterogeneity with respect to MR 
Egger estimates; the comparison with Cochrane’s Q informed whether IVW or MR Egger 
models provided a better fit to the data (323). 
To ensure inferences concerning causality were directionally accurate, where causal effects 
were indicated, Steiger filtering was completed (335). The variance in exposure and outcome 
explained by the instrument was estimated for each SNP. Where the association between 
genetic instrument and exposure is stronger than corresponding associations between the 
same instrument and outcome, a direction of causal effect from exposure to outcome is 
supported. MR analyses were replicated using the subsample of (filtered) variants meeting 
this criteria.  
6.3.2 Results 
The IVW estimate indicated that worry increases AN risk (OR = 2.14, 95% CI: 1.18 to 3.90, 
p = 0.013). The weighted median estimate was consistent with this finding (OR = 2.49, 95% 
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CI: 1.15, 5.41, p = 0.021), and outcomes of the weighted mode analysis provided weak 
evidence for a positive association (OR = 3.08, 95% CI: 0.52 to 18.19, p = 0.220). The MR 
Egger estimate was in the opposite direction to the IVW, weighted median and weighted 
mode estimates, but confidence intervals were very wide (OR = 0.80, 95% CI: 0.04 to 16.57, 
p = 0.887). All estimates are detailed in Figure 6-3. Wald ratio estimates for each SNP are 
presented in Appendix F (Figure 3).  
 
Figure 6-3 Mendelian randomization estimates for causal influence of anxiety phenotypes on 
AN 
Steiger filtering indicated that 37 of 57 variants instrumenting the worry exposure showed 
stronger associations with the exposure as compared to the outcome (Appendix F, Table 3). 
Point estimates of MR analyses using only these 37 variants to assess the causal influence of 
worry on AN were consistent with those of the original analysis, although smaller in 
magnitude and relatively imprecise (Appendix F, Figure 4). 
There was no clear evidence for a causal influence of genetic liability to anxiety disorders on 
AN in single SNP analyses, across case-control and quantitative anxiety disorder phenotypes 
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(OR = 1.02, 95% CI: 0.69 to 1.50, p = 0.922; OR = 4.26, 95% CI: 0.49 to 36.69, p = 0.187, 
respectively). These results are also displayed in Figure 6-3. Findings from sensitivity 
analyses that used multiple independent SNPs (less strongly associated with the anxiety 
disorder exposures) were consistent with those of single SNP analyses (Appendix F, Figures 
5 and 6). 
The MR Egger intercept did not provide evidence for horizontal pleiotropy in multiple 
instrument analyses. Cochrane’s Q statistic indicated heterogeneity in the analysis of the 
causal effect of worry on AN. However, I2 (and associated confidence intervals) did not, and 
leave-one-out analyses did not support substantial influences of any single SNP on the 
estimate. For further details, see Appendix F (Tables 4-6, Figure 7).  
6.3.3 Discussion 
MR results support a causal influence of worry on AN development, but provide no clear 
evidence for a causal effect of genetic liability to anxiety disorders on AN. Confidence in 
findings is increased by the general alignment of sensitivity analysis point estimates with 
those of primary analyses. The absence of substantial heterogeneity across SNP estimates in 
multiple instrument analyses also supports the validity of inferences arising from IVW 
analyses. Steiger tests indicated the majority of variants instrumenting worry were more 
strongly associated with this exposure, as compared to AN, supporting a direction of causal 
effect from worry to AN. Providing further support for the conclusion that worry causally 
influences AN risk, analyses completed with the subset of filtered variants produced results 
consistent with those of original analyses.  
We used summary statistics from the largest AN GWAS available to enhance power, which 
could explain the discrepancy with a previous MR analysis that did not indicate a causal 
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effect of worry on AN (358). The primary determinant of power in MR analyses is instrument 
strength, or variance in exposure explained by the genetic instruments (184). The strength of 
anxiety disorder instruments was low, given few SNPs were robustly associated with anxiety 
disorder exposures. As a result, tests of the causal effects of anxiety disorder susceptibility on 
AN risk are likely underpowered. 
Critically, findings in respect of both worry and anxiety disorders are inconsistent with 
outcomes of the Observational Study. The evidence for a causal influence of worry on AN 
risk in the MR investigation supports the possibility that the absence of association between 
worry and AN in the Observational Study results from limitations in the measurement of 
worry. The lack of evidence for a causal influence of genetic liability to anxiety disorders on 
AN in the MR Study may indicate at least some confounding of the anxiety disorder and AN 
association in the Observational Study – with a common factor contributing to risk for 
anxiety disorders and AN. 
6.4 General discussion 
Triangulating findings across two studies, each with different strengths, limitations and 
sources of bias, allows for more robust conclusions concerning the nature of association 
between anxiety exposures and AN (180, 181). The Observational Study found anxiety 
disorders present at age 10 to predict subsequent AN development, but there was no evidence 
to support a similar association between worry and AN. The MR Study indicated that the 
association between anxiety disorders and AN is not causal, but that worry may play a causal 
role in AN development.  
As well as being implicated in the development of AN in the current investigation, worry is 
supported to exert a causal influence on anxiety disorder development (131, 348). It is 
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possible therefore that worry confounds the association between anxiety disorders and AN in 
observational studies, while anxiety disorders themselves do not have a causal role in AN 
development. A recent study probed associations between independent transdiagnostic 
anxiety disorder factors (measured at age 10) and lifetime AN by age 16, in the same 
population cohort as that of the Observational Study (170). In the earlier investigation (170), 
a quantitative worry component (derived from a factor analysis, and reflecting worry across 
multiple domains) predicted AN development, while alternative anxiety disorder components 
did not. This finding is discrepant with outcomes of our prospective analysis. The 
discordance may be explained by different operationalisations of worry (i.e. the tendency to 
worry, versus the tendency to worry about multiple different things), and our focus on anxiety 
disorder diagnoses rather than other transdiagnostic symptoms. Nonetheless, outcomes of the 
previous study (170) are consistent with the suggestion that worry is the component of 
anxiety disorders that specifically increases risk of AN, and that underlies the anxiety 
disorder and AN association.  
In terms of how worry increases AN risk, perhaps the focus on eating and weight, and even 
the neurobiological effects of dietary restriction, alleviates worry in individuals who develop 
AN, encouraging continued engagement in behaviour typical of AN. This would be 
consistent with proposals that concerns not explained by AN diagnosis are causal in disorder 
onset (e.g. (97, 98, 102, 196)). Alternatively, it is only when worry becomes directed onto 
eating and weight that fears of weight gain and severe dietary restriction, or AN pathology, 
manifests. Certainly, individuals with AN have elevated worry generally, but concern is 
particularly heightened in relation to eating, weight and shape (142). Here, worry comprises a 
process that independently contributes to risk of both anxiety disorders and AN, as has been 
suggested for personality and neuropsychological traits (153, 361, 362). There may exist a 
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cluster of shared risk factors for anxiety disorders and AN, which potentially mediates effects 
of an underlying genetic liability (118, 362, 363). 
Further examination of the influence of worry on AN risk is required, ideally within studies 
of trial design that are best able to make causal inferences. Existing AN prevention 
interventions largely do not address non-specific cognitive processes or pathology, tending to 
focus solely on reducing disordered eating/weight-associated cognition and behaviour (75, 
76). A recent review highlighted the efficacy of some existing interventions in reducing 
future eating disorder symptoms, although only for individuals who were asymptomatic at 
baseline (75). Future trials might explore whether the addition of modules that address non-
specific worry can improve outcomes of existing interventions.  
The conclusions drawn from findings across the two studies have been made in light of the 
limitations of the Observational Study, and it is necessary to acknowledge the shortcomings 
of the MR Study. MR makes various assumptions concerning the nature of association 
between genetic variants and the outcome, which if violated compromise valid interpretation 
of results. The apparent evidence for a causal role of worry in AN development could be 
explained by genetic instruments relating to parental traits (dynastic effects), or by 
individuals with greater worry being more likely to reproduce with those with greater AN 
pathology (cross-trait assortative mating). MR analyses testing the causal influence of genetic 
liability to anxiety disorders on AN were underpowered, and the relationship requires further 
study using stronger instruments for anxiety disorder exposures.  
Conclusion  
We triangulated findings across a prospective cohort study and a MR study to investigate the 
role of anxiety phenotypes in AN development. While results across studies were not 
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consistent, the MR study provided support for a causal influence of worry on AN 
development, highlighting potential utility in addressing worry for AN prevention. Evidence 
to support a causal influence of genetic liability to anxiety disorders on AN was weak, but 
interpretation is complicated by low power in the relevant MR analyses. Further exploration 
of the anxiety disorder and AN relationship is recommended, and future studies should seek 
to elucidate mechanisms underlying observed causal effects of anxiety phenotypes on AN. 
6.5 Contribution to thesis 
The triangulation of findings across a longitudinal study, and MR analyses robust to the 
confounding that complicates interpretations of observational research, allows for stronger 
inferences concerning the nature of association between anxiety disorders and AN 
development. There was no support for the detected longitudinal association between anxiety 
disorders and AN being causal, although further investigation is required to confirm the 
robustness of this finding. A causal influence of the worry central to anxiety disorders on AN 
was indicated. As worry comprises a vulnerability factor for anxiety disorders, the findings 
raise the possibility that the association between anxiety disorders and AN detected in 
observational studies to some extent reflects the contribution of worry to both pathologies. 
This directed the next study of the thesis, which explored the common causal influence of 




7 Chapter 7: Shared risk factors for anxiety disorders and AN 
7.1 Overview of chapter 
In this chapter I present an investigation that was informed by the outcomes of Study 3, 
which supported a causal role of worry in AN development. As worry is also implicated in 
anxiety disorder development, the findings of Study 3 highlight the possibility that anxiety 
disorders and AN are associated, at least in part, due to the two sharing causal risk factors. To 
inform this hypothesis, Study 4 extends the investigation of Study 3, assessing the causal 
influence of worry on anxiety disorder and AN development within a MR framework. Worry 
and depressed affect are manifestations of neuroticism. By probing the causal effects of 
depressed affect and neuroticism, in addition to worry, on anxiety disorders and AN, Study 4 
also informs the specificity of causal effects of worry. The study appears as per the 
manuscript that is in preparation for journal submission, apart from the abbreviation of some 
methodological information that prevents duplication of Chapter 5. Following the 
presentation of Study 4, I discuss its contribution to the broader thesis. 
 
 Lloyd EC, Sallis HM, Verplanken B, Haase AM, Munafò MR. Something to worry about? Exploring 
transdiagnostic mechanisms underlying the association between anxiety disorders and anorexia nervosa with 
Mendelian randomization.  
Author contributions: Myself, HMS and MRM developed research questions and designed the study. I accessed 





Anorexia nervosa is characterised by a severe fear of weight gain or fatness, and persistent 
restriction of food intake. The aetiology of AN remains enigmatic, limiting effective 
prevention and treatment (78). Models of illness propose a causal influence of anxiety 
disorder pathology (97, 102, 114, 196), on the basis of cross-sectional and longitudinal 
associations between anxiety disorders and AN (117, 364, 365). Studies of traditional 
epidemiologic design (i.e. observational studies) are subject to confounding by factors that 
causally influence both the exposure (e.g. anxiety disorders), and the outcome (e.g. AN). 
Confounding complicates the interpretation of causal estimates, and limits the extent to which 
outcomes of observational research may guide intervention development (301). 
Plausible confounders of the association between anxiety disorders and AN include 
transdiagnostic risk factors, or factors that influence the development of multiple pathologies. 
The identification and study of such factors is encouraged under the latest research domain 
criteria (RDoC) issued by the US National Institute of Mental Health (366, 367). It is hoped 
that this approach will be better able to elucidate putative factors, and consequently 
intervention targets, as compared to the study of disorder-specific risk factors or symptoms, 
while also explaining patterns of comorbidity amongst psychiatric disorders (368).  
One factor that has been studied in relation to both anxiety disorders and AN is worry, 
defined as an uncontrollable thought process intended to resolve an issue that has at least one 
possible negative outcome (129). Worry is present across the anxiety disorders (1, 131), and 
implicated in their development (348, 369). It is proposed that while a tendency to worry 
increases risk of anxiety disorder onset generally, the focus of worry dictates the precise 
pathology that develops (113). For example, worry directed onto social situations may 
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specifically increase risk of social anxiety disorder. This model may be extended to account 
for AN development. General worry is elevated in AN as compared to HC, to a similar 
degree as that observed in individuals with anxiety disorders (141). However, the majority of 
arising worries experienced in AN surround eating and weight (142), and it may be these 
particular worries that create a vulnerability for AN development. 
A causal influence of worry on AN development is supported by findings of a recent 
Mendelian randomization (MR) study (222). MR comprises an instrumental variable analysis 
that minimises the risk of bias due to confounding and reverse causality that affects studies of 
observational design, for robust assessment of causal effects (183). Specifically, MR uses 
genetic variants to instrument an exposure of interest, assessing the association between a 
genetic variant strongly related to the exposure (e.g. worry), and the outcome of interest (e.g. 
AN). Unlike the exposure, the genetic instrument (most often a single nucleotide 
polymorphism; SNP) is generally not associated with the wide range of factors that 
potentially confound associations in observational research. As genetic instruments cannot be 
influenced by the outcome, detected associations cannot be explained by reverse causal 
mechanisms (301). For an overview of MR, see (184).  
The current study extends the previous MR investigation (222) to assess the causal influence 
of the same worry exposure on anxiety disorder pathology. This allows for comparison with 
the existing findings concerning AN, to inform whether worry operates as a shared causal 
risk factor for anxiety and AN pathology. The current investigation addresses whether the 
effects of worry are specific, by also probing the causal influence of neuroticism and 
depressed affect on anxiety disorders and AN. Worry and depressed affect are strongly 
related to neuroticism (370-372), and supported to comprise facets of neuroticism (187, 354, 
373, 374), which is defined as the disposition to experience negative affect and a sensitivity 
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to negative events (185, 186). Neuroticism is associated with increased vulnerability for 
multiple psychopathologies, including anxiety disorders (188) and AN (189). Exploring the 
causal influence of this broader trait, and its subcomponents, can inform the way in which a 
vulnerability to psychopathology manifests as anxiety disorders and AN, and promotes a 
more precise understanding of shared risk factors. A previous study considered these same 
associations, and within a MR framework (358), however analyses of the current study 
benefit from increased power relative to those of the previous study. In particular, we use a 
quantitative anxiety disorder phenotype, and a substantially larger AN genome-wide 
association study (GWAS) to probe associations between genetic instruments and AN (317). 
We also complete various sensitivity analyses robust to some of the core MR assumptions to 
improve confidence in resulting causal inferences. Finally, we provide a novel contribution to 
the evidence base by assessing the independent direct influence of each of the subcomponents 
of neuroticism (i.e. worry and depressed affect) on both anxiety disorders and AN, extending 
the MR investigation to the multivariable setting (345). These analyses are able to inform 
whether either subcomponent is able to explain unique variance in anxiety disorder and AN 
development, to further inform whether certain manifestations of neuroticism are particularly 
relevant to the two psychiatric pathologies. 
It was hypothesised that a causal influence of worry on anxiety disorders would be observed. 
Given the centrality of worry to both anxiety disorders and AN (131, 361), it was expected 
that there would be most support for worry operating as a shared causal risk factor, and 
explaining unique variance in AN and anxiety disorder outcomes, as compared to neuroticism 




Figure 7-1 Proposed model of shared risk factors for anorexia nervosa and anxiety disorders 
7.3 Method 
A two-sample MR approach (312) was adopted to assess the causal influence of worry, 
neuroticism and depressed affect on anxiety disorders and AN. In two-sample MR 
associations between genetic instruments and the exposure are established in a different 
sample to that in which associations between genetic instruments and the outcome are 
assessed (312). Providing that exposure and outcome samples are drawn from the same 
underlying population, this approach will yield valid estimates of causal effect (299). Only 
the exposure(s) of interest are included in the univariable and multivariable MR models (i.e. 
there is no adjustment for additional covariates), given the assumption that genetic 
instruments are not associated with confounders of exposure-outcome associations (183, 
345). 
7.3.1 Data sources 
Details of the exposure and outcome GWAS data used in the current study are provided in 
Table 7-1. Neuroticism was measured by the 12-item Eysenck Personality Questionnaire-
Revised Short Form (353) neuroticism subscale. Participants could respond to each question 
with ‘Yes’, ‘No’, ‘Do not know’, or ‘Prefer not to answer’. The number of ‘Yes’ responses 
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was counted, which equated to the neuroticism score - higher scores indicating greater 
neuroticism (375). The neuroticism GWAS data was accessed through the MR base platform 
(360). Four items of the neuroticism scale have previously been indicated as forming a 
unique worry cluster, and four separate items found to contribute to a depressed affect cluster 
(354). Supporting the validity of these two clusters, the items within each cluster are 
genetically homogenous – that is, genetic variants across the genome are similarly associated 
with items of each cluster (355). The number of ‘Yes’ responses to items of each of these 
clusters were summed to derive quantitative worry and depressed affect phenotypes. Only 
individuals who responded with ‘Yes’ or ‘No’ (deemed valid responses) to all items of a 
given cluster were included in the respective GWAS (355). See Appendix G for details of 
EPQ-RS neuroticism items.  
The anxiety disorder phenotype is quantitative and indicates an individuals’ risk for a 
continuous dimension of anxiety disorders. The anxiety disorder phenotype was developed 
from modelling covariation across five pathologies: generalised anxiety disorder; panic 
disorder; social phobia; agoraphobia; and specific phobia (356). The AN phenotype was 
binary, and indicated a diagnosis of lifetime AN, or eating disorder not otherwise specified 
AN subtype (357). 
Table 7-1 GWAS Study Characteristics 
Phenotype Study Resource Sample size Population Data Source  
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ANGST = Anxiety Neuro Genetics STudy; PGC = Psychiatric Genetics Consortium 
7.3.2 Genetic instrument selection (abbreviated) 
Genetic instruments for each exposure of interest were identified from relevant GWAS 
statistics (Table 7-1). A significance threshold of 5 x 10-8 was used to select instrumental 
SNPs. SNPs were clumped to ensure independence, applying a LD threshold of r2 < 0.001 
and distance threshold of 10,000kb. When palindromic SNPs were indicated as eligible 
instruments, effect allele frequency information was used to harmonise exposure and 
outcome datasets. Where effect allele frequency information was not available (as was the 
case for the AN GWAS), proxy variants, associated with original instruments at R2 > .85, 
were identified with the R (359) package proxysnps (377), and replaced original instruments. 
Using the same approach, where instrumental SNPs were missing from the outcome GWAS, 
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original instruments were replaced by proxy variants. Proxy variant details are provided in 
Appendix G (Table 1). 
The neuroticism instrument comprised 68 SNPs, 67 of which (or proxies) were available in 
the anxiety disorder GWAS, and all of which were available in the AN GWAS. There were 
60 SNPs associated with the worry exposure; 58 of these were available in the anxiety 
disorder GWAS, and 57 were available in the AN GWAS. The depressed affect instrument 
included 61 SNPs, 58 of which were available in the anxiety disorder GWAS, and 59 in the 
AN GWAS.  
7.3.3 Statistical analysis 
The TwoSampleMR package (360) in R (359) was used to complete MR analyses.  
7.3.3.1 Univariable MR analyses (abbreviated) 
Single SNP estimates were calculated using the ratio method (316). A weighted average of 
ratio estimates was calculated using the inverse variance weighted (IVW) formula (320). 
Cochrane’s Q statistic and I2 were derived using formulae from the meta-analysis literature 
(328), to assess the extent and influence of heterogeneity across ratio estimates combined in 
the IVW analysis. Consistency across effect estimates enhances confidence in the results, 
since it is unlikely all estimates would be biased in a manner that supported the same 
association in the absence of a true causal effect (325). Leave-one-out analyses involve 
repeating the IVW analysis but leaving estimates of one SNP out each time, and were 
completed when heterogeneity was detected. This approach identifies individual ratio 
estimates that are markedly different to others in the analysis, serving to increase the 
heterogeneity amongst ratio estimates, and potentially distorting the IVW estimate.  
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The largest potential source of bias in MR is horizontal pleiotropy, whereby genetic 
instruments independently influence traits other than the exposure, and act via these traits to 
cause the outcome (294). The IVW analysis assumes that the average pleiotropic effect across 
all instruments is zero (325). Three sensitivity analyses robust to this assumption were 
completed: MR Egger (297); weighted median (333); weighted mode (334). MR Egger 
provides an estimate of bias in the IVW analysis arising from unbalanced horizontal 
pleiotropy (i.e. the average pleiotropic effect), and corrects for detected horizontal pleiotropy 
to provide an unbiased estimate of the causal effect. Rucker’s Q (Q’), which estimates 
heterogeneity while allowing for pleiotropic effects (323), was calculated and compared with 
Cochrane’s Q to inform whether MR Egger or IVW models provide a better fit to the data. A 
larger value of Q compared to Q’, combined with evidence of pleiotropy, would support the 
MR Egger model (323).  
When causal associations were supported by outcomes of a MR analysis, Steiger filtering was 
completed (335). This compares estimated R2 values in the regression of exposure and 
outcome onto the genetic variants, for each variant of the analysis, to identify those variants 
more strongly associated with the exposure as compared to the outcome. These variants have 
ratio estimates consistent with a direction of effect from exposure to outcome, rather than the 
reverse, and MR analyses were repeated using this subsample of (filtered) variants. Where 
the majority of variants remain in the analysis following filtering, and where outcomes of 
analyses with filtered variants are consistent with those of original analyses, the validity of 
conclusions arising from original analyses is supported.  
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7.3.3.2 Multivariable MR analyses 
Independent instruments associated with at least one of the worry and depressed affect 
exposures at the 5 x 10-8 threshold (116 SNPs) were included in the analysis. In multivariable 
IVW analyses, SNP-outcome association estimates were regressed onto SNP-exposure 
association estimates for both worry and depressed affect, at the same time, with regression 
weights inversely proportionate to the variance of the SNP-outcome association. 
Multivariable MR Egger analyses (347) were completed to determine the robustness of 
multivariable IVW estimates, and in particular to inform whether pleiotropy was likely to be 
introducing bias into the IVW estimates. As with univariable MR Egger, the multivariable 
extension provides an estimate of unmeasured pleiotropy (unaccounted for by inclusion of 
additional exposures), as well as pleiotropy-corrected estimates of causal effect. SNP 
estimates were oriented so that the effect allele was the risk-increasing variant with respect to 
the worry exposure of primary interest, as per existing recommendations (347).  
7.4 Results 
7.4.1 Univariable MR analyses 
The outcomes of IVW, MR Egger, weighted median and weighted mode analyses are 
reported below. For the ratio estimates of individual SNPs in each analysis see Appendix G 
(Figures 1-6). 
7.4.1.1 Causal influence of worry 
The IVW estimate indicated that worry causally influenced AN, with greater worry 
associated with increased likelihood of AN diagnosis. The statistical evidence supporting this 
association was strong: OR = 2.14. 95% CI [1.18, 3.90], p = 0.013. The weighted median 
estimate was consistent with the IVW finding (OR = 2.49, 95% CI [1.15, 5.41], p = 0.021), 
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while variability surrounding the weighted mode estimate meant there was weak evidence for 
a positive association (OR = 3.08, 95% CI [0.52, 18.19], p = 0.220). The MR Egger point 
estimate was not directionally consistent with outcomes of IVW, weighted median and 
weighted mode analyses, but precision of the estimate was such that there was no strong 
statistical evidence supporting the association (OR = 0.80, 95% CI [0.04, 16.57], p = 0.887). 
These findings have been previously reported (in Chapter 6 and (222)). 
Outcomes of IVW analyses indicated worry causally increased the risk of anxiety disorders, 
with moderate statistical evidence supporting this association (B = 0.09, 95% CI [-0.01, 
0.18], p = 0.072). The weighted median and MR Egger estimates identified the same causal 
association, although the magnitude of effect differed, and the statistical evidence for a causal 
effect was weak: B = 0.03, 95% CI [-0.10, 0.16], p = 0.649); B = 0.18, 95% CI [-0.35, 0.70], 
p = 0.514, respectively. There was no clear evidence for a causal association between worry 
and anxiety disorders in weighted mode analyses (B = 0.03, 95% CI [-0.03, 0.24], p = 0.817).  






Figure 7-2 Outcomes of MR analyses assessing causal influence of worry 
 
7.4.1.2 Causal influence of depressed affect 
The IVW estimate indicated depressed affect causally influenced risk of AN, however the 
supporting statistical evidence was weak (OR = 1.12, 95% CI [0.63, 2.03], p = 0.688). The 
weighted median and weighted mode estimates were directionally consistent with the IVW 
estimate, and also weakly supported an association: OR = 1.52, 95% CI [0.71, 3.22], p = 
0.279; OR = 2.42, 95% CI [0.41, 14.25], p = 0.334, respectively. The MR Egger estimate 
indicated a different direction of association between depressed affect and AN, as compared 
to the other MR analyses, with moderate evidence to support this association: OR = 0.09, 
95% CI [0.01, 1.37], p = 0.09.  
The IVW estimate provided strong evidence for a causal effect of depressed affect on anxiety 
disorder pathology (B = 0.14, 95% CI [0.06, 0.23], p = 0.001), as did the weighted median 
estimate (B = 0.15, 95% CI [0.03, 0.27], p = 0.015). The weighted mode and MR Egger point 
estimates were consistent with the IVW estimate, but their variability meant there was no 
strong evidence for a causal effect in these analyses: B = 0.06, 95% CI [-0.19, 0.31], p = 
0.656; B = 0.09, 95% CI [-0.48, 0.65], p = 0.764, respectively.  





Figure 7-3 Outcomes of MR analyses assessing causal influence of depressed affect 
 
7.4.1.3 Causal influence of neuroticism 
The IVW estimate indicated a causal influence of neuroticism on AN, with greater 
neuroticism increasing risk of AN. The statistical evidence to support this association was 
moderate: OR = 1.15, 95% CI [0.98, 1.35], p = 0.078. The weighted median and weighted 
mode estimates were consistent with those of the IVW analysis, although the evidence for a 
causal effect was weaker: OR = 1.14, 95% CI [0.95, 1.38], p = 0.163; OR = 1.57, 95% CI 
[0.91, 2.73], p = 0.112, respectively. The MR Egger analysis identified a different direction 
of association between neuroticism and AN, however the statistical evidence was weak: OR = 
0.80, 95% CI [0.33, 1.92], p = 0.614).  
The IVW estimate indicated a causal effect of neuroticism on anxiety disorders, with greater 
neuroticism associated with greater anxiety disorder pathology. The statistical evidence in 
support of this association was strong (B = 0.04, 95% CI [0.02, 0.06], p < 0.001). The 
weighted median estimate was consistent with the IVW estimate, and the association was 
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strongly supported (B = 0.04, 95% CI [0.01, 0.07], p = 0.01). The weighted mode estimate 
was also consistent with that of the IVW analysis, however the supporting statistical evidence 
was weak (B = 0.03, 95% CI [-0.05, 0.10], p = 0.484). The MR Egger estimate was consistent 
with a causal influence of neuroticism on anxiety, and identified a greater magnitude of effect 
compared to the other MR analyses, with moderate supporting statistical evidence: B = 0.13, 
95% CI [-0.02, 0.29], p = 0.091.  
Findings relating to the causal influence of neuroticism are summarised in Figure 7-4 
 
Figure 7-4 Outcomes of MR analyses assessing causal influence of neuroticism 
 
7.4.1.4 Assessment of pleiotropy in univariable MR analyses 
The intercept term in MR Egger models did not indicate bias due to horizontal pleiotropy in 
any of the univariable IVW MR analyses. Cochrane’s Q statistic indicated heterogeneity 
across SNP estimates in IVW analyses of the causal effects of worry and neuroticism on AN. 
However I2 statistics did not provide strong evidence for heterogeneity. Leave-one-out 
analyses did not suggest a marked influence of any single ratio estimate in analyses probing 
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the causal influence of worry, or neuroticism, on AN. Comparison of Cochrane’s and 
Rucker’s Q values did not support MR Egger models providing a better fit to the data as 
compared to IVW models, in any of the analyses. The general consistency of inferences from 
sensitivity analyses more robust to horizontal pleiotropy (i.e. weighted median, weighted 
mode, MR Egger) with those resulting from IVW analyses also further supports the validity 
of the latter. For full results of heterogeneity and pleiotropy assessments, see Appendix G 
(Tables 2-4, Figures 7 and 8). 
7.4.1.5 Assessment of direction of causal effect 
Steiger filtering was completed in respect of analyses assessing the causal influence of worry 
and neuroticism on AN, and the causal influence of all three exposures on anxiety disorders, 
given IVW analyses provided moderate or strong evidence for causal effects. In each 
analysis, the majority of genetic instruments were more strongly associated with the exposure 
as compared to the outcome. Analyses completed with the majority subset of variants 
produced estimates that were generally directionally consistent with those of original 
analyses, although effect sizes were smaller and the statistical evidence supporting 
associations was weaker. Outcomes of Steiger tests and subsequent sensitivity analyses are 
fully reported in Appendix G (Tables 5-9, Figures 9-13). 
7.4.2 Multivariable MR analyses  
The multivariable IVW estimate for the unique causal influence of worry on risk for AN 
development indicated a positive association, with strong supporting statistical evidence (OR 
= 3.51, 95% CI [1.57, 7.84], p = 0.002). In contrast, depressed affect was independently 
associated with reduced risk of AN, however the evidence to support the association was not 
strong (OR = 0.51, 95% CI [0.23, 1.17], p = 0.114). The multivariable MR Egger estimates 
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were directionally consistent with those of IVW analyses, although there was no clear 
evidence for a causal effect of worry (OR=2.20, 95% CI [0.61, 7.91], p = 0.225), and only 
moderate evidence to support a causal influence of depressed affect (OR=0.37, 95% CI [0.10, 
1.32], p = 0.073). These results are summarised in Figure 7-5. 
 
Figure 7-5 Results of multivariable MR analyses assessing the causal influence of 
neuroticism subcomponents on AN 
 
The multivariable IVW estimates in respect of the causal influence of both worry and 
depressed affect indicated a positive association between these exposures and anxiety 
disorders, however the statistical evidence did not provide strong evidence for unique causal 
effects. For worry, B = 0.03, 95% CI [-0.03, 0.25], p = 0.525; for depressed affect, B = 0.04, 
95% CI [-0.09, 0.17] , p = 0.117. The MR Egger estimates were directionally consistent, but 
similarly provided no strong evidence for causal effects of either exposure on anxiety 
disorder development (for worry, B = 0.10, 95% CI [-0.12, 0.31], p = 0.383; for depressed 
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affect, B = 0.15, 95% CI [-0.04, 0.33], p = 0.117). See Figure 7-6 for summary of analysis 
outcomes. 
 
Figure 7-6 Results of multivariable MR analyses assessing the causal influence of 
neuroticism subcomponents on anxiety disorders 
Estimates of the intercept term in multivariable MR Egger analyses were close to zero, 
suggesting an absence of bias due to unmeasured pleiotropy in the multivariable IVW 
analyses. For further details, see Appendix G (Table 10). 
7.4.3 Discussion 
This study sought to inform the existence of shared causal risk factors for anxiety disorders 
and AN, with a particular focus on neuroticism and its subcomponents worry and depressed 
affect (354, 355, 358). Our hypothesis that worry is the component of neuroticism 
particularly important in explaining both AN and anxiety disorder development was partially 
supported. There was strong evidence to support a causal influence of worry (yet not 
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neuroticism or depressed affect) on AN, and to support worry increasing risk of AN 
development independently of depressed affect. In contrast, there was only modest statistical 
support for a causal influence of worry on anxiety disorders in univariable MR analyses, and 
strong evidence to support a causal influence of neuroticism and depressed affect on anxiety 
disorders. There was no clear evidence for a unique influence of worry or depressed affect on 
anxiety disorder development. The sensitivity analyses produced results that were broadly 
consistent with outcomes of original IVW analyses, in both univariable and multivariable 
contexts, and did not indicate any substantial bias in IVW estimates – supporting the validity 
of inferences arising from these.  
Collectively outcomes support a causal role of the trait of neuroticism in both anxiety 
disorders and AN, with worry being the specific manifestation of neuroticism most relevant 
to AN development. While elevated levels of depressed affect have been reported in AN 
(378), findings of the current study suggest this is not a consequence of any direct causal 
effect of depressed affect on AN pathology. In contrast, multiple components of neuroticism 
appear to be important in explaining anxiety disorder development. A revised model of the 
influence of neuroticism on anxiety disorders and AN based on findings of the current study 




Figure 7-7 Model of associations resulting from study findings  
Neuroticism operating as a shared risk factor for anxiety disorders and AN is consistent with 
previously reported associations in observational studies (188, 189, 379), and supports the 
proposal that neuroticism is a causal risk factor for multiple psychiatric pathologies (187). It 
also means that the association between anxiety disorders and AN reported in observational 
studies may not entirely reflect causal effects, unless studies have successfully accounted for 
the influence of neuroticism on the analysis outcome variable.  
The precise manner in which neuroticism manifests, or the consequential psychiatric 
diagnoses, is suggested to depend on various moderating factors, such as the content of 
individual concerns (380). For example, a proneness to neuroticism may translate into 
elevated likelihood of AN when concerns become directed onto eating and weight, leading to 
excessive worry surrounding weight gain that is dealt with by dietary restriction (e.g. (286)). 
Certainly, while individuals with AN are characterised as highly neurotic (381), extreme and 
irrational worry surrounding eating and weight gain is one of the dominating features of 
illness (142, 361). Whilst identifying transdiagnostic causal risk factors is necessary to 
understand disorder aetiology, it is not sufficient (380). It will be important for future 
research to elucidate the moderating factors that determine how an underlying propensity for 
psychiatric illness manifests as AN, as well as anxiety disorders. 
Worry is supported to be a central component of anxiety disorders (131), and has been 
implicated in their development (348, 382). As such, it was surprising that the MR findings 
did not provide strong support for a causal influence of worry on anxiety disorders. The 
previous MR study (358) considered a binary case-control anxiety disorder outcome, 
measured in the same population as that in which our quantitative phenotype was derived, 
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and reported strong evidence for a causal influence of worry on anxiety disorder 
development. It is possible use of the quantitative anxiety disorder variable rendered analyses 
less sensitive to an association. This might be the case if the association between worry and 
anxiety disorder pathology is non-linear, which is plausible given the quantitative anxiety 
disorder variable reflects presence and severity of five different anxiety disorders. Such could 
also have prevented the detection of effects of worry that were independent of depressed 
affect in the multivariable analysis. 
The evidence for a causal influence of depressed affect on anxiety disorders in the univariable 
MR analysis is consistent with observational evidence reporting both cross-sectional and 
longitudinal associations between depression and anxiety (383-386), as well as with 
outcomes of the existing MR study (358) mentioned above. There is evidence to suggest that 
neuroticism manifests as depressed affect via rumination (370, 387): previously reported 
associations between rumination and anxiety disorder pathology (388) may be mediated by 
depressed affect.  
Rumination is characterised as dwelling on the negative (389), with a focus on current 
symptoms and their implications (390). This may be in contrasted with worry, which 
typically adopts a future orientation and is concerned with resolving an uncertain or 
unpredictable process (129). There is however considerable overlap between worry and 
rumination, and the two are well supported to be forms of repetitive negative thinking (391, 
392), or repeatedly thinking about negative topics, with little control over the thought process 
(393). Repetitive negative thinking is considered a cognitive expression of neuroticism (394). 
The absence of unique and direct influences of components of neuroticism on anxiety 
disorders perhaps reflects the role of repetitive negative thinking processes more generally, 
rather than worry specifically, in the development of anxiety disorders. Prior research has 
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indeed identified associations between repetitive negative thinking and anxiety disorder, as 
well as depressive, symptomatology (392, 395). 
Repetitive negative thinking has been targeted in prevention interventions for anxiety 
disorders and depression, with favourable outcomes of randomized controlled trials further 
supporting repetitive negative thinking as a transdiagnostic and causal risk factor (348). The 
findings of the current study suggest the benefits of interventions addressing repetitive 
negative thinking may extend to further diagnoses, and in particular to AN. This hypothesis 
may quite feasibly be tested, and would add to evidence concerning the causal role of 
transdiagnostic cognitive processes (i.e. worry) in AN. Future studies might include AN 
pathology as an additional outcome of interest when implementing interventions primarily 
designed to address other forms of psychopathology. Alternatively, existing AN prevention 
efforts, which currently tend to exclusively focus on reducing eating disorder-specific risk 
factors (e.g. drives for thinness (75, 76)), may include adjunctive modules that target 
repetitive negative thinking.  
The finding that neuroticism and its subcomponents are implicated in anxiety disorders and 
AN does not preclude the possibility that anxiety disorders themselves causally influence 
AN. Notably, if this should be the case, preventing anxiety disorder development by way of 
transdiagnostic intervention means such interventions may be even more effective in terms of 
reducing AN onset.  
This study has a number of strengths. Given emerging evidence for the existence of a general 
vulnerability to psychopathology (396), the transdiagnostic approach adopted may best 
elucidate mechanisms of illness as compared to the study of disorder-specific risk factors, 
while also informing the way by which different diagnoses overlap (366). The use of MR 
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minimised bias due to confounding and reverse causality to promote confidence in arising 
causal inferences (183, 294). The completion of various sensitivity analyses allowed for 
evaluation of the robustness of findings from primary analyses, increasing confidence in 
conclusions arising from the current study, relative to those of a previous MR investigation 
(358) . The use of large GWAS datasets to identify instruments, and to assess associations 
between these instruments and outcomes of interest, served to minimise bias and enhance 
power (305, 320). The use of multivariable MR to probe the unique influence of each of the 
neuroticism subcomponents was novel, and further informed the specificity of these 
components in terms of their role in anxiety disorders and AN. This in turn enabled a more 
nuanced understanding of how anxiety disorders and AN may be related.  
This study also had limitations that should be considered when attempting to interpret 
findings. The robustness of MR findings depends on genetic instruments being valid, which 
can never be fully tested (183). It is possible that findings concerning the causal influence of 
depressed affect on anxiety disorders in univariable analyses reflects a common influence of 
rumination on the two phenotypes, rather than direct effects of depressed affect. However, the 
Steiger filtering and subsequent sensitivity analyses supported a direction of effect from 
depressed affect to anxiety disorders. Furthermore, should a common influence of rumination 
be responsible for the observed association, it would not invalidate the conclusion that 
repetitive negative thinking processes underlie anxiety disorder development, as was 
indicated by outcomes of multivariable analyses. Limitations also result from potential 
measurement error in the neuroticism phenotype, given ‘do not know’/’prefer not to answer’ 
were considered valid negative responses. This may have served to bias estimates of the 
causal effect of neuroticism towards the null (397), invalidating conclusions surrounding the 
relative importance of neuroticism versus its subcomponents in anxiety disorder and AN 
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pathology. Weak instrument bias, which results in bias towards the null in the two-sample 
setting, may have been introduced in multivariable analyses. This is due to genetic variants 
meeting instrument criteria for one of the exposures generally not being robustly associated 
with other exposures. While this also increases the risk of bias due to unmeasured pleiotropic 
effects (i.e. pleiotropy not accounted for by the inclusion of multiple exposures), such bias 
was not indicated by outcomes of multivariable MR Egger analyses. Finally, given 
rumination itself was not an exposure in this study, findings cannot directly inform the role of 
rumination in anxiety disorder or AN psychopathology.  
Conclusion  
The study provides evidence for a causal role of neuroticism in both anxiety disorders and 
AN, supporting shared mechanisms explaining at least some of the association between the 
two psychiatric pathologies. Findings highlight the particular importance of worry, a form of 
repetitive negative thinking, relative to other components of neuroticism, in AN development. 
This is relevant to AN prevention efforts, and suggests the potential benefit of existing 
interventions that target repetitive negative thinking processes. Future studies should clarify 
factors moderating the manifestation of neuroticism/its subcomponents as anxiety disorders 
and AN, to further improve aetiological knowledge and intervention effectiveness.  
7.5 Contribution to thesis 
Study 4 confirmed the causal influence of neuroticism, which comprises the subcomponents 
worry and depressed affect, on both anxiety disorders and AN. An such, the findings indicate 
that the associations between anxiety disorders and AN reported in observational studies are 
not entirely causal in nature. Instead, associations may be explained, at least to some extent, 
by the operation of shared risk factors. Outcomes of Study 4 are therefore consistent with 
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findings of Study 3, which provided no clear evidence to support causal effects of anxiety 
disorders on AN development, despite the presence of longitudinal associations. 
The findings of Study 4 support the particular relevance of worry, as opposed to other 
manifestations of neuroticism, on AN development. This facilitates a more precise 
understanding of AN aetiology and in particular of the transdiagnostic mechanisms central to 
the disorder. Outcomes raise the important question of how transdiagnostic risk factors 
translate into AN, which when addressed may provide further and important insights into AN 
aetiology. Study 4 also suggests that repetitive negative thinking processes could be a useful 
target of AN prevention, to improve outcomes of current prevention efforts. The study is 
therefore informative for future research and intervention practice in relation to AN, which 




8 Chapter 8: Discussion 
8.1 Overview of chapter 
The aim of this chapter is to aggregate findings across the studies of my thesis, and to provide 
a detailed discussion of my doctoral work. I begin by summarising the key findings of my 
research, and compare these findings with outcomes of prior investigations to emphasise my 
unique contribution to the evidence base. I provide an interpretation of my results, 
particularly considering what the conclusions mean for models of AN aetiology. I next 
discuss the implications of my findings with respect to both clinical/community intervention 
practice as well as policy, before outlining the strengths and limitations of my work, and 
future directions. I reflect on what I have learnt about myself in the course of completing my 
PhD, and finish the chapter with a brief conclusion. 
8.2 Summary of findings across studies of the thesis 
The primary intention of my doctoral work was to inform the nature of association between 
anxiety disorders and AN. In particular, I sought to further understanding of whether there is 
a causal influence of anxiety disorder pathology, comprising anxiety that does not surround 
weight gain and the eating that promotes this, on AN. This addresses the key hypothesis that 
anxiety unexplained by a diagnosis of AN plays a causal role in AN onset. Four studies were 
completed with respect to my broader aims, each designed to probe more specific research 
questions concerning the anxiety disorder and AN association. In Table 8-1, I outline the 
aims and key findings of each study. I also consider how the findings compare with existing 




Table 8-1 Summary of Thesis Studies and How Outcomes Extend Existing Knowledge   
Studies 1, 2, 3 
Aims Key findings Comparison with existing 
literature 
Novelty of findings 
x To determine 
whether there 
is robust 













presence of any of 





x No single anxiety 
disorder, relative 
to others, explains 
unique variance in 
AN development. 
 
x Findings consistent with 
cross-sectional and 
retrospective research, 
which has found elevated 
symptoms and diagnoses 
of anxiety disorders in 
AN populations (e.g. 
(117, 121, 128)), with 
anxiety disorders 
repeatedly reported to 
precede AN onset (32, 
119). 
x Association between the 
presence of any anxiety 
disorder and subsequent 
AN is consistent with 
findings of the single 
prospective study that 
has probed this specific 
question (e.g. (169)). 










important in the 
prediction of AN 
development. 
x This indicates the 
role of core 
anxiety 
components in 





Aims Key findings Comparison with existing 
literature 
Novelty of findings 
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x To apply 
Mendelian 
randomization 
(MR) to the 
study of AN 






















x No clear evidence 
to support the 
association 
between anxiety 
disorders and AN 
being causal. 
x Observational 




between worry and 
AN. 
x Outcomes of MR 
analysis provided 
strong evidence to 
support causal 
influence of worry, 
a cognitive process 





x The absence of evidence 
for causal influence of 
anxiety disorders on AN 
is discrepant with 
outcomes of 
observational research. 
x Causal influence of 
worry on AN consistent 
with associations 
reported in cross-
sectional (398), as well 
as prospective (170) 
research, although 
notably not my own 
observational findings. 
x Outcomes consistent with 
the finding that worry is 
the component of anxiety 
disorders particularly 
relevant to AN risk 
(170). 
x Prior research supports 
worry as central to 
anxiety disorder 
development (e.g. (399, 
400)). 
x Findings suggest 
the association 
between anxiety 
disorders and AN 
reported in 
observational 
studies is not 
causal in nature, 
which is a novel 
insight. 







role of worry in 
AN. 
x Findings support 
common 
influence of 




the first time) 






Aims Key findings Comparison with existing 
literature 
Novelty of findings 















x Outcomes suggest 
particular 
importance of 
worry, relative to 
x Findings consistent with 
observational research 
outcomes that indicate 
neuroticism as a 




disorders (188, 401) and 
AN (189).  
















x To assess 
whether worry 









of neuroticism (i.e. 
depressed affect), 
and neuroticism 
more broadly, in 
AN aetiology. 
x Neither worry nor 
depressed affect 
explain unique 
variance in anxiety 
disorder 
development. 
x Outcomes inconsistent 
with those of previous 
investigations that 
support worry in 
particular as being 
central to anxiety 
disorders (e.g. (399, 
400)), and relative 
importance of worry over 
neuroticism and its other 
subcomponents in 
explaining anxiety 
disorder pathology (370, 
395, 402-404). 
x Outcomes inconsistent 
with robust evidence 
from 
experimental/intervention 
studies and randomized 
trials supporting a causal 
influence of worry 
specifically, and a causal 
influence of worry as 
opposed to other 
components of 
neuroticism, on anxiety 




x The further and 




and AN in the 
form of 
neuroticism 




support for role 











relevant to AN 
risk. 
x Given worry 
























8.3 Implications for understanding of AN aetiology 
The finding that non-specific worry causally influences AN development, in the context of 
there being no strong evidence to support a causal influence of anxiety disorders themselves, 
has implications for models of AN aetiology. There are two main explanations for the pattern 
of findings observed. First, it is possible that worry increases risk of AN only when it 
becomes focused on eating and weight gain. Alternatively, the worry typical of anxiety 
disorders, but not other anxiety disorder symptoms (e.g. distress, avoidance behaviour), 
causally influences AN onset. The two proposed mechanisms for the results observed across 
studies of this thesis are discussed below, with reference to relevant supporting evidence and 
theoretical models 
Model 1: Worry increases risk of AN when directed onto weight gain and eating 
This account reflects the extension of transdiagnostic models of anxiety disorders, which 
posit that a set of core processes create a vulnerability to anxiety disorders generally, to AN. 
Worry is posited as one central and nonspecific process that causes other anxiety disorder 
symptoms, with the content of worry dictating the precise pathology, or the specific anxiety 
disorder, that develops (e.g. (113, 131, 399)). Worry is present in children as young as three 
years old, and emerges with the development of cognition - in particular the ability to 
elaborate (409). Worry increases in prevalence from childhood into adolescence (410), 
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peaking in late adolescence (411), and the content of worry changes with developmental 
stage (412). Transdiagnostic models can account for the variability in typical onset periods of 
the different anxiety disorder diagnoses (e.g. (197)) given the focus of worry in anxiety 
disorders typically emerging at a given developmental stage is normative for that stage. For 
example, interpersonal/social concerns are fairly usual during adolescence, the period in 
which social anxiety disorder most commonly develops (197). Transdiagnostic models can 
also account for reports that while the precise diagnosis changes with time, anxiety disorder 
presence is relatively stable (385, 413).  
Supporting the application of transdiagnostic accounts of anxiety disorders to AN, the high 
level of weight-concern (288) and normative increase in body dissatisfaction during 
adolescence (414, 415) corresponds with the period of peak AN incidence (40). In addition, 
although the tendency to worry is elevated in AN, worries tend to predominantly be focused 
on AN-related phenomena (142), and concern around eating, weight and shape constitutes a 
core psychological feature of illness (12). The proposed transdiagnostic account is also 
consistent with preliminary evidence from retrospective studies that suggests varying 
temporal associations of different anxiety disorders with AN. Comorbid anxiety disorders 
more typical of earlier developmental periods (e.g. social phobia, specific phobia, generalised 
anxiety disorder, separation anxiety disorder) are reported to precede AN, while those that 
tend to develop later in life (e.g. panic disorder, agoraphobia) have been found to onset after 
AN development (32, 119).  
There is various evidence consistent with worry causally influencing other anxiety disorder 
symptoms, and consequently its role in anxiety disorder development. Worry is well 
supported to result in heightened physiological activation, for example increased sympathetic 
nervous system activity (136, 416). Worry increases attention to threat (406), and perception 
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of threat (417, 418). Worry also influences fear learning, to affect responses symptomatic of 
anxiety disorders that are implicated in their maintenance (419): worry enhances fearful 
responding to threatening stimuli/subsequent generalisation of fear responses to non-
threatening stimuli, and compromises the ability to extinguish learned fear responses (420). 
These described direct outcomes of worry may then lead to the various cognitive (e.g. 
hypervigilance), emotional (distress), physical (e.g. tension), and behavioural (e.g. avoidance) 
symptoms of anxiety disorders, to which worry is itself related (421-424). 
The proposal that worry surrounding eating and weight gain gives rise to other AN symptoms 
is supported by available observational data. Concern around eating, weight and shape is a 
central component of AN pathology in terms of its relation to various other symptoms of 
illness (425, 426), and is prospectively associated with initiation of the restrictive eating core 
to AN (427). In individuals with AN, worries about weight gain, fatness and eating predicts 
subsequent dietary restriction, purging, and excessive exercise (428). It is possible that 
restrictive eating and compensatory behaviour functions to reduce weight and body-related 
worries, given engagement in these behaviours prevents weight gain and promotes weight 
loss. The reduction in weight concern may reinforce engagement in disordered eating 
behaviours, with concerns increasing in situations when behaviours cannot be performed (82, 
83), prompting the formation of a vicious cycle of restrictive eating/compensatory behaviour 
and worry about eating/weight gain. Dietary restriction may also reduce worry via dampened 
activity of the serotonergic neurotransmitter system implicated in worry (429, 430), due to 
reduced intake of the serotonin dietary precursor tryptophan (95). This would provide a 
neurobiological mechanism by which restrictive eating reduces worry, which in this case is 
focused on eating and weight, to again encourage continued engagement in restrictive eating. 
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The effects of concern with weight and body size on eating behaviour may also be mediated 
by psychological constructs such as drive for thinness (e.g. (428)). 
In the same way that worry translates into fear in anxiety disorders, it is possible worry about 
eating and weight promotes the acquisition of another key feature of illness in AN: fear of 
weight gain (1). Worry may also maintain learned fear responses to eating and other 
behaviours that promote weight gain or maintenance (i.e. abstaining from exercise and 
purging), by preventing corrective learning through distraction or hyperarousal (431). Fear 
responses conceivably encourage continued starvation, ensuring the onset and maintenance of 
full syndrome AN (361). However, fear acquisition and extinction, and the relationship 
between these and other cognitive processes (e.g. worry), have not yet been directly studied 
in the context of AN (432).  
Worry is a component of neuroticism, a broad personality trait that may manifest in a variety 
of different ways (433) and that is associated with multiple psychiatric pathologies (187). A 
model of AN holding worry as a central causal factor may thus fit in to a broader account of 
psychopathology that focuses on the transdiagnostic influence of neuroticism (434). Such an 
account is consistent with the existence of a general psychopathology factor that cuts across 
all psychiatric diagnoses, particularly given the association of this psychopathology factor 
with neuroticism (396).  
Worry is closely related to rumination (389), another component of neuroticism (433), and 
the two are collectively characterized as repetitive negative thinking – or repetitive thinking 
focused on negative content, from which it is difficult to disengage (393, 435). Worry and 
rumination are supported to arise from common processes (436, 437), and distinguished 
largely by their temporal orientation and content: worry is typically focused on future 
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scenarios; while rumination involves analyzing causes, meanings and consequences of 
mood/past events (438). When automatic, unintentional or uncontrollable, and frequent, 
worry and rumination appear particularly detrimental for mental wellbeing (e.g. anxiety, 
depression, self-esteem) (439, 440), suggesting the processes underpinning negative thought 
generation, as well as the content of these thoughts, may explain psychopathology.  
Although the general tendency to engage in repetitive negative thinking is associated with, 
and causally implicated in, anxiety disorder pathology (348, 392, 441), there is evidence 
supporting the greater relevance of worry, as compared to rumination (e.g. (370, 382, 405, 
442, 443). Existing evidence also supports the particular importance of worry in AN, as 
opposed to repetitive negative thinking more generally. As outlined above, there is support 
for worry surrounding eating and weight gain predicting AN behaviour (428), but evidence in 
respect of disorder-specific rumination is less convincing (444, 445). Furthermore, 
rumination on eating/weight is likely to be in the context of considering the potential for 
future weight gain/fatness in AN (e.g. (445)), and thus perhaps more reflective of worry. My 
findings certainly support worry being the specific component of neuroticism that is causally 
related to AN development, although notably rumination was not directly measured.  
The centrality of worry, as compared with other transdiagnostic constructs or manifestations 
of neuroticism, to both anxiety disorders and AN may explain the particularly high 
comorbidity of AN with anxiety disorders, relative to a number of other psychiatric 
conditions (446-448). This model of illness (depicted in Figure 8-1) is also consistent with 
the phenomenological similarity between anxiety disorders and AN, with the two sharing 
common features such as nervousness, tension, irrational fears and avoidance of feared 




Figure 8-1 One possible model of AN aetiology arising from findings of my doctoral work 
Various other traits typical of individuals with anxiety disorders have been strongly 
implicated in AN. These include personality and temperamental factors such as harm-
avoidance and perfectionism (361), as well as dysfunctional emotion regulation (398, 449). 
These traits are associated with worry (450-452), and thus worry may be one of a cluster of 
related factors that causally influence risk for anxiety disorders and AN. This cluster may 
mediate the effects of an underlying genetic liability that appears to be common to both 
anxiety disorders and AN. Indeed, anxiety disorders and AN aggregate together in families 
(362). Twin studies support this aggregation to result from a common genetic underpinning 
of the two disorders (118), as does the fact genetic variants across the genome show similar 
associations with anxiety disorders and AN (363, 453). 
The proposal that findings of studies of this thesis reflect the existence of shared risk factors 
for anxiety disorders and AN is not consistent with the model of AN aetiology presented in 
Chapter 1, which asserts anxiety disorder pathology (and specifically the anxiety typical of 
anxiety disorders) causally influences AN development.  
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Model 2: Worry typical of anxiety disorders causally influences AN 
An alternative explanation for the collection of results is that the worry typical of anxiety 
disorders causally influences AN development, while other anxiety disorder symptoms, 
which include fear responses, distress and avoidance behaviour (1), do not. In this case 
anxiety disorder pathology is causal in AN development, rather than simply reflective of 
increased risk for AN. Although this explanation is consistent with the account of AN 
aetiology presented in Chapter 1, it offers a more precise explanation for the way in which 
anxiety disorder pathology causally influences AN. It also highlights the importance of 
considering the role of distinct components of anxiety pathology when studying AN 
aetiology. This model is depicted in Figure 8-2. 
Figure 8-2 Alternative model for pattern of observed results 
In terms of how worry typical of anxiety disorders increases risk of AN, perhaps this worry 
promotes the concern around eating and weight proposed as central to AN development. For 
example, the focus on eating and weight gain may provide a welcome distraction from other, 
perhaps more distressing, concerns (102, 454, 455), such as those surrounding possible 
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rejection/negative evaluation by peers (103), or physical attack. Individuals with AN are 
consistently found to be poor at regulating negative emotions (398). The worries of AN are 
generally experienced as ego-syntonic rather than upsetting (74), and importantly they may 
actually be dealt with (at least initially) by dietary restriction. This is in contrast to other 
concerns that surround situations over which an individual often has little control, which 
could make the fixation on eating and weight particularly appealing (455). Equally, 
pathological worry focused on eating and weight gain may result from strong desires to 
restrict intake (456) that arise from initial dietary restriction reducing worries typical of 
anxiety disorders, causing dietary restriction to be experienced favourably (114, 196). Dieting 
and use of weight-control behaviour increases from childhood to adolescence, and is fairly 
normative in the latter period (289, 457). The suggestion that there is an interaction between 
dietary restriction and worries typical of anxiety disorders in explaining AN onset is thus 
consistent with the peak period of AN development.  
An alternative pathway from worries more typical of anxiety disorders to AN is via 
compromised function of particular brain regions and networks. Worry itself is a stressor, and 
as discussed earlier has various physiological effects, giving rise to increased activity within 
endocrine (e.g. cortisol production) and cardiovascular (heart-rate) systems (138, 458). 
Evidence also supports worry prolonging the effects of other stressors on these systems (e.g. 
(459, 460)). Chronic stress has various detrimental effects on neural function (461), which 
may enhance vulnerability for AN as well as anxiety disorders. In particular, stress has been 
shown to affect brain circuitry implicated in fear learning and extinction (461), potentially 
promoting the acquisition and maintenance of fear responses (462). Stress also increases 
habit formation and responding via effects on neural structure and function (109, 463, 464). 
Current data support the relevance of neural circuits implicated in habitual behaviour to AN 
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(465), with formation of strong restrictive eating habits suggested to underlie development 
and maintenance of the disorder (196, 466, 467). Stress arising from worry may interact with 
the emergence of desires for weight loss and initiation of restrictive eating, to influence the 
embedding of AN behaviour, both directly and via the acquisition of fears typical of AN. 
The role of multiple types of worry in AN development 
Given the complexity of psychiatric disorders (468), it is likely that a number of factors and 
processes influence AN development. A transdiagnostic account that suggests a causal 
influence of worry surrounding eating/weight gain on AN development does not preclude a 
causal influence of anxiety disorder pathology. Worries focused on various stimuli may 
interact with each other, and bring about AN via many mediators. A simple interpretation of 
my findings, agnostic to the particular content or mediating mechanisms of worry, is that 
processes underlying worry have a causal role in AN development. The absence of evidence 
for a causal influence of anxiety disorders on AN, combined with evidence to support the 
existence of shared risk factors for anxiety disorders and AN (i.e. processes underlying 
worry) suggests estimates of association between the disorders in observational studies have 
likely been subject to confounding however.  
That the processes underlying worry are biological in nature (469, 470) could aid in 
understanding why, despite the increasing emphasis placed on the importance of thinness by 
media and society (471), rates of AN have remained remarkably stable over time (40, 472, 
473). Though there is some evidence to support media messages surrounding thin being the 
ideal body type increasing dieting and body dissatisfaction (474), these effects may be limited 
to those with an underlying vulnerability to eating disorder development (475, 476). 
Furthermore, there is currently no evidence to support sociocultural influences alone 
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predicting increased risk of AN (193), or influencing restrictive eating/compensatory 
behaviour in individuals with AN (477). 
8.4 Implications for practice 
The findings of my thesis provide insights relevant to various theoretical models of AN 
development (in addition to my own account). A number of models of illness have proposed 
a causal role of anxiety broadly in AN development (e.g. (97, 114-116)). Though supported 
by outcomes of my doctoral research, my findings specifically suggest a role for anxiety 
focused on eating and weight gain. As such, outcomes of my doctoral work particularly 
support accounts of AN development that highlight the importance of AN-specific anxiety 
(e.g. (102, 285, 286, 361)). The proposal that anxiety-generating mechanisms influence both 
anxiety disorder and AN development is central to some existing models of AN, and 
consistent with the role of worry in AN development that was identified across studies of this 
thesis. Two theoretical models suggest a role of fear learning abnormalities in AN onset (285, 
286). My findings raise the possibility that a wider collection of anxiety-generating processes 
(i.e. including those giving rise to worry) may be relevant, allowing for an extension of these 
existing accounts of AN development. Notably, although my findings are consistent with a 
number of models of illness, they do in fact oppose assertions of others. The support for a 
causal influence of a cognitive process in AN development, and existence of a risk factor that 
is shared with anxiety disorders in some capacity, is consistent with AN being characterised 
as a psychiatric disorder. This contrasts with proposals of certain evolutionary accounts of 




As well as informing the validity of existing theoretical models, my findings may inform 
current clinical practice, and in ways that may be helpful from an AN prevention perspective. 
Regardless of the mechanisms by which they are associated, there is robust evidence to 
support the presence of an anxiety disorder signaling increased risk of AN development. 
Should clinicians treating childhood anxiety disorders be aware of this elevated risk, eating 
disorder symptoms may be detected earlier, prompting signposting or referral towards 
specialist services. The benefits of addressing AN symptoms earlier could be substantial 
given the difficulty in treating full syndrome AN, and the negative prognostic effect of illness 
duration (479-481). 
My findings also have relevance for the way in which childhood anxiety disorders (i.e. those 
emerging prior to AN onset) are treated. Currently, the majority of evaluated treatments for 
childhood anxiety disorders, and thus those typically used in current practice, are cognitive 
behaviour therapy approaches (482). These interventions consist of generic modules designed 
to: enable recognition of anxiety; change automatic, negative thoughts elicited in anxiety-
provoking situations to more positive thoughts that emphasise coping; and reduce anxiety and 
fear responses via gradual exposure to the anxiety-provoking situation. The content of 
existing interventions is tailored towards the specific diagnosis being treated, so as to address 
particular presenting symptoms (483). Consequentially, children may not develop more 
general skills that might reduce risk of psychiatric symptomatology in relation to multiple 
disorders. The evidence supporting the stability yet non-specificity of childhood anxiety 
disorder diagnoses (385, 484, 485), and maintenance of comorbid anxiety pathologies 
following treatment for the primary diagnosis (486), suggests this is the case. Reducing the 
risk of psychiatric symptomatology generally may be achieved by addressing cognitive 
processes such as worry, or repetitive negative thinking more broadly, rather than thought 
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content - the target of cognitive behavioural therapies (487). Indeed the tendency to engage in 
repetitive negative thinking contributes to the development and maintenance of symptoms 
across diagnoses (e.g. (132, 348, 393, 488-490), explaining psychopathology over and above 
the effects of thought content (439), and the persistence of anxiety symptoms following 
cognitive behavioural therapy (489). My findings particularly highlight the potential utility of 
addressing general thinking processes in the treatment of childhood anxiety disorders for the 
purposes of AN prevention. Notably this is regardless of the way in which a propensity for 
worry translates into elevated risk of AN development.  
For adults, transdiagnostic treatments that specifically target repetitive negative thinking have 
been developed. Metacognitive therapy focuses on changing beliefs around the nature of 
repetitive negative thinking (e.g. its uncontrollability and utility), promoting attentional 
flexibility and mindfulness (sustaining attention on the present), and developing strategies to 
avoid repetitive negative thinking. Metacognitive therapy has demonstrated efficacy, with 
trial outcomes supporting the superiority of the approach over disorder-specific cognitive 
behavioural treatments, particularly when considering comorbid disorder symptoms (491-
495). These treatments might be adapted for delivery to children, to address presenting 
psychiatric disorders, and prevent the onset of others. Addressing non-specific processes such 
as worry in AN treatment is likely to be helpful for the amelioration of comorbid disorder 
symptoms – though whether this approach would be beneficial in terms of promoting AN 
recovery requires investigation. 
My doctoral work also has direct implications for community-based eating disorder 
prevention programmes. Again, the confirmation of anxiety disorder presence as a risk factor 
for AN, regardless of whether the association is causal, may provide direction in terms of 
identifying those who might be prioritized to receive preventative interventions in community 
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settings (e.g. schools, universities). However, simply continuing to apply existing 
interventions that largely only address eating disorder psychopathology and behaviour (e.g. 
drive for thinness and restrictive eating) is not indicated. The absence of evidence to support 
favourable effects of these interventions on diagnosis prevention, or symptom reduction in 
individuals already displaying behaviour and cognition typical of AN (75, 76), suggests novel 
approaches are needed.  
Addressing the processes underlying worry could be useful for AN prevention in a 
community, as well as clinical, setting. Testing this hypothesis is very feasible given 
transdiagnostic prevention interventions targeting repetitive negative thinking already exist, 
and have been administered to reduce anxious and depressive symptomatology. Like the 
treatment interventions described above, these transdiagnostic prevention efforts primarily 
seek to change thought processes rather than content. One existing programme frames 
repetitive negative thinking as a habitual process (348). Individuals are guided to identify 
cues that trigger the repetitive negative thought processes, and subsequently to avoid these 
same cues or to withhold the automatic response to engage in repetitive negative thinking 
when cues are encountered. Individuals are taught more concrete styles of thinking, which are 
situationally-specific and involve step-by-step processing, as an alternative to repetitive 
negative thinking that tends to be cross-situational and lacking in clarity. The concrete mode 
of thinking enables improved emotional processing and problem solving, and so the 
intervention provides individuals with an adaptive coping strategy that reduces risk of 
psychopathology (130, 496). A gratitude intervention that promotes the experience, 
perception and expression of gratitude has also been developed to address repetitive negative 
thinking. This programme similarly aims to enable individuals to identify dysfunctional 
patterns of thinking, while also encouraging a more positive outlook that may improve 
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attentional control and ability to disengage from negative thoughts, to in turn reduce 
repetitive negative thinking (497). Both described transdiagnostic interventions have 
demonstrated efficacy in reducing anxiety disorder pathology, with effects mediated via 
reductions in repetitive negative thinking. Furthermore, they have been delivered in group, 
internet and app-based settings, supporting their ease of administration as well as their 
potential utility for AN prevention (348, 497).  There are broadly two strategies for the 
implementation of such interventions in the context of AN prevention. First, they may be 
delivered as standalone interventions. This might be appropriate for a universal intervention 
seeking to reduce multiple psychopathologies. Alternatively, modules addressing processes 
underlying repetitive negative thinking could augment evidence-based programmes that 
target other causal, and potentially AN-specific, risk factors. This may constitute the best 
approach for individuals at increased risk of AN development, or who are already 
symptomatic.  
Notably, mindfulness-based interventions delivered in school and university settings in 
attempts to prevent eating disorder onset are not supported as beneficial (498). Mindfulness is 
defined as attending to the present moment and adopting an open and accepting orientation 
towards one’s thoughts and experience (499); mindfulness-based interventions involve a 
range of activities and exercises (e.g. yoga, breathing practices) that promote this approach 
(500). While there is mixed evidence to support mindfulness-based interventions reducing 
weight concerns in the short term, effects are not lasting, and there is no clear evidence for 
reductions in disordered eating (498). Similarly, interventions purely promoting engagement 
in mindfulness-based activities are ineffective in the prevention of anxiety symptoms in a 
classroom setting (501). Although mindfulness-based interventions aim to discourage 
dwelling or elaborating on negative thoughts, mindfulness-based interventions do not 
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explicitly target the cognitive mechanisms underlying repetitive negative thinking. This 
contrasts with the successful interventions described above, and serves to support the 
potential benefit of interventions that do address mechanisms promoting engagement in 
repetitive negative thinking for the prevention of AN. The habitual nature of repetitive 
negative thinking may be particularly important to target for sustained changes in/protection 
from psychopathology, given habits are likely to promote the persistence of maladaptive 
forms of cognition. Supporting this proposal in the context of AN prevention, in a non-
clinical population, the extent to which individuals endorsed negative body-related thoughts 
being habitual predicted severity of restrictive eating independently of the severity of such 
thoughts (502). 
8.5 Implications for policy 
Emphasising the existence of processes that cut across disorders to bring about 
psychopathology further supports the proposed move away from considering these disorders 
as distinct entities with distinct aetiologies (e.g.(503)). This has two important implications 
for health policy. The first is that it encourages the adoption of a transdiagnostic strategy for 
the prevention and treatment of psychiatric disorders. This may in turn promote changes to 
clinical and community-based practice in the manner proposed above. The second 
implication concerns the recommended framework in which psychiatric disorders are 
researched, with my findings supporting the study of transdiagnostic processes such as worry 
across multiple disorders. This constitutes research aligned with the United States (US) 
National Institute of Mental Health Research Domain Criteria, and may enhance aetiological 
understandings as well as account for patterns of comorbidity. Such an approach may be 
further embraced into research outside the US by altering current research funding policies; 
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for example, allocating grant funding specifically for research into transdiagnostic 
mechanisms of illness.  
In addition to highlighting the importance of transdiagnostic research funding, my doctoral 
work identifies the (not mutually exclusive) need for greater investment into eating disorders 
research. In the UK there have been substantial investments into eating disorders treatment 
for young people, intended to widen access to treatment and reduce waiting times (504). 
Unfortunately, this spending is unlikely to translate into the anticipated improved recovery 
rate in the absence of more effective treatment for full and subsyndromal AN. It also does not 
negate the need for effective prevention. Without a better understanding of AN aetiology, it is 
unlikely that AN prevention and treatment may be adapted in ways that enhance current 
outcomes. My research has contributed to an improved understanding of the association 
between anxiety phenotypes and AN onset, which may direct future research and AN 
prevention efforts. It is clear however that there remains much to be learnt about this specific 
relationship, and that much is unknown in relation to the many other potential risk and 
maintaining factors for AN. This point is emphasised across the work of this thesis, but an 
acceleration in understanding depends on an increased research budget (505). In the UK the 
spend on eating disorders research as a proportion of all mental health research has increased 
from 0.4% in 2008-13, to 1.2% in 2014-2017 (506, 507). Yet, spending remains markedly 
lower than that for various other psychiatric conditions that are reduced in both prevalence 
and mortality risk, for example schizophrenia and autism (508, 509). One potential cause of 
the particularly inadequate funding for eating disorders research is the stigma that continues 
to surround these conditions (505). It is an unfortunate truth that there remains a widespread 
perception that eating disorders are driven by vanity, with the pathology entirely within an 
individual’s control (510). Producing evidence that supports a causal influence of cognitive 
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processes in AN may prompt eating disorders to be more seriously considered as biological 
conditions, reducing stigma (511), and potentially improving the research funding situation 
dictated by policymakers.  
The support for AN comprising a biologically underpinned disorder also has implications for 
education surrounding eating disorders. Policy changes may instigate a greater emphasis on 
biological explanations in the teaching of eating disorders, at school and university level, 
within training for healthcare professionals, and in educational materials provided to 
individuals with eating disorders and their carers. A biological rhetoric in eating disorders 
education may similarly lead to reductions in stigma surrounding eating disorders (511), as 
well as reductions in self-blame amongst individuals with eating disorders and their families. 
This may confer a number of benefits in terms of AN outcomes, for example creating an 
environment in which individuals experiencing AN symptoms feel more able to seek help 
(512), facilitating earlier identification and intervention. Reduced self-blame amongst carers 
may improve their ability to support individuals with AN (513), while reduced self-blame 
amongst those with AN may translate directly into symptom improvements (514, 515) 
8.6 Strengths and limitations 
The collection of work included in this thesis has a number of strengths, but is also subject to 
limitations. Both are important to consider when interpreting findings and considering 
directions for future research. In this section the strengths and limitations that exist across 
studies of this thesis are summarised and discussed; those particular to individual studies are 
not described, to prevent duplication of information presented in previous chapters. Table 8-2 
provides an overview of the strengths and limitations, categorised by components of study 
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methodology. I provide further detail in respect of the major strengths and limitations raised, 
discussed in the order in which they appear in Table 8-2. 
Table 8-2 Brief Summary of Limitations Across the Thesis Studies 
Methods Strengths Limitations 
Design x Use of a range of designs, each of 
which subject to unique limitations, 
enabled triangulation across different 
studies, promoting robustness of 
conclusions. 
x Studies addressed novel research 
questions. 
x Studies introduced new 
methodological approaches to the 
field of eating disorders research. 
x Research questions and design of 
thesis studies informed by outcomes 
of other doctoral work, to promote a 
coherent set of studies and 
conclusions. 
x Secondary data analysis enhanced 
feasibility of study completion, and 
increased study sample sizes relative 
to attempts to collect data myself. 
x Some sources and effects of bias 
are consistent across different 
studies; conclusions may still be 
invalid even if they align across 
studies. 
x The quality of data included in 
studies is unclear as I did not 
oversee data collection. 
x Use of secondary data meant I 
was limited to the available data; 
measures were not always the 
gold-standard, or were missing 
from datasets. 
 
Participants x Participant demographics similar to 
those of other studies in the eating 
disorders field, promoting 
comparison of findings across 
different studies. 
x In analyses with AN outcomes, 
participants were of an age where 
outcomes are likely to already have 
emerged, increasing sensitivity to 
detect associations. 
x Participants not representative of 
general population in terms of 
ethnicity, socio-economic status 
or sex, reducing generalisability. 
x Loss of participants to follow-
up, and consequential missing 
data, could introduce bias into 
estimates of association. 
Data 
Sources 
x Use of large datasets to enhance 
power.  
x Certain analyses could not be 
completed within the constraints 
of available data. 
x Despite the use of large datasets, 
certain analyses are likely still to 




x The AN outcome was relatively 
rare in study datasets.  
Measures x Use of range of different measures in 
respect of exposures and outcomes, 
promoting subtle form of 
triangulation. 
x Consideration of AN behaviour as 
well as AN diagnosis allows findings 
to be extended to individuals not 
meeting all diagnostic criteria for 
AN, increasing their relevance and 
potential impact. 
x Diagnostic interview data (gold-
standard for psychiatric assessment) 
used to capture psychiatric disorders 
where possible. 
x Operationalisation of concepts of 
interest consistent with approaches of 
other studies.  
x Anxiety and AN variables, as 
well as analysis covariates, 
measured with potential error. 
x The use of range of measures 
makes discrepancies in findings 
across studies using different 
measures difficult to interpret. 
x Measures may capture similar 
and overlapping, but distinct, 
concepts, resulting in misleading 
conclusions. 
x AN diagnosis based on low body 
weight; failure to capture those 
with severe psychopathology yet 




x Completion of various sensitivity 
analyses to promote robustness of 
conclusions. 
x Consideration of sources of bias at 
each stage of the analysis, and 
adoption of methods designed to 
minimise bias. 
x Analyses reliant on various 
assumptions that are untestable 
or untenable. 
x Residual confounding in 
observational studies is likely. 
x Multiple testing not accounted 
for. 
x Estimates of association do not 
always have clear interpretation. 
 
Strengths 
One of the major strengths of work of this thesis is the use of a range of different study 
designs, statistical methods and measures of concepts of interest, to evaluate the association 
between anxiety disorders and AN. This approach allowed for the triangulation of findings 
across studies, to inform the robustness of conclusions (181). It also enabled a more nuanced 
understanding of the nature of association between anxiety disorders and AN.  
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The second significant strength of my doctoral work is that it offers a novel contribution to 
the existing literature. The precise research questions addressed in studies of this thesis have 
not been previously considered, allowing new insights into how anxiety disorders and AN 
may be related and, in turn, AN aetiology. I also implemented methods that are new to eating 
disorders research. In particular, I introduced MR to the field, which may encourage wider-
spread use of the technique for improved causal inference. 
Third, the studies of my thesis have been informed by each other. For example, limitations of 
prospective studies included in the systematic review were addressed in my own prospective 
analyses, and the identified association between worry and AN in Study 3 directed analyses 
of Study 4. In this way my findings are able to give rise to a coherent understanding, as 
opposed to a set of disconnected conclusions.  
To promote the validity of resulting conclusions, I engaged in practices that enhanced 
statistical power; capitalising on the use of large datasets to assess relationships within 
multivariable/multivariate regression frameworks, and to complete MR analyses. Finally, in 
each of the studies I adopted methods that minimised the potential for bias, for example: 
instructing two reviewers at various stages of the systematic review; imputing missing 
data/accounting for the clustering of repeated measurements/adjusting for potential 
confounding, in observational research; using MR; and completing various sensitivity 
analyses across studies of the thesis.  
Limitations 
One key limitation is that there are potential sources of bias that are shared across the 
different studies, and that might be expected to affect results in the same way. This 
undermines the strength of the triangulation approach adopted. One common source of bias 
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across observational and MR studies is parental anxiety. Elevated parental anxiety, both 
maternal and paternal, predicts an increased likelihood of child AN in observational research 
(167, 169, 516, 517). These associations may result from the environment created by parental 
anxiety, as opposed to effects of child anxiety that follow from the transmission of 
anxiogenic genetic variants from parents to offspring. In my observational analyses I did not 
include parental anxiety as a covariate, and MR analyses were not adjusted for parental 
genotype, meaning positive findings across studies could reflect direct effects of parental 
anxiety genotype (i.e. parent anxiety). Patterns of parental mating may also have influenced 
results, given individuals with psychiatric disorders are more likely to reproduce with each 
other as compared to individuals without a psychiatric disorder (mating is non-random). In 
particular, females with AN, relative to female HC, are more likely to mate with males with 
an anxiety disorder diagnosis (518). Established mating patterns could conceivably induce 
associations between anxiety disorder phenotypes and AN in observational and MR analyses, 
given these mechanisms were not controlled for (519).  
These possibilities demonstrate that while the comparison of findings across different types 
of study can strengthen causal inference, particularly when steps to minimise bias within each 
investigation are taken, mechanisms other than causal influence may still account for 
identified associations. The gold-standard for causal inference remains the well-designed 
randomized controlled trial (RCT), given its randomisation and experimental components, 
and all research is limited in its ability to make causal inferences in comparison (184). 
However, my findings are absolutely necessary to inform whether completion of an RCT is 
justified for evaluation of causal effects.  
Another study design limitation is that all analyses depended on the use of secondary data. As 
a result of me not collecting the data myself, the quality of data included in my studies could 
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not be evaluated. It is possible that study measures were not administered properly, which 
could be particularly problematic in respect of data collected by way of diagnostic interview. 
Data may have been recorded, or entered into databases, with error. Poor data quality would 
introduce bias into estimated associations, and could invalidate study conclusions. 
The next limitation relates to participants of my studies, and consequential limited 
generalisability of my findings. The Avon Longitudinal Study of Parents and Children 
(ALSPAC) cohort is not representative of the rest of the UK in terms of ethnicity or socio-
economic status (SES) (258), and UK biobank participants have higher SES relative to non-
participants (520). The MR analysis included participants with European ancestry only; 
reducing the potential for biased estimates of association due to population stratification, but 
also limiting the ability to generalise conclusions of my work to the wider population. AN 
samples are typically all female, and in Study 2 I included only females in my analyses. It is 
plausible that my findings do not generalise well to men, with existing observational research 
suggesting that associations between anxiety disorders and AN are more pronounced for 
males as compared to females (169). Given my dependence on secondary data, with the 
majority of existing AN research completed in predominantly female populations, this 
limitation is somewhat inevitable. While the extent of sex differences in AN prevalence is 
potentially subject to overestimation due to stigma or diagnostic error, AN is more common 
amongst females as compared to males (38). As such, the largely female AN samples may 
not serve to invalidate conclusions of my studies in relation to the majority of individuals 
with AN. 
The nature of data used to complete my research also prevented the completion of certain 
additional analyses that may have furthered understanding to a greater extent. It was not 
possible to pool estimates of association between anxiety disorders and AN across studies 
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included in the systematic review, which would have informed the magnitude of effect, and 
confidence in the estimate of association. This resulted from substantial differences between 
studies of the review, and inadequate reporting practices. Low power, which serves to 
complicate interpretation of null findings, also prevented the completion of particular 
analyses; for example, the formal test of whether associations between anxiety disorders and 
fasting varied over time in Study 2. In both cases, statistical analyses would have been useful, 
but were not necessary to provide insight. On other occasions, when an estimate of 
association was required, I completed analyses acknowledging they were likely to be 
underpowered. Low power is a particular limitation in respect of MR analyses assessing the 
causal influence of anxiety disorders on AN, and this association requires further 
investigation. The absence of clear evidence for a causal effect of anxiety disorders does not 
necessarily reflect the absence of a true underlying causal effect. As such, my conclusions 
concerning the role of the full collection of anxiety disorder symptoms in AN development 
could be invalid. The possibility of anxiety disorders causally influencing AN is not mutually 
exclusive with confounding of the anxiety disorder and AN association by transdiagnostic 
processes or risk factors. In this case though, the magnitude of anxiety disorder influence may 
be smaller than anticipated, to which my MR analyses would be even less sensitive. As well 
as reducing sensitivity to true effects, low power can result in false positives (521), and effect 
estimates for which there is strong statistical evidence being inflated above their true values 
(522). It is doubtful such is an issue for findings of this thesis however, given associations 
were observed only within analyses that were likely to be sufficiently powered.  
Existing research findings required for the completion of my own analyses were also subject 
to power issues, which conferred limitations into my studies. Rare outcomes in cohort studies 
of the systematic review reduced power to detect associations, complicating interpretation of 
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outcomes of the qualitative synthesis. The relatively small sample size of anxiety disorder 
GWAS that informed selection of genetic instruments in my MR analyses meant low power 
to detect eligible instruments. Subsequently, the variance in exposure explained by 
instruments was low, which translated into low power (321), and potentially bias towards the 
null (341), in my MR analyses.  
Measurement error in phenotypic assessment is likely to be an issue in all of the studies. 
Investigations included in the systematic review may not have captured AN outcomes 
accurately, either relying on self-reported symptoms, or being sensitive to the detection of 
only the most severe cases. My observational data analyses relied on self-reported measures 
of AN behaviour (e.g. restrictive eating and exercise), and in the case of AN assessment, the 
cognitive and behavioural criteria used may not map precisely on to DSM diagnosis (1). A 
population assessment strategy was similarly implemented in some of the contributing 
samples of the AN GWAS (357, 523). However, given the presentation of AN is remarkably 
stereotyped, assigning diagnoses based on core behavioural and psychological features is 
likely to comprise valid assessment of the AN phenotype. Furthermore, the self-report 
measures of AN behaviour and cognition used across studies of this thesis had been 
validated. My precise approach to deriving AN diagnoses in the ALSPAC dataset constitutes 
an established method (170, 190), promoting consistency and valid comparison of findings, 
with existing research. Measurement of anxiety phenotypes was subject to similar potential 
inaccuracies given the methods of assessment, which included medical records (insensitive to 
all but the most severe cases), self-report questionnaire, and diagnostic instruments 
administered to parents. Across observational and MR studies the assessment of worry was 
quite crude. In the case of MR studies, the measure may have captured aspects of tension and 
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arousal perhaps more reflective of non-specific physical anxiety – though such physical 
symptoms are established sequalae of worry (136).  
Where measurement error in the exposure is random, such that the measurement is imprecise 
across all individuals, the effect estimate will be biased towards the null. When there is 
random measurement error in the outcome, standard errors are inflated, decreasing precision 
and confidence in the estimate of effect (524). When measurement error is differential, that 
is, the error in the measured exposure depends on values of the outcome, or vice versa, this 
can introduce bias away from the null into effect estimates (525). It is plausible that certain 
anxiety disorder symptoms (e.g. concerns or fears over being observed eating, an indicator 
for social anxiety disorder (1)) reflect AN pathology. If, as a consequence, individuals with 
AN are more likely to falsely receive an anxiety disorder diagnosis as compared to HC, both 
observational and MR study estimates could be biased. The misdiagnosis of anxiety disorders 
in the presence of AN pathology has been noted in the application of computer algorithms to 
diagnostic assessment data (262), the approach used in Studies 2 and 3, although is less likely 
when diagnoses are clinician or researcher assigned – as in other studies of this thesis.  
Measurement error in potential confounders is also possible given the use of self-report 
measures. Various confounding factors were measured at quite a high level (e.g. binary 
indicators of SES status). Failure to accurately and fully capture confounding factors results 
in residual confounding, and inflation of the effect estimate away from the null (179).  
Variability in the anxiety exposures and AN outcomes across studies of my thesis 
complicates the interpretation of differing results. Variability is not only with regard to the 
way in which phenotypes were captured (i.e. by self-report, formal diagnostic assessment), 
but also the exact phenotype (e.g. AN symptoms versus diagnosis, or the collection of anxiety 
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disorders included in the any anxiety disorder category). As a consequence, where one study 
indicates an association that is not present in another, this does not necessarily reflect bias in 
the former. However, differences can highlight limitations of particular measures that may be 
addressed going forward. For example, identified limitations of parent-reported internalising 
symptoms may prompt future studies to supplement parent reports with child-reported 
symptoms. Furthermore, in my research, contrary results across studies using different 
operationalisations of anxiety disorder pathology has given rise to novel hypotheses 
concerning AN aetiology. In particular, differential associations of anxiety disorder diagnosis 
versus worry with AN, and predictive effects of any anxiety disorder yet not specific 
diagnoses, suggest the role of core anxiety disorder components in AN. 
Another issue that may complicate interpretation of findings is that constructs of interest 
overlapped with other phenotypes. Worry is closely associated with rumination, and detected 
associations could therefore reflect a role of processes/factors other than worry. However, 
although there is evidence to support the forms of repetitive negative thinking arising from 
similar cognitive processes (436, 437), the content of worry and rumination is also rather 
different (438), suggesting the two may be discriminable. Worry and rumination are found to 
be differentially associated with psychiatric outcomes (e.g. (404, 443)), and the measure of 
worry in the MR study captured sequalae particular to worry (e.g. physical anxiety 
symptoms, nervousness (136, 382, 402)), further supporting the specificity of detected 
associations. Finally, the potential overlap of worry and rumination would not invalidate 
conclusions surrounding the common influence of repetitive negative thinking processes on 
anxiety disorder and AN development. 
The validity of inferences drawn from the studies of my thesis rests on various assumptions 
being satisfied, and in some cases it was impossible to fully evaluate these assumptions (e.g. 
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mechanisms underlying missing data patterns, or the validity of instruments in MR analyses). 
Certain assumptions are even likely to have been violated, such as the absence of 
confounding in observational analyses. In prospective studies it is likely that a number of 
plausible confounders were not included in analytical models. In some cases confounding 
variables may not have been identified. When assessing the association between anxiety 
disorders and AN in the observational analysis of study 3 I did not include earlier childhood 
worry as a covariate, only concurrent worry. Yet, should a propensity to worry explain 
anxiety disorder as well as AN development, as the proposed transdiagnostic framework 
asserts, earlier worry may have accounted for the relationship between anxiety disorders and 
AN that was observed. The omission is now fairly obvious, however was identified only as a 
consequence of the understanding generated from the body of my doctoral work. As such, my 
findings may inform the confounding factors considered in future investigations. There were 
other potential confounders that I was aware of but which were not available in the datasets I 
used to complete analyses, and thus were necessarily omitted from regression models. For 
instance, cognition and behaviour typical of AN was not assessed at age 10 in ALSPAC, 
meaning baseline AN pathology could be not included as a covariate in the observational 
analysis of Study 3. As mentioned earlier, residual confounding is also probable due to the 
failure to perfectly capture the measured confounders that were included in statistical 
analyses. 
Across studies of the thesis I did not account for the completion of multiple statistical tests, 
which will have inflated the risk of type 1 error, or wrongly rejecting the null hypothesis. 
While this may lead to invalid inferences concerning the strength of evidence supporting a 
given association, it does not bias estimates of effect or precision (526). 
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Other limitations relate to the interpretation of estimates of association. Effect estimates 
across the studies cannot be taken as indicative of the likely effects of an RCT. The AN 
outcomes of my studies were binary (indicating the presence or absence of AN pathology), 
and estimates of association took the form of odds ratios. Odds ratios are not collapsible, and 
thus estimates reflect population-average associations between anxiety exposures and AN 
outcomes; effects of an RCT administered to particular populations (e.g. high-risk) may differ 
(340). Further, observational study estimates are vulnerable to inflation via confounding, and 
MR assesses the causal influence of a slightly elevated exposure to a given risk factor across 
the lifetime – not effects of a substantial change in the risk factor over a short intervention 
period, as often is the intention in an RCT (344). Findings should therefore be considered in 
terms of whether they collectively provide evidence to support the presence of causal 
associations, with literal interpretation of effect estimates avoided. 
8.7 Future research 
My doctoral work may direct future research in a number of broad ways. First there is a need 
to replicate findings in different samples, and using methods that minimise the biases my 
studies were subject to. In the case of observational analyses, this might involve using 
different measures of worry, anxiety disorders and AN, and the use of confounding variables 
measured with greater granularity. For MR, there is the potential to use genetic data from 
genetic trios (mother, father, child), which can ameliorate bias due to direct effects of parent 
genotype and parent mating preferences (519, 527). Opportunities to address research 
questions in larger datasets, and using a greater number of robust instruments for anxiety 
exposures (as GWAS grow in size), will be important to capitalise upon with respect to MR 
investigations. It is especially important to consider further the potential for causal effects of 
anxiety disorders on AN development given the power limitations discussed above. A 
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substantially larger AN GWAS compared to that used to perform my MR analyses (357) has 
just been completed (453). Use of summary data from this GWAS would also improve power 
in MR analyses probing causal effects on AN (312). Notably the recently published study 
(453) reported outcomes of a MR analysis probing the causal effects of low BMI on AN 
development. Whilst an association was observed, causal inference is complicated by the fact 
AN is defined by low BMI (1), and thus the association may simply reflect overlapping 
phenotypes. Such is an example of how mechanisms other than causal influence may explain 
associations detected in a MR framework, despite the risk of bias due to confounding being 
minimised. It follows that evidence from an RCT should supplement that arising from MR as 
well as observational analyses. Assessing whether interventions addressing worry, or 
repetitive negative thinking more broadly, are beneficial from an AN prevention perspective 
are necessary to confirm the validity of causal inferences arising from my findings.  
The second broad direction is to refine the understanding generated by my research outputs. 
Future research may directly probe the factors mediating the association between a propensity 
to worry and AN development. To test the hypothesis that transdiagnostic models of anxiety 
disorders may be extended to AN, mediators should include worry focused on eating and 
weight gain, as well as worries specific to anxiety disorders. Analyses may then determine 
whether particular types of worry explain unique variance in AN development. Various other 
mediators might be probed, for example neurocognitive outcomes, to assess the validity of 
alternative explanations for my findings (e.g. effects of stress), and further understanding. 
One particularly interesting mediator to explore might be the vulnerability to habit 
development. Habitual processes have been implicated in the development and maintenance 
of pathology across disorders, and habit formation and performance is enhanced under 
conditions of stress (e.g.(109, 110)). The stereotyped and ritualised nature of AN has long 
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been noted (3) and there is support for the characteristic restrictive eating and excessive 
exercise of the illness being dependent on habit-based circuitry (528, 529). The formation of 
mental habits surrounding repetitive negative thinking processes may explain the persistence 
of these processes, as well as exacerbate their effects on pathology across multiple disorders 
(439, 502).  
Another valuable area of future research would be to elucidate the factors dictating the 
precise psychiatric pathology that develops from processes fundamental to multiple disorders, 
such as worry. For example, a drive for thinness/thin-ideal internalisation may influence the 
way in which an underlying vulnerability is expressed. Explaining divergent trajectories is an 
important quality of transdiagnostic accounts of illness (380), and can allow for more 
accurate models of AN.  
To further understand whether common processes underlie the development of anxiety 
disorders and AN, future studies might explore where there is overlap in the neural, as well as 
genetic, risk factors associated with both disorders. One particularly useful direction might be 
to consider whether the function of frontal and subcortical neural circuitry that has been 
implicated in worry (e.g. (530, 531)) comprises a risk factor for both anxiety disorders and 
AN. Linking different types of data, including genetic, neuroimaging, and psychological, to 
explain psychiatric outcomes like anxiety disorders and AN may allow for a more 
comprehensive and mechanistic understanding of disorder development. To inform whether 
worry is underpinned by the same processes across disorders, studies could probe whether 
common neurobiological factors (e.g. genetic, brain activity) are associated with worries 
typical of anxiety disorders and worries typical of AN.  
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A final direction of research that might be informed by my doctoral work is the study of 
associations between anxiety disorder phenotypes and AN maintenance. Although not central 
to this thesis, the findings of my systematic review highlighted a need for further studies 
addressing the predictive influence of anxiety disorders on AN recovery. Studies have 
considered the role of affective states, worry and rumination in AN behaviour using 
observational analyses (e.g. (428, 444, 532, 533)). Future research may focus on parsing apart 
different types of anxiety and repetitive negative thinking (i.e. that typical of AN versus 
anxiety disorders) in the analysis. The use of intervention designs may better establish 
whether associations are causal. This line of investigation has important implications for AN 
treatment specifically, as well as transdiagnostic interventions. 
8.8 Personal reflection on research 
My thesis comprises the result of three years of incredibly hard work. In this time, I have 
learnt a phenomenal amount about my topic, but also about myself, which I think it is 
important to reflect on. First, I have learnt that if I spend long enough trying to understand 
something, eventually I will. I note this particularly in relation to developing a solid 
knowledge of MR theory and methods. At first this task seemed slightly overwhelming given 
the requirement to familiarise myself with a whole new set of terms and concepts, as well as 
comprehend different statistical modelling approaches. My ability to achieve a thorough 
understanding of MR, and other approaches employed in this thesis (e.g. multivariate 
statistics, systematic reviews), has given me great confidence for pursuing a career in 
research. I am immensely looking forward to applying a variety of different methods in the 
pursuit of novel research questions. Secondly, I have found that I truly enjoy statistics, having 
needed to fully engage with statistical concepts, theories and models for a full understanding 
of my findings. This has been important for me to acknowledge, particularly since it served to 
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further encourage my acquisition of a sound knowledge of methodological approaches. 
Thirdly, I have recognized that I have a tendency to want to know everything about 
everything, and that there is a need to maintain focus on the primary goal or task while 
appreciating that expertise in multiple domains is near-impossible to achieve. Dampening the 
desire to know as much as possible about each aspect of my research has been an important 
challenge to overcome. I have learnt to be strict with myself to prevent distraction by topics 
that are not directly relevant, or which are not necessary to understand in any depth. Finally, 
and perhaps most importantly, I have realised that I am absolutely fascinated by AN, and 
extremely passionate about better understanding the disorder in manner that translates into 
real and tangible improvements in outcomes of prevention and treatment efforts.  
 
8.9 Conclusion 
The findings of my thesis support a prospective association between anxiety disorders and 
AN. Outcomes also indicated a causal role of worry, a central component of anxiety 
disorders, in the development of AN. This suggests that the identified prospective association 
between anxiety disorders and AN may be explained, at least partly, by the existence of 
shared risk factors. The knowledge produced in the course of my doctoral work has 
implications for understandings of AN aetiology, transdiagnostic models of illness, and AN 
prevention efforts, which may target worry for improved efficacy. Future research should 
seek to further understand the overlap between anxiety disorders and AN. The factors 
mediating and moderating effects of a propensity to worry require elucidation, as do the 
neurobiological mechanisms underlying worry. Finally, causal effects of anxiety disorders 
cannot be ruled out, and should be further probed in studies more sensitive to these 
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influences. AN tends to onset when individuals have their whole lives ahead, with its severe 
consequences on physical and mental health contributing to its status as the deadliest of all 
psychiatric disorders. I am passionate about continuing with research in this field to further 
demystify the illness in a manner that improves outcomes of prevention and treatment; 
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A B S T R A C T
The US National Institute of Mental Health’s Research Domain Criteria (NIMH RDoC) advocates the study of
features common to psychiatric conditions. This transdiagnostic approach has recently been adopted into the
study of anorexia nervosa (AN), an illness that can be considered compulsive in nature. This has led to the
development of an account of AN that identifies key roles for the heightened reinforcement of starvation, leading
to its excessive repetition, and goal-directed system dysfunction. Considering models of illness in other com-
pulsive disorders, we extend the existing account to explain the emergence of reinforcement and goal-directed
system abnormalities in AN, proposing that anxiety is central to both processes. As such we emphasise the
particular importance of the anxiolytic effects of starvation, over other reinforcing outcomes, in encouraging the
continuation of starvation within a model that proposes a number of mechanisms by which anxiety operates in
the development and maintenance of AN. We suggest the psychopathology of AN mediates the relationship
between the anxiolytic effects of starvation and excessive repetition of starvation, and that compulsive starvation
has reciprocal effects on its determinants. We thus account for the emergence of symptoms of AN other than
compulsive starvation, and for the relationship between different features of the disorder. By extending and
adapting an existing explanation of AN, we provide a richer aetiological model that invites new research
questions and could inform novel approaches to prevention and treatment.
Introduction
Anorexia nervosa (AN) is a mental illness whereby a dangerously
low body weight is maintained by extreme dietary restriction [1]. The
abnormal eating behaviour that is central to AN [2] persists despite its
adverse effects on daily and social functioning [3], and physical health
[4]. AN affects approximately 1–2% of Western populations, and has
the highest mortality rate of any psychiatric illness, this figure ap-
proaching 6.0% [5].
AN tends to be chronic, with less than 50% of individuals who de-
velop the illness making a full recovery [6,7]. It is suggested that cur-
rent pharmacological and psychological therapies cannot address the
neurobiological factors or mechanisms responsible for illness develop-
ment and maintenance because it is unclear what these are [8]. To
better understand the aetiology of psychiatric illnesses, Research Do-
main Criteria (RDoC), resulting from the National Institute of Mental
Health (NIMH) 2008 strategic plan [9], encourages a transdiagnostic
approach [10,11]. Central to this approach is investigating the causes of
features common to a number of disorders, rather than the causes of
symptoms specific to discrete diagnostic categories [12]. Studying the
characteristics that AN shares with other psychiatric disorders can
allow new and testable theories of AN aetiology to be developed [13].
Potentially causal neural abnormalities that have not previously been
considered in aetiological models of AN can be highlighted using this
transdiagnostic approach [14].
Compulsivity has been identified as a transdiagnostic trait that is
central to obsessive-compulsive disorders and substance and beha-
vioural addictions. Compulsivity describes a tendency to engage in re-
petitive and stereotyped acts that have unwanted outcomes [15], and
arises from a reduced ability to control inflexible yet maladaptive be-
haviour [16]. Recently compulsive behaviour has been characterised as
an imbalance between the influence of the goal-directed system (the
ventral medial prefrontal cortex; vmPFC) and the habit system (the
dorsal striatum; [17,18]). The habit system guides behaviour based on
past outcomes of actions, due to the formation of stimulus-response (S-
R) links, a process that occurs when a response produces a favourable
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outcome. S-R links strengthen with behavioural repetition and their
establishment allows stimuli to initiate the responses they are paired
with automatically, even when these responses are inappropriate [19].
In contrast, the goal-directed system considers predicted outcomes of
various actions, and the present value of these outcomes, to elicit be-
haviour tailored to the current situation [20]. It is suggested that
compulsive behaviour arises from a failure of the goal-directed system
to override the influence of the habit system when the latter produces
maladaptive responses [21].
Steinglass and Walsh [22] and Walsh [2] proposed that the extreme
restriction of food intake that epitomises AN is habitual. Later Park and
colleagues proposed this behaviour to be compulsive [13,23]. Indeed
starvation persists in the face of negative consequences, both im-
mediate, for example interfering with academic/occupational/social
interests, and longer-term; the behaviours promoting further, and po-
tentially dangerous, weight-loss. Although individuals with AN often
express desires to recover [22], they are seemingly unable to stop en-
gaging in behaviour that contributes to the maintenance of an ex-
tremely low weight [24,25].
Godier and Park [13] considered models of compulsivity developed
in relation to other disorders to propose the importance of both the
reinforcement of starvation, and of a goal-directed system deficit, in the
development of compulsive starvation. Greater reinforcement of star-
vation is suggested to cause excessive repetition of behaviour conducive
to caloric restriction. Combined with a reliance on the habit-system for
learning and behavioural control, this excessive repetition results in the
development of strong S-R habits surrounding dietary restriction that
are able to exert a dominant influence over behaviour.
In this paper we consider factors and mechanisms identified as re-
levant to reinforcement and goal-directed system abnormalities in other
compulsive disorders to understand how these develop in AN. Thus we
adopt a transdiagnostic approach to extend the aetiological model of
AN proposed by Godier and Park [13]. We also adapt the existing ac-
count to highlight the particular importance of the anxiolytic properties
of dietary restriction, over other potentially reinforcing effects of the
behaviour, and explain the emergence of symptoms of AN other than
compulsive starvation.
A novel model of anorexia nervosa development and maintenance
In brief, we suggest high levels of anxiety serve to make the an-
xiolytic effects of dietary restriction more reinforcing, and that anxiety
contributes to reduced function of the goal-directed system. Thus, we
propose a central role for anxiety in the development of compulsive
starvation, with part of the novelty of our hypothesis being in the dual
mechanisms by which anxiety is suggested to operate in AN onset. We
propose that the reinforcing effects of starvation cause excessive re-
petition of behaviour via the development of psychological symptoms
of AN. We also suggest that starvation becoming compulsive has ad-
verse implications on anxiety, the goal-directed system, and psycholo-
gical symptoms of AN, to encourage the formation of a vicious cycle
that ensures the persistence of extreme dietary restriction. The pro-
posed aetiological model is displayed in Fig. 1 below.
Given the complexity of AN we fully recognise the involvement of
factors additional to those included in the proposed model, however we
suggest testing the set of central hypotheses proposed here prior to
expanding the model further. In the following section we outline each
part of the model, and provide evidence to support inclusion of the
factor or pathway.
1. Individuals who develop AN experience high levels of anxiety
Clinical observations characterize individuals with AN as highly
anxious, and this is supported by empirical studies reporting greater
trait anxiety and higher rates of anxiety disorders in AN populations as
compared to the general population [26]. Importantly anxious
pathology is consistently documented to precede AN onset [27–30],
supporting a role of anxiety in AN development. Notably high levels of
anxiety tend to also precede the onset of addiction and OCD [31,32].
2. Dietary restriction is anxiolytic, and the relief of anxiety (or negative
reinforcement) provided by dietary restriction increases with anxiety
Engagement in dietary restriction reduces activity of serotonin (5-
HT) and noradrenalin (NA) systems that modulate anxiety, due to re-
duced intake of the dietary precursors of the neurotransmitters (tryp-
tophan for 5-HT, and tyrosine for NA; [33,34]). Indeed, ill AN women
have reduced 5-HT metabolites in their cerebral spinal fluid, reduced
concentrations of NA in their blood plasma, and excrete reduced NA
metabolites, compared to healthy women [35,36]. Recovered AN
women have elevated levels of 5-HT metabolites [36], and gene var-
iants linked to more active 5-HT and NA systems are implicated in AN
[34,37], supporting the involvement of these neurotransmitter systems
in the heightened anxiety that precedes AN. Increased ratios of omega-
3:omega-6 fatty acids are suggested to result from a calorie and fat
restricted diet, and there is some evidence that this ratio is negatively
related to anxiety in AN [38], providing another mechanism by which
dietary restriction could ameliorate anxiety.
Anxiety relief is easier to achieve, and more beneficial, for anxious
individuals, such as those who develop AN, suggesting starvation has
greater anxiolytic effects in these individuals [39,40]. Experimentally
induced tryptophan depletion significantly reduced anxiety in women
receiving inpatient treatment for AN, and those recovered from the
illness, but did not affect the anxiety levels of healthy women [33].
These results can be explained by floor effects given the baseline an-
xiety of healthy women was comparable to that of current/recovered
AN women following tryptophan depletion.
3. Experiencing greater anxiolytic effects of dietary restriction gives rise to
the psychological symptoms of AN
The effects of greater reinforcement of starvation (which we pro-
pose to consist of anxiety relief) are proposed by O’Hara et al. [41] to
result in the induction of a strong drive to starve. The drive to starve in
turn results in fears of stimuli/behaviours not conducive to restrictive
eating, such as food and weight-gain, and preoccupations with eating
and weight [41]. These drives, fears and preoccupations collectively
represent AN psychopathology [42].
4. AN psychopathology causes excessive repetition of behaviour that is
conducive to starvation
Like O’Hara et al. [41] we suggest AN psychopathology directly
encourages the excessive repetition of dietary restriction that results in
habit formation. Interestingly individuals with AN may be physiologi-
cally more able to engage in starvation over the period of time required
for habits surrounding the behaviour to form given enhanced 5-HT
activity increases satiety as well as anxiety [43]. The intestinal micro-
biota of individuals with AN may possess unique characteristics that
also contribute to the ability to maintain a diet that is severely calorie
restricted [44].
Given the alleviation of anxiety is proposed to promote AN psy-
chopathology we suggest heightened anxiolytic effects of dietary re-
striction, resulting from greater baseline anxiety, encourages con-
tinuation of the dietary restriction, albeit indirectly. Similarly, avoiding
an aversive state, and particularly an anxious one, is proposed to mo-
tivate continued drug-taking, hair-pulling, gambling and behaviours
that become compulsive in OCD [45–48].
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5. Excessive engagement in dietary restriction contributes to the development
of compulsive starvation
The dominance of behavioural habits increases with their repetition
[19]. Thus, like with other compulsive disorders, one pathway by which
the maladaptive behaviour of AN (starvation) becomes resistant to the
influence of the goal-directed system is via excessive engagement in the
behaviour [13,49].
6. The compulsive nature of starvation intensifies AN psychopathology
Compulsive behaviour has an urge-like characteristic [49], thought
to result from the habit system exerting a dominant influence [21], and
certainly individuals with AN report a “need” to engage in starvation
[24]. Thus starvation becoming compulsive may increase the drive to
starve, which then heightens fears of food and weight-gain, and pre-
occupations with eating and weight. Relationships of compulsive star-
vation, and rituals/compulsions surrounding eating, with the psycho-
pathology of AN have been reported [25,50,51]. This further explains
how the emergence of compulsivity in AN is detrimental to recovery,
given disorder drives, fears and preoccupations are associated with a
lack of motivation to eat and gain weight [52].
7. Anxiety causes goal-directed system dysfunction in AN
Goal-directed system dysfunction in OCD and addiction is suggested
to derive from anxiety [18,53]. This is because anxiety gives rise to
stress [54], and stress promotes the use of the habit system over the
goal-directed system, and is associated with increased volume and ac-
tivity of the dorsal striatum [55]. These effects are thought to be due to
goal-directed system dysfunction since enhanced activity of
glucocorticoid and noradrenergic systems, that serves to impair pre-
frontal cortex (PFC) function, also co-occurs with stress [54,56]. Fur-
ther supporting anxiety causing goal-directed system dysfunction,
under conditions of anxiety attention is governed by the stimulus-
driven system, and not the goal-directed system [57].
Evidence for goal-directed system dysfunction in individuals with
AN comes from studies reporting altered vmPFC volume in individuals
with AN compared to healthy women [58,59]. The vmPFC is hyper-
active in response to pictures of food in AN [60,61], and individuals
with the disorder consistently show deficits on set-shifting tasks that
depend on vmPFC integrity [13]. In a non-clinical population Gillan
et al. [62] found the severity of desires to be thin, and preoccupations
with weight, that are typical of AN, increased with decreased recruit-
ment of the goal-directed system to complete a task, which is suggested
to reflect poor function of this system. Godier et al. [63] found in-
dividuals with AN learnt relationships between actions and outcomes in
a similar manner to healthy women, suggesting comparable goal-di-
rected system function of the two groups. It may be that inefficiencies of
the goal-directed system could not be detected behaviourally with the
particular task however. Further, a reliance on the habit system in AN
individuals is indicated by their heightened dorsal striatal activity, re-
lative to healthy women, during reward learning tasks [64,65], and
when making decisions about what to eat [66].
8. Goal-directed system impairment contributes to the development of
compulsive starvation
For individuals with OCD and addictive disorders goal-directed
system abnormalities correlate with the development and control of
behavioural habits generally, not just those relevant to the specific
disorder [67,68]. Similarly, we propose that in AN goal-directed system
Fig. 1. The hypothesised model of anorexia nervosa development and maintenance.
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dysfunction impacts behaviour globally, but specifically promotes the
development of compulsive starvation when dietary restriction is re-
peatedly engaged in. Thus we suggest anxiety encourages the devel-
opment of compulsive starvation via two pathways: 1. by causing goal-
directed system dysfunction; and 2. by heightening the reinforcement of
starvation to cause its excessive repetition.
9. Continued starvation, resulting from the dietary restriction now being
compulsive, weakens the goal-directed system further
Starvation increases the production of stress hormones that impair
the goal-directed system [26]. In addition, the depletion of tryptophan
or tyrosine, both of which are outcomes of starvation [33,34,65], causes
a reliance on the habit system for learning [69,70], suggested to result
from reduced function of the goal-directed system [71]. Further im-
pairment of the goal-directed system means withholding the restrictive
eating habits that have developed becomes less possible.
10. The compulsive nature of starvation maintains high levels of anxiety
Key to compulsivity is the extremely aversive state that is experi-
enced when compulsions are not performed, which results from adap-
tions within neurobiological systems that mediate reward and affect,
following repeated performance of the particular behaviour [13]. This
is well characterised in addiction and OCD, where compulsions are
performed to temporarily alleviate negative affect [72–74]. Individuals
with AN experience very high levels of anxiety when they do eat, or
when starvation is not engaged in, and this anxiety becomes food and
weight focused [13]. The resurgence of anxiety, to levels even greater
than previously (before food restriction was engaged in), is suggested to
be partly mediated by enhanced sensitivity of 5-HT and NA systems,
which have adapted in response to reduced intake of tryptophan and
tyrosine respectively [75,76].
11. Heightened anxiety aggravates AN psychopathology
When starvation becomes necessary to avoid an extremely anxious
state the desire to starve is enhanced. This is particularly so given the
poor emotion regulation abilities of individuals with AN limits the use
of alternative strategies to overcome dysphoria [93], and increases in
the desire to starve results in increases in the fears and preoccupations
of AN. Indeed studies have reported relationships between anxiety and
AN psychopathology in clinical populations [77,78].
12. Anxiety becomes able to trigger restrictive eating
Anxiety precedes and coincides with restrictive eating in AN
[79–81], which is not the case for individuals without the disorder [82].
Repeatedly engaging in dietary restriction in an anxious state con-
ceivably enables anxiety to become able to directly evoke restrictive
eating habits, due to a pairing of emotion and behaviour, or the for-
mation of a S-R link. Increased state anxiety is related to reduced in-
hibitory control in individuals with AN [83], and we propose anxiety
impairs the goal-directed system. Thus a number of mechanisms likely
explain how anxiety promotes engagement in maladaptive dietary re-
striction habits that have developed in the course of a compulsive ill-
ness.
Summary
Our model proposes that the anxiety of individuals with AN pre-
disposes them to the development of, and reliance on, habits by af-
fecting the function of the goal-directed system, and encouraging the
repetition of anxiolytic behaviours. While such promotes compulsivity
generally, when dieting behaviour is engaged for a sufficient period,
which is possible in AN due to unique biological factors, the
compulsions surround dietary restriction. The formation of such com-
pulsions has a negative impact on the determinants of compulsive
starvation, promoting the maintenance of AN pathology. Thus we
suggest a number of factors and mechanisms act synergistically in the
development and persistence of a complex illness.
Comparison with other theories
We have repositioned anxiety in the model of Godier and Park [13]
and proposed novel mechanisms by which anxiety acts in AN to explain
the emergence of reinforcement and goal-directed system abnormalities
in the disorder. Park and colleagues propose starvation continues in-
itially in individuals with AN because weight loss is highly rewarding,
the rewarding effects being positive comments from others about one’s
body and a sense of achievement [13,23]. Only with progression of AN
is the avoidance of negative emotions, or negative reinforcement,
suggested to be relevant to on-going starvation. In contrast we focus on
the anxiolytic properties of dietary restriction as the initial motivation
for continued engagement in the behaviour. We recognise that dietary
restriction has positively reinforcing effects, however whether these
effects are greater for individuals who develop AN, is unknown. Con-
versely anxiolytic effects of behaviour are increased when anxiety, a
known risk factor for AN, is greater.
Also in contrast to Godier and Park’s [13] model we suggest that
experiencing greater reinforcement (and specifically anxiety relief)
from starvation encourages further starvation via the development of
the psychological symptoms of AN, as was proposed by O’Hara et al.
[41]. In this way we are able to account for the emergence of these
psychological symptoms, as well as behavioural features of the dis-
order, and relationships between the two. Finally, our model further
extends that of Godier and Park [13] by outlining the implications that
starvation being compulsive has on other disorder-relevant factors. This
is important since it means we are better able to account for the per-
sistence of AN.
Kaye and colleagues [8,33] and Nunn et al. [34] have previously
proposed that the anxiolytic properties of dietary restriction explain
why anxious individuals are more likely to repeatedly and excessively
engage in the behaviour, and thus why heightened anxiety is a risk
factor for AN development and maintenance. These accounts propose
either 5-HT [8,33] or NA systems [34] underlie high levels of anxiety,
and mediate the anxiolytic effects of starvation, in AN. In contrast we
suggest the involvement of both neurotransmitter systems, and ac-
knowledge mechanisms other than changes to tryptophan and tyrosine
intake by which a calorie and fat restricted diet may reduce anxiety.
Our account also differs in that we suggest anxiety operates in the de-
velopment and maintenance of AN through effects on goal-directed and
inhibitory control systems, in addition to affecting the reinforcement
(or heightening the anxiolytic properties) of starvation. In addition, the
proposal that anxiety becomes able to cue food avoidance through S-R
mechanisms is unique to our hypothesis.
Implications for treatment and prevention
Treatment
The treatment implications of starvation being habitual or com-
pulsive in AN have been discussed by Godier and Park [13] and will not
be considered here. We will instead focus on the implications of the
proposal that anxiety has a key role in the maintenance of AN. This
proposal suggests a need for AN interventions to focus on alleviating
anxiety and training individuals to manage the emotion, which is not a
priority of the treatments that are currently used widely.
Improved emotion regulation can be achieved with psychological
therapies that teach individuals effective and safe methods to manage
and express their feelings, such as Emotion Acceptance Behaviour
Therapy [84], which has been trialled in the treatment of AN. Ideally
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extremely anxious states are avoided, but when such states do arise
individuals should be better able to employ successful anxiolytic tech-
niques that do not involve starvation, as a result of the therapy. A recent
pilot of EABT in adolescents found it had clinically significant effects on
AN symptoms, which were maintained at the 6 month follow-up point
[85].
We suggest anxiety becomes able to cue food avoidance, making re-
feeding particularly difficult given the anxiety evoked by food and
eating in AN. As such we recommend treatments that seek to reduce
anxiety around eating, such as Exposure and Response Prevention
therapy for AN (AN-EXRP; [86]), which also aims to encourage the
effortful withholding of automatic restrictive eating responses. In AN-
EXRP patients are presented with food items and supported in con-
suming these without concurrently/subsequently resorting to endorsed
rituals or routines that promote dietary restriction [87]. The repeated
exposure to, and consumption of, feared foods in AN-EXRP reduces
anxiety by way of habituation, while also lessening the influence of
maladaptive food avoidance habits [86,88].
Pharmacological interventions seeking to normalise neuro-
transmission within 5-HT and NA systems may be of great value in the
treatment of AN given evidence for the involvement of these systems in
the anxiety of AN. Development of such an intervention is in progress,
with Hart et al. [75] releasing a rationale, and plan, for a trial of tyr-
osine supplementation treatment for AN. Findings from experimental
trials of such pharmacological interventions can elucidate the role of
neurotransmitter systems in AN to enable a better understanding of the
disorder. Attempts to identify effective pharmacological treatments for
AN are encouraged given the potential to reduce costs of treatment and
enhance its accessibility.
Future research might explore the efficacy of anxiolytic interven-
tions that have shown success in other disorders in the treatment of AN.
This would allow for a transdiagnostic approach to the treatment, as
well as the study, of AN, potentially resulting in vastly improved out-
comes. Investigating the mechanisms by which existing and novel an-
xiety-targeted treatments operate to improve eating behaviour, for ex-
ample by affecting goal-directed system function or AN
psychopathology, will also inform the validity of our model.
Prevention
Highlighting anxiety as a key risk factor for AN allows the identi-
fication of individuals for whom existing prevention interventions could
be most beneficial, enabling improved efficacy. As the influence of
heightened reinforcement of starvation and goal-directed system dys-
function, proposed to mediate the effects of anxiety on AN develop-
ment, are dependent on initiation of dieting behaviour, further justifi-
cation for the targeting of this dieting behaviour by existing prevention
interventions is provided by our model. The Body Project [89] and
Healthy Living intervention [90] successfully reduce the practicing of
unhealthy/extreme weight control methods in adolescents/young
adults. This is thought to be responsible for the significantly lower
number of AN cases that subsequently develop in intervention, as
compared to control, groups [91].
Risk factors of the model may be targets for prevention, as well as
treatment, interventions. Training for adolescents that improves their
emotion regulation ability, and goal-directed system function, to reduce
anxiety, and lower vulnerability to forming habits, respectively, may be
valuable additions to existing eating disorder prevention programmes.
Mindfulness interventions might be particularly useful given these im-
prove emotion regulation [92], and reduce dietary restraint [93]. Initial
studies indicate the utility of mindfulness-based techniques in AN pre-
vention, but the trialled interventions require refinement for their ef-
ficacy to be maximised [93].
Conclusion
Having formulated AN as a compulsive disorder and taking a
transdiagnostic approach to studying the illness, theorists have pro-
posed the reinforcement of starvation, and goal-directed system dys-
function, as causal in the onset of AN. By extending and adapting this
account of AN we have been able to highlight the particular relevance
of anxiety to the aetiology of the disorder, as well as account for the
emergence of psychological symptoms of AN in addition to compulsive
starvation. The hypotheses proposed should be tested to allow the va-
lidation and improvement of the model, which may then be expanded
to include other explanatory factors. The model can justify the use of
existing and planned prevention and treatment programmes, but may
also guide the development of novel interventions to favourably affect
the incidence and recovery rates of a life-threatening condition.
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Abstract
Purpose Compulsions surrounding restrictive eating, exercise, and weight monitoring are thought to maintain abnormal 
eating behaviour in individuals with anorexia nervosa (AN). This study aimed to determine if AN psychopathology and trait 
anxiety explain the presence of restrictive eating, exercise, and weight monitoring compulsions in a mixed sample.
Methods Participants were 31 females with AN and 31 age and gender-matched healthy individuals (HC). Restrictive eating, 
exercise and weight monitoring compulsion presence was compared between AN and HC groups. Multivariable poisson 
regression analyses, adjusted for diagnostic status, were conducted to assess the association of both AN psychopathology 
and trait anxiety with compulsions across the mixed group.
Results Individuals with AN endorsed a greater number of restrictive eating, exercise and weight monitoring compulsions 
compared to HC. In adjusted poisson regression analyses neither AN psychopathology nor trait anxiety predicted compul-
sion presence: incidence rate ratio (IRR) for AN psychopathology = 1.15 [95% CI 0.84, 1.57], p = 0.39; IRR for trait anxi-
ety = 1.01 [95% CI 0.97, 1.06], p = 0.50.
Conclusions Greater presence of restrictive eating, exercise and weight monitoring compulsions was reported by individuals 
with AN, supporting the conceptualisation of disorder behaviours as compulsive. The study was underpowered to robustly 
evaluate the association between predictors of interest and the compulsions outcome, largely owing to the small sample size. 
Further investigation is required, ideally using methods able to identify causal and mediation effects.
Level of evidence Level V, cross-sectional study.
Keywords Anxiety · Anorexia nervosa · Compulsive behaviour · Compulsions
Introduction
Anorexia nervosa (AN) has a range of severely detrimen-
tal effects on physical wellbeing [1], and the highest mor-
tality rate of any psychiatric condition [2]. These adverse 
outcomes arise from individuals with AN consistently 
restricting their intake, such that a significantly low weight 
is maintained [3].
The inadequate calorie intake of individuals with AN is 
supported by rituals surrounding restrictive eating, exercise 
and weight monitoring. At mealtimes individuals with AN 
tend to eat in very particular ways, for example cutting food 
into tiny pieces, and completing meals extremely slowly 
[4]. Engagement in rule-driven and repetitive schedules of 
exercise [5, 6], and body checking, or stereotyped weight 
monitoring behaviour [7], is also common to individuals 
with AN. It is thought that body checking behaviours foster 
fears and preoccupations with eating and weight-gain, to 
encourage the continued dietary restriction that is achieved 
directly by eating and exercise behaviours [8, 9].
The rituals surrounding restrictive eating, exercise and 
weight monitoring are maladaptive for individuals with AN 
given their need to gain weight. Individuals with AN report 
having little control over the rituals, and feeling a “need” 
 * E. Caitlin Lloyd 
 e.caitlin.lloyd@bristol.ac.uk
1 Centre for Exercise, Nutrition and Health Sciences, School 
of Policy Studies, University of Bristol, Bristol BS8 1TZ, 
UK
2 Regional Unit for Eating Disorders (RASP), Division 
of Mental Health and Addiction, Oslo University Hospital, 
Oslo, Norway
3 Institute of Clinical Medicine, University of Oslo, Oslo, 
Norway
4 University of Bath, Bath, UK
 Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
1 3
to engage in them, despite often simultaneously express-
ing desires to recover [10]. As such, the rituals endorsed by 
individuals with AN are suggested to be compulsive [11], 
compulsivity defined as a trait promoting the persistent rep-
etition of actions that have adverse outcomes [12]. Further, 
compulsions are well characterised to possess a strong urge-
like quality [13]. Given their role in maintaining the low 
weight of individuals with AN, it would be useful to address 
compulsive behaviours surrounding restrictive eating, exer-
cise and weight monitoring in AN treatment. For this to be 
possible; however, the determinants of compulsions must 
be identified.
Existing literature suggests that AN psychopathology 
(drive for thinness/restriction, and eating/weight concern 
[3, 14]) and trait anxiety predict engagement in compulsive 
behaviour surrounding restrictive eating, exercise and weight 
monitoring. AN psychopathology is associated with more 
frequent body checking, and compulsive exercise, in clini-
cal and community samples [15–18]. Using a novel measure 
of compulsive starvation, Godier and Park [19] found this 
construct to be positively associated with AN psychopathol-
ogy in a healthy control (HC) and AN group. The severity 
of rituals surrounding restrictive eating, exercise and weight 
monitoring, in terms of the interference with daily func-
tioning and distress caused, also increases with greater AN 
psychopathology [20].
Trait anxiety is positively associated with restrictive 
eating behaviour [21] and compulsive exercise [22] in AN 
populations, and with compulsive exercise in community 
samples [23]. Furthermore, trait anxiety predicts a greater 
frequency and duration of episodes characterised by high 
levels of state anxiety [24], and state anxiety is associated 
with an increased likelihood of engaging in restrictive eat-
ing, exercise, and weight monitoring behaviour in indi-
viduals with AN [25–27]. The role of anxiety in behaviour 
typical of AN is particularly important to clarify, given 
treatment tends to focus on weight-restoration and address-
ing eating disorder specific cognition, as opposed to more 
general psychopathology.
The current study aims to confirm the presence of com-
pulsions surrounding restrictive eating, exercise and weight 
in AN. In addition, the study will evaluate the relationships 
of AN psychopathology and trait anxiety with compulsive 
behaviour typical of AN in a clinical and community popu-
lation, with a view to informing how AN behavior may be 
maintained. It was hypothesised that greater levels of AN 
psychopathology, and greater levels of anxiety, would be 
associated with greater engagement in compulsions typical 
of AN – in AN and HC groups.
Methods
Data sources
Data for the present study was originally collected to 
investigate memory and perception of body image in AN 
[28]. The study was completed at the Regional Department 
for Eating Disorders (RASP), Oslo, Norway, and approved 
by the Regional Ethical Committee for Medical Research. 
Informed written consent was obtained from all partici-
pants, or from parents of participants when participants 
were under the age of 16 (the legal age at which consent 
may be provided in Norway).
Participants
Fifty females with AN were included in the original study, 
recruited from 5 specialist eating disorder units in Norway 
(inpatient and outpatient). Once AN participant recruit-
ment was complete, 35 healthy adolescent/young adult 
females (HC) from schools and universities local to RASP 
were recruited. This group was selected on the basis of 
having a similar age-distribution to the AN sample.
Participants were excluded from the current investiga-
tion if they were missing measures of the study variables. 
Of the originally recruited participants, 13 individuals (11 
AN and 2 HC) had not completed the measure assessing 
the presence of eating, exercise and weight monitoring 
compulsions, and one AN participant was missing trait 
anxiety information.
The AN group were administered the Eating Disorder 
Examination, based on the Diagnostic and Statistical Man-
ual of Mental Disorders, fourth edition (DSM-IV [29]), 
to validate diagnoses. Duration of illness was assessed by 
way of self-report questionnaire. Height and weight of AN 
participants was assessed by clinical staff and reported to 
researchers if participants consented, for calculation of body 
mass index (BMI). Seven of the recruited AN group were 
excluded from the current investigation because records indi-
cated that they did not meet any AN criteria (n  = 3), or did 
not experience psychopathology that is typical of AN (n  = 4). 
The Norwegian translation of the Eating Disorders Exami-
nation self-report, the EDE-Q [30], was used to screen HC 
for AN psychopathology. Three HC were excluded because 
their global EDE-Q scores were above four, thus indicat-
ing clinically significant AN psychopathology. The EDE-Q 
is described further in the measures section. Researchers 
recorded the BMI of HC during the study assessment, fol-
lowing height and weight measurement.
Participants of the current study comprised 31 AN, and 
31 HC, who were aged between 14 and 27. Of the AN 
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group, 20 participants met all DSM-IV criteria for AN. 
Eleven individuals with AN had a bodyweight that was 
higher than 85% of that expected, due to weight increases 
resulting from hospital treatment, and/or did not meet 
menstruation criteria. These participants were included. 
Amenorrhea is no longer a criterion for AN [3], and we 
were interested in the factors underlying engagement in 
maladaptive behaviour that can persist following weight-
gain. There were no significant differences in trait anxiety, 
AN psychopathology, and endorsement of eating, exer-
cise and weight-related compulsions, between individuals 
meeting full versus partial criteria for AN.
Measures
Explanatory variables
Trait anxiety was measured by the trait anxiety subscale of 
the State-Trait Anxiety Inventory (STAI; [31]). AN psycho-
pathology was indexed by global score on the Norwegian 
translation of the EDE-Q [30]. The EDE-Q assesses AN 
psychopathology: desire for thinness and weight-loss; fears 
surrounding eating and weight-gain; and dissatisfaction and 
preoccupation with weight, shape and eating. The global 
score is the average of four subscales: restraint; weight con-
cern; shape concern; and eating concern. Both the EDE-Q 
and STAI are well established to have excellent psychomet-
ric properties and are commonly used to assess the con-
structs of interest [32–37]. The Norwegian translation of 
the EDE-Q has demonstrated satisfactory psychometric 
properties [38].
Outcome variable
The presence of eating, exercise and weight monitoring-
related compulsions was assessed by the compulsions sever-
ity subscale of the Child Obsessive Compulsive Inventory 
(ChOCI; [39]). In particular, we were interested in responses 
to the question that asks participants to name their 3 most 
severe, or upsetting, compulsions. Responses to this question 
indicated the extent to which participants experience severe 
compulsions related to eating, exercise or weight monitor-
ing. Participants are guided that a compulsion is something 
they feel they ‘have to do and cannot stop’ to ensure relevant 
behaviours are reported. The ChOCI is reported to reliably 
and validly measure obsessive and compulsive symptom 
severity in adolescents [39], and so was deemed appropriate 
for use in a mid-adolescent/early adulthood sample.
An independent rater determined whether named compul-
sions were related to restrictive eating, exercise or weight 
monitoring. The number of such compulsions was recorded, 
to comprise the count variable ‘restrictive eating, exercise 
and weight monitoring compulsions’, which had possible 
values of 0 to 3. The presence of restrictive eating, exercise 
and weight monitoring compulsions is a marker of abnor-
mal behaviour, as opposed to cognition, surrounding eating, 
exercise, and weight.
Data preparation and analysis
All analyses were conducted using the statistics program 
Stata [40]. Mean AN psychopathology and trait anxiety, of 
AN and HC, was compared using t tests. The number of 
restrictive eating, exercise and weight monitoring compul-
sions of AN and HC groups was compared using a Chi-
square test. The correlation between AN psychopathology 
and trait anxiety, both unadjusted and adjusted for diagnostic 
status, was calculated.
Univariable (single predictor) poisson regression models 
estimated the association of the predictors AN psychopathol-
ogy and trait anxiety with the compulsions count variable. A 
multivariable poisson regression model, adjusted for diag-
nostic status (i.e., AN versus HC), assessed the independent 
association of each predictor variable with the compulsions 
outcome. Model coefficients indicate the increased log of 
expected compulsions count per one unit increase in the pre-
dictor. The coefficients were exponentiated to produce inci-
dence rate ratios, indicating the increase in expected com-
pulsions count per one unit increase in the given predictor.
Exploratory analyses assessed whether there was a dif-
ference between AN and HC groups in the association of 
predictors (trait anxiety and eating disorder psychopathol-
ogy) with restrictive eating, exercise and weight monitoring 
compulsions. This was achieved by adding relevant inter-
action terms to the poisson regression model. The sample 
size was such that interaction effect coefficients could not 
be estimated with confidence, and outcomes of this analysis 
are not reported; further details are available upon request.
Results
Sample characteristics
Table 1 details the demographic and clinical characteristics 
of the sample. AN psychopathology was much higher in 
AN as compared to HC (Cohen’s d for between group dif-
ferences = 3.00), as was trait anxiety (Cohen’s d for between 
group differences = 3.22). Individuals with AN also reported 
a greater number of compulsions compared to HC.
Preliminary analyses
AN psychopathology and trait anxiety were correlated 
(R = 0.82, p < 0.001). This association remained but was 
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much weaker when adjusting for diagnostic status (R = 0.20, 
p = 0.12). Greater AN psychopathology and trait anxiety 
were associated with an increased rate of eating, exercise 
and weight monitoring compulsions in univariable models 
(Table 2).
Main analyses
The multivariable regression model accounted for 21.0% 
of the variance in the count of restrictive eating, exer-
cise and weight monitoring compulsions; χ2(3) = 32.18, 
p ≤ 0.001. There was no strong evidence to support any of 
the predictors explaining unique variance in the compulsions 
outcome. Table 3 provides further information.
Discussion
This study found that individuals with AN endorsed a greater 
number of restrictive eating, exercise and weight monitor-
ing compulsions compared to HC, supporting behaviours 
typical of AN being conceptualised as compulsive [4]. The 
compulsive nature of disorder behaviours likely promotes 
the persistence of AN, and thus it is important to understand 
Table 1  Participant characteristics
a Precise age information was missing for one HC
b BMI data for one AN participant, and two HC, was missing
Women with AN (N = 31) Healthy women (N = 31) T statistic (p)
M (SD) M (SD)
Agea 19.6 (3.27) 18.6 (3.71) 1.10 (0.28)
BMI (kg/m2)b 16.33 (2.13) 21.78 (2.73) 8.58 (< 0.001)
Duration of illness (months) 32 (27.55)
AN psychopathology 3.62 (1.09) 0.81 (0.75) 11.87 (< 0.001)
Trait anxiety 62.81 (7.23) 37.10 (8.68) 12.68 (< 0.001)
Count (N) Count (N) χ2 statistic (p)
Number of eating, exercise and weight monitoring compulsions




Table 2  Univariable poisson regression models for the prediction of restrictive eating, exercise and weight monitoring compulsions by trait anxi-
ety and AN psychopathology
Univariable regression of compulsions Coefficient estimates Model statistics
Explanatory variable B SE Incident rate ratio [95% CI] p value χ2 (df) Pseudo R2
Model 1 AN psychopathology 0.46 0.10 1.59 [1.31, 1.93] < 0.001 25.96 (1)
p < 0.001
0.17
Constant − 1.57 0.37 0.21 [0.10, 0.42] < 0.001
Model 2 Trait anxiety 0.06 0.01 1.06 [1.03,1.08] < 0.001 26.52 (1)
p < 0.001
0.17
Constant − 3.35 0.74 0.03 [0.01, 0.15] < 0.001
Table 3  Adjusted Multivariable 
poisson regression model for 
the prediction of restrictive 
eating, exercise and weight 
monitoring compulsions by 




Coefficient estimates Model statistics
Explanatory variable B SE Incident rate ratio [95% CI] P value χ2 (df) Pseudo R2
Diagnostic status (AN) 1.19 0.73 3.30 [0.80, 13.68] 0.10 32.18 (3)
p ≤ 0.001
0.21
AN psychopathology 0.14 0.16 1.15 [0.84, 1.57] 0.39
Trait anxiety 0.01 0.02 1.01 [0.97, 1.06] 0.50
Constant − 2.30 0.88 0.10 [0.02, 0.56] < 0.01
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the determinants of disorder-relevant compulsions in order 
to develop effective treatment interventions.
The present study particularly sought to understand 
whether AN psychopathology and trait anxiety predicted 
compulsive behaviours centred on restrictive eating, exer-
cise and weight monitoring, in individuals with AN and 
HC. In univariable models, greater AN psychopathology 
and greater trait anxiety predicted an increased number of 
AN compulsions. The direction of association was consist-
ent in multivariable models adjusted for diagnostic status, 
however, the strength of association was reduced and point 
estimates less precise (for both trait anxiety and AN psycho-
pathology). Neither AN psychopathology nor trait anxiety 
was able to explain unique variation in compulsion pres-
ence beyond that accounted for by diagnostic status. This 
contrasts with findings of other studies. Previously relation-
ships between AN psychopathology/anxiety and compulsive 
behaviour surrounding restrictive eating, exercise and weight 
monitoring have been reported in populations of either AN 
or HC individuals [19, 20, 23, 41–43]. One plausible cause 
of the discrepancy is low power in the current study, mainly 
owing to a relatively small number of participants—a limita-
tion of the present investigation.
The nature of the compulsions outcome variable will also 
have limited sensitivity to detect an association between this 
and AN psychopathology/trait anxiety. Assessment of the 
number of severe compulsions surrounding restrictive eat-
ing, exercise and weight monitoring allowed for the cap-
ture of different compulsive behaviours typical of AN. This 
approach promoted validity in the assessment of whether 
compulsions were present. However, the range of possible 
responses was limited. Most individuals with AN reported 
a non-zero number of compulsions, while most HC reported 
no compulsions, meaning variability in the response was 
particularly low within diagnostic status categories—which, 
like sample size, has implications for statistical power. Indi-
vidual differences would be captured to a finer degree by 
alternative measures of compulsivity. Future studies might 
use multi-item scales that separately assess compulsive 
starvation, compulsive exercise and body checking. Alter-
natively, studies might investigate the presence and sever-
ity of a variety of specific restrictive eating, exercise and 
weight monitoring compulsions characteristic of AN using 
the Yale–Brown–Cornell Eating Disorder Scale [44].
The study has some important strengths, such as the use 
of strict inclusion criteria to ensure the AN sample was 
typical of this population, and appropriate modelling of the 
count outcome variable within poisson regression models. 
However, given the discussed methodological shortcom-
ings relating to outcome measurement and sample size, we 
encourage further investigation into predictors of restrictive 
eating, exercise and weight monitoring compulsions—in 
AN and HC. In addition to AN psychopathology and trait 
anxiety, other potentially relevant factors (e.g., cognitive 
processing style, psychiatric comorbidity) may be studied 
for their association with compulsive behaviour typical of 
AN. Ideally studies would be adequately powered to explore 
interaction effects, to understand how predictors of com-
pulsive behaviour may differ between AN and HC. To gain 
further insight, it would be useful to compare AN subtypes 
for severity of various illness-related compulsions, as well 
as for predictors of these compulsions. Future studies might 
also examine the mechanisms by which determinants are 
associated with compulsive behaviour surrounding restric-
tive eating, exercise and weight monitoring, to identify fac-
tors that might most usefully be targeted in AN treatment. 
For example, in this study anxiety and AN psychopathol-
ogy were related, consistent with findings from studies in 
clinical [45, 46] and subclinical [47] populations. Should, 
as has been proposed (e.g., [48–50]), anxiety exert a causal 
influence on AN psychopathology, and should AN psycho-
pathology in turn cause compulsive behaviour typical of 
AN, it might be advantageous to address general anxiety 
(i.e., not that specific to eating and weight-gain) for reduc-
tion of both cognitive and behavioural symptoms of AN. 
Cross-sectional studies such as the present one cannot make 
inferences regarding the direction of observed associations. 
For rigorous tests of causal and mechanistic hypotheses lon-
gitudinal and experimental designs should be implemented.
Conclusion
Our findings support AN being characterised as a compul-
sive disorder, highlighting the importance of identifying 
determinants of compulsive behaviour surrounding restric-
tive eating, exercise and weight monitoring to inform AN 
treatment. The study did not find strong evidence to sup-
port trait anxiety or AN psychopathology being associated 
with greater engagement in compulsive behaviour typical 
of AN, in a clinical or community population. The direc-
tion of the associations that were observed was, however, 
consistent with findings of previous studies that do support 
such relationships to exist. The present investigation was 
underpowered to assess associations robustly, and further 
investigation is encouraged—particularly using designs 
able to establish causality and elucidate mechanisms 
underpinning causal effects.
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University of Bristol authors must update PURE (the University’s research information system and 
institutional repository) when a paper is submitted, accepted and published.  As part of the PURE 
entry there is a keywords section (see figure below). Authors are requested to click on the ‘Add 
Keywords’ button under ‘Structured keywords’, click on the arrow next to ‘Faculty of Health 
Sciences’ and then click on ‘ALSPAC’. 
   
 
3. Description of study numbers  
ALSPAC recruited 14,541 pregnant women resident in Avon, UK with expected dates of delivery 1st 
April 1991 to 31st December 1992.  14,541 is the initial number of pregnancies for which the mother 
enrolled in the ALSPAC study and had either returned at least one questionnaire or attended a 
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“Children in Focus” clinic by 19/07/99. Of these initial pregnancies, there was a total of 14,676 
foetuses, resulting in 14,062 live births and 13,988 children who were alive at 1 year of age.  
When the oldest children were approximately 7 years of age, an attempt was made to bolster the 
initial sample with eligible cases who had failed to join the study originally. As a result, when 
considering variables collected from the age of seven onwards (and potentially abstracted from 
obstetric notes) there are data available for more than the 14,541 pregnancies mentioned above.  
The number of new pregnancies not in the initial sample (known as Phase I enrolment) that are 
currently represented on the built files and reflecting enrolment status at the age of 18 is 706 (452 
and 254 recruited during Phases II and III respectively), resulting in an additional 713 children being 
enrolled. The phases of enrolment are described in more detail in the cohort profile paper (see 
footnote 4 below). 
The total sample size for analyses using any data collected after the age of seven is therefore 15,247 
pregnancies, resulting in 15,458 foetuses.  Of this total sample of 15,458 foetuses, 14,775 were live 
births and 14,701 were alive at 1 year of age. 
A 10% sample of the ALSPAC cohort, known as the Children in Focus (CiF) group, attended clinics at 
the University of Bristol at various time intervals between 4 to 61 months of age. The CiF group were 
chosen at random from the last 6 months of ALSPAC births (1432 families attended at least one 
clinic). Excluded were those mothers who had moved out of the area or were lost to follow-up, and 
those partaking in another study of infant development in Avon. 
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website for details (https://projectredcap.org/resources/citations/). 
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7. Ethical approval 
ALSPAC has its own Ethics and Law Committee that reviews all proposals for new data collection and 
approves policies for data handling and analysis. Proposals for new data collection are also approved 
by the Local Research Ethics Committees (LRECs). A statement describing this that should be 
included in all papers is shown below:  
“Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and 
the Local Research Ethics Committees.”     
Please note that some journals are now requesting precise details on the ethics 
committee/institutional review board(s) that approved aspects of the study when submitting your 
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http://www.bristol.ac.uk/alspac/researchers/research-ethics/ 
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“GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome 
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10. Statistical significance 
We discourage the use of the term “statistical significance” and encourage authors to describe the 
observed effect sizes and the strength of the evidence that supports these effect size estimates. For 
a detailed justification see: Sterne JAC, Davey Smith G. Sifting the evidence—what's wrong with 
significance tests? British Medical Journal 2001: 322; 226-231. 
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button under ‘Structured keywords’, click on the arrow next to ‘Faculty of Health Sciences’ and then 
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4. Description of study numbers  
Pregnant women resident in Avon, UK with expected dates of delivery 1st April 1991 to 31st December 
1992 were invited to take part in the study.  The initial number of pregnancies enrolled is 14,541 (for 
these at least one questionnaire has been returned or a “Children in Focus” clinic had been attended by 
19/07/99). Of these initial pregnancies, there was a total of 14,676 foetuses, resulting in 14,062 live 
births and 13,988 children who were alive at 1 year of age.  
When the oldest children were approximately 7 years of age, an attempt was made to bolster the initial 
sample with eligible cases who had failed to join the study originally. As a result, when considering 
variables collected from the age of seven onwards (and potentially abstracted from obstetric notes) 
there are data available for more than the 14,541 pregnancies mentioned above.  
The number of new pregnancies not in the initial sample (known as Phase I enrolment) that are 
currently represented on the built files and reflecting enrolment status at the age of 24 is 904 (452, 254 
and 198 recruited during Phases II, III and IV respectively), resulting in an additional 811 children being 
enrolled. The phases of enrolment are described in more detail in the cohort profile paper (see 
footnote 4 below). Please note that phase 4 enrolment (age 18-24) is not currently included in the 
cohort profile. 
The total sample size for analyses using any data collected after the age of seven is therefore 15,247 
pregnancies, resulting in 15,458 foetuses.  Of this total sample of 15,656 foetuses, 14,973 were live 
births and 14,899 were alive at 1 year of age. 
A 10% sample of the ALSPAC cohort, known as the Children in Focus (CiF) group, attended clinics at the 
University of Bristol at various time intervals between 4 to 61 months of age. The CiF group were 
chosen at random from the last 6 months of ALSPAC births (1432 families attended at least one clinic). 
Excluded were those mothers who had moved out of the area or were lost to follow-up, and those 
partaking in another study of infant development in Avon. 
 
5. Reference to the cohort 
The following two references should be cited where the cohort is first described in the methods: 
Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J, Molloy L, Ness A, Ring S, Davey Smith G. 
Cohort Profile: The ‘Children of the 90s’; the index offspring of The Avon Longitudinal Study of Parents 
and Children (ALSPAC). International Journal of Epidemiology 2013; 42: 111-127. 
Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Davey Smith G, Henderson J, Macleod J, 
Molloy L, Ness A, Ring S, Nelson SM, Lawlor DA. Cohort Profile: The Avon Longitudinal Study of Parents 
and Children: ALSPAC mothers cohort. International Journal of Epidemiology 2013; 42:97-110. 
 
6. Reference to REDCap 
For papers using data gathered from participants at 22 years and onwards, you should also include a 
citation to REDCap, as the tool that ALSPAC have used to collect the data. Please see the REDCap 
website for details (https://projectredcap.org/resources/citations/). 
 
7. Data dictionary 
We ask that you include the following statement as part of your methods section: "Please note that the 
study website contains details of all the data that is available through a fully searchable data dictionary 
and variable search tool" and reference the following webpage: 
http://www.bristol.ac.uk/alspac/researchers/our-data/ 
 
8. Ethical approval and informed consent 
ALSPAC has its own Ethics and Law Committee that reviews all proposals for new data collection and 
approves policies for data handling and analysis. Proposals for new data collection are also approved by 
the Local Research Ethics Committees (LRECs). A statement describing this that should be included in all 
papers is shown below:  
“Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and 
the Local Research Ethics Committees.”     
Please note that some journals are now requesting precise details on the ethics committee/institutional 
review board(s) that approved aspects of the study when submitting your paper. You may choose the 
ethic approvals relevant to your paper from the following webpage (or simply refer to the webpage in 
your submission): http://www.bristol.ac.uk/alspac/researchers/research-ethics/ 
In addition, journals are more commonly asking for details about informed consent. Please include the 
following statement where biological samples are reported: 
“Consent for biological samples has been collected in accordance with the Human Tissue Act 
(2004).” 
For all other data please use the following sentence: 
“Informed consent for the use of data collected via questionnaires and clinics was obtained from 
participants following the recommendations of the ALSPAC Ethics and Law Committee at the 
time.” 
Please contact the Executive at alspac-exec@bristol.a.cuk if further details are required. 
 
9. Acknowledgements section 
The following standard acknowledgements section should be included in all publications as is or in a 
modified form to fit the journal requirements for all papers: 
“We are extremely grateful to all the families who took part in this study, the midwives for their 
help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and 
laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists 
and nurses.”  
 
10. Funding section 
We have standard wording that must be included in all publications to acknowledge our core funding: 
“The UK Medical Research Council and Wellcome (Grant ref: 102215/2/13/2) and the University 
of Bristol provide core support for ALSPAC. This publication is the work of the authors and 
<INSERT NAMES> will serve as guarantors for the contents of this paper.”  
In addition, you are expected to acknowledge the grant(s) which supported the collection of the 
primary exposure(s) and outcome(s) used in your study and any other grants in the checklist, which are 
pertinent to your study. The following sentences should be included with the above section: 
 “A comprehensive list of grants funding is available on the ALSPAC website 
(http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf); This 
research was specifically funded by <INSERT DETAILS FOR SPECIFIC PROJECT(S) WHERE 
APPROPRIATE, including grant number(s)>.” 
We have provided a table of grants for data collected since 2006 here; 
http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf. Please consult this 
and ensure all grants are acknowledged. If you can’t find the specific grant for the data you have used in 
the table please email alspac-data@bristol.ac.uk, including ‘Grant query’ in the subject, who will try 
and assist. 
If your paper uses child GWAS data, please also include the following sentence in the funding section: 
“GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger 
Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe.” 
 
11. Statistical significance 
We discourage the use of the term “statistical significance” and encourage authors to describe the 
observed effect sizes and the strength of the evidence that supports these effect size estimates. For a 
detailed justification see: Sterne JAC, Davey Smith G. Sifting the evidence—what's wrong with 
significance tests? British Medical Journal 2001: 322; 226-231. 
 
12. Final dataset of derived variables 
By derived variables we mean new variables that have been derived using at least two existing 
variables, (rather than simple recodes) or other variables that do not currently exist in the ALSPAC 
resource that will be of use to other collaborators. Derived variables will be archived by ALSPAC and will 
ultimately be made available to future data users and thus appropriate documentation detailing the 
derivation must also be provided. This will be followed up on approval of your manuscript. 
 
13. Small cells counts 
If any tables contain cell counts less than 5 (including zero), we ask you to consider collapsing categories 
if possible. If this is not possible, then please replace the cell count with ‘<5’. If the cell contains zero 
then please include a footnote to indicate “this many include zero”.  Please note, this also implies to 
any imputed data. Please also ensure that any percentages are dealt with in a similar manner when 
exact numbers can easily be inferred from information in the table. 
 
14. Media coverage of ALSPAC publications 
Where appropriate we encourage media coverage of ALSPAC papers to raise the study’s profile and in 
particular to show study families that the study is producing interesting and valuable findings. Please 
contact the ALSPAC executive if you know there is going to be a press release or if you have given any 
press interviews.  
 
15. Short scientific summary of the paper 
We may ask you to prepare a short summary of your paper that we can include with reports to our 
funders. 
 
16. Lay summary of the paper 
Once your paper is accepted for publication we may ask you to prepare a lay summary of your paper for 
circulation to ALSPAC staff. This may also to be used to publicize your paper.  
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Anxiety and the development and
maintenance of anorexia nervosa: protocol
for a systematic review
E. Caitlin Lloyd1*, Anne M. Haase1 and Bas Verplanken2
Abstract
Background: Several aetiological models of anorexia nervosa (AN) hold non-eating/weight-gain-related anxiety as a
factor relevant to the onset and maintenance of the disorder. Longitudinal studies that allow assessment of
this hypothesis have been conducted; however, the evidence has not yet been aggregated in a systematic
manner. The proposed study will systematically review articles describing prospective investigations of the
relationship between anxiety and AN development or maintenance, with the aim of providing a balanced
summary of current understanding and identifying areas for further research.
Methods/design: Electronic databases will be searched for articles investigating the longitudinal influence of
non-eating/weight-gain-related anxiety (anxiety disorders and trait anxiety) on the development/maintenance
of AN. References of eligible articles will be searched to ensure the identification of all relevant studies. Two
independent reviewers will complete the title and abstract, and full-text, screening, with a third independent
reviewer resolving any conflicts at each stage. A systematic review will be completed, and the quality of the
included studies, as well as the strength of the body of evidence generated, will be assessed and reported.
Discussion: Although there are limitations to the present review, understanding the current evidence for the
role of non-eating/weight-gain-related anxiety in AN can direct future research that may ensure accurate
aetiological models of AN and effective treatments.
Systematic review registration: The study is registered on PROSPERO under the reference number
CRD42017069644
Keywords: Aetiology, Anxiety, Anorexia nervosa: risk factor, Longitudinal studies
Background
Anorexia nervosa (AN) is characterised by the mainten-
ance of a significantly low body weight [1] that is
achieved by dietary restriction that persists despite se-
vere risks to physical health [2]. The factors promoting
the onset and continuation of excessive and pathological
starvation are poorly understood, preventing such fac-
tors being targeted by treatment interventions [3, 4]. As
a result, the recovery rate of AN is low, the relapse rate
is high, and the mortality rate is the greatest of any psy-
chiatric illness [5, 6].
The high levels of anxiety surrounding eating has
caused AN to be compared to anxiety disorders [3], and
anxious symptomatology in AN has been empirically in-
vestigated in attempts to better understand AN aeti-
ology. Supporting clinical observations of elevated
anxiety in individuals with AN, it is consistently reported
that individuals who experience AN are more likely to
have anxiety disorders and greater levels of anxious
symptomatology and trait anxiety, compared to the gen-
eral population [7–9]. This holds prior to the illness, at
the time of AN and in recovery [7]. Subsequently, a
number of models of illness have proposed anxiety as a
key factor in the development and maintenance of AN.
It is proposed that the high levels of anxiety individuals
with AN experience cause starvation to be particularly
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valuable, given dietary restriction affects neurobiological
systems that appear to modulate anxiety in AN [10–12].
The relief of anxiety caused by dietary restriction is
suggested to encourage excessive engagement in the
behaviour [10–12]. It is asserted that individuals with
AN come to depend on dietary restriction to avoid
extreme levels of anxiety, with this anxiety increas-
ingly focused on food and weight gain. Thus, when
anxiety is greater, it would be expected that restrict-
ive eating is more likely to occur in AN. Pre-meal
anxiety is related to reduced caloric intake at the
meal [13], and individuals with AN are more likely
to report restricting their intake at times that coin-
cide with high levels of state anxiety [14, 15]. This
suggests that traits and disorders that cause episodes
characterised by high state anxiety, such as anxiety
disorders and trait anxiety, would be negative prog-
nostic factors for AN, state anxiety serving to in-
crease engagement in dietary restriction.
An alternative hypothesis is that anxious traits and
anxiety disorders reflect underlying neurobiological ab-
normalities that predispose individuals to develop patho-
logical fear and avoidant responses [7, 16, 17]. The
abnormalities result in the development of fears and ab-
normal behaviour surrounding weight gain and eating
when weight concern is present and dieting is initiated.
In these models, it is only anxiety surrounding eating
and weight gain that is directly associated with contin-
ued dietary restriction. Non-eating/weight-gain concerns
are factors predictive of the onset and maintenance of
AN because they reflect the severity of eating/weight-re-
lated anxiety and of eating behaviours designed to man-
age this anxiety.
The relationship of trait anxiety and symptoms/diag-
noses of anxiety disorders (i.e. stable forms of anxiety
that do not specifically relate to eating/weight gain) with
both AN onset and maintenance has been probed in a
number of longitudinal studies. However, the evidence
gathered across these studies has not yet been synthe-
sised in a systematic manner. This prevents a fair evalu-
ation of the longitudinal relationship between anxiety
and AN, which is necessary for theoretical accounts of
AN, and disorder prevention/treatment interventions, to
be appropriately informed. It also means that the need
for further investigation in this area may not be fully ap-
preciated. This systematic review will gather and
organize evidence from a diverse range of observational
studies, to critically evaluate the nature of the relation-
ship between non-eating/weight gain-related anxiety,
which we refer to as anxiety in this manuscript, and AN.
The current protocol outlines the methods of our inves-
tigation, in accordance with the PRISMA-P checklist
(available in Additional file 1), which will address the fol-
lowing research questions:
1. Is anxiety related to the later onset of AN?




Retrospective and prospective cohort and case-control
studies that present original data and that investigated
the longitudinal relationship between anxiety and AN
development or maintenance will be eligible for inclu-
sion in the review. Studies must have measured anxiety
at one time point and have assessed AN symptoms at
least 1 year later to be included.
Participants
We will only include studies that include a human AN
population, and individuals in the AN sample recruited
must meet, or have previously met, full diagnostic cri-
teria for the disorder.
Exposures
Eligible exposures are symptoms/diagnosis of any anx-
iety disorder (excluding obsessive-compulsive disorder
or posttraumatic stress disorder) and trait anxiety, pro-
vided they have been assessed with a validated measure.
Studies that have assessed relationships between state
anxiety and AN pathology will not be included given we
are considering the relevance of more stable forms of
anxiety to AN. Further, we are specifically interested in
the relationship between non-eating/weight gain-related
anxiety and AN, and state anxiety assessments are likely
to capture anxiety related to eating and weight gain in
individuals with AN. While the range of eligible expo-
sures may seem broad, an initial scoping review of the
literature suggests this approach is reasonable and will
not result in an unmanageable amount of data to
synthesise.
Comparators
Studies may compare individuals with anxiety disorders,
or high levels of anxiety disorder symptoms/trait anxiety,
with individuals without these disorders/characteristics.
Outcomes
For studies investigating the relationship between anx-
iety and the development of AN, AN diagnosis is the
primary outcome. Secondary outcomes are severity of
behavioural/psychological symptoms of AN and body
mass index (BMI).
For studies investigating the relationship between anx-
iety and AN maintenance, the primary outcome is recov-
ery from AN. Secondary outcomes are severity of
behavioural/psychological symptoms of AN/changes in
these symptoms and BMI/change in BMI.
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Timing
Outcome data may be collected at different time points;
however, AN onset or maintenance must be assessed at
least 1 year after the time at which anxiety is measured
for the study to be included.
Setting
We impose no restrictions pertaining to study setting.
Language
Only studies reported in English will be included.
Information sources
Literature searches will be conducted on articles held in
Medline and PsychInfo using the OVID interface. To
identify relevant articles in these databases, a search
strategy has been produced and is available in
Additional file 2. Eligible studies will have been pub-
lished in a peer-reviewed journal and in the year 1980 or
subsequently. Reference lists of eligible studies identified
from database searches will be scanned to ensure we
capture all relevant research articles.
Data collection and analysis
Study selection
Following removal of duplicates, the titles and abstracts
of studies retrieved using the database searches will be
screened by two reviewers. The full text of potentially
eligible studies will be retrieved and assessed for inclu-
sion in the review by two reviewers. Should the full text
of a study not be accessible through institutional mem-
berships study authors will be contacted in order to re-
trieve the manuscript. The decision to include studies
will be based on criteria outlined in the preceding sec-
tion, and a third reviewer will resolve any discrepancies
between the screeners at both stages. Two reviewers
must also approve the inclusion of further studies identi-
fied from reference lists of the eligible articles found
using database searches. The reason for exclusion of any
study will be recorded, and the study selection process
presented in a PRISMA flow diagram.
Data extraction
Using a tailored data collection form, the following in-
formation will be extracted from each study:
1. Publication details: authors, title, publication date,
and country.
2. Study information: study setting and design, details
of exposure and outcome, details of comparator (if
appropriate), sample size at recruitment and
completion, follow-up period, and study measures.
3. Participant characteristics: demographics, illness
duration, BMI, number of hospitalisations, length of
illness, psychiatric co-morbidities, and use of
psychotropic medication.
4. Study results: findings in relation to the primary and
secondary outcomes will be reported, as will the
statistical methods employed in the investigation.
Where data are missing, we will attempt to contact
study authors to obtain this.
Risk of bias
The National Institute of Health’s Quality Assessment
Tool for Observational Cohort and Cross-Sectional
Studies [18] will be used to assess risk of bias for each
study. The checklist considers selection bias, blinding of
outcome assessors (researcher bias), withdrawal (attri-
tion bias), and selective reporting (reporting bias). Other
aspects of study quality are also considered: the validity
of exposure and outcome measures, risk of confounding,
sample size, and potential to capture dose-response rela-
tionships. Regarding the validity of exposure measures,
we are particularly concerned with evaluating the poten-
tial for these to capture anxiety that reflects the AN (i.e.
that related to eating and weight gain). For example, so-
cial phobia assessments may capture fears of eating in
public, which could be symptomatic of the AN rather
than of social phobia. This would give rise to false infer-
ences concerning the relationship between non-eating/
weight gain-related anxiety and AN.
Risk of bias and quality for all studies will be assessed
by two reviewers, with discrepancies resolved by a third
reviewer, to ensure reliability of the review. If eligible
review studies are identified, the outcomes of these
review studies will be compared to the outcomes re-
ported by articles included in the present review, to
detect systematic reporting biases. The strength of the
body of evidence collected in the course of the review
will be assessed using the Grading of Recommendations
Assessment, Development and Evaluation (GRADE) sys-
tem [19].
Data synthesis
Studies will be categorised according to whether they as-
sess the relationship of anxiety with the development or
the maintenance of AN. Within these two categories,
studies will be grouped further, according to the type of
anxiety considered for its influence on AN (i.e. specific
anxiety disorders and trait anxiety). Ideally, meta-
analyses would be conducted to determine the pooled
effect size pertaining to the longitudinal relationship of
each type of anxiety with both AN onset and AN main-
tenance. However, preliminary investigations suggest
that the number of eligible studies within each category,
and the heterogeneity of these studies, will mean meta-
analyses are not feasible.
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A systematic narrative review will describe findings of
the included studies, and the similarities and differences
between studies, for studies grouped by outcome (AN
onset or maintenance) and type of anxiety measured. A
table outlining findings of each study will also be pro-
vided. RevMan version 5.3 [20] will be used to handle
and synthesise the data of the included studies, for com-
pletion of the qualitative review.
Discussion
With the inclusion of anxiety in aetiological models of
AN, it is important that the relevance of anxiety to AN
development and maintenance is clarified. This study
will provide the first, much needed, systematic synthesis
of longitudinal studies that investigate the relationship
between anxiety and AN. By considering a range of anx-
iety exposures (i.e. anxiety disorder diagnoses/symptoms
and trait anxiety), we hope to be able to evaluate a suffi-
cient number of studies for our research questions to be
addressed.
The planned quality assessment is extensive, to enable
a comprehensive evaluation of the risk of bias within
and across included studies, promoting the validity of
conclusions arising from the review. The extent of the
data extracted from studies will allow for the identifica-
tion of differences in findings that may arise from par-
ticipant and study characteristics. Most importantly, our
method is transparent and explicitly outlined in detail,
allowing its replication, as well as assessment of its qual-
ity, by others.
Anticipated challenges lie in collecting a sufficient
number of studies for firm conclusions regarding the re-
lationship between particular types of anxiety and AN
onset/maintenance to be made. Interpreting the body of
evidence surrounding AN maintenance may also be
problematic given the definitions of recovery are not
standardised in the field of eating disorders [21]. We
consider the outcome of AN recovery, as opposed to re-
mission or relapse, in an attempt to focus the research
question. However, understanding the relationship of
anxiety with both remission and relapse in AN would
further inform knowledge of the factors associated with
AN maintenance.
Because of their longitudinal nature, studies of the re-
view are likely to be subject to high levels of attrition,
which is an issue that has implications on the validity of
conclusions that may be drawn from the review. A fur-
ther limitation is that we will be unable to parse apart
the explanatory power of different types of anxiety on
AN development/maintenance given studies may have
measured only one type of anxiety, focusing on one dis-
order or trait anxiety for example. Alternatively, studies
may not have considered the unique contribution of
each type of measured anxiety to AN risk. The review
will not be able to determine whether non-eating/weight
gain-related anxiety directly causes dietary restriction, or
if such reflects an underlying process that promotes con-
cern surrounding eating and weight gain. However, find-
ings can inform the value of continuing to study anxiety
that does not surround eating and weight gain in rela-
tion to AN.
Despite the discussed limitations, it is important for
evidence surrounding the longitudinal influence of anx-
iety on AN to be synthesised so that progress with inves-
tigation and understanding may be presented. By
highlighting areas that require further study, the review
may encourage the development of accurate aetiological
models of AN, which may inform effective treatment.
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Systematic review search strategy 
1. anorexia.tw.  
2. exp Anorexia Nervosa/ or exp Anorexia/  
3. exp Anxiety Disorders/ or exp Anxiety/  
4. anxiety.tw.  
5. antecedent 
6. risk factor*.tw.  
7. risk-factor*.tw 




12. prospective*.tw.   
13. exp Prospective Studies/ 
14. exp Retrospective Studies/ 
15. exp LONGITUDINAL STUDIES/  
16. exp Cohort Studies/ 
17. (cohort adj (study or studies)).tw. 
18. Cohort analy*.tw. 
19. Longitudinal*.tw. 
20. Retrospective*.tw. 
21. Follow up.tw. 
22. Follow-up.tw. 
23. 1 or 2 
24. 3 or 4  
25. Or/5-11 
26. Or/12-22  
27. 24 or 25   
28. 23 and 26 and 27    
29. limit 28 English language and journal article 











 Study Selection Comparability Exposure  Total 
Case-
control 








Kim et al. 
2010 
           5 
Kim et al. 
2011 
           5 
Machado et al. 
2016 
           6 
Taborelli et 
al., 2013 
           5 
 Study Selection Comparability Outcome   











Comparability  Assessment Adequacy of 
follow up 
  
Buckner et al., 
2010 
        8 
Meier et al., 
2015 
        8 
Ranta et al., 
2017 
        5 
Rigaud et al., 
2011 
        7 
287 
 
Items for Case-Control studies 
 Selection 
1) Is the case definition adequate? 
2) Representativeness of the cases 
3) Selection of Controls 
4) Definition of Controls 
Comparability 
1) Comparability of cases and controls on the basis of the design or analysis 
Exposure 
1) Ascertainment of exposure 
2) Same method of ascertainment for cases and controls 
3) Non-Response rate 
Items for Cohort Studies 
Selection 
1) Representativeness of the exposed cohort 
2) Selection of the non exposed cohort 
3) Ascertainment of exposure 
4) Demonstration that outcome of interest was not present at start of study 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
Outcome 
1) Assessment of outcome  





Study 2 Supplementary Material 
 
Stata code for imputation model 
mi set wide 
mi register imputed purge1 purge2 purge3 binge1 binge2 binge3 /// 
SCbin weight1 weight2 weight3 mother_age_at_delivery fasting1 /// 
fasting2 fasting3 anxiety1 anxiety2 anxiety3 mother_parity  
mi register regular fast1 fast2 fast3 anxietydiag1 anxietydiag2 anxietydiag3 longfast1 longfast2 longanxiety1 
longanxiety2 
set seed 12345 
mi impute chained (logit) purge1 purge2 binge1 binge2 /// 
binge3 SCbin weight1 weight2 weight3 fasting14_c anxiety17 paritybi /// 
fast16 fast18 /// 
(logit, omit (i.anxiety15 i.purge3)) anxiety13 ///   
(logit, omit (i.anxiety13)) purge3 anxiety15 /// 
(regress) mother_age_at_delivery, dots add(70) augment 
 
Note: Fasting and anxiety variables appear twice because data was imputed for these variables to improve 
prediction of covariate data, but only individuals with complete data for anxiety and fasting for a given wave 
were included in the analysis. 
 
Stata code for primary analysis 
*reshape data into wide format* 
mi reshape long fast anxietydiag binge purge weight longfast longanxiety, i(id) j(wave) 
mi xtset id 
mi convert flong, clear 
mi passive: generate longbinge = binge if wave == 1 | wave == 2 
mi passive: generate longpurge = purge if wave == 1 | wave == 2 
*GEE analysis* 
mi estimate: xtgee longfast longdiag baseline_fast SCbin paritybi mz028b longpurge longbinge wave, /// 
family(binomial) link(logit) corr(unstructured) t(time) vce(robust) 
*within-wave analyses* 
mi estimate: logit longfast longdiag baseline_fast SCbin paritybi mz028b longpurge longbinge if wave ==1  





Multiple imputation model checks 
 
Table 1 Comparison Between Observed and Imputed Covariate Data  
 
 
a For time-varying covariates proportions are in respect of individuals included in the particular wave of analysis  
Variable Available data Imputed data 
 N  Proportion (%) N  Proportion (%) 
Purging wave 1a   
 
  
Yes 2,193 98 11 99 
No 02 01 
Binge eating wave 1 a  
 
  
Yes 1,963 93 241 88 
No 07 12 
Purging wave 2 a  
 
  
Yes 1,276 90 106 89 
No 10 11 
Binge eating wave 2  a   
 
  
Yes 1,270 85 112 86 
No 15 14 
Socio-economic status  
 
  
Manual 1,996 15 410 18 
Non-manual 85 82 
Mother parity  
 
  
Primipari 2,248 48 158 47 
Multipari 52 53 
 Available data 
 
Imputed data 
Mother age at delivery  N M (SE) N M (SE) 
















Associations between monthly fasting and subsequent AN 
Table 2 Prospective Prediction of Anorexia Nervosa Diagnosis at Wave 17-18 by Monthly Fasting at Wave 15-16 
Outcome: Anorexia Nervosa 
Diagnosis at Wave 17-18 
(n = 1552) 
Logistic Regression Model Estimate 
OR [95% CIs] P value 
Monthly Fasting at Wave 15-16 3.35[1.09, 10.26] 0.034 





Identification of potential confounders 
 
Table 3 Associations of Potential Confounders with Anxiety Disorder Exposure and Fasting Outcome 
 Outcome  
Anxiety disorder at same wave Fasting at subsequent wavea  
OR 
 [95% CI] 
P value N OR  
[95% CI] 
p N 
Predictor       
Wave 13-14 










Binge eating  3.01 
[1.00,9.05] 
0.05  2047  1.75 
[1.06,2.88] 
0.028  2040 
Purging  3.42 
[0.79,14.77] 
0.10 2290 6.07 
[3.30,11.18] 
<0.001 2281 
Weight status 0.91 
[0.47,1.76] 









<0.001 1885 3.35 
[2.07,5.41] 
0.07 1678 
Binge eating 3.69 
[1.85,7.34] 
<0.001 1779 6.85 
[4.46,10.52] 
<0.001 1572 
Purging  1.41 
[0.64,3.07] 
0.393 1772 3.02 
[1.99,4.57] 
<0.001 1566 
Weight status  1.61 
[0.87,2.98] 
0.129 1179 1.4 
[0.92,2.13] 
0.119 1035 
aFor predictors at wave 13-14, the subsequent wave is wave 15-16; for predictors at wave 15-16, the subsequent wave is wave 17-
18.  
b Fasting at baseline refers to fasting at wave 13-14; coefficients are in respect of the regression of anxiety disorder presence at 
















Logistic regression models stratified by wave 
 






Total N 2,396 2,301 1,771 1,265 









P value OR  
[95% CIs] 
P value OR  
[95% CIs] 
P value OR  
[95% CIs] 
P value 
Anxiety disorder 2.95  
[1.9, 4.58] 
<0.001 1.82  
[0.64, 5.12] 





Binge eatingc 2.37  
[1.79, 3.14] 
<0.001 3.53  
[2.28, 5.47] 
<0.001 2.14  
[1.4, 3.28] 
<0.001 1.86  
[1.1, 3.14] 
0.02 
Purgingc 8.88  
[6.52, 12.1] 
<0.001 19.61  
[10.47, 36.75] 
<0.001 9.08  
[6.09, 13.53] 







0.04 0.65  
[0.42, 1.01] 
0.056 0.67  
[0.4, 1.14] 
0.14 1.29  
[0.57, 2.9] 
0.542 
Mother parity 1.34  
[1.05, 1.71] 
0.018 1.25  
[0.88, 1.78] 
0.219 1.51 
 [1.01, 2.25] 












Effect estimates are fully adjusted, or conditional on each of the other variables included in the table. 
 
a At wave 13-14 the association between anxiety and any fasting in the past year is assessed, unlike at the later waves, where the association between anxiety and monthly 
fasting during the past year is assessed. 
b At wave 17-18 anxiety disorder presence was assessed with the Clinical Interview Schedule-Revised (CIS-R) rather than the DAWBA. The CIS-R is a semi-structured 
computerized assessment of psychopathology that yields symptom presence indicators and diagnoses based on ICD-10 criteria.  
c Treated as time-varying predictor in the Generalized Estimating Equation model, such that the effect estimate reflects the concurrent association between the variable and 
the fasting outcome across the three cross-sectional waves of data. 




0.038 1  
[0.96, 1.03] 
0.853 0.94  
[0.9, 0.98] 
<0.0017 0.95  
[0.9, 1.01] 
0.129 
Wave 0.63  
[0.54, 0.73] 




Table 5 Correlations between variables of the imputation model 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
(1) Purging wave 
1                    
R -----                  
SE -----                  
P -----                  
N -----                  
(2) Binge eating 
wave 1                   
R 0.29 -----                 
SE 0.09 -----                 
P 
<0.00
1 -----                 
N 2130 -----                 
(3) Purging wave 
2                   
R 0.53 0.22 -----                





1 -----                
N 2289 2047 -----                
(4) Binge eating 
wave 2                   
R 0.20 0.49 0.41 -----               





1 -----               
N 2282 2040 2293 -----               






1 0.03 0.03 -----              
SE 0.09 0.07 0.06 0.05 -----              
P 0.20 1.00 0.66 0.72 -----              
N 1987 1769 1905 1899 -----              
(6) Mother 
parity                   
R 0.16 0.05 0.14 -0.04 -0.15 -----             
SE 0.07 0.05 0.05 0.04 0.04 -----             




1 -----             
N 2237 1993 2149 2143 1961 -----             
(7) Mother age at 
delivery                   
R -0.03 0.02 0.03 0.01 0.20 0.34 -----            
SE 0.06 0.04 0.04 0.03 0.04 0.02 -----            




1 -----            
N 2294 2046 2200 2193 1996 2248 -----            
(8) Fasting at 
baseline                    
R 0.68 0.38 0.42 0.11 -0.15 0.10 -0.01 -----           







1 0.04 0.01 0.04 0.79 -----           
N 2394 2139 2300 2293 1996 2248 2305 -----           
(9) Fasting wave 
1                   
R 0.42 0.14 0.61 0.32 -0.10 0.08 -0.09 0.40 -----          







1 0.09 0.09 0.02 
<0.00




N 2281 2040 2292 2285 1898 2141 2192 2292 -----          
(10) Fasting 
wave 2                   
R 0.19 0.29 0.52 0.32 
<0.00
1 0.05 -0.12 0.32 0.60 -----         











1 -----         
N 1672 1490 1572 1566 1399 1569 1607 1678 1564 -----         
(11) Anxiety 
disorder wave 1                   
R 0.22 0.22 0.16 0.05 -0.06 0.01 0.04 0.21 -0.16 -0.06 -----        
SE 0.15 0.12 0.11 0.11 0.12 0.09 0.09 0.11 0.16 0.18 -----        
P 0.13 0.06 0.18 0.59 0.54 1.00 0.54 0.04 0.51 1.00 -----        
N 2290 2047 2212 2205 1923 2152 2204 2301 2204 1573 -----        
(12) Anxiety 
disorder wave 2                   
R 0.22 0.26 0.31 0.08 -0.12 0.08 -0.01 0.32 0.44 0.48 -1.00 -----       
SE 0.13 0.10 0.09 0.10 0.10 0.08 0.06 0.09 0.08 0.09 . -----       
P 0.09 0.01 
<0.00






1 1.00 -----       
N 1875 1675 1779 1772 1578 1757 1804 1885 1771 1382 1780 -----       
(13) Anxiety 
disorder wave 3                   
R 0.14 0.20 0.24 0.19 -0.02 0.02 0.02 0.23 0.33 0.42 0.25 0.52 -----      
SE 0.10 0.07 0.06 0.06 0.07 0.05 0.04 0.06 0.06 0.07 0.13 0.07 -----      












1 -----      
N 1662 1487 1597 1590 1410 1558 1597 1670 1589 1265 1597 1510 -----      
(14) Purging age 
18                   

















1 0.39 0.01 
<0.00
1 -----     
N 1669 1488 1569 1563 1397 1566 1604 1675 1561 1675 1570 1380 1262 -----     
(15) Binge eating 
age 18                   
R 0.10 0.50 0.34 0.57 0.01 0.03 0.06 0.15 0.20 0.36 0.04 0.07 0.34 0.53 -----    















1 -----    
N 1671 1489 1571 1565 1398 1568 1606 1677 1563 1675 1572 1381 1265 1673 -----    
(16) Weight 
status at age 14                   
R 0.17 0.24 0.07 0.12 -0.12 0.02 -0.13 0.21 0.16 0.19 -0.10 0.09 0.02 0.21 0.13 -----   
SE 0.08 0.06 0.05 0.05 0.05 0.04 0.03 0.05 0.05 0.07 0.12 0.09 0.06 0.05 0.07 -----   
P 0.04 
<0.00








1 0.60 0.33 0.68 
<0.00
1 0.05 -----   
N 2101 1875 2027 2020 1775 1969 2017 2110 2019 1479 2110 1733 1555 1478 1476 -----   
(17) Weight 
status at age 16                   
R 0.16 0.23 0.05 0.14 -0.20 0.09 -0.14 0.21 0.08 0.08 0.12 0.07 0.09 0.25 0.11 0.91 -----  
SE 0.10 0.07 0.07 0.06 0.06 0.05 0.04 0.07 0.07 0.09 0.13 0.12 0.07 0.06 0.08 0.02 -----  
P 0.13 
<0.00










1 -----  
N 1457 1293 1409 1405 1235 1376 1405 1461 1402 1035 1434 1179 1061 1035 1033 1359 -----  
(18) Weight 
status age 18                   
R 0.17 0.16 0.06 0.13 -0.08 0.02 -0.13 0.24 0.12 0.12 -1.00 0.02 0.02 0.20 0.07 0.86 0.82 ----- 
SE 0.09 0.06 0.06 0.05 0.05 0.04 0.03 0.05 0.06 0.07 . 0.09 0.05 0.05 0.07 0.02 0.03 ----- 





























Main analysis Exploratory analysis that excludes individuals reporting any fasting at baseline 
 GEE model Logistic regression models stratified by wave GEE model Logistic regression models stratified by wave 
 





1786 1593 1049 1645  1470 970 








[95% CIs] P value 
OR 
[95% CIs] P value 
OR 
[95% CIs] P value 
OR 
[95% CIs] P value 
OR 
[95% CIs] P value 
OR [95% 































0.014 NA NA NA NA NA NA 




Effect estimates are fully adjusted, or conditional on each of the other variables included in the table. 
 
  




























































































0.006 NA NA NA NA 0.69 
[0.49, 
0.98] 












Main analysis Exploratory analysis that excludes individuals reporting any fasting at baseline 
 GEE model Logistic regression models stratified by wave GEE model Logistic regression models stratified by wave 




Total N 2304  2003 1379 2099  1821 1273 








[95% CIs] P value 
OR 
[95% CIs] P value 
OR 
[95% CIs] P value 
OR 
[95% CIs] P value 
OR 
[95% CIs] P value 
OR [95% 
































0.005 NA NA NA NA NA NA 






































































































0.002 NA NA NA NA 0.66 
[0.49, 
0.89] 











Main analysis Exploratory analysis that excludes individuals reporting any fasting at baseline 
 GEE model Logistic regression models stratified by wave GEE model Logistic regression models stratified by wave 
  Wave 13-14 Wave 15-16  Wave 13-14  
Wave 15-16 
 
Total N 2318 2093 1316 2129  1926 1225 








[95% CIs] P value 
OR 
[95% CIs] P value 
OR 
[95% CIs] P value 
OR 
[95% CIs] P value 
OR 
[95% CIs] P value 
OR [95% 





























0.081 NA NA NA NA NA NA 











































































































Descriptive information for anxiety disorder diagnoses 
Table 9 Frequencies for Anxiety Disorder Diagnoses in the Study Population 
  
Wave 13-14 Wave 15-16 
N (%) N (%) 






















































(11.64)     
 
Panic Disorder     






Agoraphobia     
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Objectives To assess bidirectional effects of anxiety and anorexia nervosa (AN) phenotypes. 
Design Two-sample Mendelian randomization. 
Setting Genome-wide association study (GWAS) summary statistics from the Psychiatric 
Genomics Consortium (PGC), analysis of the UK Biobank sample, and Anxiety Neuro 
Genetics Study (ANGST) consortium. 
Participants European descent participants from the PGC (n = 14,477), UK Biobank (n = 
348,219), and ANGST consortium (n =  17,310, and n = 18,186). 
Main outcome measures AN diagnosis, worry, anxiety disorder pathology (case-control and 
quantitative phenotypes).  
Results We found evidence of a moderate genetic correlation between worry and AN (Rg = 
0.36, SE = 0.05, p < 0.001), and the Mendelian randomization analysis supported a causal 
influence of worry on AN (OR = 2.14, 95% CI: 1.18 to 3.90, p = 0.01). There was no clear 
evidence for a causal effect of AN on worry in this study (B = -0.01, 95% CI: -0.03 to 0.02, p 
= 0.55). There was no robust evidence for a causal influence of anxiety disorders on AN (for 
case-control anxiety disorder phenotype: OR = 1.02, 95% CI: 0.69, 1.50, p = 0.922; for 
quantitative anxiety disorder phenotype: OR = 4.26, 95% CI: 0.49, 36.69, p = 0.187). There 
was no robust evidence for a causal effect of AN on anxiety disorders (for case control 
anxiety disorder phenotype: OR = 1.00, 95% CI: 0.72, 1.38, p = 0.981; for quantitative 
anxiety disorder phenotype: B = 0.01, 95% CI: -0.06, 0.6=09, p = 0,761). AN and anxiety 
disorder phenotypes were not genetically correlated (for case-control anxiety disorder 
phenotype: Rg = 0.10, se = 0.17, p = .56; for quantitative anxiety disorder phenotype: Rg = 
0.12, SE = 0.17, p = 0.47).   
Conclusions Findings support a role for worry in AN development, highlighting a potential 
target of future AN prevention efforts. Mechanisms underlying the association should be a 
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focus of future investigation. The relatively small sample sizes of anxiety disorder and AN 
GWASs may have limited power to detect causal effects; these associations should be studied 
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Anorexia nervosa (AN) is a serious eating disorder that is characterised by persistent 
restriction of caloric intake and fear of weight-gain in the context of a low body weight (1). 
AN has a lifetime prevalence rate of approximately 1 to 4% (2, 3), a range of lasting physical 
health complications (4), and the highest mortality rate of any psychiatric disorder (5). No 
single treatment or set of treatments has been found to be consistently successful, with AN 
recovery rates following treatment below 50% (6).  
 
The scope for targeting putative mechanisms of AN is currently limited. Despite substantial 
development in the study of AN, with investigations focusing on a range of possible 
mechanisms (e.g. genetic, neural, psychological and personality factors), the aetiology of the 
disorder remains largely unknown (7). A number of models of illness have proposed a causal 
role of anxiety that does not surround eating and weight-gain (i.e., anxiety that is not 
explained by a diagnosis of AN) in the development of AN (8-11). Empirical evidence has 
provided some support for such models. Trait anxiety, a proneness to experiencing anxiety 
generally, is reported to be higher in individuals with AN as compared to healthy controls 
(12-14), and anxiety disorder prevalence is elevated in AN populations, as compared to the 
general population (15, 16). Importantly, retrospective studies report both anxious 
temperament and anxiety disorder pathology to precede the onset of AN (17-20), although 
findings from prospective studies are mixed (21, 22).  
 
Although current evidence generally is consistent with a causal effect of anxiety on AN, the 
reported associations are at risk of confounding by unmeasured, or inadequately measured, 
factors. Demographic characteristics or other psychiatric comorbidities may increase risk for 
both anxiety and AN, serving to induce a correlation between the two, in the absence of a 
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causal relationship. Reverse causation is also a possibility, with observed associations being 
driven by AN influencing anxiety, rather than the other way around. The association between 
malnutrition and anxiety in AN is currently unclear (23). However, nutrition affects various 
hormonal and neurotransmitter systems implicated in anxiety, changes to which have been 
observed in AN (24-27), and dietary restriction results in psychological and emotional 
changes in populations without AN (28, 29). A recent prospective study also found AN to 
increase the likelihood of a later anxiety disorder diagnosis (30). The biases that studies using 
traditional epidemiologic methods are subject to (e.g. confounding and reverse causation) 
mean that it is difficult to draw strong conclusions concerning the causal role of anxiety in 
AN using the existing evidence. However, being able to make confident inferences would 
better inform models of illness and the subsequent development of novel prevention and 
treatment interventions.  
 
Mendelian randomization (MR) is an epidemiological approach that minimises bias affecting 
traditional observational epidemiology (31-33). The method uses genetic variants that are 
associated with the exposure of interest (in this case, anxiety) as instruments for examining 
the association between exposure and outcome (Figure 1). The association of the genetic 
variant with the outcome is analysed, under the assumption that the effect of the genetic 
variant is fully mediated by the exposure. This assumption is violated when horizontal 
pleiotropy occurs, that is, when the genetic variant is associated with other traits that also 
affect the outcome. Methods robust to this form of pleiotropy, and violations of other MR 
assumptions, have been developed. Consistency between estimates using these different 
methods can strengthen conclusions from MR studies (34).  
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Figure 1: Diagram of a Mendelian randomization analysis 
 
Mendel’s laws of segregation and independent assortment describe the random allocation of 
alleles during gamete formation. An individual’s genotype is the result of two such 
randomised transmissions: one maternal, and one paternal. The result is that genetic variants 
associated with the exposure of interest are generally not associated with traits that may 
confound the exposure-outcome association in traditional observational studies (35). 
Associations of a given genetic variant with the outcome of interest cannot be explained by 
reverse causation either, since the genotype one is born with is not altered by a disease 
outcome.  
 
Where genetic variants are robustly associated with an exposure of interest, individuals with 
the risk increasing form of the variant will on average have greater levels of the exposure. 
However, groups will not differ with regard to confounding factors. MR is not concerned 
with making conclusions about the genetic underpinnings of an outcome, but rather with 
establishing an unbiased estimate of the effect of an exposure on an outcome, using genetic 
variants as proxy variables to achieve this (32). In a two-sample MR analysis an estimate of 
the association of the genetic variant with both the exposure and outcome is obtained. Gene-
exposure associations are estimated in a different sample to the gene-outcome associations, 
meaning summary statistics from different genome-wide association studies (GWAS) may be 
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used to complete the analysis. This approach will yield valid estimates providing the two 
samples are from the same underlying population (36). 
 
A bidirectional MR analysis of worry and AN has been completed previously (37). Worry is 
defined as a negatively valanced and uncontrollable thought process, intended to resolve an 
issue that has at least one possible negative outcome (38). Worry is conceptualised as the 
cognitive component of anxiety (39), correlates highly with trait anxiety (40), is present in a 
number of anxiety disorders and is a core symptom of Generalised Anxiety Disorder (1). The 
existing MR study found no evidence of a causal association between worry and AN in either 
direction, although the two were genetically correlated (37). The AN GWAS included a 
relatively small number of cases however, which will have resulted in low sensitivity to 
detect causal effects of worry on AN (41), and vice versa (42), in the MR analysis. 
 
Here we used summary data from the largest GWAS of AN completed to date (43) to 
investigate causal effects between anxiety and AN using genetic correlation and bidirectional 
two sample MR approaches. We extend previous investigations by considering the 
association of anxiety disorder phenotypes, in addition to worry, with AN. Findings from 
observational studies suggest the existence of causal influences in both directions, supporting 
the notion of a cycle in which anxiety is relieved by dietary restriction, but then elevated 
beyond initial levels to prompt further starvation (9, 44). We therefore hypothesised that we 
would observe bidirectional effects. 
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Details of the GWAS data used in the current study are provided in Table 1. The worry 
phenotype was quantitative, and measured by items comprising the worry dimension of the 
Eysenck personality questionnaire short-form neuroticism subscale (45, 46), that was 
administered to participants of the UK Biobank study. Binary responses (yes/no) to the 
questions ‘Are you a worrier?’, ‘Do you suffer from nerves?’, ‘Would you call yourself a 
nervous person?’ and ‘Would you call yourself tense or highly strung’, were summed to 
create a total score out of four, with higher scores indicating more severe worry. Only 
individuals who provided valid responses to all items were included in the GWAS. The 
cluster of worry items are reported to display a distinct genetic signal, in comparison to other 
clusters of the neuroticism subscale (37).  
 
The anxiety disorder case control phenotype reflects the presence of five core anxiety 
disorder pathologies (GAD, PD, social phobia, agoraphobia, specific phobia). Only 
individuals with threshold pathologies or no pathology were included to increase genetic 
signal. The quantitative anxiety disorder phenotype indicates liability for a common 
dimension of anxiety, and was developed from modelling covariation across the same five 
disorders (47). The AN phenotype was binary, and indicated lifetime AN, or eating disorder 
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 Table 1: GWAS Study Characteristics 
Phenotype Study Resource Sample 
size 

















































Genetic Instrument selection 
Genetic instruments for each exposure of interest were identified from relevant GWAS 
statistics (Table 1). We initially used a significance threshold of 5 x 10-8 to select single 
nucleotide polymorphisms (SNPs) for use as instruments, to ensure robust associations 
between SNPs and each exposure (48). SNPs were clumped to ensure independence using a 
threshold of LD r2=0.001, and a distance of 10000kb. Where instruments comprised a single 
SNP following clumping, we ran an additional sensitivity analysis using a significance 
threshold of 5 x 10-6 for instrument identification.  
 
If palindromic SNPs were indicated for eligible instruments, proxy variants were identified 
with the package proxysnps (49), using an R2 threshold of > 0.8, and LD scores from the 
European 1000 Genomes data. Where instrumental SNPs were missing from the outcome 
GWAS, proxy variants were identified using the same approach, and replaced original 
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instruments for estimation of instrument-outcome associations where possible. Proxy variant 
details are provided in Table 1 of the Supplementary Material. The inclusion of proxies did 
not affect the independence of instrumental SNPs. 
 
There were 60 SNPs associated with the worry exposure, 57 of which (or proxies) were 
available in the AN GWAS. Anxiety disorder and AN instruments included one independent 
SNP following clumping. When the SNP-exposure threshold was reduced, seven SNPs were 
associated with the anxiety disorder case control phenotype, and nine with the quantitative 
phenotype. The weaker AN instrument contained 16 independent SNPs; eleven were 
available in the worry GWAS, while eight were available in the anxiety disorder GWAS. 
 
Statistical Analyses 
GWAS summary statistics were downloaded from consortium/study websites (Table 1) and 
converted into the format required for statistical analyses. 
 
Genetic Correlation Analyses 
To estimate the genetic correlation between anxiety and AN phenotypes cross-trait linkage 
disequilibrium score regression (50) was implemented, using the ldsc command line tool 
(https://github.com/bulik/ldsc) and LD scores computed from the 1000 Genomes European 
data (https://data.broadinstitute.org/alkesgroup/LDSCORE/).  
 
Mendelian Randomization Analyses 
Bidirectional MR analyses were implemented in R (51) using code available in the 
TwoSampleMR package of the analytical platform MR base (52), and local data.  
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For single SNP instruments the Wald Ratio method, or the ratio of coefficients method (53), 
was used to estimate the causal effect. Where multiple SNPs were identified as eligible 
instruments, Wald ratio estimates for the different SNPs were combined in an inverse 
variance weighted (IVW) analysis (54). Cochrane’s Q statistic was calculated to assess the 
heterogeneity of estimates combined in the IVW analysis. Since the Q statistic is heavily 
affected by sample size, I2 and associated confidence intervals were also calculated, using 
formulae derived from the meta-analysis literature (55). ‘Leave one out’ analyses were 
completed when heterogeneity was detected: the IVW analysis was completed leaving out 
one SNP each time, and estimates plotted.  
 
We completed three sensitivity analyses that are robust to horizontal pleiotropy, to evaluate 
the validity of IVW estimates. MR Egger regression (56) was used to estimate pleiotropic 
effects present in the IVW analysis, and provide a pleiotropy-corrected estimate of the causal 
effect. Rucker’s Q indicates heterogeneity around the Egger estimate (57), and was deducted 
from Cochrane’s Q; a large positive value, combined with evidence of pleiotropy, suggests 
the MR Egger model is a better fit to the data than the IVW model (57). Weighted median 
(58) and weighted mode (59) analyses, which provide consistent causal estimates when a 
proportion of genetic instruments are invalid, were also completed. For an overview of MR 
methods, see (60). 
 
Where the MR analysis indicated a causal effect, we conducted a MR Steiger sensitivity 
analysis to evaluate whether the inferred direction of causal influence was correct. This 
estimates the variance explained in exposure and outcome for each variant, testing whether 
associations between genetic instruments and the exposure are stronger than corresponding 
associations between genetic instruments and the outcome. Where this is the case a direction 
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of effect from exposure to outcome is supported (61). The MR analysis was replicated using 
the subsample of variants that showed stronger associations with the exposure as compared to 
the outcome.  
 
Estimate interpretation 
The causal estimate reflects the change in outcome resulting from a unit change in exposure, 
and estimates for binary outcomes are exponentiated to reflect the increase in odds of an 
outcome per unit change in exposure. When the exposure is binary, estimates denote the 
change in outcome, or odds of outcome, per log-odds increase in the exposure. 
 
Results 
Genetic Correlation Analyses 
Figure 2 displays the full results of the genetic correlation analyses. We found evidence that 
AN was genetically correlated with the worry phenotype: Rg = 0.36, SE = 0.05, p < 0.001. 
There was no strong evidence of a genetic association between AN and either anxiety 
disorder exposure.  
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Figure 2: Genetic correlations between anxiety phenotypes and AN  
Mendelian Randomization Analyses 
Bidirectional causal effects between worry/anxiety and AN phenotypes were assessed. 
Findings are summarised below.   
Causal influence of worry/anxiety disorders on AN 
The IVW estimate indicated that worry increased the likelihood of AN diagnosis (OR = 2.14, 
95% CI: 1.18, 3.90, p = 0.013). The weighted median estimate was consistent with this 
finding (OR = 2.49, 95% CI: 1.15, 5.41, p = 0.021), and the weighted mode estimate 
provided weak evidence for a positive association. The MR Egger estimate was not consistent 
with IVW, weighted median and weighted mode estimates, and confidence intervals around 
the estimate were very wide (Figure 3). Wald ratio estimates for each SNP are available in 
Figure 1 of Supplementary Material.  
 
Outcomes of the MR Steiger investigation indicated that 37 of 57 variants showed stronger 
associations with the exposure as compared to the outcome (Supplementary Material, Table 
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2). Point estimates of the MR analysis using only these variants were consistent with those of 
the analysis including all 57 genetic instruments (i.e. supported worry increasing risk for 
AN), however the former were relatively imprecise (Supplementary Material, Figure 2). 
 
There was no evidence for a causal influence of anxiety disorder pathology on AN in the 
single SNP analyses (Figure 3). Findings from sensitivity analyses that used multiple 
independent SNPs (less strongly associated with the anxiety disorder exposure) were 
consistent with those of single SNP analyses (Supplementary Material, Figures 3 and 4). 
 
Figure 3: Mendelian randomization analysis to estimate causal influence of anxiety 
phenotypes on AN  
 
 
Causal influence of AN on worry/anxiety disorders 
There was no strong evidence for a causal influence of AN on the worry phenotype, or either 
anxiety disorder phenotype, using the single SNP instrument (rs4622308) that was significant 
at the genome-wide level (Figure 4). Inferences from analyses using multiple SNP 
instruments did not qualitatively differ (Supplementary Material, Figures 5 - 7), with effect 
estimates remaining close to the null. 
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Figure 4: Mendelian randomization analysis to estimate causal influence of AN on anxiety 
phenotypes 
 
Pleiotropy and Heterogeneity 
The MR Egger intercept did not provide evidence for horizontal pleiotropy in analyses 
including multiple SNPs. Cochrane’s Q statistic did indicate heterogeneity in the analysis of 
the causal effect of worry on AN. However, the I2 statistic (and associated confidence 
intervals) did not. In the multiple SNP analysis of the causal effect of AN on the quantitative 
anxiety disorder phenotype, heterogeneity was indicated by Cochrane’s Q and I2. A leave one 
out sensitivity analysis did not suggest an overriding influence of any individual SNP, and in 
all multiple SNP analyses the confidence intervals of each SNP estimate overlapped. There 
was no marked improvement in heterogeneity with MR Egger estimates, relative to IVW 
estimates, in any of the multiple SNP analyses. Collectively there is no evidence to support 
bias caused by horizontal pleiotropy in IVW estimates of the study (for more detail see 
Supplementary Material, Tables 3 - 5 and Figures 8 and 9).  
Discussion 
This study introduced MR to the study of AN, to investigate bidirectional effects of anxiety 
phenotypes and AN. The results of our MR analyses suggest that the genetic correlation 
identified between worry and AN is at least partly driven by worry exerting a causal 
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influence on AN. In contrast there was no evidence to support a causal effect of AN on 
worry. There was also no evidence for causal effects between anxiety disorder pathology and 
AN, or of a genetic correlation between these phenotypes. 
 
The finding that non-specific worry (i.e. worry that is not particularly directed towards eating 
and weight-gain) exerts a causal effect on AN risk is consistent with findings from previous 
cross-sectional (62-64) and longitudinal (65) observational studies. It has been suggested that 
worry inhibits emotional processing, and hinders problem solving (62), leading to a 
dependence on less adaptive coping mechanisms. Alternatively the focus on eating and 
weight (44), and even the neurobiological effects of dietary restriction (10, 66), may serve to 
alleviate worry in individuals who develop AN. Another possibility is that the process of 
worrying may put individuals at risk for a range of psychopathologies, with the content of 
worry determining the specific disorder that develops. Individuals with AN have elevated 
worry generally, but concern is particularly heightened in relation to eating, weight and shape 
(67, 68). Such may result when individuals prone to worrying direct their attention towards 
eating and weight, to drive the severe dietary restriction that is characteristic of AN.  
 
While the precise mechanisms by which worry exerts its causal effects on AN require further 
investigation, our findings highlight the potential utility of addressing worry in eating 
disorder prevention. Existing interventions largely do not target non-specific forms of worry, 
and instead address disordered eating/weight-associated cognition. Two recent reviews 
highlight the efficacy of a number of existing interventions (particularly dissonance-based, 
cognitive-behavioural based, healthy weight programmes, media literacy programmes), in 
reducing disordered eating behaviour, and eating disorder symptoms, in individuals identified 
as at risk of eating disorders (69, 70). Future trials might explore whether the addition of 
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components that reduce worry enhance the beneficial outcomes of these existing 
interventions. Worry may be targeted by a variety of adjunctive therapies (71). Mindfulness 
modules may be particularly useful additions to existing interventions given mindfulness 
practice discourages automatic and habitual patterns of thinking, including worry (71), and is 
reported to reduce body dissatisfaction (72). The benefits of reducing worry are likely to 
extend beyond eating disorder prevention, given the relevance of worry to both anxiety and 
depression (71).  
 
Worry being a shared feature of both AN and anxiety disorders could explain the absence of 
causal association between AN and anxiety disorders observed in this study. Both anxiety and 
AN phenotypes may be underpinned by the common process of worry, with the presence of 
one signalling heightened risk for the other. Confounding of the anxiety disorder – AN 
association by a common factor would explain why the MR finding does not converge with 
previous observational studies (21, 30, 73). The latter report associations between anxiety 
disorders and AN but are subject to confounding, which is minimised in MR.  
 
Strengths and Limitations 
A strength of the study is the use of MR, an approach that minimises risks of confounding 
and reverse causality, to robustly address questions of aetiology using secondary data. 
Sources of bias in MR are different from those affecting traditional observational 
epidemiology. The result of this is that where inferences from MR studies and those using 
other methods are consistent, as is the case for effects of worry on AN risk, we may be more 
confident that inferences are valid (74). This is particularly so when bias operates in different 
directions across studies, which might be expected here given bias in two-sample MR is 
typically towards the null (36).  
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A limitation of the MR approach is that it makes a number of assumptions that cannot be 
fully tested. The risk of confounding is reduced as compared to within studies of traditional 
epidemiological design, however it remains possible. We could not verify whether the genetic 
instruments were associated with plausible confounders of the exposure-outcome association 
in our sample, given the use of summary data (36). It is also impossible to determine whether 
instruments are associated with outcomes through pathways other than via the exposure of 
interest (75). To reduce the risk of incorrect inferences we completed a number of sensitivity 
analyses when multiple genetic instruments were available, with each sensitivity analysis 
robust to different MR assumptions. The causal effect of worry on AN was supported by all 
but the MR Egger estimate, which was very imprecise. Furthermore, the absence of evidence 
for pleiotropy, and the lack of improvement in heterogeneity in the MR Egger versus IVW 
model, suggests the IVW model provided a better fit to the data (57). Using estimates of R2 
we confirmed that the majority of variants supported a direction of effect from worry to AN. 
Furthermore, MR estimates (IVW and sensitivity analyses) completed with this majority 
subsample of variants were consistent with the inference that worry increases risk of AN. We 
reduced the threshold for the strength of association between genetic variant and exposure to 
complete multiple-variant analyses of causal effects of anxiety disorders and AN, and 
subsequent sensitivity analyses. Findings of these analyses were consistent with those of the 
single-variant analyses. There was little evidence for heterogeneity across SNP estimates in 
all multiple-variant analyses, further supporting the absence of bias due to horizontal 
pleiotropy (76).  
 
We used the largest GWAS for each phenotype of interest to date to maximise power (77), 
which could explain the discrepancy with a prior MR analysis that did not observe a causal 
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effect of worry on AN (37). The anxiety disorder and AN GWAS sample sizes remained 
relatively small however, limiting power to detect a genetic correlation (50), as well as causal 
effects (77), between the two. This situation is likely to have been exacerbated by the anxiety 
disorder GWAS identifying variants associated with five anxiety disorders, introducing noise 
into the genetic signal (47). The primary determinant of power in a MR analysis is instrument 
strength, or variance in the exposure explained by the genetic instruments (41). Instrument 
strength in respect of the anxiety disorder and AN exposures is low, given few SNPs were 
robustly associated with these exposures, even when the threshold for association was 
reduced. This is likely to result from low statistical power of the GWASs, due to their sample 
size (78). Reducing the threshold for instrument identification further would have improved 
power (41). However the use of additional instruments increases the potential for pleiotropy 
(31), particularly when these instruments are weak. The use of weak instruments also 
introduces bias into the MR estimate due to confounding factors explaining greater variation 
in exposure and outcome compared to the instruments (42). In the case of two-sample MR 
this bias is in the direction of the null (77). Given the limitations surrounding power it is 
possible meaningful genetic associations between, and causal effects of, anxiety disorders 
and AN went undetected. Future studies should explore such further, using larger GWASs 
(with greater power to detect meaningful associations between instrumental SNPs and 
exposures) as these become available.  
 
Conclusion  
The current study provides evidence for a causal influence of worry on AN. This finding is 
consistent with outcomes of previous observational studies, and may inform directions for 
future AN research and intervention. The low genetic signal in anxiety disorder and AN 
GWASs means we were not able to adequately assess the causal influence of these 
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phenotypes. GWAS sample sizes are constantly growing, hopefully allowing for 
identification of increasingly robust genetic instruments for anxiety disorders and AN. This in 
turn will minimise bias and improve power, for rigorous assessment of causality that (with 
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Supplementary Material for Observational Study 
Stata code for imputation of missing data  
mi set wide 
mi register imputed fast14 fast16 fast18 fast24 exc_ex14 exc_ex16 exc_ex18 exc_ex24 z_BMI10 z_BMI14 
z_BMI16 z_BMI18 BMI24 /// 
wt_con_bin14 wt_con_bin18 wt_con_bin24 parent_sympt14 parent_sympt16 any_anxietydisorder worry 
worry_bin lifetime_AN /// 
parity_bin mz028b SC_bin mother_AN sex  
mi impute chained (logit, omit (i.fast16 i.fast18 i.fast24 i.wt_con_bin18 i.wt_con_bin24 i.parent_sympt16 
i.mother_AN)) exc_ex14 ///  
(logit, omit (i.exc_ex16 i.exc_ex18 i.exc_ex24 i.wt_con_bin18 i.wt_con_bin24 i.parent_sympt16 i.mother_AN 
i.lifetime_AN)) fast14 /// 
(logit, omit (i.exc_ex16 i.exc_ex18 i.exc_ex24 i.fast16 i.fast18 i.fast24 i.wt_con_bin18 i.wt_con_bin24 
i.mother_AN i.lifetime_AN)) parent_sympt14 /// 
(logit, omit (i.exc_ex16 i.exc_ex18 i.exc_ex24 i.fast16 i.fast18 i.fast24 i.parent_sympt16 i.mother_AN 
i.lifetime_AN)) wt_con_bin14 /// 
(logit, omit (i.fast14 i.fast18 i.fast24 i.wt_con_bin18 i.wt_con_bin14 i.wt_con_bin24 i.parent_sympt14)) 
exc_ex16 ///  
(logit, omit (i.exc_ex14 i.exc_ex18 i.exc_ex24 i.wt_con_bin18 i.wt_con_bin14 i.wt_con_bin24 
i.parent_sympt14 i.mother_AN)) fast16 /// 
(logit, omit (i.exc_ex14 i.exc_ex18 i.exc_ex24 i.fast14 i.fast18 i.fast24 i.wt_con_bin14 i.wt_con_bin18 
i.wt_con_bin24 i.mother_AN)) parent_sympt16 /// 
(logit, omit (i.fast16 i.fast14 i.fast24 i.wt_con_bin14 i.wt_con_bin18 i.wt_con_bin24 i.parent_sympt14 
i.parent_sympt16)) exc_ex18 ///  
(logit, omit (i.exc_ex16 i.exc_ex14 i.exc_ex24 i.wt_con_bin14 i.wt_con_bin18 i.wt_con_bin24 
i.parent_sympt14 i.parent_sympt16)) fast18 /// 
(logit, omit (i.exc_ex16 i.exc_ex14 i.exc_ex24 i.fast16 i.fast14 i.fast24 i.parent_sympt14 i.parent_sympt16)) 
wt_con_bin18 /// 
(logit, omit (i.fast16 i.fast14 i.fast18 i.wt_con_bin14 i.wt_con_bin18 i.parent_sympt14 i.parent_sympt16)) 
exc_ex24 ///  
(logit, omit (i.exc_ex16 i.exc_ex14 i.wt_con_bin14 i.wt_con_bin18 i.parent_sympt14 i.parent_sympt16 
i.lifetime_AN)) fast24 /// 
(logit, omit (i.exc_ex16 i.exc_ex14 i.exc_ex18 i.fast16 i.fast14 i.fast18 i.parent_sympt14 i.parent_sympt16 
i.lifetime_AN)) wt_con_bin24 /// 
(logit, omit (i.fast16 i.exc_ex16 i.wt_con_bin18 i.parent_sympt16 i.fast18 i.exc_ex18 i.fast18 i.exc_ex24 
i.wt_con_bin24)) worry_bin any_anxietydisorder /// 
(logit, omit (i.fast16 i.exc_ex14 i.wt_con_bin18 i.parent_sympt16 i.parent_sympt14 i.fast14 i.wt_con_bin14)) 
mother_AN /// 
(logit) SC_bin parity_bin sex /// 
(truncreg, ll(-5.0) ul(4.8)) z_BMI10 z_BMI14 z_BMI16 z_BMI18 /// 
(truncreg, ll(13.6) ul(63.7)) BMI24 /// 
(truncreg, ll(14) ul(44)) mz028b /// 
(truncreg, conditional (if worry_bin  == 1) ll(0) ul(14) omit (i.worry_bin)) worry /// 
(logit, include((worry_bin*sex) (worry*sex)) omit (i.wt_con_bin14 i.wt_con_bin24 i.fast24 i.fast14 
i.parent_sympt16 i.parent_sympt14)) lifetime_AN, add(100) augment savetrace(imp_trace_z_weight_sens, 
replace) rseed(12345) dots 
 
Stata code for main analysis 
*unadjusted* 
logit lifetime_AN any_anxietydisorder 
logit lifetime_AN worry_bin 
*adjusted* 
logit lifetime_AN any_anxietydisorder sex SES BMI_age10 parity mother_AN 










Multiple imputation model checks 
 
Table 1 Comparison between Observed and Imputed Data for Analysis Variables 
 
Variable Complete case Imputed 
Lifetime AN Proportion N Proportion  N 
No 0.97 2634 0.96 12248 
Yes 0.03 0.04 
Age 10 Anxiety Disorder   
   
No 0.98 7445 0.98 7437 
Yes 0.02 0.02 
Age 10 Worry  
   
No 0.41 7700 0.43 7182 
Yes 0.59 0.57 
Mother Parity  
   
Primipari 0.45 12924 0.47 1958 
Multipari 0.55 0.53 
Social class 
    
Manual 0.23 12206 0.28 2676 
Non-manual 0.77 0.72 
Mother Lifetime AN  
   
No 0.95 7759 0.95 7123 
Yes 0.05 0.05  
M (SE) N M(SE) N 

















Supplementary Material for MR Study 
Neuroticism subscale of Eysenck Personality Questionnaire-Revised Short Form (1) 
1. Does your mood often go up and down?  
2. Do you ever feel ‘just miserable’ for no reason?  
3. Are you an irritable person?  
4. Are your feelings easily hurt?  
5. Do you often feel ‘fed-up’?  
6. Would you call yourself a nervous person?  
7. Are you a worrier?  
8. Would you call yourself tense or ‘highly strung’?  
9. Do you worry too long after an embarrassing experience?  
10. Do you suffer from ‘nerves’?  
11. Do you often feel lonely?  
12. Are you often troubled by feelings of guilt?  






Table 2 Proxy Variant Information 
Original SNP Proxy 
variant 
Analysis 
rs1296171 rs1295647 Worry -> AN 
rs4405857 rs1830021 Worry -> AN 
rs2407746 rs7845515 Worry -> AN 
rs10501320 rs11039165 Worry -> AN 
rs55997507 rs35851985 Worry -> AN 
rs62516012 rs10956359 Anxiety disorder (quantitative) -> AN 






Single and Combined SNP Estimates  





Outcomes of MR Steiger analyses and sensitivity analyses with Steiger filtered variants 
Table 3 R2 Estimates for SNP Associations with Worry Exposure and AN Outcome 
SNP R
2 exposure R2 outcomea SNP-Exposure association 
> SNP-Outcome 
associationb 
rs10005233 0.0001153 0.0000570 TRUE 
rs10034259 0.0001130 0.0001131 FALSE 
rs10871777 0.0001500 0.0000538 TRUE 
rs11039165 0.0001210 0.0000543 TRUE 
rs11090045 0.0001366 0.0001636 FALSE 
rs11204421 0.0000868 0.0000007 TRUE 
rs112591851 0.0000867 0.0000902 FALSE 
rs1295647 0.0000880 0.0001196 FALSE 
rs13262595 0.0001526 0.0007385 FALSE 
rs1330745 0.0001138 0.0001621 FALSE 
rs13324323 0.0001033 0.0001323 FALSE 
rs13328187 0.0001138 0.0000146 TRUE 
rs1534091 0.0000826 0.0000005 TRUE 
rs1593304 0.0000924 0.0000275 TRUE 
rs17196295 0.0001034 0.0000130 TRUE 
rs1724725 0.0000946 0.0001382 FALSE 
rs17532098 0.0001021 0.0000231 TRUE 
rs1826787 0.0001029 0.0000019 TRUE 
rs1890184 0.0001541 0.0000124 TRUE 
rs1998122 0.0000943 0.0003541 FALSE 
rs2269426 0.0001637 0.0000340 TRUE 
rs2488401 0.0001035 0.0000237 TRUE 
rs2672852 0.0000952 0.0000558 TRUE 
rs3026401 0.0001271 0.0001379 FALSE 
rs34644694 0.0001013 0.0000463 TRUE 
rs353547 0.0001372 0.0000277 TRUE 
rs35851985 0.0001120 0.0001387 FALSE 
rs3742020 0.0001157 0.0000513 TRUE 
rs3751855 0.0000930 0.0003302 FALSE 
rs391236 0.0000978 0.0000031 TRUE 
rs4245150 0.0001063 0.0002763 FALSE 
rs45536634 0.0001197 0.0000360 TRUE 
rs4684833 0.0000856 0.0003227 FALSE 
rs4799723 0.0000912 0.0000155 TRUE 
rs480330 0.0001326 0.0000647 TRUE 
rs488359 0.0000895 0.0000051 TRUE 
rs502652 0.0000874 0.0001751 FALSE 
rs56084168 0.0001160 0.0001913 FALSE 
rs56133711 0.0000895 0.0001933 FALSE 
rs57360718 0.0000981 0.0000014 TRUE 
rs60642411 0.0000874 0.0002919 FALSE 
rs61731122 0.0001032 0.0000217 TRUE 
rs62081501 0.0001352 0.0000564 TRUE 
rs62551581 0.0000905 0.0000277 TRUE 
rs6478623 0.0000949 0.0000271 TRUE 
rs6807666 0.0002363 0.0000047 TRUE 
rs7033345 0.0000967 0.0000488 TRUE 
rs7152906 0.0001582 0.0000187 TRUE 




rs75195552 0.0000990 0.0000300 TRUE 
rs75614054 0.0000945 0.0000802 TRUE 
rs7567451 0.0001006 0.0001028 FALSE 
rs78260322 0.0000899 0.0000061 TRUE 
rs7845515 0.0001140 0.0000615 TRUE 
rs79827531 0.0001013 0.0000001 TRUE 
rs9936170 0.0000994 0.0003650 FALSE 
rs998884 0.0001161 0.0000001 TRUE 
a To compute R2 estimates for AN, a prevalence of 0.9% was specified for consistency with the AN GWAS 
(Duncan et al., 2017) in MR analyses. Allele frequency for relevant variants was estimated using information 
from the worry GWAS (2). 












Figure 5 Individual SNP MR estimates for causal influence of genetic liability to anxiety disorders (case-control 




Figure 6 Individual SNP MR estimates for causal influence of genetic liability to anxiety disorders (quantitative 







Assessments of heterogeneity and pleiotropy in MR analyses 
Table 4 Heterogeneity Statistics for IVW Estimates 
Exposure Outcome Cochrane's Q P value I
2 
 [95% CI] 
Worry AN 76.84 0.03 
27.0%  
[0.00%, 73.0%] 
Anxiety disorder  
(case-control) AN 2.52 0.87 
0.0%  
[0.0%, 52.0%] 




Table 5 Heterogeneity Statistics for MR Egger Estimates 
Exposure Outcome Rucker's Q P value (Rucker's 
Q) 
Cochrane’s Q – 
Rucker’s Q’a 
Worry AN 76.26 0.03 0.58 
Anxiety disorder  
(case control) 
AN 2.52 0.77 0.00 
Anxiety disorder 
(quantitative) 
AN 12.61 0.08 2.73 
a Large positive value of Q – Q’, combined with evidence of pleiotropy, suggests the MR Egger model is a 
better fit to the data than the IVW model. 
 
Table 6 MR Egger Intercept Estimates for Assessment of Pleiotropy 
Exposure Outcome Egger Intercept SE P value 
Worry AN 0.02 0.03 0.52 
Anxiety disorder  
(case control) 
AN 0.00 0.05 0.97 
Anxiety disorder 
(quantitative) 






Additional sensitivity analyses following detection of heterogeneity  
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Study 4 Supplementary Material 
Neuroticism subscale of Eysenck Personality Questionnaire-Revised Short Form (1) 
1. Does your mood often go up and down?  
2. Do you ever feel ‘just miserable’ for no reason?  
3. Are you an irritable person?  
4. Are your feelings easily hurt?  
5. Do you often feel ‘fed-up’?  
6. Would you call yourself a nervous person?  
7. Are you a worrier?  
8. Would you call yourself tense or ‘highly strung’?  
9. Do you worry too long after an embarrassing experience?  
10. Do you suffer from ‘nerves’?  
11. Do you often feel lonely?  
12. Are you often troubled by feelings of guilt?  
Worry subscale = items 6-8, 10. 





Proxy variant information 
Table 1 Proxy Variant Information 
Exposure Outcome Proxy SNP Original SNP Reason for Proxy 
Worry Anorexia Nervosa rs11039165 rs10501320 Original SNP is palindromic 
Worry Anorexia Nervosa rs1295647 rs1296171 Original SNP is palindromic 
Worry Anorexia Nervosa rs1534091 rs4405857 Original SNP is palindromic 
Worry Anorexia Nervosa rs35851985 rs55997507 Original SNP is palindromic 
Worry Anorexia Nervosa rs7845515 rs2407746 Original SNP is palindromic 
Worry Anxiety rs1295647 rs1296171 Original SNP is palindromic 
Neuroticism Anorexia Nervosa rs10757411 rs4977844 Original SNP is palindromic 
Neuroticism Anorexia Nervosa rs12602854 rs12601333 Original SNP is palindromic 
Neuroticism Anorexia Nervosa rs1371325 rs10032297 Original SNP is palindromic 
Neuroticism Anorexia Nervosa rs28694084 rs28413916 Original SNP is palindromic 
Neuroticism Anorexia Nervosa rs3767240 rs11805169 Original SNP is palindromic 
Neuroticism Anorexia Nervosa rs4243633 rs4902704 Original SNP is palindromic 
Neuroticism Anorexia Nervosa rs4886901 rs12438542 Original SNP is palindromic 
Neuroticism Anorexia Nervosa rs55816333 rs6709182 Original SNP is palindromic 
Neuroticism Anorexia Nervosa rs56235965 rs6791611 Original SNP is palindromic 
Neuroticism Anorexia Nervosa rs7116341 rs10896636 Original SNP is palindromic 
Neuroticism Anorexia Nervosa rs7845515 rs2407746 Original SNP is palindromic 
Neuroticism Anxiety rs28694084 rs28413916 Original SNP is palindromic 
Neuroticism Anxiety rs4886901 rs12438542 Original SNP is palindromic 
Neuroticism Anxiety rs56235965 rs6791611 Original SNP is palindromic 
Neuroticism Anxiety rs7582403 rs6709182 Original SNP is palindromic 
Depressed affect Anorexia Nervosa rs10409264 rs10405382 Original SNP is palindromic 
Depressed affect Anorexia Nervosa rs1330933 rs10156548 Original SNP is palindromic 
Depressed affect Anorexia Nervosa rs17501927 rs7714426 Original SNP is palindromic 
Depressed affect Anorexia Nervosa rs17591264 rs12137936 Original SNP is palindromic 
Depressed affect Anorexia Nervosa rs1865868 rs3843954 Original SNP is palindromic 
Depressed affect Anorexia Nervosa rs4129243 rs7827176 Original SNP is palindromic 
Depressed affect Anorexia Nervosa rs56009471 rs34668726 Original SNP is palindromic 
Depressed affect Anorexia Nervosa rs62444881 rs11514731 Original SNP is palindromic 
Depressed affect Anorexia Nervosa rs6421301 rs12030991 Original SNP is palindromic 
Depressed affect Anorexia Nervosa rs74464991 rs62057061 Original SNP is palindromic 
Depressed affect Anorexia Nervosa rs8007859 rs4902704 Original SNP is palindromic 





Single SNP and summary estimates for MR analyses  
 































Assessments of Heterogeneity and Pleiotropy in MR Analyses 
Table 2 Heterogeneity Statistics for IVW Estimates 
Exposure Outcome Cochran's Q P value I
2 [95% CI] 
Worry Anorexia nervosa 76.84 0.03 27.1% [0%, 72.7%] 
Worry Anxiety 70.13 0.11 18.7% [0%, 66.2%] 
Depressed Affect Anorexia nervosa 74.41 0.07 22.1% [0%, 68.7%] 
Depressed Affect Anxiety 51.12 0.69 0% [0%, 40.7%] 
Neuroticism Anorexia nervosa 101.33 0.00 33.9% [0%, 76%] 
Neuroticism Anxiety 74.74 0.22 11.7% [0%, 58.2%] 
 
Table 3 Heterogeneity Statistics for MR Egger Estimates 
Exposure Outcome Rucker's Q’ P (Rucker's Q) Q - Q'
a 
Worry Anorexia nervosa 76.84 0.03 0.58 
Worry Anxiety 70.13 0.10 0.15 
Depressed Affect Anorexia nervosa 74.41 0.11 4.25 
Depressed Affect Anxiety 51.12 0.66 0.04 
Neuroticism Anorexia nervosa 101.33 0.00 1.07 
Neuroticism Anxiety 74.74 0.23 1.60 
a Large value of Q-Q’ indicates MR Egger model provides a better fit to the data as compared to the IVW model 
 
Table 4 MR Egger Intercept Estimates for Assessment of Pleiotropy 
 Exposure Outcome Egger Intercept SE P 
Worry Anorexia nervosa 0.02 0.03 0.52 
Worry Anxiety 0.00 0.00 0.73 
Depressed Affect Anorexia nervosa 0.04 0.02 0.07 
Depressed Affect Anxiety 0.00 0.00 0.84 
Neuroticism Anorexia nervosa 0.02 0.03 0.40 
























Results of Steiger Filtering and Sensitivity Analyses with Filtered Variants 
Table 5 R2 Estimates for SNP Associations with Worry Exposure and AN Outcome 
SNP R
2 exposure R2 outcomea SNP-Exposure association > SNP-Outcome 
associationb 
rs10005233 0.0001153 0.0000570 TRUE 
rs10034259 0.0001130 0.0001131 FALSE 
rs10871777 0.0001500 0.0000538 TRUE 
rs11039165 0.0001210 0.0000543 TRUE 
rs11090045 0.0001366 0.0001636 FALSE 
rs11204421 0.0000868 0.0000007 TRUE 
rs112591851 0.0000867 0.0000902 FALSE 
rs1295647 0.0000880 0.0001196 FALSE 
rs13262595 0.0001526 0.0007385 FALSE 
rs1330745 0.0001138 0.0001621 FALSE 
rs13324323 0.0001033 0.0001323 FALSE 
rs13328187 0.0001138 0.0000146 TRUE 
rs1534091 0.0000826 0.0000005 TRUE 
rs1593304 0.0000924 0.0000275 TRUE 
rs17196295 0.0001034 0.0000130 TRUE 
rs1724725 0.0000946 0.0001382 FALSE 
rs17532098 0.0001021 0.0000231 TRUE 
rs1826787 0.0001029 0.0000019 TRUE 
rs1890184 0.0001541 0.0000124 TRUE 
rs1998122 0.0000943 0.0003541 FALSE 
rs2269426 0.0001637 0.0000340 TRUE 
rs2488401 0.0001035 0.0000237 TRUE 
rs2672852 0.0000952 0.0000558 TRUE 
rs3026401 0.0001271 0.0001379 FALSE 
rs34644694 0.0001013 0.0000463 TRUE 
rs353547 0.0001372 0.0000277 TRUE 
rs35851985 0.0001120 0.0001387 FALSE 
rs3742020 0.0001157 0.0000513 TRUE 
rs3751855 0.0000930 0.0003302 FALSE 
rs391236 0.0000978 0.0000031 TRUE 
rs4245150 0.0001063 0.0002763 FALSE 
rs45536634 0.0001197 0.0000360 TRUE 
rs4684833 0.0000856 0.0003227 FALSE 
rs4799723 0.0000912 0.0000155 TRUE 
rs480330 0.0001326 0.0000647 TRUE 
rs488359 0.0000895 0.0000051 TRUE 
rs502652 0.0000874 0.0001751 FALSE 
rs56084168 0.0001160 0.0001913 FALSE 
rs56133711 0.0000895 0.0001933 FALSE 
rs57360718 0.0000981 0.0000014 TRUE 
rs60642411 0.0000874 0.0002919 FALSE 
rs61731122 0.0001032 0.0000217 TRUE 
rs62081501 0.0001352 0.0000564 TRUE 
rs62551581 0.0000905 0.0000277 TRUE 
rs6478623 0.0000949 0.0000271 TRUE 
rs6807666 0.0002363 0.0000047 TRUE 
rs7033345 0.0000967 0.0000488 TRUE 
rs7152906 0.0001582 0.0000187 TRUE 
rs7207400 0.0001805 0.0000270 TRUE 
rs75195552 0.0000990 0.0000300 TRUE 
rs75614054 0.0000945 0.0000802 TRUE 




rs78260322 0.0000899 0.0000061 TRUE 
rs7845515 0.0001140 0.0000615 TRUE 
rs79827531 0.0001013 0.0000001 TRUE 
rs9936170 0.0000994 0.0003650 FALSE 
rs998884 0.0001161 0.0000001 TRUE 
a To compute R2 estimates for AN, a prevalence of 0.9% was specified for consistency with the AN GWAS (2) 
in MR analyses. Allele frequency for relevant variants was estimated using information from the worry GWAS 
(3). 









Table 6 R2 Estimates for SNP Associations with Worry Exposure and Anxiety Disorder Outcome 
SNP R
2 exposure R2 outcome SNP-Exposure association > SNP-Outcome 
associationa 
rs10005233 0.00011529 0.00005722 TRUE 
rs10034259 0.00011301 0.00024166 FALSE 
rs10501320 0.00012657 0.00003815 TRUE 
rs10871777 0.00015003 0.00010826 TRUE 
rs11090045 0.00013664 0.00001813 TRUE 
rs11204421 0.00008679 0.00001526 TRUE 
rs1295647 0.00008796 0.00000000 TRUE 
rs13262595 0.00015261 0.00016691 FALSE 
rs1330745 0.00011382 0.00002181 TRUE 
rs13324323 0.00010329 0.00007030 TRUE 
rs13328187 0.00011379 0.00000384 TRUE 
rs1593304 0.00009239 0.00000098 TRUE 
rs17196295 0.00010336 0.00000397 TRUE 
rs1724725 0.00009465 0.00001804 TRUE 
rs17532098 0.00010215 0.00000007 TRUE 
rs1826787 0.00010293 0.00033257 FALSE 
rs1890184 0.00015407 0.00001294 TRUE 
rs1998122 0.00009430 0.00000395 TRUE 
rs2269426 0.00016374 0.00012739 TRUE 
rs2407746 0.00012068 0.00017826 FALSE 
rs2488401 0.00010355 0.00000296 TRUE 
rs2672852 0.00009521 0.00000016 TRUE 
rs3026401 0.00012708 0.00021356 FALSE 
rs34354815 0.00009433 0.00001781 TRUE 
rs34644694 0.00010130 0.00007195 TRUE 
rs353547 0.00013716 0.00036336 FALSE 
rs3742020 0.00011569 0.00000379 TRUE 
rs3751855 0.00009295 0.00001673 TRUE 
rs391236 0.00009776 0.00000059 TRUE 
rs4245150 0.00010629 0.00037382 FALSE 
rs4405857 0.00008617 0.00010244 FALSE 
rs45536634 0.00011970 0.00000645 TRUE 
rs4684833 0.00008561 0.00005095 TRUE 
rs4799723 0.00009119 0.00000861 TRUE 
rs480330 0.00013264 0.00008006 TRUE 
rs488359 0.00008954 0.00000423 TRUE 
rs502652 0.00008742 0.00002597 TRUE 
rs55997507 0.00011730 0.00014368 FALSE 
rs56084168 0.00011599 0.00012349 FALSE 
rs56133711 0.00008950 0.00000884 TRUE 
rs57360718 0.00009812 0.00002505 TRUE 
rs60642411 0.00008741 0.00018454 FALSE 
rs62081501 0.00013516 0.00004709 TRUE 
rs62551581 0.00009051 0.00000149 TRUE 
rs6478623 0.00009491 0.00012355 FALSE 
rs6807666 0.00023630 0.00000071 TRUE 
rs7033345 0.00009668 0.00014501 FALSE 
rs7152906 0.00015818 0.00000059 TRUE 
rs7207400 0.00018052 0.00049376 FALSE 
rs75195552 0.00009899 0.00002374 TRUE 
rs75614054 0.00009447 0.00007880 TRUE 
rs7567451 0.00010064 0.00010692 FALSE 




rs78260322 0.00008988 0.00000033 TRUE 
rs79827531 0.00010132 0.00002022 TRUE 
rs9835772 0.00013396 0.00006536 TRUE 
rs9936170 0.00009937 0.00019187 FALSE 
rs998884 0.00011614 0.00010497 TRUE 











Table 7 R2 Estimates for SNP Associations with Neuroticism Exposure and AN Outcome 
SNP R
2 exposure R2 outcomea SNP-Exposure association > SNP-Outcome 
associationb 
rs10119773 0.00012564 1.3771E-05 TRUE 
rs10144845 0.00017894 0.00012519 TRUE 
rs10455007 0.00014841 2.9971E-06 TRUE 
rs10497655 0.0001142 7.3612E-05 TRUE 
rs10501696 0.00011615 1.2848E-05 TRUE 
rs10757411 0.00011939 5.68E-05 TRUE 
rs11090045 0.0001786 0.0001651 TRUE 
rs11509880 0.00013122 5.912E-06 TRUE 
rs11665070 0.00025307 9.7001E-05 TRUE 
rs11682716 0.0001099 6.9044E-05 TRUE 
rs117298864 0.0001087 3.4871E-06 TRUE 
rs12602854 0.0001142 4.0563E-05 TRUE 
rs12938775 0.00013212 0.00075764 FALSE 
rs12969553 0.00014951 0.00015107 FALSE 
rs13226841 0.00015798 0.00012454 TRUE 
rs1371325 0.00013149 3.9875E-05 TRUE 
rs1442129 0.00011309 4.8617E-05 TRUE 
rs147861665 0.00012368 0.00056535 FALSE 
rs1542212 0.00014745 2.0679E-05 TRUE 
rs1673931 0.00011074 1.8263E-05 TRUE 
rs1806153 0.00015965 9.4146E-05 TRUE 
rs2102341 0.00015719 1.0789E-05 TRUE 
rs2206544 0.00012691 5.6251E-05 TRUE 
rs2269426 0.00017871 3.381E-05 TRUE 
rs2278609 0.00012495 0.00019109 FALSE 
rs2715147 0.00010901 0.00030051 FALSE 
rs2791459 0.00011963 3.2148E-05 TRUE 
rs28427480 0.00014089 8.561E-05 TRUE 
rs28694084 0.00011215 0.00015135 FALSE 
rs2921036 0.00033976 0.0001001 TRUE 
rs297346 0.00011438 1.4147E-05 TRUE 
rs34796300 0.00012997 0.00031705 FALSE 
rs3741475 0.0001459 6.49E-05 TRUE 
rs3767240 0.00011067 9.9822E-06 TRUE 
rs3811489 0.00011352 8.1159E-05 TRUE 
rs3849470 0.00011869 8.0562E-05 TRUE 
rs4140799 0.00015459 2.8216E-05 TRUE 
rs4243633 0.00011133 8.9051E-05 TRUE 
rs4632195 0.00016837 7.9236E-05 TRUE 
rs4738602 0.00010994 0.0001154 FALSE 
rs4886901 0.00013625 1.9896E-05 TRUE 
rs55816333 0.00018217 5.3778E-06 TRUE 
rs56116032 0.0001138 3.6651E-05 TRUE 
rs56226325 0.00012065 5.394E-06 TRUE 
rs56235965 0.00013993 6.0869E-05 TRUE 
rs57838764 0.00012719 6.7159E-05 TRUE 
rs59970005 0.00013054 4.149E-05 TRUE 
rs62062288 0.00032041 5.3967E-06 TRUE 
rs6743916 0.00011599 0.00025871 FALSE 
rs6916891 0.00011919 4.647E-08 TRUE 
rs6976111 0.00013227 2.628E-06 TRUE 
rs7107293 0.00023768 6.982E-05 TRUE 




rs7116341 0.00015337 2.7314E-05 TRUE 
rs716508 0.0001105 1.9825E-05 TRUE 
rs7338774 0.00014262 4.3207E-05 TRUE 
rs7502590 0.00014212 0.00017742 FALSE 
rs7567451 0.0001164 0.00010257 TRUE 
rs7696796 0.0001299 4.1313E-05 TRUE 
rs7845515 0.00014092 6.2065E-05 TRUE 
rs7869969 0.00012993 6.3375E-05 TRUE 
rs7871494 0.00011833 0.000479 FALSE 
rs8053004 0.00011463 0.00018946 FALSE 
rs8062719 0.00011315 0.00035559 FALSE 
rs836927 0.00011019 3.6017E-05 TRUE 
rs9298995 0.00012954 7.0051E-05 TRUE 
rs9424100 0.00011035 5.7735E-06 TRUE 
rs9462364 0.0001303 0.00015309 FALSE 
a To compute R2 estimates for AN, a prevalence of 0.9% was specified for consistency with the AN GWAS (2) 
in MR analyses. Allele frequency for relevant variants was estimated using information from the worry GWAS 
(3). 














Table 8 Estimates for SNP Associations with Neuroticism Exposure and Anxiety Disorder Outcome 
SNP R
2 exposure R2 outcome SNP-Exposure association > SNP-Outcome 
associationa 
rs10032297 0.00013858 9.4073E-05 TRUE 
rs10119773 0.00012564 9.1004E-05 TRUE 
rs10144845 0.00017894 7.7592E-05 TRUE 
rs10455007 0.00014841 3.6791E-05 TRUE 
rs10497655 0.0001142 6.2602E-05 TRUE 
rs10501696 0.00011615 8.357E-05 TRUE 
rs10896636 0.0001627 0.00027381 FALSE 
rs11090045 0.0001786 1.8135E-05 TRUE 
rs11509880 0.00013122 1.4366E-06 TRUE 
rs11665070 0.00025307 0.00041934 FALSE 
rs11682716 0.0001099 1.7208E-05 TRUE 
rs11805169 0.0001156 2.8256E-05 TRUE 
rs12601333 0.00011473 2.664E-06 TRUE 
rs12938775 0.00013212 0.00012381 TRUE 
rs12969553 0.00014951 2.4337E-05 TRUE 
rs13226841 0.00015798 4.3591E-05 TRUE 
rs1442129 0.00011309 9.1126E-05 TRUE 
rs147861665 0.00012368 0.00012836 FALSE 
rs1542212 0.00014745 1.5525E-05 TRUE 
rs1673931 0.00011074 8.3778E-05 TRUE 
rs1806153 0.00015965 3.9939E-05 TRUE 
rs2102341 0.00015719 2.6577E-06 TRUE 
rs2206544 0.00012691 6.2318E-06 TRUE 
rs2269426 0.00017871 0.00012739 TRUE 
rs2278609 0.00012495 0.00012001 TRUE 
rs2407746 0.00014981 0.00017826 FALSE 
rs2715147 0.00010901 2.3267E-05 TRUE 
rs2791459 0.00011963 2.9516E-05 TRUE 
rs28427480 0.00014089 4.7756E-05 TRUE 
rs28694084 0.00011215 8.9045E-05 TRUE 
rs2921036 0.00033976 4.8925E-06 TRUE 
rs297346 0.00011438 0.00039738 FALSE 
rs34796300 0.00012997 5.6798E-05 TRUE 
rs3741475 0.0001459 0.00018478 FALSE 
rs3811489 0.00011352 8.1366E-06 TRUE 
rs3849470 0.00011869 1.3786E-05 TRUE 
rs4140799 0.00015459 2.296E-06 TRUE 
rs4632195 0.00016837 0.0002522 FALSE 
rs4738602 0.00010994 2.6449E-05 TRUE 
rs4886901 0.00013625 6.001E-05 TRUE 
rs4902704 0.00011636 8.589E-06 TRUE 
rs4977844 0.00012216 4.2348E-06 TRUE 
rs56116032 0.0001138 2.2955E-08 TRUE 
rs56226325 0.00012065 2.3219E-06 TRUE 
rs56235965 0.00013993 2.9635E-05 TRUE 
rs57838764 0.00012719 3.0274E-06 TRUE 
rs59970005 0.00013054 0.00020914 FALSE 
rs62062288 0.00032041 0.00037047 FALSE 
rs6743916 0.00011599 2.7135E-07 TRUE 
rs6916891 0.00011919 2.1908E-06 TRUE 
rs6976111 0.00013227 4.5983E-05 TRUE 
rs7107293 0.00023768 3.7282E-05 TRUE 




rs716508 0.0001105 2.4302E-07 TRUE 
rs7338774 0.00014262 0.00011995 TRUE 
rs7502590 0.00014212 0.00012217 TRUE 
rs7567451 0.0001164 0.00010692 TRUE 
rs7582403 0.00018389 0.00034645 FALSE 
rs7696796 0.0001299 2.8417E-05 TRUE 
rs7869969 0.00012993 1.7281E-05 TRUE 
rs7871494 0.00011833 2.6926E-05 TRUE 
rs8053004 0.00011463 0.00020491 FALSE 
rs8062719 0.00011315 0.00010526 TRUE 
rs836927 0.00011019 4.1471E-07 TRUE 
rs9298995 0.00012954 1.8881E-06 TRUE 
rs9424100 0.00011035 7.0955E-05 TRUE 
rs9462364 0.0001303 8.3851E-05 TRUE 
 






























Table 9 R2 estimates for SNP Associations with Depressed Affect Exposure and Anxiety Disorder Outcome 
SNP R
2 exposure R2 outcome SNP-Exposure association > SNP-Outcome 
association a 
rs10020288 8.7565E-05 1.0271E-06 TRUE 
rs10144845 0.0001166 7.7592E-05 TRUE 
rs10156548 0.0001521 8.9097E-06 TRUE 
rs10405382 0.00011928 1.6079E-05 TRUE 
rs10950393 0.00012481 1.2418E-07 TRUE 
rs11039149 0.00015746 3.1926E-05 TRUE 
rs11209175 0.00010273 2.9515E-07 TRUE 
rs11514731 8.5196E-05 3.0061E-05 TRUE 
rs11599236 0.00012667 5.0025E-05 TRUE 
rs11605020 0.00010096 0.00015709 FALSE 
rs11608355 9.5886E-05 9.6056E-06 TRUE 
rs11693031 0.00011338 2.7025E-05 TRUE 
rs12030991 8.5859E-05 8.619E-05 FALSE 
rs12137936 8.5947E-05 8.768E-05 FALSE 
rs12938775 8.679E-05 0.00012381 FALSE 
rs12967855 0.0001403 0.00039034 FALSE 
rs13122395 8.4793E-05 5.1447E-08 TRUE 
rs1422192 0.00010227 1.098E-05 TRUE 
rs1542212 8.8185E-05 1.5525E-05 TRUE 
rs17432675 8.6776E-05 0.00016392 FALSE 
rs1782179 9.0023E-05 0.0001034 FALSE 
rs2042555 0.00010489 0.00013701 FALSE 
rs2149351 0.00010073 8.7448E-05 TRUE 
rs2396133 9.2121E-05 5.0736E-05 TRUE 
rs2717043 0.00011492 9.6533E-05 TRUE 
rs28893517 0.00010788 3.3569E-05 TRUE 
rs2895249 8.8082E-05 0 TRUE 
rs297346 0.00012675 0.00039738 FALSE 
rs34668726 0.00012935 1.2682E-06 TRUE 
rs35738585 0.00015289 3.725E-05 TRUE 
rs35755513 8.4066E-05 1.1197E-05 TRUE 
rs3795310 9.8121E-05 2.7925E-05 TRUE 
rs3843954 8.5108E-05 0.00015186 FALSE 
rs4129243 7.9934E-05 1.811E-06 TRUE 
rs4578918 0.0001299 4.7008E-05 TRUE 
rs4625 0.00010898 6.0757E-06 TRUE 
rs4632195 0.00013228 0.0002522 FALSE 
rs4902704 9.1108E-05 8.589E-06 TRUE 
rs55965054 9.9477E-05 0.0001699 FALSE 
rs59382200 0.00012604 1.9759E-05 TRUE 
rs599550 0.00019939 8.4308E-06 TRUE 
rs60393230 9.8497E-05 6.717E-07 TRUE 
rs62057061 0.00026415 0.00059005 FALSE 
rs62172117 9.5197E-05 3.2835E-05 TRUE 
rs6795372 0.00010259 6.41E-06 TRUE 
rs6818081 8.6102E-05 2.5477E-05 TRUE 
rs6900114 8.7895E-05 2.2415E-05 TRUE 
rs7175083 0.00011295 1.9386E-05 TRUE 
rs721496 9.6075E-05 1.9828E-05 TRUE 
rs7502590 8.574E-05 0.00012217 FALSE 
rs77087420 0.00011668 6.9672E-05 TRUE 
rs7714426 9.0071E-05 1.2459E-05 TRUE 




rs7912226 0.00010749 4.2437E-05 TRUE 
rs836927 0.00011268 4.1471E-07 TRUE 
rs9852417 8.7309E-05 3.8699E-06 TRUE 
rs9858071 0.00011139 7.4866E-05 TRUE 
rs9930139 9.2653E-05 1.4276E-06 TRUE 
 










Assessment of pleiotropy in multivariable MR analyses 
 
 









Outcome Egger Intercept SE P value 
Anorexia nervosa 0.01 0.01 0.35 
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